data_2ncp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ncp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.878 0.371 . . . . 74.12 110.911 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.62 161.12 62.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.721 . . . . 75.22 110.9 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -18.87 36.81 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.678 2.252 . . . . 73.33 112.326 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -82.04 -23.56 35.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 62.11 110.873 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.55 -63.28 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 62.44 111.119 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -51.86 -30.66 24.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 72.43 110.855 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -37.91 63.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 75.32 111.107 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -87.98 -25.73 23.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.926 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.3 mt -72.92 -27.27 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.895 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -66.64 -51.8 52.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 74.15 110.853 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.35 -25.15 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 71.5 111.121 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.25 -25.62 36.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.085 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -67.13 -47.18 71.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.3 110.842 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -63.41 -35.21 79.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.882 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.72 -29.48 69.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.896 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -65.5 -59.55 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 74.04 110.852 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -64.47 -28.07 69.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 74.43 110.882 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -55.5 -26.75 44.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 73.41 110.89 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -108.21 -30.48 8.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 65.5 110.919 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.23 84.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.892 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -85.03 -32.01 23.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.15 110.925 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.56 -10.57 59.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 53.13 110.864 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.75 23.29 43.88 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.722 -0.752 . . . . 64.04 112.476 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.9 p -75.25 -22.17 58.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 74.43 110.845 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.5 19.64 58.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.734 . . . . 73.34 112.463 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -148.34 130.75 15.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 64.35 110.918 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 21.7 mt -94.13 101.67 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 74.25 110.897 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -66.26 174.13 2.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 72.33 110.924 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.98 -30.15 23.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 75.05 110.868 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.73 -54.7 6.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.213 -0.448 . . . . 74.31 110.882 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -55.24 -28.36 52.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.45 110.872 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.6 mt -79.69 -25.44 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 74.24 111.102 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.31 -53.12 48.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 72.2 111.124 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.05 -23.03 56.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.678 -0.772 . . . . 63.43 112.506 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -56.61 -52.6 64.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 75.55 110.922 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.9 mt -52.02 -41.43 62.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 75.53 110.905 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -51.93 -38.87 57.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 73.13 110.881 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -85.11 -49.58 8.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.23 110.86 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.2 m -53.09 -29.02 28.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.32 111.163 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -76.82 -33.57 57.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 75.12 110.961 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.71 -25.16 66.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 75.24 111.062 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -55.71 -26.97 47.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.44 110.9 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 19.9 mtm -109.81 16.8 21.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 71.12 110.889 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 19.46 69.47 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 73.12 112.468 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.3 tpp -63.39 168.41 4.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 73.2 110.883 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 43.2 t -71.12 -10.38 59.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 75.22 110.82 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.2 m120 63.34 51.82 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 75.2 110.957 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -52.99 152.51 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 52.11 110.893 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.4 m -108.22 90.84 7.3 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.54 0.686 . . . . 74.25 111.129 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -177.37 1.84 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.664 2.242 . . . . 64.25 112.338 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 73.1 p -123.82 -176.1 3.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 74.12 111.131 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -55.5 -27.32 47.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 75.3 110.9 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -73.15 -61.13 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 75.44 110.891 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -52.02 -44.91 64.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.823 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 86.7 t -57.47 -28.69 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 62.03 111.117 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -68.03 -45.69 73.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.904 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.4 mp -66.44 -25.98 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.3 111.15 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -83.21 -30.42 27.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 75.33 110.92 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.71 -37.89 79.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.93 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -63.02 -27.39 69.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 63.33 110.903 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.0 ttm -71.93 -54.51 9.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 75.43 110.912 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.27 -66.27 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 73.11 111.119 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -53.27 129.17 30.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 54.01 110.851 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 25.1 m -85.67 -25.16 26.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 73.33 111.135 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -98.58 -12.45 21.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.936 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.3 p 51.97 37.77 22.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 71.14 110.845 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -95.42 23.96 5.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.87 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.31 31.64 74.67 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 70.12 112.478 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.44 126.98 9.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 72.44 110.858 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.0 t -115.6 104.85 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 74.53 111.133 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 37.3 t -69.4 170.67 9.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 72.23 110.878 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.81 -36.66 72.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 73.32 110.956 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.46 -25.64 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 74.53 110.892 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -81.77 -23.3 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 73.12 110.891 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -83.8 -51.85 6.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.906 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.03 -43.81 63.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 71.41 110.871 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.93 -41.17 61.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 63.31 110.881 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.0 tp -53.89 -35.68 61.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 74.23 110.916 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.99 -25.12 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 71.54 111.091 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.18 -50.88 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 71.22 111.163 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -55.85 -36.09 67.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 73.11 110.877 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -77.94 -35.36 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 72.43 110.841 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 22.9 mt -62.32 -28.33 69.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 65.4 110.943 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -64.19 -43.49 94.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 70.41 110.928 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -85.94 -24.92 26.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.45 110.901 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.94 -22.58 67.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.099 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.5 31.86 1.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 71.05 112.486 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.68 122.89 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 72.44 111.124 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -83.01 119.5 24.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 72.22 110.897 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.31 111.124 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.925 0.393 . . . . 71.34 110.918 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -53.18 160.55 1.61 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 65.44 110.922 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -20.1 35.44 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.705 2.27 . . . . 72.54 112.394 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -82.85 -20.33 35.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 61.25 110.908 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.3 -63.35 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 72.53 111.149 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -25.43 42.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 63.25 110.897 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.34 78.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 61.12 111.081 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -88.45 -25.37 22.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 74.1 110.903 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.9 mt -79.33 -24.06 43.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.933 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.68 -46.51 65.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 74.13 110.904 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.19 -23.61 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 72.33 111.106 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -77.4 -21.79 52.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 74.13 111.078 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 55.5 mtt85 -69.12 -52.29 29.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.889 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -52.03 -29.95 23.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 75.04 110.856 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.71 -44.53 64.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 74.33 110.929 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -52.36 -48.05 65.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 75.52 110.895 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -75.93 -28.41 57.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.86 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -67.9 -25.91 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 73.33 110.886 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -104.51 -26.2 12.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 73.32 110.968 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -90.43 64.45 5.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.521 . . . . 72.33 110.886 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -28.19 67.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 75.53 110.893 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -70.76 -10.52 59.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.889 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.86 25.74 53.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 50.35 112.502 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.8 p -75.85 -22.1 56.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.924 0.392 . . . . 73.44 110.882 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.62 19.57 65.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 74.35 112.513 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -149.91 130.8 14.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 70.34 110.922 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.7 mt -94.97 101.74 13.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.879 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -70.16 171.81 9.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.932 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -52.13 -30.14 25.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 62.45 110.826 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -74.61 -45.95 41.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 64.24 110.881 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.36 -38.95 88.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 64.23 110.859 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.46 -30.97 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 73.25 111.157 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.78 -45.76 63.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 72.34 111.102 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.32 -27.45 39.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 61.21 112.493 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.2 tp -54.81 -56.56 18.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 74.23 110.919 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.0 mt -51.96 -33.93 39.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.934 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -52.71 -50.5 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 75.43 110.854 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -82.26 -44.25 16.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 64.4 110.871 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.9 m -52.16 -29.55 22.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 75.2 111.18 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -79.33 -49.17 12.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 72.03 110.968 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.97 -24.71 55.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 72.23 111.105 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -27.14 42.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 72.21 110.852 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.1 mtm -111.28 21.71 15.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 75.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.92 19.05 69.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 72.24 112.494 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.4 tpp -64.38 164.04 12.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 74.34 110.896 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.8 t -62.47 -17.62 59.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 74.33 110.848 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 63.52 56.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.05 110.9 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -65.87 152.61 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.855 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 p -108.23 90.84 7.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.544 0.688 . . . . 74.12 111.11 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -172.88 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 51.41 112.347 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 79.9 p -120.76 -177.37 3.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 75.05 111.16 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -60.18 -25.69 65.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 72.54 110.93 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -72.51 -61.5 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 72.32 110.9 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -52.22 -49.0 64.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 72.32 110.871 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.1 t -52.76 -33.53 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 63.44 111.124 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -62.44 -49.9 73.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 73.12 110.92 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.0 mp -61.15 -25.15 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 75.0 111.098 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -78.15 -30.29 49.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.956 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.1 tt -72.54 -34.77 67.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 72.12 110.933 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -61.25 -28.74 69.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 70.01 110.923 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 5.9 ttp -86.92 -39.09 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 74.14 110.87 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.33 -49.95 56.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 72.24 111.113 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -84.24 127.59 34.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 71.54 110.894 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 21.3 p -76.08 -42.69 46.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 73.11 111.101 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -76.32 -12.41 60.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 72.15 110.891 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.1 p 52.15 37.19 21.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 72.55 110.827 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -79.04 -16.21 57.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 75.42 110.887 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.1 22.82 8.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 71.23 112.489 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.2 p -153.6 127.14 8.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.916 0.389 . . . . 64.15 110.82 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.41 124.83 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 75.14 111.096 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -174.77 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 71.21 110.897 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.11 -33.62 67.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 72.12 110.927 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.06 -62.35 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.87 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -52.37 -46.16 66.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 71.12 110.878 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -62.04 -58.34 8.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 75.31 110.888 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -54.89 -28.12 48.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.914 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -72.5 -29.54 63.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 75.53 110.819 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.4 tt -64.0 -35.08 79.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 73.12 110.897 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -73.34 -24.91 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 74.33 111.116 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.7 mm -58.4 -43.37 86.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 72.24 111.11 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -67.81 -48.16 67.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 75.24 110.889 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 53.5 p -52.18 -40.86 62.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 74.3 110.864 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.99 -33.16 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 75.21 110.926 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -43.3 89.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 64.14 110.911 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -86.11 -25.77 25.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 74.02 110.908 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.98 -22.76 67.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 72.01 111.094 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.43 20.14 5.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.739 . . . . 74.2 112.49 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.15 102.75 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.815 0.341 . . . . 72.14 111.121 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -71.06 126.03 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 75.23 110.871 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.05 111.128 179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.888 0.375 . . . . 71.4 110.944 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -78.3 160.82 72.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.615 0.721 . . . . 74.43 110.926 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -20.26 35.05 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.733 2.289 . . . . 52.11 112.329 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -82.89 -20.94 34.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 73.21 110.887 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.74 -61.99 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 63.33 111.132 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.66 -30.08 20.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.44 110.894 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.5 -34.52 71.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.125 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -88.36 -23.98 23.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.53 110.954 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.7 mt -80.88 -24.31 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 72.53 110.878 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.04 -29.48 65.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 72.41 110.876 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.99 -23.38 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 75.14 111.115 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.14 -37.51 20.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.41 111.11 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -54.65 -29.99 54.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 75.22 110.87 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -70.58 -28.98 65.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 75.11 110.872 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.64 -25.85 35.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 70.11 110.893 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.43 -63.21 1.19 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 71.33 110.89 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -60.18 -26.58 66.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 75.31 110.926 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -52.08 -30.02 24.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.852 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -101.54 -26.29 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 74.33 110.894 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.2 85.4 0.56 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 63.22 110.84 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -80.7 -26.29 37.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 75.24 110.892 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.79 -10.58 59.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 73.11 110.894 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.23 20.45 50.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 62.41 112.503 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 p -87.26 -22.18 25.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.945 0.402 . . . . 73.22 110.852 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.74 21.58 42.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.7 -0.762 . . . . 73.02 112.472 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -136.73 138.07 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 73.45 110.925 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.0 mt -103.89 112.53 25.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 74.54 110.91 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -79.83 173.66 12.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.54 110.915 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -53.07 -28.85 26.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 63.51 110.883 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -78.74 -37.85 40.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.901 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -75.7 -26.18 57.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 74.14 110.901 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 25.8 mt -76.81 -34.59 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.149 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.78 -46.65 64.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 73.15 111.083 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.59 -23.3 56.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 73.33 112.482 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 18.0 tp -60.7 -56.49 20.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.858 0.361 . . . . 70.35 110.917 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 45.7 mt -52.15 -36.42 51.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 72.12 110.922 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -51.88 -45.77 64.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.883 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.24 -45.05 13.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.24 110.869 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.4 m -51.85 -30.44 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.2 111.137 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -81.03 -53.62 6.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.892 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.13 -24.69 42.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 70.31 111.12 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -54.69 -31.06 57.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.896 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -107.21 21.85 16.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 74.2 110.873 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.95 21.45 71.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.727 . . . . 74.54 112.447 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.43 165.47 16.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.341 . . . . 74.31 110.86 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.1 m -60.05 -20.61 58.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 73.45 110.881 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 63.6 59.48 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 74.25 110.952 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -67.83 152.4 45.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 72.22 110.902 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.5 m -108.18 90.78 7.18 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.564 0.697 . . . . 71.42 111.134 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.75 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.69 2.26 . . . . 71.21 112.343 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 71.3 p -126.43 -176.03 3.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 72.01 111.165 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -57.37 -25.72 59.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 65.53 110.829 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -74.65 -60.81 2.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 75.14 110.881 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -45.91 64.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 72.51 110.859 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 97.2 t -56.2 -31.02 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 75.33 111.103 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -65.38 -49.81 67.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 71.4 110.886 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.0 mp -60.14 -26.76 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.11 111.153 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 87.3 t90 -82.39 -26.32 32.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.919 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.9 tt -76.08 -36.46 58.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.892 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -52.38 -49.5 64.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.5 -26.85 65.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 74.12 110.88 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.69 -68.83 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.0 111.108 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -62.28 118.83 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 75.44 110.886 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.1 m -86.74 -37.54 17.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.146 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -78.48 -12.46 60.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 72.11 110.888 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.8 t 61.75 45.4 7.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 63.4 110.891 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -91.0 -16.17 28.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 63.42 110.835 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.25 19.46 12.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 63.14 112.515 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.52 152.4 30.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 72.24 110.876 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.1 t -108.39 114.17 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 74.24 111.106 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.6 t -85.08 -171.1 3.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 65.15 110.878 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.81 -57.55 10.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 74.42 110.923 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.47 -43.74 96.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 63.31 110.847 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.53 -59.85 4.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.857 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -53.73 -49.87 67.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 72.04 110.94 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -24.35 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 73.31 110.835 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -69.67 -26.16 64.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 64.03 110.875 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.17 -38.5 85.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 74.02 110.916 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.2 mp -69.49 -24.32 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 72.14 111.125 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.7 mm -55.91 -49.63 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.211 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -51.94 -62.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.3 110.878 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.1 m -53.44 -28.6 30.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 73.53 110.836 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.8 -42.68 94.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 74.22 110.903 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -52.22 -39.61 60.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.13 110.948 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -85.95 -24.24 26.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.89 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.89 -22.81 67.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 74.43 111.111 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.36 30.01 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.773 -0.727 . . . . 53.44 112.458 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.03 137.57 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 75.21 111.151 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -98.94 113.84 26.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.904 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 70.54 111.179 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.917 0.389 . . . . 72.34 110.912 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -65.13 160.74 54.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.665 0.745 . . . . 74.32 110.848 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -20.29 35.34 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.743 2.295 . . . . 71.32 112.354 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -82.89 -21.15 34.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 75.11 110.859 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.69 -63.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.04 111.089 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -52.08 -29.92 23.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.84 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.04 -36.13 65.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.114 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.7 tptt -82.74 -26.5 31.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 72.14 110.841 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 21.0 mt -78.69 -25.76 44.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 64.31 110.897 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -69.3 -32.14 71.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.854 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.6 -24.78 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.22 111.119 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.64 -43.93 36.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 64.44 111.071 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -52.08 -29.98 23.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.862 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -75.98 -35.32 59.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 75.15 110.913 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.4 tp -69.41 -25.66 64.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 73.22 110.911 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.01 -64.58 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 74.24 110.856 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -27.41 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.935 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -53.37 -28.64 30.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.55 110.863 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -109.11 -26.69 10.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 75.31 110.918 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -76.44 69.81 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.485 . . . . 73.4 110.881 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -67.62 -26.95 66.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.931 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.62 -10.49 59.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 70.43 110.842 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.31 24.58 52.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 52.35 112.478 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.3 t -77.65 -22.07 51.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 73.12 110.841 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.14 23.8 56.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.666 -0.778 . . . . 73.14 112.503 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -148.16 134.57 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 75.22 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.8 mt -106.33 101.99 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.894 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.83 174.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 75.42 110.874 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -54.57 -27.24 37.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 71.1 110.88 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.3 -51.01 7.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 72.15 110.866 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -54.84 -30.99 58.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 64.31 110.855 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.9 mt -73.89 -26.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 75.54 111.124 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.69 -47.88 63.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.54 111.074 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.35 -22.87 55.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 73.4 112.456 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.3 tp -58.61 -54.88 42.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 75.5 110.914 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 33.6 mt -51.91 -32.81 34.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.45 110.901 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -52.58 -60.7 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 71.11 110.954 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -73.81 -38.26 64.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.55 110.874 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.1 m -57.48 -30.19 64.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 74.12 111.117 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -82.31 -55.12 4.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 72.44 110.902 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.21 -25.7 34.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 73.4 111.098 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.95 -25.9 45.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 73.14 110.88 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.3 mtm -110.24 19.2 19.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.839 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.78 19.24 69.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 74.04 112.505 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.5 mtt -64.65 172.97 2.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 74.13 110.886 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 49.1 p -59.77 -21.03 60.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 75.14 110.868 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 5.8 t30 63.56 58.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 65.23 110.898 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -78.01 152.6 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.13 110.837 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 60.9 m -108.23 90.84 7.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.561 0.696 . . . . 74.15 111.141 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 168.96 19.99 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.706 2.271 . . . . 73.34 112.378 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 27.8 p -108.76 -178.02 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 72.11 111.124 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -55.58 -25.89 40.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 71.21 110.891 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -72.88 -61.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.885 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -51.91 -36.6 49.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 52.14 110.856 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.98 -40.87 86.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 73.24 111.103 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -54.56 -40.92 69.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 74.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.8 mp -69.99 -25.97 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 72.13 111.166 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -83.76 -31.12 26.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.901 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.7 tt -78.32 -46.3 20.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 71.44 110.911 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.99 -31.55 29.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.9 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 53.3 ttp -90.51 -25.89 20.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 65.33 110.883 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -73.95 -52.12 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 74.43 111.095 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -85.31 127.8 34.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.43 110.864 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 3.2 m -69.39 -24.53 63.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 73.53 111.158 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -98.08 -10.4 24.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.228 -0.442 . . . . 73.42 110.872 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.4 p 52.99 36.3 21.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.86 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.0 -16.24 57.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 62.2 110.836 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.19 22.9 8.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.731 . . . . 61.43 112.532 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.14 126.93 11.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 70.52 110.828 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.8 t -109.4 112.94 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 72.3 111.12 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.04 -174.89 4.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.875 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.69 -33.84 76.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 73.24 110.892 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.48 -36.8 32.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 63.01 110.931 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.19 -21.64 60.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 71.24 110.91 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -84.48 -51.71 6.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 74.13 110.889 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -53.99 -43.69 70.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 54.42 110.859 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.84 -26.13 63.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 71.5 110.853 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.5 tt -67.48 -38.24 84.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.881 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -73.75 -24.58 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 73.32 111.086 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mm -56.6 -57.22 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 75.4 111.098 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -56.18 -25.14 45.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 71.24 110.903 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.4 m -83.23 -26.31 30.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 73.53 110.849 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 36.2 mt -79.35 -45.0 20.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 63.3 110.956 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -51.99 -37.83 54.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.874 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -86.09 -29.07 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 74.22 110.901 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -18.2 65.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 72.2 111.135 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.96 23.05 4.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.774 -0.727 . . . . 43.32 112.517 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.63 101.87 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.343 . . . . 73.23 111.158 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.5 111.44 1.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 72.1 110.891 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 74.44 111.153 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.892 0.377 . . . . 73.44 110.902 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.65 160.52 3.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 73.4 110.883 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -19.31 36.65 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 73.23 112.355 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -80.3 -24.8 39.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 75.34 110.896 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.39 -63.42 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 74.22 111.155 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -51.49 -30.84 21.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.14 110.875 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.6 -33.15 59.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 70.22 111.068 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -88.36 -30.54 19.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 75.51 110.947 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.81 -26.28 61.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.42 110.922 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -65.41 -46.17 81.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.84 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.35 -23.73 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.34 111.097 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.86 -22.04 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 72.01 111.091 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -76.08 -57.19 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.869 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -58.22 -25.33 61.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.14 110.866 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.2 tp -78.3 -26.66 47.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.165 -0.471 . . . . 74.3 110.953 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -69.61 -57.51 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.842 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -65.55 -27.6 68.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 71.32 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 -54.12 -27.87 35.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 62.24 110.86 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -105.65 -40.43 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 75.14 110.909 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -73.03 84.66 1.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 71.11 110.849 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -73.03 -26.24 61.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 74.3 110.93 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.47 -10.52 59.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 75.41 110.847 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.71 22.44 40.15 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 62.34 112.536 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.5 t -76.12 -22.1 55.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 73.45 110.886 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.74 19.3 61.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 65.43 112.489 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -138.47 131.35 29.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.804 0.335 . . . . 72.5 110.933 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 55.8 mt -100.97 104.11 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 73.45 110.903 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.04 173.56 2.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.12 110.92 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -52.82 -29.13 26.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.897 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -80.44 -53.28 6.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 71.22 110.877 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.25 -39.17 59.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 72.13 110.889 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.1 mt -65.85 -30.51 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 74.44 111.131 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.73 -45.72 63.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.33 111.124 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.33 -23.21 55.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 72.53 112.507 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.91 -54.65 43.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 72.23 110.932 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 36.0 mt -51.91 -35.24 44.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.25 110.923 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -52.73 -51.76 59.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 74.43 110.882 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -78.81 -43.7 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.5 110.85 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.2 m -54.55 -31.16 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 74.44 111.133 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -82.42 -59.56 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.25 110.934 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -53.4 -28.08 27.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 75.23 111.098 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -55.63 -26.17 42.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.45 110.91 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.2 mtm -110.54 21.79 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.924 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 18.78 68.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.768 -0.729 . . . . 74.53 112.513 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.1 mmt -60.66 172.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 73.41 110.891 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 69.4 m -62.46 -17.72 60.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 75.1 110.847 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 63.49 48.24 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 60.02 110.888 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -68.61 152.57 45.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.861 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 p -108.21 90.83 7.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.588 0.709 . . . . 75.22 111.154 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 175.3 8.29 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.687 2.258 . . . . 73.24 112.387 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 72.1 p -121.21 -176.14 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 72.42 111.116 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -55.66 -25.81 41.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.928 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -72.54 -61.51 1.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.938 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.51 -40.84 65.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.31 110.899 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.72 -31.12 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 71.35 111.09 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -65.13 -41.65 94.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.873 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.5 mp -70.39 -26.48 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 72.32 111.133 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 57.4 t90 -83.6 -40.09 19.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 75.01 110.945 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.2 tt -58.6 -26.89 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 75.14 110.855 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -70.96 -49.38 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.923 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.6 ttp -64.9 -26.97 68.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 72.23 110.887 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.63 -59.23 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 63.44 111.092 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -81.69 128.66 34.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 65.14 110.863 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.14 -28.87 34.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 74.41 111.135 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -89.7 -9.41 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 72.45 110.891 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.8 p 46.24 58.22 4.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.877 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -113.69 24.04 12.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 73.54 110.857 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.17 27.56 73.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 73.4 112.508 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.66 127.2 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.919 0.39 . . . . 71.32 110.858 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.7 106.17 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.34 111.171 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.53 178.09 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.849 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.66 -36.12 82.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 75.11 110.882 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -81.32 -28.58 34.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 75.44 110.868 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -77.57 -22.48 50.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.885 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -85.13 -53.36 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 65.14 110.923 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.02 -43.69 63.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 75.51 110.908 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.43 -42.41 67.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 74.42 110.851 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.4 tt -51.9 -39.76 59.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.948 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -72.82 -29.35 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 71.33 111.138 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.3 mm -63.79 -44.07 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 64.34 111.136 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -67.63 -46.87 71.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 75.31 110.881 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 43.4 m -57.45 -37.03 72.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 70.22 110.849 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.72 -34.42 64.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 73.35 110.857 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -60.28 -37.54 80.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 74.45 110.941 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -24.04 26.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 75.01 110.893 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.67 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 53.34 111.088 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.82 26.18 3.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 75.45 112.486 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.3 102.17 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 73.41 111.103 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -72.93 102.78 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.874 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 75.25 111.066 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.905 0.383 . . . . 74.45 110.952 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -75.1 160.77 79.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.652 0.739 . . . . 72.24 110.857 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -17.88 37.25 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.704 2.269 . . . . 73.02 112.352 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -83.11 -22.55 33.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.12 110.853 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.55 -61.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 71.01 111.103 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -52.18 -30.04 25.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 62.31 110.835 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.02 -32.32 67.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 72.04 111.099 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.48 -22.22 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.907 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 16.4 mt -81.67 -32.9 31.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 71.25 110.932 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -29.28 64.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 71.33 110.826 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.5 p -85.95 -23.3 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.45 111.16 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.12 -39.28 21.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 70.12 111.11 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -54.86 -38.15 67.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 75.14 110.919 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -63.72 -25.8 68.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.829 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.56 -28.87 41.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 72.1 110.946 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -61.66 -64.55 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.1 110.876 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -54.71 -27.62 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 74.3 110.899 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -56.0 -26.16 47.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 74.3 110.812 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -110.12 -26.58 9.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 73.31 110.923 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.77 79.92 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 74.45 110.865 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -25.73 42.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 72.12 110.917 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.78 -10.57 59.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 72.45 110.904 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.57 19.99 58.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 72.43 112.487 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.4 p -82.46 -22.12 35.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 73.35 110.889 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.82 22.42 59.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 73.44 112.477 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -140.6 151.77 44.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 73.43 110.869 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 71.7 mt -119.11 120.67 37.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 72.51 110.929 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -84.44 179.88 7.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 72.11 110.895 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -52.2 -29.82 24.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.24 110.839 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -77.97 -54.79 5.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 74.23 110.818 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -57.28 -51.81 67.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.889 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 52.2 mt -51.8 -30.93 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 73.34 111.145 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.0 -56.72 18.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 72.11 111.137 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.06 -23.26 77.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.792 -0.718 . . . . 71.32 112.452 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 tp -57.17 -55.99 27.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.88 0.371 . . . . 73.33 110.932 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.8 mt -54.17 -33.21 57.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 74.1 110.896 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -52.11 -53.56 41.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 74.1 110.886 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.87 -42.33 21.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 55.4 110.875 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.2 m -52.35 -30.55 29.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 75.44 111.148 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -78.56 -52.97 7.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 73.12 110.952 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.97 -24.59 58.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.056 -0.52 . . . . 73.03 111.133 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.93 -25.93 45.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 70.21 110.835 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.0 mtm -109.68 21.59 16.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 70.21 110.856 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 23.61 72.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.77 -0.728 . . . . 52.52 112.473 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.8 mmt -65.28 175.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 74.21 110.845 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 79.3 p -66.68 -14.27 62.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 72.12 110.862 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 63.65 61.67 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.858 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -83.01 152.57 25.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.01 110.894 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.9 m -108.22 90.87 7.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.576 0.703 . . . . 71.15 111.111 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 156.43 63.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.701 2.267 . . . . 72.12 112.31 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 48.8 p -95.57 -179.34 4.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 62.22 111.146 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -56.01 -25.66 45.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 75.45 110.921 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -73.4 -57.27 4.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 75.32 110.89 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.93 -38.88 58.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.31 110.852 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.5 t -59.85 -42.55 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 71.23 111.099 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -52.46 -45.1 65.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.1 110.898 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.0 mp -63.27 -27.41 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 65.0 111.145 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -83.63 -32.77 25.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.915 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.1 tp -73.21 -37.78 66.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 75.43 110.901 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -56.18 -35.27 67.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 74.41 110.924 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.6 ttp -90.23 -39.18 12.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 74.52 110.926 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.31 -58.96 6.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 73.04 111.155 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.48 113.94 13.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.05 110.878 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.2 p -84.31 -46.34 11.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 64.51 111.1 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -74.6 -12.36 60.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 63.23 110.886 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 t 62.59 44.94 6.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 60.21 110.847 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -79.39 -16.26 56.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 75.41 110.879 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.05 -15.46 51.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 55.22 112.485 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.1 m -136.22 135.9 39.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.4 . . . . 75.42 110.835 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.0 109.71 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 75.32 111.135 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.5 t -87.97 -172.77 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 65.24 110.868 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.9 tp -68.57 -28.08 66.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 60.51 110.908 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -81.2 -32.61 33.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.906 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -84.78 -26.05 27.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.51 110.925 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -79.26 -54.41 5.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.3 110.952 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -54.96 -32.58 61.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 74.52 110.936 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -68.68 -26.12 65.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.882 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.1 tt -68.04 -35.56 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.928 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -73.43 -24.73 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 73.33 111.12 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.8 mm -55.66 -50.94 63.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 72.33 111.121 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -56.26 -46.46 79.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 75.41 110.908 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 9.9 p -61.84 -33.0 73.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 63.12 110.861 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.6 mt -69.74 -31.21 69.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 73.21 110.961 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.31 -43.95 96.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 65.21 110.952 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -86.02 -24.02 26.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.888 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.03 -22.71 67.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.54 111.086 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.98 32.01 1.79 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 54.45 112.492 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.86 128.58 75.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 73.43 111.142 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.7 107.37 19.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.879 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 74.41 111.173 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.929 0.395 . . . . 73.22 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -52.01 160.57 1.14 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.645 0.735 . . . . 74.04 110.854 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -19.27 36.36 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 63.45 112.356 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -82.84 -24.66 33.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 75.24 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.77 -60.62 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 74.41 111.141 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -51.77 -30.12 21.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 73.11 110.875 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.84 63.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.13 111.076 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -88.48 -36.67 16.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.906 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.9 mt -63.94 -30.53 71.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 73.25 110.919 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -63.45 -46.42 86.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 73.04 110.866 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.71 -23.68 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 74.31 111.132 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.79 -21.78 60.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.33 111.125 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -72.23 -55.64 6.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -54.81 -27.05 38.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 75.24 110.871 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.1 tp -77.77 -29.01 50.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 71.51 110.893 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -66.53 -49.77 65.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 74.23 110.852 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -72.03 -26.42 62.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 75.01 110.883 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -54.4 -27.91 40.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 73.32 110.874 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -108.12 -30.31 8.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 74.53 110.897 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -74.97 73.19 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 54.5 110.873 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -84.72 -25.03 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 71.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -70.66 -10.58 59.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.853 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.64 19.57 62.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 74.54 112.525 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.6 t -79.42 -22.14 44.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 64.44 110.856 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.82 18.77 76.63 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.763 . . . . 64.22 112.467 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -147.36 131.02 16.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 73.53 110.867 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.51 101.76 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.908 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.56 175.65 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 74.1 110.924 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -52.02 -30.13 24.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.832 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.31 -55.29 6.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.824 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -56.5 -46.57 80.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.15 110.838 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 29.0 mt -51.73 -43.07 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 75.4 111.146 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.96 -41.21 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.129 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.28 -24.17 52.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 74.14 112.492 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.06 -50.33 62.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 74.32 110.919 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.5 mt -52.92 -29.55 29.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 74.35 110.938 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.71 -60.66 3.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 73.44 110.864 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.11 -41.35 70.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 61.11 110.888 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.6 m -51.76 -46.78 64.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 75.13 111.124 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -64.66 -29.14 70.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 74.5 110.922 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 -24.7 55.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 71.44 111.116 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -57.94 -49.51 76.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 70.33 110.865 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 29.5 mtm -79.47 -18.45 52.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.898 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.75 18.32 30.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 62.11 112.487 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 5.6 mtt -61.33 175.88 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 72.11 110.869 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.1 m -60.88 -18.95 59.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 72.35 110.818 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.9 t30 63.81 63.65 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 71.12 110.905 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -79.98 152.79 29.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 72.22 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.0 p -108.23 90.78 7.24 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.591 0.71 . . . . 73.12 111.134 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -175.28 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.689 2.259 . . . . 71.15 112.363 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 23.0 p -117.23 -176.27 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 73.45 111.172 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -59.25 -24.8 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 74.13 110.88 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -78.04 -57.46 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.876 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -51.76 -35.15 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 70.52 110.895 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.2 t -64.77 -39.69 86.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 72.42 111.074 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -55.47 -44.45 76.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 73.44 110.918 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mp -62.01 -34.8 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 75.04 111.097 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -79.39 -26.13 42.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 74.41 110.921 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 10.0 tp -81.66 -39.03 24.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 71.11 110.912 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -56.9 -28.41 61.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.866 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.5 mtm -83.44 -52.61 6.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 70.22 110.893 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -52.09 -62.04 1.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 74.51 111.089 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -67.62 124.62 23.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 54.35 110.839 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.3 m -73.96 -25.44 59.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.53 111.151 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -104.01 -12.47 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 64.3 110.866 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.6 t 55.79 50.79 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 74.42 110.809 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -100.94 23.91 10.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 74.24 110.867 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.27 31.72 71.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.752 . . . . 74.25 112.519 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.6 157.29 43.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 73.24 110.892 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.04 101.37 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 75.41 111.148 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 40.2 t -71.08 165.74 22.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.05 110.872 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.92 -40.77 61.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 73.21 110.904 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -74.51 -38.18 62.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.891 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.81 -38.22 90.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 75.51 110.919 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -75.98 -43.03 46.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 74.13 110.93 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.72 -44.1 97.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 65.25 110.853 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -53.03 -40.91 64.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 74.51 110.908 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.2 tp -51.7 -52.19 50.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 75.53 110.927 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 4.5 mp -51.42 -44.96 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 64.54 111.118 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.9 -40.28 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 72.22 111.098 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -60.09 -38.38 82.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 75.15 110.928 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 58.1 m -84.48 -31.75 24.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.867 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 13.5 mt -63.73 -29.4 70.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 71.44 110.927 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -51.85 -42.3 62.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 73.12 110.923 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -86.09 -24.19 26.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.922 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.93 -22.76 67.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 71.24 111.103 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.17 19.57 5.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 71.13 112.461 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.2 mp -121.99 101.85 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.798 0.333 . . . . 75.01 111.12 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -74.54 128.06 34.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.847 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.2 111.121 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.458 -0.041 0 CA-C-O 120.93 0.395 . . . . 74.42 110.902 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -58.57 160.66 9.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.588 0.709 . . . . 74.42 110.884 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -20.48 34.9 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.666 2.244 . . . . 74.32 112.367 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.0 -23.09 41.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.876 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.05 -62.64 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 73.05 111.133 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -51.56 -30.59 21.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 72.15 110.881 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.48 -31.04 61.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 72.15 111.146 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -88.4 -21.68 24.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 73.1 110.883 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.22 -46.45 16.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 75.22 110.912 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.02 -31.34 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 75.02 110.855 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 p -85.87 -23.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 75.33 111.131 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.62 -44.43 21.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 75.5 111.103 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.83 -33.41 35.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.857 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -74.58 -40.42 61.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 75.5 110.876 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.3 tp -68.3 -25.09 64.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 74.52 110.918 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.08 -64.57 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.865 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -59.28 -25.97 64.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 74.31 110.868 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -52.71 -30.49 32.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.823 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -101.4 -26.52 13.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.928 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -75.75 82.92 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 75.13 110.852 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -81.52 -26.5 35.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 75.12 110.884 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -72.43 -10.56 59.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.42 . . . . 54.32 110.892 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.05 20.54 54.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 72.11 112.484 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 59.5 p -77.13 -22.06 53.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.943 0.401 . . . . 73.52 110.882 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.11 59.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 62.21 112.503 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -144.03 137.36 27.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 73.11 110.942 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.3 mt -100.93 105.29 16.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 73.21 110.917 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -67.8 171.38 6.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 72.44 110.934 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.02 -30.36 25.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 71.22 110.858 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.33 -50.87 11.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.4 110.889 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -57.28 -26.25 60.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 62.22 110.856 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 26.5 mt -78.1 -26.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 65.41 111.153 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.93 -54.98 23.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 72.32 111.141 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.22 -22.86 69.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 74.22 112.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.8 tp -57.86 -58.69 7.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 73.12 110.939 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.8 mt -51.81 -36.64 48.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.945 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -54.39 -41.93 69.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 71.43 110.942 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -85.06 -46.49 11.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 70.45 110.893 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.3 m -54.61 -33.0 59.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 74.1 111.129 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -69.13 -26.13 64.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 74.54 110.918 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.27 -30.23 71.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.499 . . . . 75.23 111.087 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.38 -26.06 64.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.858 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.8 mtm -94.05 -18.38 21.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 75.2 110.84 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 93.13 24.01 23.41 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.731 . . . . 72.51 112.443 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.3 ttm -81.95 175.81 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 74.44 110.854 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.4 m -75.73 -6.26 49.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 71.12 110.84 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.2 m120 62.9 69.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 61.22 110.886 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -68.07 152.64 45.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.906 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 m -108.18 90.82 7.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.575 0.702 . . . . 70.14 111.175 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 175.86 7.55 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.661 2.241 . . . . 75.14 112.379 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.1 p -115.41 -176.57 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 73.4 111.154 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -52.19 -29.9 24.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.34 110.95 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -67.41 -57.65 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.864 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.02 -53.76 54.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 71.14 110.868 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.5 t -52.66 -41.12 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.42 111.126 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -54.79 -54.51 41.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 74.14 110.895 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.35 -47.9 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.133 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -61.89 -25.95 67.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.132 -0.485 . . . . 75.4 110.904 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 tt -81.61 -40.51 22.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 73.33 110.92 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.51 -28.76 70.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.903 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 43.3 ttp -91.22 -35.08 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -71.41 -48.25 50.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 51.21 111.096 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -52.55 120.3 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.851 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.87 -23.59 25.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 64.43 111.126 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.44 -10.71 18.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 72.11 110.874 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.4 p 58.99 27.19 16.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.852 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -78.94 -15.87 57.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 73.11 110.869 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.34 17.26 16.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 70.24 112.49 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.78 126.9 7.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 74.44 110.854 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.7 t -86.92 107.63 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 70.13 111.131 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.2 t -83.68 -176.65 6.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.862 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.7 tp -66.61 -36.03 81.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 74.41 110.962 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.35 -24.75 42.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 73.1 110.87 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -85.89 -20.43 29.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 74.14 110.85 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -87.32 -40.16 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.931 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -52.68 -41.42 63.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.899 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.86 -25.16 63.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.828 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.9 -40.24 94.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.466 . . . . 71.45 110.91 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.22 -24.69 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.21 111.134 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.1 mm -60.81 -37.51 76.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 73.03 111.154 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -52.56 38.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 72.01 110.858 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 2.6 m -57.44 -30.67 65.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 70.32 110.885 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.01 -37.93 69.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 71.35 110.925 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -58.03 -35.57 71.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 75.53 110.897 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -26.64 26.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 65.23 110.929 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.2 -22.65 66.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 73.02 111.13 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.75 26.45 3.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 71.43 112.491 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.52 103.12 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 74.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -71.17 110.88 6.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 75.33 110.839 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 60.35 111.119 179.944 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.917 0.389 . . . . 71.43 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -52.59 160.52 1.35 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.595 0.712 . . . . 74.42 110.889 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -18.81 36.92 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.72 2.28 . . . . 75.24 112.344 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -82.69 -23.63 34.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.45 110.877 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -77.93 -63.33 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 75.32 111.163 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -51.99 -30.9 27.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.31 110.883 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -37.5 63.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 53.43 111.116 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -88.19 -25.94 22.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.893 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.5 mt -73.94 -28.23 61.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.89 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.51 -59.01 4.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.449 . . . . 71.5 110.899 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 p -55.29 -26.46 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 73.12 111.152 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.91 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 74.1 111.11 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -61.39 -50.66 71.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 75.01 110.874 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -63.68 -41.48 98.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 72.31 110.863 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 tp -57.1 -38.92 74.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 71.4 110.905 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -56.47 -59.74 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.12 110.873 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.6 mmmm -66.39 -26.27 67.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 73.42 110.87 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.3 ttm-85 -54.14 -27.71 35.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 75.21 110.872 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -109.74 -30.55 7.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.941 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.07 84.28 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 72.11 110.862 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -84.94 -28.17 26.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 74.2 110.878 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -72.63 -10.57 59.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 73.14 110.899 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.96 47.12 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 72.25 112.462 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 45.4 t -75.36 -22.11 57.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.953 0.406 . . . . 74.32 110.853 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.23 19.67 60.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 75.14 112.483 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -146.04 141.75 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 70.2 110.889 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.7 mt -105.23 101.41 10.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 65.32 110.927 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -70.41 170.68 11.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 63.34 110.95 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -52.06 -30.02 23.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.42 110.842 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -80.41 -35.02 35.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.1 110.891 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.08 -29.19 60.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 75.33 110.896 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 54.8 mt -77.78 -26.67 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 74.5 111.145 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.76 -45.85 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 73.01 111.071 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.24 -23.04 55.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 65.44 112.495 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.15 -57.04 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 73.54 110.9 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.7 mt -51.94 -35.84 47.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 75.31 110.959 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -51.97 -45.68 64.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 75.34 110.834 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -84.77 -45.69 12.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.833 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 33.5 m -52.99 -31.23 39.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.113 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -77.07 -55.37 5.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.914 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.81 -24.81 38.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 75.3 111.081 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -53.64 -29.17 36.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 72.11 110.879 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -113.02 16.8 19.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 73.03 110.878 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.83 28.93 74.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 70.12 112.451 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.16 175.75 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 75.32 110.884 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 94.8 p -60.92 -21.25 63.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 72.53 110.879 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 63.45 57.47 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 74.03 110.889 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -80.22 152.55 29.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.924 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.8 p -108.21 90.75 7.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.589 0.709 . . . . 73.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 174.47 9.44 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.662 2.242 . . . . 72.33 112.327 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 39.2 p -117.53 -176.06 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 60.42 111.12 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -52.14 -29.95 24.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 73.4 110.879 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -69.43 -57.36 5.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 71.54 110.918 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.15 -52.54 64.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 75.23 110.852 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.7 t -52.42 -38.15 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 73.4 111.126 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -58.11 -54.85 42.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 75.45 110.907 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.5 mt -54.5 -47.47 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 74.12 111.143 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -57.97 -29.84 65.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 71.33 110.88 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.2 tt -74.88 -30.54 61.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 72.2 110.949 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -65.01 -26.17 68.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.23 110.938 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.5 ttm -90.97 -42.83 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 72.11 110.895 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.32 -50.47 53.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 74.24 111.085 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -51.98 105.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.836 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.5 m -87.18 -25.15 24.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 74.24 111.156 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -95.11 -12.42 26.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 65.14 110.906 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 60.74 37.93 18.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.855 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -102.01 23.99 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 73.03 110.855 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 65.19 19.42 66.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 74.41 112.509 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.73 160.4 41.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 70.44 110.871 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.23 124.93 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 72.02 111.11 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.28 -170.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 74.51 110.876 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -39.01 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 74.15 110.892 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -74.11 -35.59 64.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.25 110.859 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.58 -53.4 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 75.14 110.94 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -58.47 -47.91 82.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 74.02 110.911 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -55.2 -31.04 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 44.01 110.89 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.77 -26.41 64.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 65.43 110.88 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 tp -67.46 -34.03 76.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.887 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -75.04 -27.44 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 75.12 111.133 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.5 mm -52.11 -60.09 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 64.5 111.135 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -52.08 -30.13 24.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 74.34 110.884 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.9 m -69.98 -41.88 73.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 73.44 110.872 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.83 -36.05 81.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.49 . . . . 75.02 110.936 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -57.07 -44.23 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 71.22 110.904 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -86.06 -24.83 26.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 75.51 110.91 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.05 -22.71 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 74.22 111.063 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.92 19.26 5.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.756 -0.735 . . . . 73.14 112.527 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.32 101.84 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 74.24 111.128 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.13 98.66 3.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.14 110.887 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 74.23 111.157 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.913 0.387 . . . . 74.25 110.916 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -51.77 162.15 0.8 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.584 0.707 . . . . 72.5 110.883 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -16.87 37.69 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 71.33 112.346 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -83.42 -18.97 36.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.5 110.892 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.16 -61.44 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 63.33 111.134 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -51.54 -31.38 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.45 110.891 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.03 -34.32 55.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.54 111.14 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.47 -30.99 18.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.42 110.945 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.9 mt -69.68 -32.72 71.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 72.11 110.876 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -58.27 -57.58 12.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 64.31 110.857 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.2 p -57.75 -23.79 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 70.4 111.127 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.43 -30.77 67.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.41 111.118 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -49.44 63.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 75.1 110.919 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -61.77 -24.65 66.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.885 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.7 tp -82.17 -36.67 27.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.92 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.0 -53.31 59.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.881 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -69.62 -25.97 64.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 70.44 110.906 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -52.2 -29.94 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 75.02 110.861 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -106.0 -34.18 7.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 71.52 110.895 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.75 88.95 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 72.33 110.873 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -84.72 -25.42 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 75.42 110.92 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -70.65 -10.61 59.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.878 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.66 22.54 40.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 61.4 112.489 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -76.38 -22.1 55.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.895 0.379 . . . . 74.04 110.844 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.76 19.04 57.24 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.752 . . . . 71.22 112.48 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -142.96 130.74 21.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 75.2 110.894 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.7 mt -89.03 102.57 15.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 74.13 110.944 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -71.6 173.11 8.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 73.32 110.894 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -55.54 -26.42 43.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -80.02 -34.28 38.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 73.24 110.85 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -80.92 -26.75 36.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 75.22 110.84 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 21.4 mt -74.82 -36.25 39.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 73.05 111.133 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.83 -47.27 64.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 74.34 111.067 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.42 -23.5 53.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 65.25 112.458 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.48 -49.12 70.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 74.45 110.942 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.7 mt -52.12 -33.91 41.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 63.34 110.921 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -54.59 -55.2 31.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.855 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.34 -45.06 41.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.877 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.3 m -51.67 -30.71 22.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 70.52 111.154 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -77.85 -44.69 26.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.914 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.2 -23.24 46.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 74.4 111.087 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -55.52 -25.94 40.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 75.24 110.893 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 mtm -111.73 19.44 18.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.889 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.76 21.46 71.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 51.3 112.492 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.2 tpp -62.22 175.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.758 0.314 . . . . 64.31 110.911 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.1 t -78.3 -3.91 45.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.24 110.868 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.8 m120 55.72 61.74 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 74.14 110.909 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -72.86 152.63 41.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.11 110.905 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.4 m -108.11 90.77 7.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 72.35 111.136 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 171.45 14.44 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.704 2.269 . . . . 73.2 112.364 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 3.4 p -102.35 177.83 4.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 73.55 111.124 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -55.19 -27.74 48.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 75.11 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.23 -54.28 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 74.31 110.901 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.16 -35.87 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.823 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.97 -39.36 85.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 75.2 111.101 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -56.83 -52.99 62.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.877 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mp -55.38 -30.68 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.13 111.118 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -79.55 -31.21 41.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 64.25 110.934 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.9 tt -77.46 -39.98 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.888 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -51.92 -58.47 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.906 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 27.5 ttp -63.7 -24.46 67.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.893 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -94.51 21.89 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 61.0 111.097 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -141.73 120.93 13.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 64.34 110.864 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 14.5 m -87.17 -43.71 12.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 63.15 111.097 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.42 -12.45 60.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.868 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.0 t 57.98 48.15 13.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.21 110.836 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -93.27 -16.24 24.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 70.02 110.854 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.23 25.12 14.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 63.44 112.46 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.24 144.12 24.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 75.0 110.902 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.89 121.95 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 74.14 111.123 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.15 -177.74 4.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 70.01 110.891 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.91 -32.67 66.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 75.45 110.949 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.53 -58.87 3.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.31 110.874 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -56.2 -25.46 47.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.45 110.929 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -85.34 -50.17 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 74.55 110.917 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -52.08 -40.98 62.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 71.45 110.877 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -53.56 -43.9 68.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.886 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 36.5 mt -51.84 -35.66 45.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 71.42 110.958 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.2 mp -77.0 -30.0 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 62.44 111.156 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.7 mm -64.66 -43.06 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 75.41 111.11 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -63.83 -36.05 82.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 75.25 110.905 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 62.7 m -77.66 -39.74 44.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.54 110.851 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 22.4 mt -57.63 -46.03 84.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.494 . . . . 73.03 110.902 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -52.59 -35.18 53.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.03 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.12 -31.33 21.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 72.2 110.88 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.91 -22.28 66.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 52.42 111.081 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.89 32.42 1.56 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.739 . . . . 53.4 112.496 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.04 110.94 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 74.44 111.112 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 131.32 46.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.15 110.841 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 18.3 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 72.31 111.119 179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.927 0.394 . . . . 74.22 110.95 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -51.73 160.97 0.95 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.661 0.743 . . . . 70.42 110.853 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -25.35 28.42 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.651 2.234 . . . . 61.33 112.318 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -79.36 -19.55 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 62.44 110.923 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.74 -61.03 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 72.1 111.111 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -51.35 -30.7 19.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 74.55 110.9 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.37 79.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 75.24 111.089 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -88.39 -40.73 13.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 72.34 110.914 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.2 mt -57.28 -25.81 59.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.928 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -70.03 -59.27 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 75.22 110.855 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.87 -23.62 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 73.15 111.111 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.35 -21.69 59.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 61.54 111.137 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.8 mtt-85 -70.13 -53.41 17.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 62.41 110.885 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -54.57 -26.88 34.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 72.54 110.822 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -79.89 -35.17 38.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 62.34 110.964 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.41 -43.02 91.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 72.04 110.885 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -79.49 -26.93 41.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.89 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -51.96 -40.44 60.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 74.21 110.889 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -94.23 -26.12 16.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 75.23 110.932 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.14 62.58 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 74.44 110.883 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -26.16 68.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 73.23 110.887 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -70.83 -10.56 59.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 73.12 110.875 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.04 20.89 43.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.709 -0.757 . . . . 71.04 112.464 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.5 m -78.45 -22.1 48.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 75.33 110.85 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.84 20.19 66.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 72.05 112.451 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -138.51 131.54 29.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.798 0.332 . . . . 75.02 110.935 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 24.1 mt -101.92 111.43 23.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 75.02 110.945 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -79.93 175.7 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 71.44 110.895 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -53.47 -28.51 31.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 72.3 110.87 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -77.34 -44.81 28.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.888 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.04 -33.19 73.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.928 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 30.6 mt -70.72 -37.5 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 75.05 111.201 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.84 -46.2 64.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 75.43 111.085 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.77 -23.13 56.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 65.42 112.505 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.3 tp -58.87 -55.95 28.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 72.05 110.902 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 25.1 mt -52.28 -35.66 50.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.931 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -43.59 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.885 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.07 -47.17 10.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.871 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.2 m -52.19 -31.16 30.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 75.24 111.142 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -76.17 -44.19 39.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.923 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.18 -25.53 64.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 74.53 111.097 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -52.25 -30.44 27.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 74.01 110.903 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -102.62 -18.45 15.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.24 110.869 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.77 27.24 9.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 63.12 112.481 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.63 175.2 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 72.24 110.873 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.1 p -55.6 -25.96 41.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 62.15 110.864 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 63.31 54.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 75.44 110.911 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -60.45 152.49 25.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 75.14 110.921 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p -108.27 90.8 7.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 72.31 111.136 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -171.02 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.643 2.228 . . . . 72.32 112.38 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 70.1 p -127.86 -176.35 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 72.41 111.131 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -57.63 -25.56 60.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 72.32 110.93 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.42 -60.16 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 74.43 110.909 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.84 -49.2 76.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 65.04 110.832 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.0 t -55.37 -43.87 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.424 . . . . 73.04 111.089 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -50.27 62.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 75.2 110.888 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.7 mt -59.46 -49.22 84.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.22 111.173 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -54.74 -28.63 49.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 74.25 110.89 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.8 tt -61.38 -45.64 93.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 74.45 110.906 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -72.52 -29.91 64.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.03 110.89 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.6 ttp -60.96 -31.18 70.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.25 110.871 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -101.26 -48.54 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 73.04 111.086 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -52.35 112.74 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 65.43 110.808 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 27.9 m -83.71 -33.34 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.3 111.141 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -83.51 -12.46 56.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 73.11 110.881 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.8 m 54.87 49.99 16.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 63.42 110.874 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -110.07 23.94 13.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.903 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.54 25.47 70.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 73.44 112.484 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.7 p -154.64 133.78 12.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 71.03 110.848 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.3 t -101.51 105.48 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 74.54 111.121 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -75.02 178.17 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 75.54 110.841 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.8 tp -54.79 -61.02 2.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 72.54 110.916 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -60.78 -41.54 95.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.913 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -29.38 66.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.53 110.92 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -87.94 -47.63 8.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.955 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.18 -25.84 59.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 72.42 110.905 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.9 -25.75 60.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.89 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.9 tp -69.07 -35.9 77.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 74.1 110.889 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -71.24 -24.5 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.13 111.135 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.0 mm -52.33 -61.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 71.35 111.073 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -49.57 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 71.51 110.919 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 49.0 m -52.15 -33.28 39.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 64.53 110.885 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.9 mt -76.59 -44.53 34.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 72.41 110.867 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -56.26 -30.1 61.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 74.34 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -16.41 38.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 71.42 110.924 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -94.72 24.81 4.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 62.11 111.102 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 66.52 32.39 81.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.763 . . . . 72.32 112.499 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 18.7 mt -114.72 102.89 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.353 . . . . 72.44 111.121 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -57.0 106.31 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 73.33 110.862 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 85.5 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 64.21 111.142 179.939 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.917 0.389 . . . . 73.13 110.938 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -52.23 160.62 1.2 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.587 0.708 . . . . 75.31 110.891 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -16.02 37.63 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.701 2.267 . . . . 74.41 112.37 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.61 -26.86 34.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.883 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.8 -61.81 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 62.23 111.107 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -51.62 -30.34 20.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 73.35 110.942 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.16 58.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 74.5 111.129 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.87 -25.37 28.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.888 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.3 mt -78.67 -29.66 45.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 74.55 110.918 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.21 -48.76 69.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 70.22 110.838 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -65.47 -30.5 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 52.25 111.13 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.85 -27.89 57.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 73.53 111.086 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -66.74 -34.3 77.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.44 110.836 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -74.19 -29.83 61.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 70.11 110.878 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.52 -32.64 64.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 74.54 110.908 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.53 -63.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 75.03 110.874 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -58.02 -26.76 62.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.52 110.94 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -54.12 -29.24 44.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.886 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.04 -28.89 8.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 75.04 110.922 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.53 70.88 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 74.24 110.88 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -25.76 53.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 73.22 110.927 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -70.83 -10.5 59.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 73.15 110.853 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.43 19.78 58.08 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.738 -0.744 . . . . 74.53 112.463 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.4 t -82.33 -22.13 35.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.932 0.396 . . . . 45.21 110.892 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.83 22.44 63.92 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 75.22 112.523 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -140.09 148.99 42.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.858 0.361 . . . . 72.42 110.879 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.7 mt -120.14 119.89 34.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.33 110.912 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -85.37 177.85 7.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 74.41 110.92 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -52.0 -30.08 23.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.895 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.65 -52.14 9.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 63.32 110.856 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.25 -34.32 73.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.905 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.6 mt -68.6 -38.57 79.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.11 111.126 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.79 -58.35 7.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 73.03 111.114 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.22 -23.53 76.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 75.23 112.502 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.8 tp -67.9 -53.35 27.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 73.24 110.911 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.6 mt -51.86 -29.86 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 72.02 110.94 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -60.28 -43.82 95.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.41 110.887 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -85.02 -38.85 18.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 70.13 110.875 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.0 m -51.75 -30.0 20.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.1 111.182 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -81.5 -50.21 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.44 110.924 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.29 -25.11 32.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 74.23 111.136 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -54.52 -28.99 49.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.917 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -110.74 16.93 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.51 110.906 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 29.02 74.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 74.53 112.489 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.1 mmt -69.31 175.85 3.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.821 0.344 . . . . 74.23 110.843 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 75.2 m -61.56 -18.4 59.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 74.43 110.899 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 3.5 t30 63.67 55.88 1.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 71.54 110.933 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -73.81 152.89 40.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.03 110.873 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 m -108.27 90.76 7.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 75.44 111.131 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 143.65 51.33 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.703 2.269 . . . . 71.44 112.312 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 33.5 p -82.58 -178.43 7.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 73.42 111.138 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -56.32 -29.8 61.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 71.12 110.932 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -69.42 -52.44 26.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 72.04 110.895 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -54.7 -42.01 70.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.482 . . . . 71.12 110.846 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.57 -41.94 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 74.33 111.118 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -52.89 -48.85 66.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.913 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.07 -25.61 36.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 75.35 111.093 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -81.87 -22.85 36.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 74.33 110.905 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.4 tt -78.22 -35.4 48.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 74.4 110.892 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -64.6 -31.95 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 54.34 110.933 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.5 ptp -91.72 -30.84 16.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 74.04 110.875 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -75.6 -51.27 13.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 62.01 111.128 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.36 129.57 21.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 70.02 110.866 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.5 m -88.31 -48.78 7.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 73.31 111.15 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -113.86 16.69 18.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.15 110.895 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.5 t 51.78 58.67 5.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.878 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -96.17 -14.44 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.494 . . . . 72.34 110.851 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.37 16.77 17.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.728 . . . . 62.4 112.475 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.5 m -154.66 -179.26 7.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.397 . . . . 72.42 110.851 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.59 101.41 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 72.14 111.159 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -76.07 -174.74 2.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 61.33 110.857 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 21.6 tp -65.3 -45.82 82.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 72.31 110.904 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -70.48 -26.11 63.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 74.4 110.902 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.86 -31.89 31.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 72.42 110.865 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -85.87 -34.96 20.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.885 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -70.26 -32.15 69.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 74.42 110.868 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.83 -28.53 70.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 72.31 110.836 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mt -63.9 -36.6 84.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.34 110.926 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -74.86 -24.84 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 73.23 111.142 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.49 -47.44 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 74.15 111.138 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -67.15 -40.4 86.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.912 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -47.54 65.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 74.2 110.852 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.9 mp -73.88 -29.44 62.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 73.42 110.895 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -62.9 -44.87 94.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.879 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -84.12 -24.19 30.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 75.54 110.876 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.9 -22.67 67.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 71.43 111.093 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.0 32.46 1.53 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 73.32 112.463 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.4 101.83 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.859 0.361 . . . . 54.32 111.102 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -68.76 108.07 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.872 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 65.31 111.126 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.882 0.372 . . . . 75.23 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -51.88 160.99 0.99 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 71.34 110.894 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -18.13 37.01 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.714 2.276 . . . . 62.1 112.335 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -83.04 -21.29 33.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.911 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.25 -51.78 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 70.24 111.128 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -51.06 -31.58 19.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.863 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.14 80.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 62.11 111.099 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -88.58 -32.36 18.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 75.23 110.885 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.8 -25.95 68.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 74.41 110.935 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -67.59 -59.3 3.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 75.0 110.854 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 p -56.1 -24.83 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.129 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.48 -47.74 84.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 75.34 111.093 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -44.62 64.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.85 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -65.11 -29.14 69.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.879 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.52 -36.85 57.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 74.44 110.892 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -61.3 -41.95 97.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 74.42 110.893 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -79.1 -28.48 43.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 74.42 110.927 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -52.26 -29.88 25.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 74.44 110.834 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -108.25 -34.52 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 72.21 110.917 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -76.7 66.44 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 72.52 110.919 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -70.7 -26.09 63.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 72.31 110.885 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.9 -10.51 59.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 73.42 110.859 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.26 22.56 44.38 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 63.22 112.469 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.3 t -76.08 -22.13 55.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.915 0.388 . . . . 73.12 110.875 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.31 20.16 65.14 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 74.05 112.489 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -142.64 141.29 31.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 73.51 110.87 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 58.0 mt -109.33 118.12 35.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 74.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -85.19 175.3 9.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 75.41 110.896 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -51.88 -30.31 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 72.43 110.883 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -81.08 -52.39 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.34 110.823 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.56 -28.36 65.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 75.24 110.874 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.2 mt -81.32 -30.83 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 73.34 111.167 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.04 63.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 65.04 111.12 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.23 -22.86 56.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 72.31 112.509 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.92 -47.76 83.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 64.03 110.95 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.36 -36.41 77.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.927 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -52.62 -46.07 66.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.33 110.882 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -83.11 -47.19 11.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 72.42 110.882 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.8 m -51.79 -35.52 44.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 72.31 111.186 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -76.56 -53.69 7.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.97 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.06 -25.76 59.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 70.21 111.129 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -57.39 -25.68 59.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.866 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 36.9 mtm -110.01 21.74 16.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 75.2 110.873 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.69 68.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 72.52 112.435 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.6 mmt -60.79 174.98 0.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.805 0.336 . . . . 65.25 110.834 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -66.02 -14.91 62.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 65.0 110.821 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.7 t30 63.69 42.92 5.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 55.12 110.882 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -62.49 152.45 34.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 62.44 110.863 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 m -108.22 90.82 7.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.59 0.71 . . . . 70.42 111.152 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 159.93 51.6 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.672 2.248 . . . . 73.34 112.324 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 79.7 p -106.87 -176.03 2.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.25 111.167 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -54.85 -26.57 36.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 74.51 110.932 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -75.42 -41.47 55.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 72.35 110.873 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.61 -25.11 59.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 73.21 110.85 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -79.33 -32.64 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.132 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -22.73 66.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.915 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.58 -41.96 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 74.11 111.132 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -69.98 -31.27 68.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 64.54 110.951 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.25 -38.81 92.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 73.21 110.885 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -68.79 -28.18 66.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.924 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 6.1 mmm -70.47 -33.83 71.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 71.43 110.862 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -88.99 -49.34 6.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 51.33 111.111 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -75.0 119.34 19.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 54.2 110.88 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.9 m -87.59 -26.55 23.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 75.52 111.108 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.22 -12.47 56.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 70.1 110.846 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.6 m 53.61 53.65 11.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 61.14 110.834 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -106.66 -16.22 14.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 63.45 110.906 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.29 19.42 11.53 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.709 -0.758 . . . . 72.1 112.447 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.0 p -149.4 126.88 11.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 74.23 110.859 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.66 106.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 74.3 111.142 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.71 178.86 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 64.32 110.884 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 21.3 tp -63.16 -33.23 75.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 72.52 110.921 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -81.32 -40.04 24.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.858 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -65.05 -32.57 74.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.859 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -78.89 -34.95 44.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 75.21 110.937 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -51.84 -56.76 12.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.499 . . . . 75.2 110.88 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -56.87 -33.28 66.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 75.03 110.931 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.91 -45.1 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 64.12 110.932 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 4.7 mp -72.37 -34.42 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 71.53 111.126 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.0 mm -52.98 -44.96 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 75.4 111.085 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -63.62 -44.96 92.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 70.44 110.891 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.3 m -59.44 -57.93 10.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 73.01 110.795 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.2 mp -51.97 -40.24 60.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 73.32 110.937 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -42.97 74.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 75.22 110.916 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -85.96 -6.99 58.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 65.1 110.899 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -94.94 25.48 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 73.21 111.1 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.72 32.41 83.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.719 -0.753 . . . . 73.53 112.5 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 17.0 mt -120.18 110.47 28.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 72.53 111.14 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.69 114.78 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 74.41 110.871 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 74.52 111.142 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.897 0.379 . . . . 74.3 110.917 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -51.49 161.07 0.87 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.672 0.748 . . . . 70.25 110.863 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -14.37 35.87 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.677 2.251 . . . . 64.3 112.346 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.23 -26.77 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.88 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.15 -63.53 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 64.45 111.103 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.64 -26.2 43.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 75.12 110.847 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.45 83.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 72.14 111.135 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -87.99 -26.65 22.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.43 110.928 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.86 -25.57 59.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 60.12 110.931 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -76.37 -49.58 16.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 75.15 110.87 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.0 p -62.49 -25.81 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 74.11 111.143 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.81 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 61.23 111.125 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -51.91 -36.35 48.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 72.54 110.833 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -67.41 -48.31 67.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.846 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 tp -61.98 -27.91 69.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.9 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -69.54 -60.05 2.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.841 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -63.07 -28.67 70.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.874 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -52.65 -33.45 47.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 75.33 110.907 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -99.19 -29.47 12.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 62.35 110.887 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.94 85.47 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 71.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -85.06 -26.31 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.928 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.09 -10.53 59.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.885 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.58 24.47 47.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 53.35 112.523 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.2 p -90.51 -22.14 21.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 70.44 110.86 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.99 19.81 49.32 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.766 -0.731 . . . . 71.04 112.444 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -133.47 132.04 40.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 74.41 110.922 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.5 mt -99.56 110.82 23.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 72.42 110.916 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -77.94 176.94 8.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 75.21 110.893 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.94 -30.18 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.2 110.879 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.67 -51.82 15.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 61.12 110.893 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.26 -30.69 71.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.87 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.7 mt -77.06 -42.62 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 74.4 111.151 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.65 -49.07 63.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 61.41 111.106 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.87 -23.2 67.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 73.02 112.509 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.93 -45.7 60.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 74.01 110.9 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.6 mt -52.86 -30.86 36.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 72.34 110.871 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -60.81 3.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 75.22 110.881 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -27.48 67.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 73.03 110.888 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.0 m -65.05 -54.6 27.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 74.11 111.121 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -56.47 -25.99 52.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 73.23 110.933 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.86 -27.66 60.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 75.24 111.083 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -53.27 -28.68 29.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 62.13 110.858 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.3 mtm -104.26 -18.47 14.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 74.41 110.879 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.92 20.81 22.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.723 -0.751 . . . . 74.04 112.5 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 10.2 mtm -67.51 175.8 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.33 . . . . 71.04 110.852 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.7 t -60.63 -19.86 59.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 55.43 110.834 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 63.67 60.23 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 71.14 110.885 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -70.63 152.52 43.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 71.04 110.854 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.6 p -108.15 90.91 7.28 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.581 0.705 . . . . 74.44 111.151 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -178.33 2.31 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.646 2.23 . . . . 74.44 112.352 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 51.5 p -118.62 179.56 4.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 53.33 111.15 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -54.74 -26.84 36.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 65.23 110.859 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -72.87 -60.75 2.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.421 . . . . 73.14 110.844 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.0 -39.63 59.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 71.11 110.843 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.0 t -56.9 -43.25 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 71.5 111.136 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -52.01 -42.79 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 75.3 110.892 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.9 mp -68.84 -26.37 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.128 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -83.0 -26.45 31.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.471 . . . . 75.05 110.912 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.5 tt -77.14 -49.19 15.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 74.35 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -54.77 -28.79 51.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 75.21 110.895 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 31.5 ttm -72.68 -55.33 6.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.42 110.846 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.82 -60.81 2.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.52 111.101 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -66.26 128.72 37.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 74.04 110.904 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.26 -35.14 18.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.133 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -74.66 -12.46 60.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.866 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.9 p 46.24 57.42 5.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.812 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -114.17 23.56 12.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 72.11 110.851 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.06 25.89 74.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 65.42 112.467 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.8 p -152.41 135.62 15.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 65.02 110.876 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.78 111.62 36.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 74.11 111.135 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.8 t -75.37 179.95 4.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.804 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.68 -60.29 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 72.34 110.907 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -62.88 -39.21 93.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 63.2 110.88 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -61.22 -27.49 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.867 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -89.37 -44.5 10.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 74.4 110.888 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -60.46 -34.8 74.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 73.14 110.903 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -64.54 -26.18 68.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.866 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.3 tp -68.66 -44.35 74.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 75.03 110.938 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.1 mp -63.28 -24.65 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 74.32 111.122 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 48.6 mm -51.92 -48.05 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 74.44 111.124 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -69.31 -37.25 77.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.883 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 12.1 m -53.77 -42.19 68.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 73.35 110.842 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 64.8 mt -80.14 -26.42 39.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 73.3 110.893 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -62.98 -43.63 98.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 63.5 110.917 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -85.79 -24.14 26.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 74.15 110.908 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.92 -21.55 66.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.115 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.06 21.9 4.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 52.25 112.49 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.79 101.65 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 74.51 111.157 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -68.57 98.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.32 110.851 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.9 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 72.04 111.118 179.959 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.908 0.385 . . . . 75.21 110.891 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -61.0 160.9 17.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.622 0.725 . . . . 73.12 110.915 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -27.61 26.21 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 55.52 112.34 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -75.09 -18.13 60.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 63.13 110.846 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.01 -60.42 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 64.23 111.115 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -51.59 -30.32 20.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 65.52 110.854 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.4 79.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 74.23 111.079 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -88.42 -24.59 23.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.894 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.5 mt -76.83 -40.11 48.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.901 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -58.2 -43.24 87.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.827 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.39 -24.24 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 75.12 111.113 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.41 54.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 63.0 111.088 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -66.5 -50.3 63.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 75.02 110.855 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -55.29 -26.06 38.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 64.43 110.856 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.3 tp -79.44 -35.4 40.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 75.3 110.933 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.49 -60.54 3.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 73.53 110.876 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -60.35 -32.45 71.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 64.34 110.889 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -55.34 -26.51 41.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 73.3 110.912 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -108.24 -26.66 10.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 64.43 110.892 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.97 60.02 2.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 53.32 110.919 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -70.06 -25.91 63.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 75.21 110.918 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.74 -10.58 59.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.834 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.12 23.38 52.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.757 . . . . 63.21 112.499 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -83.07 -22.06 33.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.929 0.395 . . . . 61.54 110.87 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.32 20.69 60.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 74.42 112.527 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -150.08 131.74 14.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 64.4 110.901 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.5 mt -91.45 101.88 14.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.945 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -65.61 171.85 3.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 71.41 110.875 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.05 -29.99 23.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 62.23 110.86 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.81 -51.35 12.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 64.11 110.892 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -59.62 -26.4 65.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 73.53 110.904 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.78 -36.63 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 74.21 111.112 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.72 -44.77 63.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 71.34 111.126 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.27 -25.27 48.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.741 . . . . 42.34 112.486 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.23 -56.75 18.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 74.34 110.896 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.1 mt -51.95 -32.41 33.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.927 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -57.0 -43.97 82.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 75.42 110.885 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -84.93 -45.93 11.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 74.55 110.834 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.1 m -52.58 -36.63 56.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.174 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -67.33 -56.44 9.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 74.11 110.947 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -54.61 -26.79 34.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 63.03 111.107 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.95 -33.17 75.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.88 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -99.02 18.95 16.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.82 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.21 68.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 73.12 112.47 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.3 tpp -65.28 173.65 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 75.01 110.884 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 91.1 p -72.92 -9.07 58.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 72.0 110.831 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.64 47.85 3.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 63.34 110.834 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -62.63 152.6 34.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 73.42 110.846 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.3 p -108.29 90.93 7.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.626 0.726 . . . . 74.11 111.1 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 -176.35 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 2.252 . . . . 71.13 112.293 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 36.6 p -128.68 -176.07 3.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 70.03 111.17 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -55.07 -26.55 38.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 73.14 110.909 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.93 -61.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.861 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.05 -48.3 64.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 54.5 110.834 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 89.7 t -52.17 -36.62 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.55 111.152 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -59.38 -53.9 52.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.909 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.0 mp -55.23 -38.4 47.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 63.41 111.137 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -75.22 -25.27 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 72.33 110.923 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 tt -74.89 -51.21 14.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.859 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -52.75 -45.17 66.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 75.45 110.887 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.0 ttm -57.92 -26.39 62.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 64.53 110.879 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.85 -67.28 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 73.43 111.128 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -61.25 128.49 36.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 73.52 110.872 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.1 m -84.05 -28.14 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 73.51 111.135 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -91.3 -12.46 35.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 64.11 110.883 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 58.5 58.37 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 61.11 110.83 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -117.29 23.46 11.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 60.52 110.911 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.13 31.5 81.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.718 -0.753 . . . . 64.45 112.457 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.58 129.98 17.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.922 0.391 . . . . 74.31 110.887 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.99 102.31 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 74.42 111.08 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.47 176.24 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 71.22 110.821 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -29.92 70.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 75.43 110.984 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -81.39 -29.5 33.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 64.13 110.933 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.7 -22.0 29.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 63.22 110.912 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -84.04 -35.19 24.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 73.31 110.927 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.86 -41.81 82.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 64.31 110.891 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -55.33 -30.11 59.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.843 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 44.5 mt -62.26 -41.03 98.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 75.03 110.903 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 4.6 mp -66.2 -44.25 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 75.44 111.127 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.32 -35.9 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.53 111.164 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.37 -41.17 79.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 73.31 110.946 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 17.9 t -84.69 -36.05 22.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 70.34 110.881 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.4 mt -51.99 -37.9 54.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 63.23 110.929 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -51.1 -46.67 61.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 73.51 110.861 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.42 -22.62 26.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 74.14 110.885 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.79 67.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.04 111.117 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.52 26.59 3.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 43.04 112.472 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.76 136.24 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 74.43 111.108 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -102.07 115.9 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 71.25 110.891 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 71.24 111.151 179.965 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.93 0.395 . . . . 74.3 110.866 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -53.73 160.57 2.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.608 0.718 . . . . 75.42 110.905 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -20.43 34.89 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.719 2.279 . . . . 61.4 112.334 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -81.63 -20.91 38.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.881 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -80.4 -59.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 71.02 111.118 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -51.77 -30.66 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 73.24 110.905 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.4 -30.88 61.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 71.13 111.114 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -25.81 22.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 70.23 110.94 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 18.7 mt -76.32 -42.12 46.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.34 110.918 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -55.23 -51.99 64.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 60.22 110.901 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.18 -26.53 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.088 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.21 76.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 73.23 111.121 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.3 mtm-85 -56.5 -44.88 81.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 74.45 110.873 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -61.64 -37.77 85.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.41 110.857 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.91 -29.84 61.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 75.03 110.912 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -67.11 -55.29 14.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 73.44 110.882 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -66.82 -28.5 68.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 73.12 110.922 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -52.5 -39.91 61.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.11 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -96.55 -35.5 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 71.53 110.879 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -80.75 57.96 3.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.839 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -25.38 68.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 74.5 110.894 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -71.27 -10.62 60.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 73.05 110.857 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.4 29.68 57.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 65.15 112.484 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.8 p -70.69 -22.18 62.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 65.23 110.843 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.48 -16.39 58.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 73.34 112.491 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -141.44 155.76 45.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.359 . . . . 72.2 110.912 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 42.0 mt -98.62 109.74 22.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 65.52 110.893 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.55 178.34 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.21 110.948 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -57.86 -26.31 61.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 71.51 110.884 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -82.63 -53.3 6.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.23 110.877 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.92 -49.05 63.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.86 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.9 mt -51.63 -38.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 74.13 111.164 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.64 -41.34 61.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.55 111.096 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.85 -30.41 32.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.744 -0.741 . . . . 72.32 112.514 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.8 tp -58.32 -54.02 51.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 74.1 110.904 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 56.6 mt -51.85 -32.28 31.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 74.11 110.93 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -54.71 -58.13 8.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 75.43 110.852 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.96 -42.82 56.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 75.43 110.855 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 93.1 m -52.42 -32.26 38.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 64.23 111.157 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -79.16 -57.53 3.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 74.11 110.924 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.51 -26.08 40.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.45 111.102 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.64 -27.65 63.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.43 110.885 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 51.8 mtm -103.91 21.86 15.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 73.13 110.887 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.84 23.07 72.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 65.14 112.505 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.0 tpp -76.57 170.03 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 65.33 110.887 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -64.48 -17.46 63.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 75.52 110.848 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 63.5 56.72 1.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.907 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -67.69 152.65 45.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 71.23 110.902 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.5 m -108.23 90.85 7.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.555 0.693 . . . . 74.45 111.161 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 174.98 8.71 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 74.33 112.305 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 68.4 p -116.15 -176.02 2.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 70.31 111.143 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -51.82 -30.42 23.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.53 110.902 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -69.38 -61.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 65.51 110.902 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.9 -45.23 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 71.03 110.875 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.6 t -58.84 -28.51 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 75.44 111.193 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -66.92 -40.0 87.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 74.52 110.911 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mp -70.12 -31.37 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 70.42 111.127 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -83.52 -28.34 28.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 75.12 110.912 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.0 tp -83.72 -38.2 21.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 72.53 110.958 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -61.05 -30.91 70.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.906 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 48.8 ttp -91.25 -40.13 11.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 61.4 110.864 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.38 -25.26 67.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.12 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -101.25 127.84 47.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.879 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 98.0 m -83.9 -25.03 30.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 72.15 111.167 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -97.32 -12.43 22.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.846 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.6 t 56.6 39.32 29.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 75.53 110.879 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -98.05 19.55 13.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 72.13 110.885 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.08 31.71 81.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.484 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.97 134.0 18.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 61.54 110.863 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.26 97.72 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 72.3 111.119 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.06 162.45 24.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 63.23 110.875 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mt -53.29 -31.57 44.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.128 -0.487 . . . . 71.02 110.893 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -81.43 -28.12 34.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.887 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -78.03 -42.46 32.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.467 . . . . 74.32 110.859 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -65.04 -52.62 54.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.917 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -51.81 -48.37 63.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 70.32 110.917 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -51.93 -35.0 44.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 73.05 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.5 tp -61.19 -45.08 96.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.24 110.943 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.1 mp -64.95 -28.32 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.11 111.115 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.99 -52.85 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 63.23 111.122 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -56.49 -30.75 63.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 71.31 110.903 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 22.1 m -83.08 -29.94 28.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 72.32 110.814 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.81 -42.72 85.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 64.35 110.874 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -51.9 -36.53 49.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.871 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -26.02 26.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 73.41 110.938 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.72 67.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 73.42 111.108 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.81 25.09 5.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.743 . . . . 75.24 112.43 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -116.57 108.5 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 63.34 111.124 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -64.6 118.4 8.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 75.13 110.901 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.116 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.917 0.389 . . . . 63.13 110.957 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -62.7 160.58 34.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.617 0.723 . . . . 75.23 110.912 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -17.78 37.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.714 2.276 . . . . 72.31 112.373 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -82.9 -22.49 33.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.887 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.28 -61.27 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 74.11 111.114 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -51.67 -29.96 20.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 70.4 110.906 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.55 84.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 63.31 111.106 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -88.42 -26.61 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 72.44 110.893 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 61.4 mt -74.78 -26.12 59.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 72.14 110.94 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.21 -54.16 28.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 53.33 110.883 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.15 -24.95 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 75.35 111.114 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.89 -39.94 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 75.45 111.118 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -54.72 -31.09 57.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.891 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -85.03 -40.94 16.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.874 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.48 -27.25 67.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 74.13 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -72.81 -49.98 27.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 73.32 110.888 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -74.83 -25.91 59.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.901 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -57.23 -25.04 58.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.53 110.922 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -110.05 -21.31 12.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 65.43 110.919 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -77.27 61.81 2.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 75.25 110.832 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -16.72 59.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 71.4 110.952 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -70.22 -10.66 59.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 63.22 110.872 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.0 20.33 53.29 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.77 -0.729 . . . . 61.02 112.509 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.7 m -78.95 -22.12 46.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.945 0.403 . . . . 74.2 110.853 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.3 -16.06 58.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 73.42 112.533 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.63 170.71 9.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 63.43 110.891 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.98 101.29 9.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 75.34 110.89 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -73.46 172.16 11.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 75.03 110.915 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.44 -27.39 36.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 74.52 110.875 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -82.23 -45.78 14.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 73.42 110.87 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -63.71 -45.18 91.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.23 110.874 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 21.2 mt -52.43 -31.35 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 70.12 111.123 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.95 58.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 73.43 111.111 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.75 -22.85 59.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.734 . . . . 72.32 112.501 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.8 tp -70.09 -59.09 3.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.808 0.337 . . . . 74.23 110.909 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 27.3 mt -52.16 -32.65 36.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 71.33 110.944 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -51.9 -57.26 9.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 65.42 110.91 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.0 -41.54 28.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 73.12 110.867 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.5 m -51.63 -30.99 23.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 70.1 111.159 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.38 -52.47 9.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 71.54 110.922 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -54.84 -25.51 28.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 74.42 111.135 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -54.29 -32.47 56.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 75.1 110.853 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.4 ptp -105.67 21.13 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.55 110.888 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.83 16.56 66.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 70.44 112.468 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.16 166.96 0.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.82 0.343 . . . . 73.34 110.873 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.2 m -65.36 -14.58 61.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.868 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t30 64.21 58.32 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 72.05 110.908 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -73.29 153.08 40.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 73.32 110.919 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.2 m -108.09 90.91 7.2 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.685 . . . . 70.33 111.133 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -174.65 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.696 2.264 . . . . 75.04 112.355 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 71.2 p -129.01 -176.01 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 75.51 111.135 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -54.72 -26.67 35.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 72.25 110.872 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -72.56 -61.64 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.89 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.07 -48.6 64.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 75.12 110.867 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 86.6 t -51.68 -42.48 31.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 63.34 111.084 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -47.0 64.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 72.13 110.918 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.44 -26.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.44 111.088 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -83.78 -30.76 26.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 73.44 110.927 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.2 tt -77.59 -47.05 20.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.954 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -51.95 -30.92 26.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 64.5 110.912 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 37.1 ttp -90.41 -26.43 19.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.844 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -96.09 21.91 8.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 74.13 111.133 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -131.8 112.2 12.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.842 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.5 m -83.74 -41.79 17.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 61.24 111.16 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.47 -12.5 59.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 64.54 110.896 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 54.66 35.2 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 64.14 110.847 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.45 -16.23 37.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.89 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.0 20.24 16.91 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 71.21 112.48 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.52 126.71 8.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 74.35 110.864 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.49 97.53 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 72.5 111.066 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.1 t -67.71 165.18 17.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.838 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 26.1 tp -53.62 -35.94 61.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 75.52 110.875 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -77.08 -24.67 51.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 75.33 110.907 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -79.58 -53.33 6.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 71.43 110.906 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -51.98 -49.95 62.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.934 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -51.82 -47.61 64.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 73.14 110.903 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -52.8 -32.53 44.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.487 . . . . 62.25 110.904 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.5 -38.94 91.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.937 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -74.17 -24.05 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 74.43 111.11 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 45.0 mm -59.4 -55.87 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.12 111.114 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -56.24 -37.95 70.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 74.53 110.892 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.6 t -66.98 -28.48 68.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 73.23 110.869 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.3 mt -79.34 -25.42 42.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 74.53 110.956 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -59.99 -45.59 92.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.879 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -86.05 -20.37 28.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.911 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.93 -22.77 67.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.056 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 108.9 32.44 3.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.78 -0.724 . . . . 75.21 112.472 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.12 131.01 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 74.4 111.107 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -90.55 133.63 34.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.904 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.154 -179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.86 0.362 . . . . 64.04 110.964 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -52.02 160.49 1.17 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.623 0.725 . . . . 64.41 110.879 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -17.13 37.61 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.688 2.258 . . . . 72.51 112.34 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -82.9 -24.63 33.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.906 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.35 -63.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 75.1 111.115 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -52.15 -30.01 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 75.31 110.879 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.76 -32.69 60.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 72.14 111.123 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -87.96 -25.73 23.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 75.02 110.936 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.2 mt -77.9 -29.23 50.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.935 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -65.7 -32.59 74.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.896 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.7 p -86.05 -23.36 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 75.31 111.12 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -82.78 -35.55 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 70.01 111.108 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -24.46 57.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 75.32 110.817 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -83.17 -23.07 33.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 73.54 110.866 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.59 -24.34 33.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.899 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -65.54 -56.43 12.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 64.25 110.881 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -72.22 -24.22 61.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.88 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -52.08 -29.88 23.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 74.53 110.875 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -110.69 -21.14 12.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.901 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -75.62 69.66 2.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 52.12 110.872 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -85.14 0.51 51.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 71.33 110.895 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.39 -10.57 59.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.869 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.16 18.7 60.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 75.23 112.529 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 p -106.32 -22.0 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.382 . . . . 64.33 110.869 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.6 21.53 66.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 74.05 112.48 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -128.72 132.54 47.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 73.51 110.879 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mp -90.81 104.78 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.923 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -88.04 177.27 6.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 72.4 110.944 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -52.04 -30.08 23.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.33 110.898 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -80.4 -55.04 5.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 74.0 110.834 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -53.95 -46.02 71.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.04 110.929 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.3 mt -57.19 -33.72 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 74.44 111.11 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.15 -48.06 61.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 73.11 111.079 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.36 -24.72 70.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 60.1 112.492 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 tp -69.42 -55.93 8.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 75.2 110.926 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 70.7 mt -51.69 -30.16 20.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 73.51 110.884 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.15 -58.57 7.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 75.01 110.915 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -71.77 -42.85 66.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 73.42 110.86 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.1 m -52.17 -34.94 47.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 62.55 111.171 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -82.11 -25.72 34.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 74.41 110.94 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.91 -25.38 43.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 74.42 111.066 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -59.68 -44.78 93.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 75.4 110.843 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.3 mtm -75.08 -18.29 60.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 70.11 110.866 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.95 17.72 36.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 75.42 112.532 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.3 ttm -66.67 175.93 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.799 0.333 . . . . 74.34 110.828 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.4 m -65.72 -14.39 61.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 63.13 110.855 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.21 73.73 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 62.33 110.841 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -78.52 152.93 31.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 75.15 110.859 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.3 m -108.03 90.88 7.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.581 0.705 . . . . 72.53 111.124 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 169.19 19.43 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.703 2.268 . . . . 74.45 112.348 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 62.7 p -108.63 -176.06 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 74.23 111.139 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -24.97 46.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 75.5 110.89 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -77.8 -55.4 5.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.13 110.895 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.57 -35.89 43.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 73.44 110.872 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.4 t -65.83 -36.79 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 73.14 111.144 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -59.03 -46.63 87.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.898 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mp -62.61 -28.01 43.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 74.41 111.111 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -83.8 -26.03 29.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.892 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.0 tt -77.3 -35.21 55.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.14 110.875 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.67 -26.62 67.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.2 110.907 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.9 ttm -87.66 -49.81 6.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 74.23 110.895 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.32 -44.37 97.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 63.01 111.107 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -58.57 98.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 72.54 110.804 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 97.4 m -86.66 -24.75 25.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 75.14 111.133 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -95.44 -12.35 26.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 71.34 110.902 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 62.27 48.16 4.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.853 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -110.31 23.81 13.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.11 110.862 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.68 14.51 58.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 53.31 112.503 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.72 158.86 40.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 74.12 110.86 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.4 t -117.62 122.72 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 73.51 111.141 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 -169.74 2.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.873 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -43.83 84.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 72.4 110.893 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -72.49 -34.59 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 72.15 110.878 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.7 -23.03 53.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 73.52 110.899 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -82.11 -50.33 9.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 75.12 110.959 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -53.61 -43.71 68.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 71.1 110.866 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -52.01 -29.96 23.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.22 110.885 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.35 -43.1 95.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.946 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.2 mp -69.78 -24.64 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.42 111.126 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.0 mm -59.2 -55.6 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 72.11 111.142 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -52.62 -38.07 59.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 75.21 110.876 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 p -74.57 -29.81 61.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.892 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.7 mt -68.51 -33.37 74.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 74.21 110.948 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -57.67 -47.18 83.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 73.15 110.905 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -24.68 32.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 72.51 110.909 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.88 -21.18 66.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 70.52 111.118 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.89 20.7 4.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.738 . . . . 72.25 112.535 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.73 103.85 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 74.12 111.138 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -72.12 108.45 5.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.41 110.86 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.3 111.168 179.976 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.897 0.379 . . . . 75.42 110.924 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -51.93 160.88 1.03 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 65.54 110.871 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -17.19 37.61 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.715 2.277 . . . . 73.44 112.301 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -82.99 -24.84 32.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 73.23 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.59 -63.35 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 74.51 111.128 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -51.88 -33.61 37.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 73.01 110.876 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.42 -36.36 54.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 75.32 111.144 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -83.06 -26.17 31.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 74.32 110.921 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 92.5 mt -74.31 -37.19 63.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.34 110.953 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.91 -57.25 11.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 75.12 110.924 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.89 -25.23 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.14 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.86 -29.7 40.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 62.35 111.139 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -60.03 -54.26 48.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.52 110.869 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 -54.24 -46.24 72.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.841 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.8 tp -56.97 -34.37 68.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 72.41 110.925 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -59.77 -62.99 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 72.45 110.907 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -62.89 -26.96 69.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 73.44 110.902 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -31.42 36.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.902 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.29 -38.08 7.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 75.24 110.943 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.88 76.23 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 74.31 110.857 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -67.2 -30.62 70.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 75.53 110.907 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.92 -10.55 59.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.32 110.869 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.74 22.49 40.56 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.733 -0.746 . . . . 64.35 112.463 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.3 m -71.42 -22.06 61.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 75.22 110.891 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.7 23.5 57.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.514 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -145.79 130.74 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.358 . . . . 73.03 110.908 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mt -103.85 101.42 11.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 75.52 110.934 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -62.89 174.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 54.02 110.901 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.14 -26.49 38.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 34.51 110.891 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.63 -54.67 5.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 70.2 110.857 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -52.22 -38.85 59.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 72.12 110.899 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.3 mt -63.32 -32.96 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 75.23 111.115 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.7 -42.13 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 73.0 111.115 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.34 -25.9 45.77 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.713 -0.756 . . . . 72.53 112.465 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.2 tp -60.88 -55.85 28.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 73.51 110.937 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.5 mt -52.03 -33.94 40.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 70.13 110.903 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -59.73 4.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 71.33 110.923 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.13 -41.42 61.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 75.4 110.832 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 89.0 m -53.44 -32.92 52.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 74.33 111.126 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -77.33 -51.23 11.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.895 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -58.19 -30.63 66.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 65.13 111.113 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.9 -46.77 64.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 71.32 110.922 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 33.1 mtm -76.8 -18.46 58.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 63.41 110.912 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 95.89 28.66 9.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.74 -0.743 . . . . 73.35 112.426 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 6.3 ttm -86.0 175.79 8.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 75.14 110.853 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.0 m -58.29 -22.97 54.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 71.32 110.848 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 63.36 60.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 60.31 110.896 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -65.62 152.51 43.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 73.33 110.864 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.0 p -108.31 90.82 7.39 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.589 0.709 . . . . 75.05 111.135 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -171.19 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.28 . . . . 71.11 112.322 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 34.3 p -126.5 -176.17 3.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.132 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -57.45 -26.36 61.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 74.34 110.918 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -72.53 -61.56 1.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 73.14 110.886 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.27 -48.82 65.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.477 . . . . 75.22 110.849 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.7 t -51.62 -34.87 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 70.35 111.115 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.27 -52.53 64.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 75.53 110.882 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 mp -57.46 -25.83 25.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 75.4 111.171 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 49.6 t90 -82.69 -37.72 24.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 74.05 110.935 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.6 tt -57.63 -46.38 84.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 72.41 110.865 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -54.7 -36.38 64.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 71.54 110.925 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.2 mtm -65.79 -54.22 29.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 73.44 110.873 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.53 -63.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 71.34 111.098 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -69.32 129.28 39.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 73.03 110.888 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 8.5 m -85.22 -24.79 27.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.123 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -89.39 -12.4 40.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 74.43 110.904 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.5 p 51.59 39.73 25.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 73.35 110.898 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -95.24 23.92 5.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.89 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 65.58 29.3 74.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.739 . . . . 53.44 112.49 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m -154.71 126.88 7.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.401 . . . . 75.22 110.828 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.71 106.38 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 73.34 111.133 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.1 t -72.1 178.32 3.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 72.43 110.86 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.67 -38.03 89.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.946 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -81.26 -25.59 36.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 63.32 110.899 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.35 -23.19 40.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 72.01 110.882 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -84.27 -51.81 6.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 74.55 110.936 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.1 -43.83 67.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.487 . . . . 72.24 110.888 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -52.74 -41.91 64.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.909 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.0 tt -52.42 -39.61 61.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 75.3 110.919 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -73.81 -25.85 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 73.34 111.152 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.5 mm -67.45 -38.14 80.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 73.42 111.121 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -66.28 -36.88 84.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 74.41 110.9 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 43.7 m -78.36 -37.82 43.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 73.11 110.865 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.7 mt -57.8 -35.89 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 73.14 110.919 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -56.83 -37.71 71.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.908 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -85.59 -24.88 26.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.951 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.74 67.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 75.34 111.126 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.72 24.15 3.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 65.13 112.51 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.04 102.0 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 73.11 111.135 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -69.45 101.26 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 73.24 110.915 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 75.51 111.142 -179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.886 0.374 . . . . 73.51 110.955 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.66 160.8 1.84 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 72.42 110.89 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -21.41 33.27 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 2.253 . . . . 75.0 112.337 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.94 -21.83 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 74.05 110.863 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -77.73 -61.17 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 75.02 111.173 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -52.08 -29.86 23.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.03 110.892 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.81 -38.73 70.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 44.44 111.132 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -83.95 -25.39 30.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.04 110.938 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.2 mt -75.24 -30.27 60.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.933 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.65 -56.13 25.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.472 . . . . 64.51 110.847 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.97 -26.75 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 71.01 111.142 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.83 -32.2 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 51.24 111.091 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.0 mtt180 -59.94 -45.78 91.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 75.35 110.878 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -60.71 -33.03 72.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.32 110.864 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.0 tp -69.48 -26.32 64.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 73.55 110.921 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -64.07 -63.72 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 62.03 110.906 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -59.43 -26.64 65.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 71.41 110.89 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -55.99 -26.92 50.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.32 110.874 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -110.35 -27.19 9.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.959 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.12 78.74 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.848 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -26.11 33.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.926 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -70.78 -10.63 59.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.858 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.99 20.66 50.18 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.761 -0.733 . . . . 70.24 112.461 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 p -86.84 -22.09 26.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 65.11 110.829 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.21 23.1 41.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 50.13 112.473 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -138.28 152.01 48.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 74.14 110.902 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.4 mt -118.81 102.69 9.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 74.12 110.895 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -70.62 173.9 6.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.875 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -55.07 -26.76 39.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 63.25 110.879 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.4 -32.34 48.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 74.52 110.865 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -84.5 -26.26 28.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 71.24 110.857 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 21.3 mt -74.51 -41.04 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 73.24 111.149 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.56 -45.11 62.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 62.05 111.117 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.22 -22.84 56.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.754 . . . . 60.03 112.496 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.9 tp -60.31 -54.41 46.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 71.42 110.953 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.91 -34.42 41.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 64.21 110.953 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -52.94 -49.21 66.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.3 110.899 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -82.25 -43.35 17.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.869 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.2 m -53.79 -30.95 47.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 64.2 111.207 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -81.04 -57.92 3.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.46 -25.6 37.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.45 111.143 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.17 -26.3 62.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.907 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 38.7 mtm -110.75 21.68 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.867 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 18.56 68.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.749 -0.739 . . . . 72.33 112.486 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.0 mmt -63.31 171.8 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 75.35 110.903 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.1 t -59.83 -20.92 59.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 75.04 110.876 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.5 t30 63.66 63.77 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 71.55 110.896 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -88.26 152.49 21.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.25 110.868 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.5 p -108.24 90.83 7.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.577 0.703 . . . . 63.21 111.148 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 157.03 61.75 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.639 2.226 . . . . 75.52 112.369 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 71.9 p -91.91 -176.94 4.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.34 111.166 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -56.44 -25.38 50.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 75.41 110.864 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.15 -59.92 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.04 110.918 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -52.99 -30.91 37.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 64.21 110.905 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.4 -32.56 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 62.31 111.111 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.15 -43.66 94.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 70.24 110.899 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mp -63.98 -34.64 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 74.01 111.144 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -81.7 -25.72 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 72.23 110.901 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 31.1 tp -83.8 -25.34 30.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 73.04 110.89 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -52.98 -58.38 7.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 74.1 110.93 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 43.5 mtm -67.09 -46.05 75.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 63.53 110.851 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -56.1 -25.04 44.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 75.03 111.127 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -88.26 95.75 10.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.21 110.883 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.8 m -87.68 -34.5 18.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 65.32 111.11 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.29 6.34 33.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 71.54 110.9 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.9 p 46.14 36.44 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 71.22 110.83 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -96.33 -16.27 21.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 74.41 110.802 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 99.29 19.44 20.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.767 -0.73 . . . . 63.52 112.476 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.2 m -142.31 -177.35 5.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.937 0.398 . . . . 73.11 110.838 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.87 106.37 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 75.22 111.155 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -77.51 -176.05 4.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.868 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.99 -38.58 86.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 75.25 110.937 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -77.75 -25.65 49.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.905 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -84.93 -23.54 28.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 72.34 110.91 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -81.87 -43.53 18.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 72.53 110.877 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -54.06 -41.86 68.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.03 110.864 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -51.7 -44.08 63.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 73.55 110.932 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 53.4 mt -51.75 -33.88 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.921 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -79.43 -36.08 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 74.0 111.114 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.44 -29.62 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.117 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.58 -62.16 2.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 64.02 110.912 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 46.3 t -53.14 -37.37 61.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 71.32 110.904 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.9 mp -55.65 -24.57 34.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 74.11 110.944 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.95 -58.98 3.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 74.01 110.894 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -78.78 -5.81 54.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.892 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.17 13.99 15.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 61.45 111.158 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.16 33.46 85.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 62.23 112.514 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 6.5 mm -102.1 111.72 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 74.13 111.124 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 100.28 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 70.4 110.907 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 74.34 111.114 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.3 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.864 0.364 . . . . 75.43 110.816 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 86.2 p -117.88 143.71 46.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.88 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -100.13 160.95 25.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.53 0.681 . . . . 75.35 110.924 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -171.27 0.46 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.658 2.239 . . . . 75.4 112.335 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -128.72 103.77 7.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.87 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -100.83 150.82 22.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.12 110.911 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.62 161.12 62.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.721 . . . . 75.22 110.9 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -18.87 36.81 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.678 2.252 . . . . 73.33 112.326 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -82.04 -23.56 35.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 62.11 110.873 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.55 -63.28 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 62.44 111.119 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -51.86 -30.66 24.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 72.43 110.855 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -37.91 63.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 75.32 111.107 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -87.98 -25.73 23.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.926 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.3 mt -72.92 -27.27 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.895 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -66.64 -51.8 52.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 74.15 110.853 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.35 -25.15 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 71.5 111.121 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.25 -25.62 36.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.085 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -67.13 -47.18 71.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.3 110.842 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -63.41 -35.21 79.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.882 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.72 -29.48 69.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.896 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -65.5 -59.55 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 74.04 110.852 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -64.47 -28.07 69.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 74.43 110.882 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -55.5 -26.75 44.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 73.41 110.89 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -108.21 -30.48 8.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 65.5 110.919 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.23 84.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.892 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -85.03 -32.01 23.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.15 110.925 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.56 -10.57 59.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 53.13 110.864 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.75 23.29 43.88 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.722 -0.752 . . . . 64.04 112.476 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.9 p -75.25 -22.17 58.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 74.43 110.845 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.5 19.64 58.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.734 . . . . 73.34 112.463 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -148.34 130.75 15.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 64.35 110.918 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 21.7 mt -94.13 101.67 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 74.25 110.897 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -66.26 174.13 2.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 72.33 110.924 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.98 -30.15 23.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 75.05 110.868 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.73 -54.7 6.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.213 -0.448 . . . . 74.31 110.882 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -55.24 -28.36 52.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.45 110.872 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.6 mt -79.69 -25.44 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 74.24 111.102 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.31 -53.12 48.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 72.2 111.124 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.05 -23.03 56.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.678 -0.772 . . . . 63.43 112.506 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -56.61 -52.6 64.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 75.55 110.922 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.9 mt -52.02 -41.43 62.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 75.53 110.905 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -51.93 -38.87 57.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 73.13 110.881 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -85.11 -49.58 8.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.23 110.86 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.2 m -53.09 -29.02 28.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.32 111.163 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -76.82 -33.57 57.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 75.12 110.961 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.71 -25.16 66.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 75.24 111.062 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -55.71 -26.97 47.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.44 110.9 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 19.9 mtm -109.81 16.8 21.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 71.12 110.889 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 19.46 69.47 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 73.12 112.468 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.3 tpp -63.39 168.41 4.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 73.2 110.883 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 43.2 t -71.12 -10.38 59.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 75.22 110.82 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.2 m120 63.34 51.82 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 75.2 110.957 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -52.99 152.51 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 52.11 110.893 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.4 m -108.22 90.84 7.3 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.54 0.686 . . . . 74.25 111.129 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -177.37 1.84 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.664 2.242 . . . . 64.25 112.338 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 73.1 p -123.82 -176.1 3.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 74.12 111.131 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -55.5 -27.32 47.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 75.3 110.9 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -73.15 -61.13 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 75.44 110.891 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -52.02 -44.91 64.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.823 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 86.7 t -57.47 -28.69 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 62.03 111.117 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -68.03 -45.69 73.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 74.42 110.904 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.4 mp -66.44 -25.98 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.3 111.15 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -83.21 -30.42 27.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 75.33 110.92 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.71 -37.89 79.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.93 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -63.02 -27.39 69.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 63.33 110.903 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.0 ttm -71.93 -54.51 9.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 75.43 110.912 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.27 -66.27 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 73.11 111.119 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -53.27 129.17 30.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 54.01 110.851 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 25.1 m -85.67 -25.16 26.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 73.33 111.135 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -98.58 -12.45 21.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.936 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.3 p 51.97 37.77 22.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 71.14 110.845 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -95.42 23.96 5.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.87 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.31 31.64 74.67 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 70.12 112.478 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.44 126.98 9.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 72.44 110.858 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.0 t -115.6 104.85 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 74.53 111.133 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 37.3 t -69.4 170.67 9.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 72.23 110.878 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.81 -36.66 72.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 73.32 110.956 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.46 -25.64 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 74.53 110.892 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -81.77 -23.3 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 73.12 110.891 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -83.8 -51.85 6.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.906 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.03 -43.81 63.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 71.41 110.871 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.93 -41.17 61.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 63.31 110.881 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.0 tp -53.89 -35.68 61.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 74.23 110.916 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.99 -25.12 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 71.54 111.091 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.18 -50.88 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 71.22 111.163 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -55.85 -36.09 67.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 73.11 110.877 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -77.94 -35.36 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 72.43 110.841 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 22.9 mt -62.32 -28.33 69.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 65.4 110.943 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -64.19 -43.49 94.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 70.41 110.928 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -85.94 -24.92 26.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.45 110.901 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.94 -22.58 67.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.099 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.5 31.86 1.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 71.05 112.486 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.68 122.89 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 72.44 111.124 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -83.01 119.5 24.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 72.22 110.897 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.9 p -124.43 144.35 34.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.31 111.124 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.14 131.12 40.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 71.31 110.873 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.71 146.65 49.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 74.24 110.899 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -61.34 103.79 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 72.14 110.935 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.9 m -127.01 120.54 29.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.866 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.1 mt -106.37 165.59 11.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.154 -0.475 . . . . 74.5 110.943 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.79 124.41 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.3 111.137 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.874 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.879 0.371 . . . . 74.44 110.845 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.9 m -159.89 43.04 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 72.43 110.842 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -79.18 160.18 71.35 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.609 0.718 . . . . 63.31 110.901 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 142.35 47.39 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 72.43 112.342 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.4 tptm -90.96 112.3 24.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 73.03 110.924 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -109.89 135.08 51.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 71.34 110.918 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -53.18 160.55 1.61 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 65.44 110.922 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -20.1 35.44 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.705 2.27 . . . . 72.54 112.394 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -82.85 -20.33 35.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 61.25 110.908 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 t -81.3 -63.35 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 72.53 111.149 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -25.43 42.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 63.25 110.897 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.34 78.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 61.12 111.081 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -88.45 -25.37 22.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 74.1 110.903 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.9 mt -79.33 -24.06 43.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.933 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.68 -46.51 65.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 74.13 110.904 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.19 -23.61 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 72.33 111.106 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -77.4 -21.79 52.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 74.13 111.078 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 55.5 mtt85 -69.12 -52.29 29.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.889 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -52.03 -29.95 23.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 75.04 110.856 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.71 -44.53 64.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 74.33 110.929 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -52.36 -48.05 65.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 75.52 110.895 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -75.93 -28.41 57.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.86 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -67.9 -25.91 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 73.33 110.886 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -104.51 -26.2 12.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 73.32 110.968 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -90.43 64.45 5.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.521 . . . . 72.33 110.886 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -28.19 67.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 75.53 110.893 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -70.76 -10.52 59.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.889 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.86 25.74 53.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 50.35 112.502 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.8 p -75.85 -22.1 56.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.924 0.392 . . . . 73.44 110.882 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.62 19.57 65.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 74.35 112.513 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -149.91 130.8 14.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 70.34 110.922 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.7 mt -94.97 101.74 13.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.879 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -70.16 171.81 9.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.932 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -52.13 -30.14 25.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 62.45 110.826 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -74.61 -45.95 41.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 64.24 110.881 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.36 -38.95 88.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 64.23 110.859 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.46 -30.97 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 73.25 111.157 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.78 -45.76 63.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 72.34 111.102 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.32 -27.45 39.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 61.21 112.493 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.2 tp -54.81 -56.56 18.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 74.23 110.919 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.0 mt -51.96 -33.93 39.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.934 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -52.71 -50.5 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 75.43 110.854 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -82.26 -44.25 16.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 64.4 110.871 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.9 m -52.16 -29.55 22.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 75.2 111.18 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -79.33 -49.17 12.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 72.03 110.968 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.97 -24.71 55.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 72.23 111.105 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -27.14 42.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 72.21 110.852 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.1 mtm -111.28 21.71 15.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 75.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.92 19.05 69.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 72.24 112.494 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.4 tpp -64.38 164.04 12.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 74.34 110.896 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.8 t -62.47 -17.62 59.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 74.33 110.848 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 63.52 56.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 74.05 110.9 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -65.87 152.61 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.855 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 p -108.23 90.84 7.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.544 0.688 . . . . 74.12 111.11 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -172.88 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 51.41 112.347 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 79.9 p -120.76 -177.37 3.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 75.05 111.16 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -60.18 -25.69 65.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 72.54 110.93 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -72.51 -61.5 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 72.32 110.9 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -52.22 -49.0 64.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 72.32 110.871 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.1 t -52.76 -33.53 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 63.44 111.124 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -62.44 -49.9 73.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 73.12 110.92 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.0 mp -61.15 -25.15 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 75.0 111.098 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -78.15 -30.29 49.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.956 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.1 tt -72.54 -34.77 67.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 72.12 110.933 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -61.25 -28.74 69.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 70.01 110.923 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 5.9 ttp -86.92 -39.09 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 74.14 110.87 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.33 -49.95 56.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 72.24 111.113 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -84.24 127.59 34.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 71.54 110.894 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 21.3 p -76.08 -42.69 46.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 73.11 111.101 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -76.32 -12.41 60.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 72.15 110.891 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.1 p 52.15 37.19 21.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 72.55 110.827 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -79.04 -16.21 57.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 75.42 110.887 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.1 22.82 8.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 71.23 112.489 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.2 p -153.6 127.14 8.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.916 0.389 . . . . 64.15 110.82 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.41 124.83 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 75.14 111.096 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -174.77 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 71.21 110.897 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.11 -33.62 67.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 72.12 110.927 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.06 -62.35 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.87 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -52.37 -46.16 66.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 71.12 110.878 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -62.04 -58.34 8.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 75.31 110.888 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -54.89 -28.12 48.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.914 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -72.5 -29.54 63.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 75.53 110.819 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.4 tt -64.0 -35.08 79.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 73.12 110.897 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -73.34 -24.91 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 74.33 111.116 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.7 mm -58.4 -43.37 86.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 72.24 111.11 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -67.81 -48.16 67.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 75.24 110.889 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 53.5 p -52.18 -40.86 62.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 74.3 110.864 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.99 -33.16 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 75.21 110.926 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -43.3 89.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 64.14 110.911 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -86.11 -25.77 25.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 74.02 110.908 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.98 -22.76 67.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 72.01 111.094 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.43 20.14 5.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.739 . . . . 74.2 112.49 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.15 102.75 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.815 0.341 . . . . 72.14 111.121 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -71.06 126.03 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 75.23 110.871 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.3 p -118.21 124.15 72.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.05 111.128 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.23 107.83 7.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 71.31 110.904 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -142.42 127.77 18.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.927 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -121.17 157.72 29.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 71.33 110.89 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 12.0 m -146.15 -178.76 6.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 72.5 110.889 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.6 mt -85.22 71.39 10.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 73.13 110.891 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.36 160.1 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.22 -0.445 . . . . 70.24 111.154 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.852 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.922 0.391 . . . . 72.24 110.855 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.3 p -119.32 175.5 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 71.11 110.917 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -117.06 160.68 36.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.599 0.714 . . . . 74.23 110.916 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 158.01 58.49 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.721 2.28 . . . . 72.21 112.323 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.01 111.68 20.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 64.5 110.944 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -99.81 163.59 12.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 71.4 110.944 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -78.3 160.82 72.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.615 0.721 . . . . 74.43 110.926 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -20.26 35.05 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.733 2.289 . . . . 52.11 112.329 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -82.89 -20.94 34.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 73.21 110.887 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.74 -61.99 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 63.33 111.132 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.66 -30.08 20.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.44 110.894 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.5 -34.52 71.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.125 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -88.36 -23.98 23.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.53 110.954 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.7 mt -80.88 -24.31 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 72.53 110.878 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.04 -29.48 65.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 72.41 110.876 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.99 -23.38 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 75.14 111.115 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.14 -37.51 20.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.41 111.11 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -54.65 -29.99 54.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 75.22 110.87 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -70.58 -28.98 65.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 75.11 110.872 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.64 -25.85 35.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 70.11 110.893 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.43 -63.21 1.19 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 71.33 110.89 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -60.18 -26.58 66.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 75.31 110.926 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -52.08 -30.02 24.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.852 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -101.54 -26.29 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 74.33 110.894 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.2 85.4 0.56 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 63.22 110.84 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -80.7 -26.29 37.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 75.24 110.892 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.79 -10.58 59.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 73.11 110.894 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.23 20.45 50.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 62.41 112.503 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 p -87.26 -22.18 25.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.945 0.402 . . . . 73.22 110.852 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.74 21.58 42.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.7 -0.762 . . . . 73.02 112.472 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -136.73 138.07 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 73.45 110.925 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.0 mt -103.89 112.53 25.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 74.54 110.91 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -79.83 173.66 12.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.54 110.915 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -53.07 -28.85 26.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 63.51 110.883 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -78.74 -37.85 40.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.901 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -75.7 -26.18 57.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 74.14 110.901 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 25.8 mt -76.81 -34.59 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.149 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.78 -46.65 64.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 73.15 111.083 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.59 -23.3 56.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 73.33 112.482 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 18.0 tp -60.7 -56.49 20.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.858 0.361 . . . . 70.35 110.917 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 45.7 mt -52.15 -36.42 51.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 72.12 110.922 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -51.88 -45.77 64.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.883 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.24 -45.05 13.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.24 110.869 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.4 m -51.85 -30.44 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.2 111.137 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -81.03 -53.62 6.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.892 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.13 -24.69 42.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 70.31 111.12 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -54.69 -31.06 57.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.896 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -107.21 21.85 16.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 74.2 110.873 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.95 21.45 71.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.727 . . . . 74.54 112.447 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.43 165.47 16.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.341 . . . . 74.31 110.86 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.1 m -60.05 -20.61 58.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 73.45 110.881 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 63.6 59.48 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 74.25 110.952 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -67.83 152.4 45.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 72.22 110.902 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.5 m -108.18 90.78 7.18 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.564 0.697 . . . . 71.42 111.134 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.75 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.69 2.26 . . . . 71.21 112.343 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 71.3 p -126.43 -176.03 3.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 72.01 111.165 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -57.37 -25.72 59.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 65.53 110.829 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -74.65 -60.81 2.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 75.14 110.881 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -45.91 64.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 72.51 110.859 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 97.2 t -56.2 -31.02 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 75.33 111.103 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -65.38 -49.81 67.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 71.4 110.886 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.0 mp -60.14 -26.76 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.11 111.153 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 87.3 t90 -82.39 -26.32 32.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.919 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.9 tt -76.08 -36.46 58.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.892 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -52.38 -49.5 64.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.5 -26.85 65.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 74.12 110.88 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.69 -68.83 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.0 111.108 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -62.28 118.83 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 75.44 110.886 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.1 m -86.74 -37.54 17.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.146 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -78.48 -12.46 60.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 72.11 110.888 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.8 t 61.75 45.4 7.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 63.4 110.891 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -91.0 -16.17 28.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 63.42 110.835 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.25 19.46 12.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 63.14 112.515 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.52 152.4 30.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 72.24 110.876 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.1 t -108.39 114.17 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 74.24 111.106 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.6 t -85.08 -171.1 3.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 65.15 110.878 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.81 -57.55 10.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 74.42 110.923 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.47 -43.74 96.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 63.31 110.847 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.53 -59.85 4.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.857 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -53.73 -49.87 67.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 72.04 110.94 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -24.35 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 73.31 110.835 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -69.67 -26.16 64.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 64.03 110.875 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.17 -38.5 85.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 74.02 110.916 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.2 mp -69.49 -24.32 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 72.14 111.125 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.7 mm -55.91 -49.63 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.211 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -51.94 -62.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.3 110.878 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.1 m -53.44 -28.6 30.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 73.53 110.836 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.8 -42.68 94.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 74.22 110.903 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -52.22 -39.61 60.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.13 110.948 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -85.95 -24.24 26.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.89 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.89 -22.81 67.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 74.43 111.111 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.36 30.01 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.773 -0.727 . . . . 53.44 112.458 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.03 137.57 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 75.21 111.151 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -98.94 113.84 26.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.904 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.72 144.36 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 70.54 111.179 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.42 125.79 41.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 75.31 110.875 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -119.46 138.08 53.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.848 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -137.98 105.48 5.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 71.53 110.872 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.6 t -86.41 -175.85 5.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.865 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 mt -104.77 134.4 47.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 74.21 110.901 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.79 148.08 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.12 111.122 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 3.5 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 65.41 110.854 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.868 0.366 . . . . 74.43 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.1 m -81.9 165.41 20.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 73.32 110.859 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 157.53 69.85 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.581 0.705 . . . . 73.41 110.881 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 127.93 15.26 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.74 2.294 . . . . 72.44 112.284 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -81.87 102.71 11.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 73.45 110.91 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -99.63 149.6 23.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 72.34 110.912 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -65.13 160.74 54.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.665 0.745 . . . . 74.32 110.848 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -20.29 35.34 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.743 2.295 . . . . 71.32 112.354 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -82.89 -21.15 34.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 75.11 110.859 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.69 -63.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.04 111.089 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -52.08 -29.92 23.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.84 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.04 -36.13 65.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.114 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.7 tptt -82.74 -26.5 31.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 72.14 110.841 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 21.0 mt -78.69 -25.76 44.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 64.31 110.897 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -69.3 -32.14 71.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.854 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.6 -24.78 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.22 111.119 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.64 -43.93 36.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 64.44 111.071 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -52.08 -29.98 23.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.862 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -75.98 -35.32 59.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 75.15 110.913 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.4 tp -69.41 -25.66 64.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 73.22 110.911 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.01 -64.58 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 74.24 110.856 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -27.41 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.935 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -53.37 -28.64 30.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.55 110.863 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -109.11 -26.69 10.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 75.31 110.918 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -76.44 69.81 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.485 . . . . 73.4 110.881 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -67.62 -26.95 66.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.931 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.62 -10.49 59.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 70.43 110.842 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.31 24.58 52.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 52.35 112.478 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.3 t -77.65 -22.07 51.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 73.12 110.841 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.14 23.8 56.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.666 -0.778 . . . . 73.14 112.503 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -148.16 134.57 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 75.22 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.8 mt -106.33 101.99 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.894 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.83 174.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 75.42 110.874 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -54.57 -27.24 37.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 71.1 110.88 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.3 -51.01 7.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 72.15 110.866 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -54.84 -30.99 58.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 64.31 110.855 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.9 mt -73.89 -26.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 75.54 111.124 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.69 -47.88 63.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.54 111.074 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.35 -22.87 55.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 73.4 112.456 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.3 tp -58.61 -54.88 42.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 75.5 110.914 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 33.6 mt -51.91 -32.81 34.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.45 110.901 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -52.58 -60.7 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 71.11 110.954 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -73.81 -38.26 64.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.55 110.874 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.1 m -57.48 -30.19 64.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 74.12 111.117 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -82.31 -55.12 4.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 72.44 110.902 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.21 -25.7 34.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 73.4 111.098 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.95 -25.9 45.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 73.14 110.88 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.3 mtm -110.24 19.2 19.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.43 110.839 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.78 19.24 69.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 74.04 112.505 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.5 mtt -64.65 172.97 2.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 74.13 110.886 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 49.1 p -59.77 -21.03 60.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 75.14 110.868 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 5.8 t30 63.56 58.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 65.23 110.898 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -78.01 152.6 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.13 110.837 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 60.9 m -108.23 90.84 7.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.561 0.696 . . . . 74.15 111.141 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 168.96 19.99 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.706 2.271 . . . . 73.34 112.378 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 27.8 p -108.76 -178.02 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 72.11 111.124 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -55.58 -25.89 40.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 71.21 110.891 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -72.88 -61.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.885 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -51.91 -36.6 49.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 52.14 110.856 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.3 t -60.98 -40.87 86.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 73.24 111.103 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -54.56 -40.92 69.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 74.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.8 mp -69.99 -25.97 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 72.13 111.166 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -83.76 -31.12 26.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.901 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.7 tt -78.32 -46.3 20.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 71.44 110.911 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.99 -31.55 29.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.9 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 53.3 ttp -90.51 -25.89 20.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 65.33 110.883 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -73.95 -52.12 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 74.43 111.095 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -85.31 127.8 34.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.43 110.864 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 3.2 m -69.39 -24.53 63.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 73.53 111.158 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -98.08 -10.4 24.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.228 -0.442 . . . . 73.42 110.872 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.4 p 52.99 36.3 21.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.86 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.0 -16.24 57.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 62.2 110.836 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.19 22.9 8.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.731 . . . . 61.43 112.532 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.14 126.93 11.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 70.52 110.828 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.8 t -109.4 112.94 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 72.3 111.12 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.04 -174.89 4.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.875 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.69 -33.84 76.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 73.24 110.892 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.48 -36.8 32.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 63.01 110.931 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.19 -21.64 60.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 71.24 110.91 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -84.48 -51.71 6.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 74.13 110.889 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -53.99 -43.69 70.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 54.42 110.859 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.84 -26.13 63.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 71.5 110.853 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.5 tt -67.48 -38.24 84.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.881 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -73.75 -24.58 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 73.32 111.086 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mm -56.6 -57.22 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 75.4 111.098 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -56.18 -25.14 45.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 71.24 110.903 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.4 m -83.23 -26.31 30.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 73.53 110.849 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 36.2 mt -79.35 -45.0 20.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 63.3 110.956 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -51.99 -37.83 54.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.874 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -86.09 -29.07 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 74.22 110.901 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -18.2 65.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 72.2 111.135 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.96 23.05 4.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.774 -0.727 . . . . 43.32 112.517 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.63 101.87 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.343 . . . . 73.23 111.158 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.5 111.44 1.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 72.1 110.891 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.5 p -117.67 121.07 66.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 74.44 111.153 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -103.94 150.99 23.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.9 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 148.4 33.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 74.13 110.904 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -56.48 106.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.905 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 12.6 p -101.6 178.45 4.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.852 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.02 142.21 24.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 73.14 110.883 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.57 144.88 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 74.15 111.114 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 72.23 110.837 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.913 0.387 . . . . 73.43 110.82 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.1 t -98.54 156.85 16.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 65.53 110.871 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.07 160.85 24.9 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 75.22 110.878 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 168.21 22.25 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.685 2.257 . . . . 74.14 112.299 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.14 105.6 15.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 74.24 110.871 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.49 140.01 43.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.902 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.65 160.52 3.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 73.4 110.883 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -19.31 36.65 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 73.23 112.355 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -80.3 -24.8 39.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 75.34 110.896 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.39 -63.42 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 74.22 111.155 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -51.49 -30.84 21.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.14 110.875 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.6 -33.15 59.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 70.22 111.068 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -88.36 -30.54 19.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 75.51 110.947 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.81 -26.28 61.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.42 110.922 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -65.41 -46.17 81.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.84 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.7 p -74.35 -23.73 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.34 111.097 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.86 -22.04 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 72.01 111.091 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -76.08 -57.19 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.869 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -58.22 -25.33 61.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.14 110.866 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.2 tp -78.3 -26.66 47.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.165 -0.471 . . . . 74.3 110.953 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -69.61 -57.51 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.842 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -65.55 -27.6 68.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 71.32 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 -54.12 -27.87 35.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 62.24 110.86 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -105.65 -40.43 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 75.14 110.909 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -73.03 84.66 1.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 71.11 110.849 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -73.03 -26.24 61.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 74.3 110.93 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.47 -10.52 59.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 75.41 110.847 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.71 22.44 40.15 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 62.34 112.536 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.5 t -76.12 -22.1 55.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 73.45 110.886 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.74 19.3 61.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 65.43 112.489 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -138.47 131.35 29.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.804 0.335 . . . . 72.5 110.933 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 55.8 mt -100.97 104.11 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 73.45 110.903 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.04 173.56 2.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.12 110.92 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -52.82 -29.13 26.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.897 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -80.44 -53.28 6.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 71.22 110.877 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.25 -39.17 59.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 72.13 110.889 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.1 mt -65.85 -30.51 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 74.44 111.131 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.73 -45.72 63.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.33 111.124 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.33 -23.21 55.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 72.53 112.507 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.91 -54.65 43.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 72.23 110.932 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 36.0 mt -51.91 -35.24 44.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 72.25 110.923 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -52.73 -51.76 59.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 74.43 110.882 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -78.81 -43.7 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.5 110.85 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.2 m -54.55 -31.16 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 74.44 111.133 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -82.42 -59.56 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.25 110.934 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -53.4 -28.08 27.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 75.23 111.098 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -55.63 -26.17 42.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.45 110.91 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.2 mtm -110.54 21.79 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.924 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 18.78 68.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.768 -0.729 . . . . 74.53 112.513 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.1 mmt -60.66 172.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 73.41 110.891 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 69.4 m -62.46 -17.72 60.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 75.1 110.847 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 63.49 48.24 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 60.02 110.888 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -68.61 152.57 45.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.861 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 p -108.21 90.83 7.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.588 0.709 . . . . 75.22 111.154 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 175.3 8.29 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.687 2.258 . . . . 73.24 112.387 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 72.1 p -121.21 -176.14 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 72.42 111.116 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -55.66 -25.81 41.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.928 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -72.54 -61.51 1.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.938 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.51 -40.84 65.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.31 110.899 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.8 t -59.72 -31.12 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 71.35 111.09 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -65.13 -41.65 94.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.873 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.5 mp -70.39 -26.48 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 72.32 111.133 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 57.4 t90 -83.6 -40.09 19.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 75.01 110.945 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.2 tt -58.6 -26.89 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 75.14 110.855 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -70.96 -49.38 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.923 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.6 ttp -64.9 -26.97 68.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 72.23 110.887 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.63 -59.23 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 63.44 111.092 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -81.69 128.66 34.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 65.14 110.863 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.14 -28.87 34.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 74.41 111.135 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -89.7 -9.41 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 72.45 110.891 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.8 p 46.24 58.22 4.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.877 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -113.69 24.04 12.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 73.54 110.857 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.17 27.56 73.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 73.4 112.508 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.66 127.2 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.919 0.39 . . . . 71.32 110.858 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.7 106.17 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.34 111.171 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.53 178.09 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.849 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.66 -36.12 82.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 75.11 110.882 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -81.32 -28.58 34.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 75.44 110.868 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -77.57 -22.48 50.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.885 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -85.13 -53.36 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 65.14 110.923 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -52.02 -43.69 63.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 75.51 110.908 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.43 -42.41 67.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 74.42 110.851 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 6.4 tt -51.9 -39.76 59.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.948 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -72.82 -29.35 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 71.33 111.138 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.3 mm -63.79 -44.07 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 64.34 111.136 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -67.63 -46.87 71.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 75.31 110.881 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 43.4 m -57.45 -37.03 72.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 70.22 110.849 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.72 -34.42 64.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 73.35 110.857 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -60.28 -37.54 80.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 74.45 110.941 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -24.04 26.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 75.01 110.893 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.67 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 53.34 111.088 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.82 26.18 3.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 75.45 112.486 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.3 102.17 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 73.41 111.103 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -72.93 102.78 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.874 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.23 149.93 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 75.25 111.066 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -94.14 112.58 24.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 72.32 110.89 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -149.04 132.85 16.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 71.31 110.904 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -83.38 112.66 20.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 73.4 110.851 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 91.8 p -133.96 153.76 51.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 50.51 110.863 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.6 mp -67.17 168.83 9.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 75.14 110.891 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.49 144.12 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 54.21 111.095 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 35.6 p90 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.14 110.897 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.882 0.372 . . . . 63.22 110.849 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 64.4 m 60.43 48.94 7.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 75.4 110.88 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.94 161.49 38.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.61 0.719 . . . . 74.12 110.865 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -174.55 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 63.14 112.333 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -117.87 105.05 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 73.3 110.923 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -103.26 159.25 15.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 74.45 110.952 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -75.1 160.77 79.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.652 0.739 . . . . 72.24 110.857 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -17.88 37.25 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.704 2.269 . . . . 73.02 112.352 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -83.11 -22.55 33.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.12 110.853 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.55 -61.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 71.01 111.103 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -52.18 -30.04 25.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 62.31 110.835 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.02 -32.32 67.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 72.04 111.099 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.48 -22.22 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.907 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 16.4 mt -81.67 -32.9 31.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 71.25 110.932 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -29.28 64.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 71.33 110.826 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.5 p -85.95 -23.3 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.45 111.16 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.12 -39.28 21.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 70.12 111.11 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -54.86 -38.15 67.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 75.14 110.919 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -63.72 -25.8 68.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.829 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.56 -28.87 41.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 72.1 110.946 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -61.66 -64.55 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.1 110.876 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -54.71 -27.62 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 74.3 110.899 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -56.0 -26.16 47.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 74.3 110.812 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -110.12 -26.58 9.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 73.31 110.923 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.77 79.92 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 74.45 110.865 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -25.73 42.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 72.12 110.917 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.78 -10.57 59.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 72.45 110.904 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.57 19.99 58.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 72.43 112.487 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.4 p -82.46 -22.12 35.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 73.35 110.889 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.82 22.42 59.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 73.44 112.477 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -140.6 151.77 44.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 73.43 110.869 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 71.7 mt -119.11 120.67 37.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 72.51 110.929 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -84.44 179.88 7.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 72.11 110.895 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -52.2 -29.82 24.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.24 110.839 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -77.97 -54.79 5.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 74.23 110.818 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -57.28 -51.81 67.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.889 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 52.2 mt -51.8 -30.93 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 73.34 111.145 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.0 -56.72 18.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 72.11 111.137 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.06 -23.26 77.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.792 -0.718 . . . . 71.32 112.452 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.3 tp -57.17 -55.99 27.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.88 0.371 . . . . 73.33 110.932 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.8 mt -54.17 -33.21 57.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 74.1 110.896 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -52.11 -53.56 41.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 74.1 110.886 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.87 -42.33 21.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 55.4 110.875 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.2 m -52.35 -30.55 29.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 75.44 111.148 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -78.56 -52.97 7.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 73.12 110.952 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.97 -24.59 58.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.056 -0.52 . . . . 73.03 111.133 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.93 -25.93 45.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 70.21 110.835 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.0 mtm -109.68 21.59 16.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 70.21 110.856 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 23.61 72.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.77 -0.728 . . . . 52.52 112.473 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.8 mmt -65.28 175.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 74.21 110.845 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 79.3 p -66.68 -14.27 62.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 72.12 110.862 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 63.65 61.67 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.858 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -83.01 152.57 25.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.01 110.894 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.9 m -108.22 90.87 7.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.576 0.703 . . . . 71.15 111.111 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 156.43 63.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.701 2.267 . . . . 72.12 112.31 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 48.8 p -95.57 -179.34 4.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 62.22 111.146 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -56.01 -25.66 45.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 75.45 110.921 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -73.4 -57.27 4.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 75.32 110.89 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.93 -38.88 58.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.31 110.852 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.5 t -59.85 -42.55 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 71.23 111.099 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -52.46 -45.1 65.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.1 110.898 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.0 mp -63.27 -27.41 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 65.0 111.145 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -83.63 -32.77 25.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.915 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.1 tp -73.21 -37.78 66.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 75.43 110.901 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -56.18 -35.27 67.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 74.41 110.924 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.6 ttp -90.23 -39.18 12.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 74.52 110.926 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.31 -58.96 6.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 73.04 111.155 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.48 113.94 13.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.05 110.878 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.2 p -84.31 -46.34 11.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 64.51 111.1 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -74.6 -12.36 60.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 63.23 110.886 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 t 62.59 44.94 6.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 60.21 110.847 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -79.39 -16.26 56.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 75.41 110.879 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.05 -15.46 51.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 55.22 112.485 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.1 m -136.22 135.9 39.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.4 . . . . 75.42 110.835 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.0 109.71 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 75.32 111.135 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.5 t -87.97 -172.77 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 65.24 110.868 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.9 tp -68.57 -28.08 66.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 60.51 110.908 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -81.2 -32.61 33.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.906 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -84.78 -26.05 27.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.51 110.925 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -79.26 -54.41 5.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.3 110.952 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -54.96 -32.58 61.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 74.52 110.936 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -68.68 -26.12 65.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.882 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.1 tt -68.04 -35.56 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.928 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -73.43 -24.73 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 73.33 111.12 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.8 mm -55.66 -50.94 63.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 72.33 111.121 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -56.26 -46.46 79.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 75.41 110.908 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 9.9 p -61.84 -33.0 73.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 63.12 110.861 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.6 mt -69.74 -31.21 69.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 73.21 110.961 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.31 -43.95 96.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 65.21 110.952 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -86.02 -24.02 26.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.888 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.03 -22.71 67.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.54 111.086 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.98 32.01 1.79 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 54.45 112.492 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.86 128.58 75.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 73.43 111.142 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.7 107.37 19.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.879 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.5 p -110.3 142.4 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 74.41 111.173 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.99 131.42 49.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 74.22 110.874 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.36 145.43 50.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 75.5 110.914 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -137.8 140.29 40.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.898 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -131.03 151.82 51.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 72.33 110.872 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.48 147.7 24.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 72.41 110.9 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.7 m -98.08 151.93 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.33 111.169 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 35.8 p90 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 72.04 110.894 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.833 0.349 . . . . 70.42 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -94.24 123.03 37.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 61.21 110.865 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -104.64 160.67 25.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.562 0.696 . . . . 74.31 110.87 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 171.12 15.09 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.656 2.238 . . . . 73.32 112.36 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -108.99 104.44 13.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 75.12 110.878 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -106.58 140.05 40.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.922 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -52.01 160.57 1.14 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.645 0.735 . . . . 74.04 110.854 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -19.27 36.36 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 63.45 112.356 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -82.84 -24.66 33.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 75.24 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.77 -60.62 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 74.41 111.141 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -51.77 -30.12 21.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 73.11 110.875 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.84 63.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.13 111.076 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -88.48 -36.67 16.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.906 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 43.9 mt -63.94 -30.53 71.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 73.25 110.919 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -63.45 -46.42 86.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 73.04 110.866 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.71 -23.68 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 74.31 111.132 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.79 -21.78 60.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.33 111.125 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -72.23 -55.64 6.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -54.81 -27.05 38.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 75.24 110.871 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.1 tp -77.77 -29.01 50.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 71.51 110.893 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -66.53 -49.77 65.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 74.23 110.852 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -72.03 -26.42 62.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 75.01 110.883 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -54.4 -27.91 40.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 73.32 110.874 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -108.12 -30.31 8.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 74.53 110.897 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -74.97 73.19 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 54.5 110.873 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -84.72 -25.03 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 71.0 110.908 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -70.66 -10.58 59.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.853 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.64 19.57 62.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 74.54 112.525 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.6 t -79.42 -22.14 44.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 64.44 110.856 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.82 18.77 76.63 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.763 . . . . 64.22 112.467 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -147.36 131.02 16.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 73.53 110.867 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.7 mt -92.51 101.76 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.908 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.56 175.65 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 74.1 110.924 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -52.02 -30.13 24.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.832 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.31 -55.29 6.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.824 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -56.5 -46.57 80.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.15 110.838 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 29.0 mt -51.73 -43.07 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 75.4 111.146 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.96 -41.21 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.129 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.28 -24.17 52.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 74.14 112.492 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.06 -50.33 62.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 74.32 110.919 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.5 mt -52.92 -29.55 29.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 74.35 110.938 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.71 -60.66 3.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 73.44 110.864 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.11 -41.35 70.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 61.11 110.888 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.6 m -51.76 -46.78 64.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 75.13 111.124 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -64.66 -29.14 70.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 74.5 110.922 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.9 -24.7 55.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 71.44 111.116 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -57.94 -49.51 76.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 70.33 110.865 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 29.5 mtm -79.47 -18.45 52.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.898 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.75 18.32 30.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 62.11 112.487 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 5.6 mtt -61.33 175.88 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 72.11 110.869 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.1 m -60.88 -18.95 59.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 72.35 110.818 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.9 t30 63.81 63.65 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 71.12 110.905 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -79.98 152.79 29.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 72.22 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.0 p -108.23 90.78 7.24 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.591 0.71 . . . . 73.12 111.134 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -175.28 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.689 2.259 . . . . 71.15 112.363 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 23.0 p -117.23 -176.27 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 73.45 111.172 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -59.25 -24.8 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 74.13 110.88 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -78.04 -57.46 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.876 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -51.76 -35.15 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 70.52 110.895 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.2 t -64.77 -39.69 86.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 72.42 111.074 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -55.47 -44.45 76.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 73.44 110.918 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mp -62.01 -34.8 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 75.04 111.097 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -79.39 -26.13 42.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 74.41 110.921 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 10.0 tp -81.66 -39.03 24.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 71.11 110.912 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -56.9 -28.41 61.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.866 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.5 mtm -83.44 -52.61 6.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 70.22 110.893 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -52.09 -62.04 1.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 74.51 111.089 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -67.62 124.62 23.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 54.35 110.839 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.3 m -73.96 -25.44 59.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.53 111.151 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -104.01 -12.47 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 64.3 110.866 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.6 t 55.79 50.79 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 74.42 110.809 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -100.94 23.91 10.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 74.24 110.867 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.27 31.72 71.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.752 . . . . 74.25 112.519 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.6 157.29 43.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 73.24 110.892 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.04 101.37 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 75.41 111.148 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 40.2 t -71.08 165.74 22.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 74.05 110.872 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.92 -40.77 61.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 73.21 110.904 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -74.51 -38.18 62.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.891 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.81 -38.22 90.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 75.51 110.919 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -75.98 -43.03 46.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 74.13 110.93 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.72 -44.1 97.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 65.25 110.853 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -53.03 -40.91 64.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 74.51 110.908 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.2 tp -51.7 -52.19 50.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 75.53 110.927 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 4.5 mp -51.42 -44.96 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 64.54 111.118 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.9 -40.28 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 72.22 111.098 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -60.09 -38.38 82.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 75.15 110.928 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 58.1 m -84.48 -31.75 24.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.867 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 13.5 mt -63.73 -29.4 70.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 71.44 110.927 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -51.85 -42.3 62.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 73.12 110.923 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -86.09 -24.19 26.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.922 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.93 -22.76 67.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 71.24 111.103 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.17 19.57 5.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 71.13 112.461 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.2 mp -121.99 101.85 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.798 0.333 . . . . 75.01 111.12 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -74.54 128.06 34.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.847 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.8 t -110.42 146.0 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.2 111.121 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -114.69 111.48 21.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 73.41 110.922 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -122.09 106.13 10.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.54 110.878 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -122.67 160.02 26.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 72.41 110.888 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.3 m -163.69 147.23 10.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 72.21 110.865 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -54.61 158.91 2.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.498 . . . . 70.11 110.961 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.1 m -121.85 158.46 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 74.12 111.138 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 73.02 110.889 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.841 0.353 . . . . 73.4 110.838 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.2 m -96.1 158.47 15.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 63.34 110.919 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -111.11 160.26 29.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.54 0.686 . . . . 63.23 110.914 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 147.66 63.26 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.673 2.249 . . . . 61.01 112.35 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -107.82 103.96 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 70.13 110.827 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -98.89 142.58 30.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.902 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -58.57 160.66 9.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.588 0.709 . . . . 74.42 110.884 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -20.48 34.9 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.666 2.244 . . . . 74.32 112.367 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.0 -23.09 41.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.876 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.05 -62.64 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 73.05 111.133 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -51.56 -30.59 21.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 72.15 110.881 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.48 -31.04 61.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 72.15 111.146 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -88.4 -21.68 24.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 73.1 110.883 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.22 -46.45 16.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 75.22 110.912 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.02 -31.34 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 75.02 110.855 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 p -85.87 -23.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 75.33 111.131 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.62 -44.43 21.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 75.5 111.103 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.83 -33.41 35.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.857 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -74.58 -40.42 61.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 75.5 110.876 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.3 tp -68.3 -25.09 64.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 74.52 110.918 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.08 -64.57 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.865 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -59.28 -25.97 64.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 74.31 110.868 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -52.71 -30.49 32.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.823 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -101.4 -26.52 13.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.928 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -75.75 82.92 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 75.13 110.852 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -81.52 -26.5 35.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 75.12 110.884 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -72.43 -10.56 59.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.42 . . . . 54.32 110.892 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.05 20.54 54.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 72.11 112.484 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 59.5 p -77.13 -22.06 53.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.943 0.401 . . . . 73.52 110.882 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.11 59.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 62.21 112.503 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -144.03 137.36 27.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 73.11 110.942 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.3 mt -100.93 105.29 16.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 73.21 110.917 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -67.8 171.38 6.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 72.44 110.934 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -52.02 -30.36 25.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 71.22 110.858 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.33 -50.87 11.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.4 110.889 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -57.28 -26.25 60.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 62.22 110.856 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 26.5 mt -78.1 -26.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 65.41 111.153 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.93 -54.98 23.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 72.32 111.141 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.22 -22.86 69.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 74.22 112.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.8 tp -57.86 -58.69 7.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 73.12 110.939 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.8 mt -51.81 -36.64 48.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.12 110.945 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -54.39 -41.93 69.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 71.43 110.942 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -85.06 -46.49 11.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 70.45 110.893 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.3 m -54.61 -33.0 59.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 74.1 111.129 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -69.13 -26.13 64.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 74.54 110.918 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.27 -30.23 71.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.499 . . . . 75.23 111.087 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.38 -26.06 64.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.858 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.8 mtm -94.05 -18.38 21.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 75.2 110.84 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 93.13 24.01 23.41 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.731 . . . . 72.51 112.443 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.3 ttm -81.95 175.81 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 74.44 110.854 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.4 m -75.73 -6.26 49.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 71.12 110.84 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.2 m120 62.9 69.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 61.22 110.886 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -68.07 152.64 45.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.906 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.4 m -108.18 90.82 7.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.575 0.702 . . . . 70.14 111.175 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 175.86 7.55 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.661 2.241 . . . . 75.14 112.379 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.1 p -115.41 -176.57 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 73.4 111.154 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -52.19 -29.9 24.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.34 110.95 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -67.41 -57.65 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.864 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.02 -53.76 54.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 71.14 110.868 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.5 t -52.66 -41.12 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.42 111.126 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -54.79 -54.51 41.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 74.14 110.895 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.35 -47.9 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.133 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -61.89 -25.95 67.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.132 -0.485 . . . . 75.4 110.904 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 tt -81.61 -40.51 22.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 73.33 110.92 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.51 -28.76 70.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.903 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 43.3 ttp -91.22 -35.08 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -71.41 -48.25 50.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 51.21 111.096 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -52.55 120.3 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.851 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.87 -23.59 25.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 64.43 111.126 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.44 -10.71 18.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 72.11 110.874 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.4 p 58.99 27.19 16.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.852 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -78.94 -15.87 57.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 73.11 110.869 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.34 17.26 16.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 70.24 112.49 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.78 126.9 7.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 74.44 110.854 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.7 t -86.92 107.63 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 70.13 111.131 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.2 t -83.68 -176.65 6.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.862 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.7 tp -66.61 -36.03 81.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 74.41 110.962 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.35 -24.75 42.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 73.1 110.87 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -85.89 -20.43 29.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 74.14 110.85 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -87.32 -40.16 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.931 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -52.68 -41.42 63.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.899 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.86 -25.16 63.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.828 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.9 -40.24 94.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.466 . . . . 71.45 110.91 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.22 -24.69 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.21 111.134 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.1 mm -60.81 -37.51 76.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 73.03 111.154 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -52.56 38.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 72.01 110.858 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 2.6 m -57.44 -30.67 65.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 70.32 110.885 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.01 -37.93 69.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 71.35 110.925 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -58.03 -35.57 71.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 75.53 110.897 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -26.64 26.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 65.23 110.929 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.2 -22.65 66.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 73.02 111.13 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.75 26.45 3.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 71.43 112.491 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.52 103.12 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 74.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -71.17 110.88 6.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 75.33 110.839 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.33 149.55 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 60.35 111.119 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -110.24 107.96 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 73.01 110.897 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 137.59 48.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 72.55 110.897 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -76.11 95.09 3.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 64.52 110.932 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 58.3 p -108.78 -178.51 3.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 64.53 110.826 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.62 73.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 73.32 110.914 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.5 m -52.66 140.37 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 75.23 111.13 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 41.2 p90 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 75.11 110.935 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.864 0.364 . . . . 74.53 110.914 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 p -133.15 160.25 37.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 65.12 110.834 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -116.24 81.12 10.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.586 0.708 . . . . 75.44 110.935 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 176.71 6.37 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.704 2.269 . . . . 75.13 112.346 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.1 127.24 35.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.9 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -109.79 133.93 52.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 71.43 110.916 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -52.59 160.52 1.35 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.595 0.712 . . . . 74.42 110.889 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -18.81 36.92 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.72 2.28 . . . . 75.24 112.344 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -82.69 -23.63 34.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.45 110.877 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -77.93 -63.33 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 75.32 111.163 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -51.99 -30.9 27.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.31 110.883 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -37.5 63.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 53.43 111.116 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -88.19 -25.94 22.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.893 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 68.5 mt -73.94 -28.23 61.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.89 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.51 -59.01 4.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.449 . . . . 71.5 110.899 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 p -55.29 -26.46 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 73.12 111.152 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.91 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 74.1 111.11 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -61.39 -50.66 71.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 75.01 110.874 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -63.68 -41.48 98.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 72.31 110.863 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 tp -57.1 -38.92 74.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 71.4 110.905 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -56.47 -59.74 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.12 110.873 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.6 mmmm -66.39 -26.27 67.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 73.42 110.87 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.3 ttm-85 -54.14 -27.71 35.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 75.21 110.872 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -109.74 -30.55 7.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.941 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.07 84.28 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 72.11 110.862 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -84.94 -28.17 26.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 74.2 110.878 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -72.63 -10.57 59.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 73.14 110.899 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.96 47.12 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 72.25 112.462 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 45.4 t -75.36 -22.11 57.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.953 0.406 . . . . 74.32 110.853 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.23 19.67 60.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 75.14 112.483 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -146.04 141.75 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 70.2 110.889 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.7 mt -105.23 101.41 10.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 65.32 110.927 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -70.41 170.68 11.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 63.34 110.95 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -52.06 -30.02 23.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.42 110.842 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -80.41 -35.02 35.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.1 110.891 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.08 -29.19 60.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 75.33 110.896 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 54.8 mt -77.78 -26.67 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 74.5 111.145 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.76 -45.85 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 73.01 111.071 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.24 -23.04 55.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 65.44 112.495 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.15 -57.04 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 73.54 110.9 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.7 mt -51.94 -35.84 47.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 75.31 110.959 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -51.97 -45.68 64.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 75.34 110.834 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -84.77 -45.69 12.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.833 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 33.5 m -52.99 -31.23 39.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.113 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -77.07 -55.37 5.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.914 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.81 -24.81 38.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 75.3 111.081 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -53.64 -29.17 36.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 72.11 110.879 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -113.02 16.8 19.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 73.03 110.878 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.83 28.93 74.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 70.12 112.451 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.16 175.75 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 75.32 110.884 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 94.8 p -60.92 -21.25 63.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 72.53 110.879 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 63.45 57.47 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 74.03 110.889 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -80.22 152.55 29.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.924 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.8 p -108.21 90.75 7.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.589 0.709 . . . . 73.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 174.47 9.44 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.662 2.242 . . . . 72.33 112.327 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 39.2 p -117.53 -176.06 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 60.42 111.12 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -52.14 -29.95 24.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 73.4 110.879 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -69.43 -57.36 5.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 71.54 110.918 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.15 -52.54 64.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 75.23 110.852 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.7 t -52.42 -38.15 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 73.4 111.126 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -58.11 -54.85 42.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 75.45 110.907 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.5 mt -54.5 -47.47 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 74.12 111.143 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -57.97 -29.84 65.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 71.33 110.88 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.2 tt -74.88 -30.54 61.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 72.2 110.949 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -65.01 -26.17 68.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.23 110.938 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.5 ttm -90.97 -42.83 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 72.11 110.895 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.32 -50.47 53.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 74.24 111.085 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -51.98 105.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.836 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.5 m -87.18 -25.15 24.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 74.24 111.156 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -95.11 -12.42 26.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 65.14 110.906 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 60.74 37.93 18.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 73.32 110.855 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -102.01 23.99 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 73.03 110.855 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 65.19 19.42 66.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 74.41 112.509 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.73 160.4 41.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 70.44 110.871 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.23 124.93 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 72.02 111.11 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.28 -170.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 74.51 110.876 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -39.01 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 74.15 110.892 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -74.11 -35.59 64.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.25 110.859 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.58 -53.4 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 75.14 110.94 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -58.47 -47.91 82.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 74.02 110.911 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -55.2 -31.04 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 44.01 110.89 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.77 -26.41 64.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 65.43 110.88 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.5 tp -67.46 -34.03 76.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.887 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -75.04 -27.44 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 75.12 111.133 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.5 mm -52.11 -60.09 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 64.5 111.135 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -52.08 -30.13 24.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 74.34 110.884 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.9 m -69.98 -41.88 73.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 73.44 110.872 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.83 -36.05 81.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.49 . . . . 75.02 110.936 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -57.07 -44.23 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 71.22 110.904 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -86.06 -24.83 26.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 75.51 110.91 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.05 -22.71 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 74.22 111.063 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.92 19.26 5.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.756 -0.735 . . . . 73.14 112.527 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.32 101.84 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 74.24 111.128 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.13 98.66 3.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.14 110.887 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.31 138.99 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 74.23 111.157 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -91.72 108.06 19.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 71.05 110.892 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.58 134.37 22.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 73.34 110.872 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -52.73 103.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 71.31 110.931 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 19.7 p -103.36 84.53 2.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.21 110.841 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.06 134.39 57.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 71.51 110.88 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.5 m -115.4 132.94 63.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 74.54 111.193 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 22.0 p90 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.885 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.859 0.361 . . . . 62.32 110.884 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.2 p -114.98 106.9 14.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 72.53 110.846 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.69 155.98 74.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.509 0.671 . . . . 71.21 110.891 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 140.01 41.57 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.619 2.212 . . . . 72.12 112.357 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -91.39 136.57 33.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 73.44 110.926 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.14 164.32 19.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 74.25 110.916 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -51.77 162.15 0.8 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.584 0.707 . . . . 72.5 110.883 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -16.87 37.69 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 71.33 112.346 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -83.42 -18.97 36.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.5 110.892 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.16 -61.44 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 63.33 111.134 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -51.54 -31.38 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.45 110.891 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.03 -34.32 55.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.54 111.14 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.47 -30.99 18.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.42 110.945 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.9 mt -69.68 -32.72 71.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 72.11 110.876 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -58.27 -57.58 12.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 64.31 110.857 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.2 p -57.75 -23.79 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 70.4 111.127 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.43 -30.77 67.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.41 111.118 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -49.44 63.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 75.1 110.919 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -61.77 -24.65 66.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.885 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.7 tp -82.17 -36.67 27.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.92 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.0 -53.31 59.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.881 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -69.62 -25.97 64.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 70.44 110.906 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -52.2 -29.94 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 75.02 110.861 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -106.0 -34.18 7.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 71.52 110.895 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.75 88.95 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 72.33 110.873 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -84.72 -25.42 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 75.42 110.92 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -70.65 -10.61 59.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.878 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.66 22.54 40.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 61.4 112.489 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -76.38 -22.1 55.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.895 0.379 . . . . 74.04 110.844 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.76 19.04 57.24 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.752 . . . . 71.22 112.48 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -142.96 130.74 21.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 75.2 110.894 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 31.7 mt -89.03 102.57 15.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 74.13 110.944 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -71.6 173.11 8.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 73.32 110.894 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -55.54 -26.42 43.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -80.02 -34.28 38.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 73.24 110.85 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -80.92 -26.75 36.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 75.22 110.84 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 21.4 mt -74.82 -36.25 39.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 73.05 111.133 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.83 -47.27 64.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 74.34 111.067 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.42 -23.5 53.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 65.25 112.458 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -65.48 -49.12 70.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 74.45 110.942 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.7 mt -52.12 -33.91 41.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 63.34 110.921 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -54.59 -55.2 31.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.855 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.34 -45.06 41.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.877 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.3 m -51.67 -30.71 22.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 70.52 111.154 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -77.85 -44.69 26.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.914 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.2 -23.24 46.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 74.4 111.087 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -55.52 -25.94 40.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 75.24 110.893 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 mtm -111.73 19.44 18.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.889 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.76 21.46 71.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 51.3 112.492 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.2 tpp -62.22 175.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.758 0.314 . . . . 64.31 110.911 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.1 t -78.3 -3.91 45.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 74.24 110.868 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.8 m120 55.72 61.74 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 74.14 110.909 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -72.86 152.63 41.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.11 110.905 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.4 m -108.11 90.77 7.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 72.35 111.136 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 171.45 14.44 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.704 2.269 . . . . 73.2 112.364 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 3.4 p -102.35 177.83 4.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 73.55 111.124 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -55.19 -27.74 48.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 75.11 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.23 -54.28 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 74.31 110.901 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.16 -35.87 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.823 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.97 -39.36 85.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 75.2 111.101 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -56.83 -52.99 62.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 73.11 110.877 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.1 mp -55.38 -30.68 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.13 111.118 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -79.55 -31.21 41.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 64.25 110.934 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.9 tt -77.46 -39.98 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.888 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -51.92 -58.47 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.906 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 27.5 ttp -63.7 -24.46 67.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.893 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -94.51 21.89 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 61.0 111.097 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -141.73 120.93 13.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 64.34 110.864 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 14.5 m -87.17 -43.71 12.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 63.15 111.097 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.42 -12.45 60.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.868 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.0 t 57.98 48.15 13.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.21 110.836 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -93.27 -16.24 24.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 70.02 110.854 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.23 25.12 14.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 63.44 112.46 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.24 144.12 24.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 75.0 110.902 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.89 121.95 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 74.14 111.123 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.15 -177.74 4.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 70.01 110.891 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.91 -32.67 66.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 75.45 110.949 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.53 -58.87 3.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.31 110.874 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -56.2 -25.46 47.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.45 110.929 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -85.34 -50.17 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 74.55 110.917 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -52.08 -40.98 62.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 71.45 110.877 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -53.56 -43.9 68.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.886 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 36.5 mt -51.84 -35.66 45.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 71.42 110.958 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.2 mp -77.0 -30.0 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 62.44 111.156 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.7 mm -64.66 -43.06 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 75.41 111.11 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -63.83 -36.05 82.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 75.25 110.905 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 62.7 m -77.66 -39.74 44.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.54 110.851 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 22.4 mt -57.63 -46.03 84.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.494 . . . . 73.03 110.902 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -52.59 -35.18 53.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.03 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.12 -31.33 21.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 72.2 110.88 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.91 -22.28 66.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 52.42 111.081 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.89 32.42 1.56 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.739 . . . . 53.4 112.496 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.04 110.94 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 74.44 111.112 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 131.32 46.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.15 110.841 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 18.3 t -137.89 111.95 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 72.31 111.119 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.12 107.99 5.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 74.14 110.878 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.26 111.9 7.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 65.01 110.921 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -55.01 144.66 22.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 72.42 110.889 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 48.8 m -146.82 157.63 43.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 72.32 110.858 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.36 162.76 24.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 75.24 110.87 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.62 158.97 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 74.11 111.131 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 3.5 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 71.32 110.883 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.4 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.865 0.364 . . . . 74.52 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.65 120.01 19.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 72.33 110.882 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -111.34 81.0 2.78 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.538 0.685 . . . . 75.42 110.877 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 133.82 26.43 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.715 2.277 . . . . 73.21 112.334 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tptp -95.66 140.33 30.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 75.24 110.868 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -105.68 161.93 13.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 74.22 110.95 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -51.73 160.97 0.95 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.661 0.743 . . . . 70.42 110.853 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -25.35 28.42 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.651 2.234 . . . . 61.33 112.318 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -79.36 -19.55 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 62.44 110.923 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.74 -61.03 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 72.1 111.111 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -51.35 -30.7 19.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 74.55 110.9 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.37 79.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 75.24 111.089 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -88.39 -40.73 13.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 72.34 110.914 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.2 mt -57.28 -25.81 59.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 75.34 110.928 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -70.03 -59.27 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 75.22 110.855 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 p -57.87 -23.62 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 73.15 111.111 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.35 -21.69 59.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 61.54 111.137 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.8 mtt-85 -70.13 -53.41 17.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 62.41 110.885 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -54.57 -26.88 34.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 72.54 110.822 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -79.89 -35.17 38.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 62.34 110.964 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.41 -43.02 91.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 72.04 110.885 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -79.49 -26.93 41.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.89 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -51.96 -40.44 60.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 74.21 110.889 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -94.23 -26.12 16.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 75.23 110.932 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.14 62.58 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 74.44 110.883 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -26.16 68.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 73.23 110.887 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -70.83 -10.56 59.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 73.12 110.875 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.04 20.89 43.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.709 -0.757 . . . . 71.04 112.464 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.5 m -78.45 -22.1 48.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 75.33 110.85 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.84 20.19 66.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 72.05 112.451 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -138.51 131.54 29.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.798 0.332 . . . . 75.02 110.935 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 24.1 mt -101.92 111.43 23.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 75.02 110.945 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -79.93 175.7 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 71.44 110.895 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -53.47 -28.51 31.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 72.3 110.87 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -77.34 -44.81 28.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.888 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.04 -33.19 73.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.928 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 30.6 mt -70.72 -37.5 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 75.05 111.201 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.84 -46.2 64.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 75.43 111.085 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.77 -23.13 56.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 65.42 112.505 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.3 tp -58.87 -55.95 28.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 72.05 110.902 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 25.1 mt -52.28 -35.66 50.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.931 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -43.59 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.885 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.07 -47.17 10.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.871 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.2 m -52.19 -31.16 30.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 75.24 111.142 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -76.17 -44.19 39.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.923 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.18 -25.53 64.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 74.53 111.097 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -52.25 -30.44 27.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 74.01 110.903 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -102.62 -18.45 15.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.24 110.869 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.77 27.24 9.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 63.12 112.481 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.63 175.2 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 72.24 110.873 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.1 p -55.6 -25.96 41.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 62.15 110.864 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 63.31 54.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 75.44 110.911 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -60.45 152.49 25.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 75.14 110.921 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p -108.27 90.8 7.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 72.31 111.136 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -171.02 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.643 2.228 . . . . 72.32 112.38 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 70.1 p -127.86 -176.35 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 72.41 111.131 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -57.63 -25.56 60.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 72.32 110.93 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.42 -60.16 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 74.43 110.909 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.84 -49.2 76.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 65.04 110.832 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.0 t -55.37 -43.87 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.424 . . . . 73.04 111.089 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -50.27 62.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 75.2 110.888 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.7 mt -59.46 -49.22 84.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.22 111.173 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 53.5 t90 -54.74 -28.63 49.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 74.25 110.89 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.8 tt -61.38 -45.64 93.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 74.45 110.906 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -72.52 -29.91 64.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.03 110.89 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.6 ttp -60.96 -31.18 70.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.25 110.871 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -101.26 -48.54 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 73.04 111.086 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -52.35 112.74 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 65.43 110.808 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 27.9 m -83.71 -33.34 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.3 111.141 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -83.51 -12.46 56.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 73.11 110.881 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.8 m 54.87 49.99 16.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 63.42 110.874 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -110.07 23.94 13.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.903 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.54 25.47 70.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 73.44 112.484 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.7 p -154.64 133.78 12.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 71.03 110.848 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.3 t -101.51 105.48 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 74.54 111.121 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -75.02 178.17 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 75.54 110.841 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.8 tp -54.79 -61.02 2.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 72.54 110.916 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -60.78 -41.54 95.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.913 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -29.38 66.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.53 110.92 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -87.94 -47.63 8.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.955 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.18 -25.84 59.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 72.42 110.905 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.9 -25.75 60.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.89 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.9 tp -69.07 -35.9 77.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 74.1 110.889 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -71.24 -24.5 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.13 111.135 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.0 mm -52.33 -61.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 71.35 111.073 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -49.57 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 71.51 110.919 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 49.0 m -52.15 -33.28 39.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 64.53 110.885 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.9 mt -76.59 -44.53 34.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 72.41 110.867 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -56.26 -30.1 61.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 74.34 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -16.41 38.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 71.42 110.924 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -94.72 24.81 4.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 62.11 111.102 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 66.52 32.39 81.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.763 . . . . 72.32 112.499 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 18.7 mt -114.72 102.89 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.353 . . . . 72.44 111.121 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -57.0 106.31 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 73.33 110.862 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 85.5 t -110.14 126.51 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 64.21 111.142 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -95.46 108.07 20.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 73.42 110.85 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.31 143.19 46.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 72.53 110.888 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -134.9 131.18 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 73.52 110.928 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.5 t -152.82 129.41 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 74.32 110.88 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 68.9 mt -59.8 130.75 48.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 71.45 110.939 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.7 m -86.24 155.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 62.33 111.17 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 46.0 p90 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.878 -179.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.887 0.375 . . . . 72.15 110.837 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.0 t -164.15 176.97 8.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 73.23 110.85 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 156.23 58.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 71.41 110.892 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 161.81 44.52 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.661 2.241 . . . . 74.12 112.328 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 107.75 15.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.895 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -106.53 133.89 50.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 73.13 110.938 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -52.23 160.62 1.2 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.587 0.708 . . . . 75.31 110.891 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -16.02 37.63 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.701 2.267 . . . . 74.41 112.37 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.61 -26.86 34.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.883 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.8 -61.81 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 62.23 111.107 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -51.62 -30.34 20.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 73.35 110.942 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.16 58.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 74.5 111.129 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.87 -25.37 28.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.888 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.3 mt -78.67 -29.66 45.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 74.55 110.918 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.21 -48.76 69.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 70.22 110.838 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -65.47 -30.5 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 52.25 111.13 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.85 -27.89 57.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 73.53 111.086 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -66.74 -34.3 77.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.44 110.836 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -74.19 -29.83 61.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 70.11 110.878 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.52 -32.64 64.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 74.54 110.908 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.53 -63.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 75.03 110.874 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -58.02 -26.76 62.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.52 110.94 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -54.12 -29.24 44.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.886 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.04 -28.89 8.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 75.04 110.922 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.53 70.88 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 74.24 110.88 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -25.76 53.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 73.22 110.927 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -70.83 -10.5 59.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 73.15 110.853 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.43 19.78 58.08 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.738 -0.744 . . . . 74.53 112.463 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.4 t -82.33 -22.13 35.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.932 0.396 . . . . 45.21 110.892 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.83 22.44 63.92 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 75.22 112.523 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -140.09 148.99 42.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.858 0.361 . . . . 72.42 110.879 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.7 mt -120.14 119.89 34.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.33 110.912 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -85.37 177.85 7.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 74.41 110.92 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -52.0 -30.08 23.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.895 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.65 -52.14 9.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 63.32 110.856 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.25 -34.32 73.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.905 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.6 mt -68.6 -38.57 79.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 74.11 111.126 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.79 -58.35 7.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 73.03 111.114 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.22 -23.53 76.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 75.23 112.502 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 9.8 tp -67.9 -53.35 27.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 73.24 110.911 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.6 mt -51.86 -29.86 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 72.02 110.94 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -60.28 -43.82 95.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.41 110.887 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -85.02 -38.85 18.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 70.13 110.875 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.0 m -51.75 -30.0 20.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.1 111.182 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -81.5 -50.21 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.44 110.924 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.29 -25.11 32.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 74.23 111.136 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -54.52 -28.99 49.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.917 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -110.74 16.93 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.51 110.906 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 29.02 74.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 74.53 112.489 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.1 mmt -69.31 175.85 3.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.821 0.344 . . . . 74.23 110.843 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 75.2 m -61.56 -18.4 59.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 74.43 110.899 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 3.5 t30 63.67 55.88 1.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 71.54 110.933 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -73.81 152.89 40.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.03 110.873 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 m -108.27 90.76 7.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 75.44 111.131 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 143.65 51.33 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.703 2.269 . . . . 71.44 112.312 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 33.5 p -82.58 -178.43 7.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 73.42 111.138 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -56.32 -29.8 61.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 71.12 110.932 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -69.42 -52.44 26.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 72.04 110.895 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -54.7 -42.01 70.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.482 . . . . 71.12 110.846 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.57 -41.94 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 74.33 111.118 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -52.89 -48.85 66.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.913 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.07 -25.61 36.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 75.35 111.093 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -81.87 -22.85 36.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 74.33 110.905 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.4 tt -78.22 -35.4 48.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 74.4 110.892 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -64.6 -31.95 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 54.34 110.933 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.5 ptp -91.72 -30.84 16.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 74.04 110.875 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -75.6 -51.27 13.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 62.01 111.128 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.36 129.57 21.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 70.02 110.866 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.5 m -88.31 -48.78 7.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 73.31 111.15 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -113.86 16.69 18.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.15 110.895 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.5 t 51.78 58.67 5.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.878 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -96.17 -14.44 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.494 . . . . 72.34 110.851 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.37 16.77 17.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.728 . . . . 62.4 112.475 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.5 m -154.66 -179.26 7.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.397 . . . . 72.42 110.851 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.59 101.41 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 72.14 111.159 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -76.07 -174.74 2.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 61.33 110.857 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 21.6 tp -65.3 -45.82 82.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 72.31 110.904 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -70.48 -26.11 63.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 74.4 110.902 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.86 -31.89 31.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 72.42 110.865 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -85.87 -34.96 20.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.885 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -70.26 -32.15 69.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 74.42 110.868 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.83 -28.53 70.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 72.31 110.836 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.4 mt -63.9 -36.6 84.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.34 110.926 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -74.86 -24.84 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 73.23 111.142 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.49 -47.44 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 74.15 111.138 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -67.15 -40.4 86.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.912 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -47.54 65.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 74.2 110.852 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.9 mp -73.88 -29.44 62.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 73.42 110.895 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -62.9 -44.87 94.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.879 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -84.12 -24.19 30.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 75.54 110.876 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.9 -22.67 67.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 71.43 111.093 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.0 32.46 1.53 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 73.32 112.463 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.4 101.83 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.859 0.361 . . . . 54.32 111.102 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -68.76 108.07 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.872 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.19 149.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 65.31 111.126 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -97.14 108.18 20.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 75.32 110.908 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.73 128.66 12.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 75.4 110.918 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -83.12 131.0 35.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 72.21 110.883 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 20.2 m -137.25 156.87 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 73.23 110.865 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 pp -99.85 142.01 31.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 71.51 110.896 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.15 154.06 24.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 64.44 111.112 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 74.04 110.896 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.886 0.374 . . . . 75.31 110.873 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.0 m -147.93 168.71 21.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 74.22 110.845 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -103.97 161.03 24.17 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.588 0.708 . . . . 75.15 110.931 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 169.71 18.32 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.682 2.255 . . . . 73.1 112.338 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -93.93 112.6 24.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.88 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -140.32 133.64 29.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 75.23 110.915 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -51.88 160.99 0.99 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 71.34 110.894 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -18.13 37.01 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.714 2.276 . . . . 62.1 112.335 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -83.04 -21.29 33.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.911 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.25 -51.78 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 70.24 111.128 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -51.06 -31.58 19.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.863 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.14 80.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 62.11 111.099 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -88.58 -32.36 18.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 75.23 110.885 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.8 -25.95 68.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 74.41 110.935 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -67.59 -59.3 3.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 75.0 110.854 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 p -56.1 -24.83 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.129 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.48 -47.74 84.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 75.34 111.093 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -44.62 64.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.85 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -65.11 -29.14 69.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.879 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.52 -36.85 57.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 74.44 110.892 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -61.3 -41.95 97.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 74.42 110.893 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -79.1 -28.48 43.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 74.42 110.927 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -52.26 -29.88 25.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 74.44 110.834 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -108.25 -34.52 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 72.21 110.917 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -76.7 66.44 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 72.52 110.919 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -70.7 -26.09 63.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 72.31 110.885 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.9 -10.51 59.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 73.42 110.859 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.26 22.56 44.38 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 63.22 112.469 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.3 t -76.08 -22.13 55.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.915 0.388 . . . . 73.12 110.875 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.31 20.16 65.14 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 74.05 112.489 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -142.64 141.29 31.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 73.51 110.87 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 58.0 mt -109.33 118.12 35.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 74.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -85.19 175.3 9.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 75.41 110.896 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -51.88 -30.31 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 72.43 110.883 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -81.08 -52.39 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.34 110.823 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.56 -28.36 65.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 75.24 110.874 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.2 mt -81.32 -30.83 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 73.34 111.167 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.04 63.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 65.04 111.12 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.23 -22.86 56.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 72.31 112.509 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.92 -47.76 83.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 64.03 110.95 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.36 -36.41 77.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.927 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -52.62 -46.07 66.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.33 110.882 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -83.11 -47.19 11.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 72.42 110.882 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.8 m -51.79 -35.52 44.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 72.31 111.186 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -76.56 -53.69 7.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.97 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.06 -25.76 59.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 70.21 111.129 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -57.39 -25.68 59.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.866 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 36.9 mtm -110.01 21.74 16.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 75.2 110.873 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.69 68.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 72.52 112.435 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.6 mmt -60.79 174.98 0.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.805 0.336 . . . . 65.25 110.834 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -66.02 -14.91 62.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 65.0 110.821 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.7 t30 63.69 42.92 5.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 55.12 110.882 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -62.49 152.45 34.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 62.44 110.863 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 m -108.22 90.82 7.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.59 0.71 . . . . 70.42 111.152 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 159.93 51.6 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.672 2.248 . . . . 73.34 112.324 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 79.7 p -106.87 -176.03 2.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.25 111.167 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -54.85 -26.57 36.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 74.51 110.932 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -75.42 -41.47 55.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 72.35 110.873 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.61 -25.11 59.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 73.21 110.85 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -79.33 -32.64 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.132 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -22.73 66.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.915 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.2 mt -87.58 -41.96 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 74.11 111.132 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -69.98 -31.27 68.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 64.54 110.951 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.4 tt -64.25 -38.81 92.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 73.21 110.885 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -68.79 -28.18 66.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.924 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 6.1 mmm -70.47 -33.83 71.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 71.43 110.862 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -88.99 -49.34 6.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 51.33 111.111 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -75.0 119.34 19.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 54.2 110.88 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.9 m -87.59 -26.55 23.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 75.52 111.108 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.22 -12.47 56.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 70.1 110.846 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.6 m 53.61 53.65 11.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 61.14 110.834 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -106.66 -16.22 14.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 63.45 110.906 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.29 19.42 11.53 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.709 -0.758 . . . . 72.1 112.447 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.0 p -149.4 126.88 11.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 74.23 110.859 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.66 106.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 74.3 111.142 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.71 178.86 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 64.32 110.884 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 21.3 tp -63.16 -33.23 75.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 72.52 110.921 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -81.32 -40.04 24.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.858 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -65.05 -32.57 74.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.859 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -78.89 -34.95 44.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 75.21 110.937 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -51.84 -56.76 12.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.499 . . . . 75.2 110.88 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -56.87 -33.28 66.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 75.03 110.931 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.91 -45.1 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 64.12 110.932 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 4.7 mp -72.37 -34.42 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 71.53 111.126 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.0 mm -52.98 -44.96 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 75.4 111.085 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -63.62 -44.96 92.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 70.44 110.891 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.3 m -59.44 -57.93 10.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 73.01 110.795 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.2 mp -51.97 -40.24 60.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 73.32 110.937 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -42.97 74.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 75.22 110.916 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -85.96 -6.99 58.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 65.1 110.899 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -94.94 25.48 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 73.21 111.1 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.72 32.41 83.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.719 -0.753 . . . . 73.53 112.5 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 17.0 mt -120.18 110.47 28.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 72.53 111.14 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.69 114.78 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 74.41 110.871 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 4.2 p -133.68 122.73 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 74.52 111.142 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -104.82 129.02 53.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 75.32 110.859 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.75 137.12 45.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.34 110.926 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -124.01 167.74 13.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 74.12 110.899 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 m -138.73 153.46 48.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 71.31 110.836 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 6.0 mt -88.21 93.21 9.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 72.44 110.948 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.57 114.79 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 75.04 111.135 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.8 p90 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 75.0 110.889 -179.995 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.898 0.38 . . . . 65.23 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.1 m -107.78 136.2 47.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 75.34 110.828 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.42 154.94 66.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.581 0.705 . . . . 55.24 110.913 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 146.84 61.74 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.691 2.26 . . . . 73.34 112.363 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -75.11 110.6 9.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 74.34 110.908 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -116.67 132.28 56.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.3 110.917 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -51.49 161.07 0.87 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.672 0.748 . . . . 70.25 110.863 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -14.37 35.87 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.677 2.251 . . . . 64.3 112.346 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.23 -26.77 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.88 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.15 -63.53 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 64.45 111.103 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.64 -26.2 43.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 75.12 110.847 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.45 83.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 72.14 111.135 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -87.99 -26.65 22.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.43 110.928 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.1 mt -74.86 -25.57 59.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 60.12 110.931 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -76.37 -49.58 16.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 75.15 110.87 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.0 p -62.49 -25.81 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 74.11 111.143 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.81 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 61.23 111.125 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -51.91 -36.35 48.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 72.54 110.833 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -67.41 -48.31 67.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.846 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 tp -61.98 -27.91 69.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.9 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -69.54 -60.05 2.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.841 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -63.07 -28.67 70.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.874 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -52.65 -33.45 47.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 75.33 110.907 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -99.19 -29.47 12.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 62.35 110.887 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.94 85.47 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 71.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -85.06 -26.31 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 73.12 110.928 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.09 -10.53 59.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.885 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.58 24.47 47.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 53.35 112.523 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.2 p -90.51 -22.14 21.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 70.44 110.86 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.99 19.81 49.32 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.766 -0.731 . . . . 71.04 112.444 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -133.47 132.04 40.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 74.41 110.922 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.5 mt -99.56 110.82 23.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 72.42 110.916 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -77.94 176.94 8.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 75.21 110.893 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.94 -30.18 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.2 110.879 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.67 -51.82 15.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 61.12 110.893 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.26 -30.69 71.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.87 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.7 mt -77.06 -42.62 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 74.4 111.151 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.65 -49.07 63.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 61.41 111.106 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.87 -23.2 67.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 73.02 112.509 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.93 -45.7 60.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 74.01 110.9 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.6 mt -52.86 -30.86 36.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 72.34 110.871 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -60.81 3.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 75.22 110.881 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -27.48 67.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 73.03 110.888 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.0 m -65.05 -54.6 27.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 74.11 111.121 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -56.47 -25.99 52.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 73.23 110.933 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.86 -27.66 60.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 75.24 111.083 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -53.27 -28.68 29.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 62.13 110.858 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.3 mtm -104.26 -18.47 14.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 74.41 110.879 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.92 20.81 22.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.723 -0.751 . . . . 74.04 112.5 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 10.2 mtm -67.51 175.8 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.33 . . . . 71.04 110.852 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.7 t -60.63 -19.86 59.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 55.43 110.834 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 63.67 60.23 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 71.14 110.885 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -70.63 152.52 43.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 71.04 110.854 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.6 p -108.15 90.91 7.28 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.581 0.705 . . . . 74.44 111.151 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -178.33 2.31 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.646 2.23 . . . . 74.44 112.352 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 51.5 p -118.62 179.56 4.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 53.33 111.15 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -54.74 -26.84 36.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 65.23 110.859 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -72.87 -60.75 2.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.421 . . . . 73.14 110.844 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.0 -39.63 59.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 71.11 110.843 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.0 t -56.9 -43.25 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 71.5 111.136 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -52.01 -42.79 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 75.3 110.892 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.9 mp -68.84 -26.37 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.128 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -83.0 -26.45 31.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.471 . . . . 75.05 110.912 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.5 tt -77.14 -49.19 15.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 74.35 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -54.77 -28.79 51.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 75.21 110.895 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 31.5 ttm -72.68 -55.33 6.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.42 110.846 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.82 -60.81 2.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.52 111.101 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -66.26 128.72 37.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 74.04 110.904 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.26 -35.14 18.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.133 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -74.66 -12.46 60.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.866 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.9 p 46.24 57.42 5.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.812 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -114.17 23.56 12.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 72.11 110.851 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.06 25.89 74.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 65.42 112.467 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.8 p -152.41 135.62 15.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 65.02 110.876 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.78 111.62 36.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 74.11 111.135 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.8 t -75.37 179.95 4.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.804 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.68 -60.29 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 72.34 110.907 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -62.88 -39.21 93.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 63.2 110.88 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -61.22 -27.49 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.867 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -89.37 -44.5 10.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 74.4 110.888 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -60.46 -34.8 74.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 73.14 110.903 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -64.54 -26.18 68.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.866 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.3 tp -68.66 -44.35 74.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 75.03 110.938 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.1 mp -63.28 -24.65 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 74.32 111.122 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 48.6 mm -51.92 -48.05 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 74.44 111.124 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -69.31 -37.25 77.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.883 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 12.1 m -53.77 -42.19 68.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 73.35 110.842 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 64.8 mt -80.14 -26.42 39.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 73.3 110.893 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -62.98 -43.63 98.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 63.5 110.917 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -85.79 -24.14 26.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 74.15 110.908 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.92 -21.55 66.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.115 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.06 21.9 4.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 52.25 112.49 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.79 101.65 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 74.51 111.157 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -68.57 98.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.32 110.851 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.9 t -69.18 128.96 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 72.04 111.118 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.16 107.52 2.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 73.04 110.892 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -164.66 135.56 4.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 72.02 110.88 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -63.22 134.84 56.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 72.33 110.912 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 53.0 p -129.6 130.98 46.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.14 110.859 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.85 176.88 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 72.23 110.91 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.05 145.06 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 72.24 111.163 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 75.34 110.896 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.907 0.384 . . . . 71.31 110.807 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.5 t -142.14 113.42 7.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 74.45 110.851 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.42 157.73 53.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.612 0.72 . . . . 73.33 110.869 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 171.92 13.55 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.691 2.26 . . . . 74.44 112.349 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -91.8 106.13 18.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 75.23 110.867 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.48 147.84 27.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 75.21 110.891 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -61.0 160.9 17.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.622 0.725 . . . . 73.12 110.915 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -27.61 26.21 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 55.52 112.34 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -75.09 -18.13 60.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 63.13 110.846 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.01 -60.42 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 64.23 111.115 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -51.59 -30.32 20.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 65.52 110.854 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.4 79.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 74.23 111.079 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -88.42 -24.59 23.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.894 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.5 mt -76.83 -40.11 48.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.901 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -58.2 -43.24 87.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.827 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.39 -24.24 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 75.12 111.113 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.41 54.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 63.0 111.088 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -66.5 -50.3 63.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 75.02 110.855 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -55.29 -26.06 38.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 64.43 110.856 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.3 tp -79.44 -35.4 40.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 75.3 110.933 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.49 -60.54 3.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 73.53 110.876 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -60.35 -32.45 71.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 64.34 110.889 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -55.34 -26.51 41.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 73.3 110.912 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -108.24 -26.66 10.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 64.43 110.892 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.97 60.02 2.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 53.32 110.919 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -70.06 -25.91 63.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 75.21 110.918 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.74 -10.58 59.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 74.23 110.834 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.12 23.38 52.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.757 . . . . 63.21 112.499 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -83.07 -22.06 33.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.929 0.395 . . . . 61.54 110.87 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.32 20.69 60.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 74.42 112.527 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -150.08 131.74 14.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 64.4 110.901 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.5 mt -91.45 101.88 14.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.945 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -65.61 171.85 3.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 71.41 110.875 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.05 -29.99 23.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 62.23 110.86 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.81 -51.35 12.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 64.11 110.892 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -59.62 -26.4 65.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 73.53 110.904 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.78 -36.63 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 74.21 111.112 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.72 -44.77 63.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 71.34 111.126 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.27 -25.27 48.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.741 . . . . 42.34 112.486 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.23 -56.75 18.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 74.34 110.896 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.1 mt -51.95 -32.41 33.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.927 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -57.0 -43.97 82.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 75.42 110.885 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -84.93 -45.93 11.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 74.55 110.834 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.1 m -52.58 -36.63 56.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.174 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -67.33 -56.44 9.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 74.11 110.947 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -54.61 -26.79 34.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 63.03 111.107 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.95 -33.17 75.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.88 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -99.02 18.95 16.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.82 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.21 68.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 73.12 112.47 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.3 tpp -65.28 173.65 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 75.01 110.884 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 91.1 p -72.92 -9.07 58.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 72.0 110.831 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.64 47.85 3.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 63.34 110.834 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -62.63 152.6 34.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 73.42 110.846 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.3 p -108.29 90.93 7.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.626 0.726 . . . . 74.11 111.1 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 -176.35 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 2.252 . . . . 71.13 112.293 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 36.6 p -128.68 -176.07 3.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 70.03 111.17 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -55.07 -26.55 38.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 73.14 110.909 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -72.93 -61.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.861 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.05 -48.3 64.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 54.5 110.834 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 89.7 t -52.17 -36.62 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.55 111.152 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -59.38 -53.9 52.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 75.22 110.909 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.0 mp -55.23 -38.4 47.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 63.41 111.137 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 88.4 t90 -75.22 -25.27 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 72.33 110.923 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 tt -74.89 -51.21 14.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.859 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -52.75 -45.17 66.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 75.45 110.887 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.0 ttm -57.92 -26.39 62.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 64.53 110.879 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.85 -67.28 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 73.43 111.128 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -61.25 128.49 36.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 73.52 110.872 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.1 m -84.05 -28.14 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 73.51 111.135 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -91.3 -12.46 35.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 64.11 110.883 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 58.5 58.37 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 61.11 110.83 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -117.29 23.46 11.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 60.52 110.911 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.13 31.5 81.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.718 -0.753 . . . . 64.45 112.457 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.58 129.98 17.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.922 0.391 . . . . 74.31 110.887 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.3 t -114.99 102.31 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 74.42 111.08 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.47 176.24 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 71.22 110.821 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -29.92 70.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 75.43 110.984 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -81.39 -29.5 33.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 64.13 110.933 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.7 -22.0 29.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 63.22 110.912 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -84.04 -35.19 24.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 73.31 110.927 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -67.86 -41.81 82.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 64.31 110.891 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -55.33 -30.11 59.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.843 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 44.5 mt -62.26 -41.03 98.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 75.03 110.903 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 4.6 mp -66.2 -44.25 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 75.44 111.127 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.32 -35.9 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.53 111.164 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.37 -41.17 79.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 73.31 110.946 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 17.9 t -84.69 -36.05 22.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 70.34 110.881 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.4 mt -51.99 -37.9 54.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 63.23 110.929 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -51.1 -46.67 61.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 73.51 110.861 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.42 -22.62 26.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 74.14 110.885 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.77 -22.79 67.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.04 111.117 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.52 26.59 3.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 43.04 112.472 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.2 mp -124.76 136.24 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 74.43 111.108 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -102.07 115.9 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 71.25 110.891 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.3 p -122.68 132.46 71.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 71.24 111.151 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -113.65 135.74 53.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 73.33 110.853 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -129.03 134.49 48.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 75.15 110.879 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -160.29 130.61 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 73.14 110.925 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.6 t -100.24 154.68 18.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 73.4 110.86 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.0 mt -119.72 99.9 6.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.04 110.92 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.35 131.1 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 75.41 111.157 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 53.2 p90 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 63.52 110.906 -179.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.8 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.868 0.366 . . . . 74.24 110.863 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.4 p -124.41 133.74 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.919 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.38 159.84 32.52 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.57 0.7 . . . . 72.42 110.9 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 146.67 60.7 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.684 2.256 . . . . 74.11 112.33 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -99.88 109.02 21.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 72.25 110.894 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -109.34 135.44 50.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 74.3 110.866 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -53.73 160.57 2.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.608 0.718 . . . . 75.42 110.905 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -20.43 34.89 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.719 2.279 . . . . 61.4 112.334 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -81.63 -20.91 38.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.881 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -80.4 -59.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 71.02 111.118 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -51.77 -30.66 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 73.24 110.905 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.4 -30.88 61.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 71.13 111.114 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -25.81 22.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 70.23 110.94 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 18.7 mt -76.32 -42.12 46.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.34 110.918 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -55.23 -51.99 64.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 60.22 110.901 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.18 -26.53 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.088 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.21 76.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 73.23 111.121 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.3 mtm-85 -56.5 -44.88 81.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 74.45 110.873 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -61.64 -37.77 85.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.41 110.857 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.91 -29.84 61.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 75.03 110.912 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -67.11 -55.29 14.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 73.44 110.882 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -66.82 -28.5 68.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 73.12 110.922 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -52.5 -39.91 61.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.11 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -96.55 -35.5 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 71.53 110.879 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -80.75 57.96 3.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.839 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -25.38 68.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 74.5 110.894 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -71.27 -10.62 60.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 73.05 110.857 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.4 29.68 57.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 65.15 112.484 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.8 p -70.69 -22.18 62.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 65.23 110.843 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.48 -16.39 58.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 73.34 112.491 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -141.44 155.76 45.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.359 . . . . 72.2 110.912 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 42.0 mt -98.62 109.74 22.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 65.52 110.893 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.55 178.34 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.21 110.948 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -57.86 -26.31 61.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 71.51 110.884 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -82.63 -53.3 6.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.23 110.877 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.92 -49.05 63.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.86 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.9 mt -51.63 -38.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 74.13 111.164 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.64 -41.34 61.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 74.55 111.096 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.85 -30.41 32.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.744 -0.741 . . . . 72.32 112.514 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.8 tp -58.32 -54.02 51.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 74.1 110.904 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 56.6 mt -51.85 -32.28 31.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 74.11 110.93 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -54.71 -58.13 8.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 75.43 110.852 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.96 -42.82 56.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 75.43 110.855 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 93.1 m -52.42 -32.26 38.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 64.23 111.157 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -79.16 -57.53 3.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 74.11 110.924 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.51 -26.08 40.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.45 111.102 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.64 -27.65 63.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 75.43 110.885 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 51.8 mtm -103.91 21.86 15.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 73.13 110.887 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.84 23.07 72.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 65.14 112.505 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.0 tpp -76.57 170.03 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 65.33 110.887 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -64.48 -17.46 63.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 75.52 110.848 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 63.5 56.72 1.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.907 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -67.69 152.65 45.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 71.23 110.902 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.5 m -108.23 90.85 7.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.555 0.693 . . . . 74.45 111.161 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 174.98 8.71 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 74.33 112.305 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 68.4 p -116.15 -176.02 2.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 70.31 111.143 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -51.82 -30.42 23.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.53 110.902 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -69.38 -61.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 65.51 110.902 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.9 -45.23 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 71.03 110.875 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.6 t -58.84 -28.51 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 75.44 111.193 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -66.92 -40.0 87.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 74.52 110.911 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mp -70.12 -31.37 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 70.42 111.127 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -83.52 -28.34 28.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 75.12 110.912 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 23.0 tp -83.72 -38.2 21.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 72.53 110.958 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -61.05 -30.91 70.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 74.54 110.906 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 48.8 ttp -91.25 -40.13 11.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 61.4 110.864 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.38 -25.26 67.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.12 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -101.25 127.84 47.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.879 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 98.0 m -83.9 -25.03 30.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 72.15 111.167 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -97.32 -12.43 22.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.846 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.6 t 56.6 39.32 29.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 75.53 110.879 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -98.05 19.55 13.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 72.13 110.885 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.08 31.71 81.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.484 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.97 134.0 18.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 61.54 110.863 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.26 97.72 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 72.3 111.119 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.06 162.45 24.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 63.23 110.875 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.6 mt -53.29 -31.57 44.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.128 -0.487 . . . . 71.02 110.893 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -81.43 -28.12 34.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.887 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -78.03 -42.46 32.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.467 . . . . 74.32 110.859 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -65.04 -52.62 54.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.917 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -51.81 -48.37 63.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 70.32 110.917 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -51.93 -35.0 44.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 73.05 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 2.5 tp -61.19 -45.08 96.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.24 110.943 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.1 mp -64.95 -28.32 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.11 111.115 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.0 mm -63.99 -52.85 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 63.23 111.122 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -56.49 -30.75 63.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 71.31 110.903 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 22.1 m -83.08 -29.94 28.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 72.32 110.814 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.81 -42.72 85.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 64.35 110.874 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -51.9 -36.53 49.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.871 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -26.02 26.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 73.41 110.938 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.72 67.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 73.42 111.108 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.81 25.09 5.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.743 . . . . 75.24 112.43 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -116.57 108.5 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 63.34 111.124 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -64.6 118.4 8.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 75.13 110.901 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.34 123.05 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.116 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -78.1 108.09 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 74.22 110.882 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.4 142.58 29.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.889 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -118.21 144.22 45.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.929 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 34.4 t -142.02 167.19 22.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 75.34 110.897 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.8 83.25 3.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.914 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.66 136.02 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 72.13 111.126 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 50.6 p90 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 75.44 110.864 -179.963 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.862 0.363 . . . . 74.13 110.869 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.0 m -95.79 69.67 2.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 73.03 110.879 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.06 155.12 60.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.607 0.717 . . . . 70.41 110.898 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 166.13 28.58 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 71.22 112.377 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -122.91 103.79 8.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.13 110.867 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -102.26 145.54 29.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 63.13 110.957 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -62.7 160.58 34.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.617 0.723 . . . . 75.23 110.912 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -17.78 37.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.714 2.276 . . . . 72.31 112.373 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -82.9 -22.49 33.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.887 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.28 -61.27 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 74.11 111.114 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -51.67 -29.96 20.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 70.4 110.906 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.55 84.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 63.31 111.106 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -88.42 -26.61 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 72.44 110.893 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 61.4 mt -74.78 -26.12 59.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 72.14 110.94 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.21 -54.16 28.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 53.33 110.883 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.15 -24.95 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 75.35 111.114 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.89 -39.94 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 75.45 111.118 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -54.72 -31.09 57.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.891 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -85.03 -40.94 16.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.874 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.48 -27.25 67.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 74.13 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -72.81 -49.98 27.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 73.32 110.888 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -74.83 -25.91 59.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.901 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -57.23 -25.04 58.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.53 110.922 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -110.05 -21.31 12.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 65.43 110.919 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -77.27 61.81 2.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 75.25 110.832 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -16.72 59.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 71.4 110.952 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -70.22 -10.66 59.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 63.22 110.872 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.0 20.33 53.29 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.77 -0.729 . . . . 61.02 112.509 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.7 m -78.95 -22.12 46.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.945 0.403 . . . . 74.2 110.853 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.3 -16.06 58.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 73.42 112.533 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.63 170.71 9.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 63.43 110.891 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.98 101.29 9.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 75.34 110.89 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -73.46 172.16 11.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 75.03 110.915 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.44 -27.39 36.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 74.52 110.875 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -82.23 -45.78 14.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 73.42 110.87 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -63.71 -45.18 91.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.23 110.874 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 21.2 mt -52.43 -31.35 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 70.12 111.123 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.95 58.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 73.43 111.111 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.75 -22.85 59.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.734 . . . . 72.32 112.501 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.8 tp -70.09 -59.09 3.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.808 0.337 . . . . 74.23 110.909 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 27.3 mt -52.16 -32.65 36.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 71.33 110.944 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -51.9 -57.26 9.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 65.42 110.91 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.0 -41.54 28.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 73.12 110.867 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.5 m -51.63 -30.99 23.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 70.1 111.159 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.38 -52.47 9.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 71.54 110.922 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -54.84 -25.51 28.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 74.42 111.135 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -54.29 -32.47 56.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 75.1 110.853 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.4 ptp -105.67 21.13 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.55 110.888 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.83 16.56 66.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 70.44 112.468 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.16 166.96 0.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.82 0.343 . . . . 73.34 110.873 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.2 m -65.36 -14.58 61.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.868 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t30 64.21 58.32 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 72.05 110.908 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -73.29 153.08 40.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 73.32 110.919 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.2 m -108.09 90.91 7.2 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.685 . . . . 70.33 111.133 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -174.65 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.696 2.264 . . . . 75.04 112.355 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 71.2 p -129.01 -176.01 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 75.51 111.135 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -54.72 -26.67 35.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 72.25 110.872 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -72.56 -61.64 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.89 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.07 -48.6 64.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 75.12 110.867 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 86.6 t -51.68 -42.48 31.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 63.34 111.084 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -47.0 64.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 72.13 110.918 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.9 mp -62.44 -26.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.44 111.088 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -83.78 -30.76 26.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 73.44 110.927 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.2 tt -77.59 -47.05 20.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 74.32 110.954 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -51.95 -30.92 26.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 64.5 110.912 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 37.1 ttp -90.41 -26.43 19.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.844 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -96.09 21.91 8.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 74.13 111.133 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -131.8 112.2 12.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.842 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.5 m -83.74 -41.79 17.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 61.24 111.16 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.47 -12.5 59.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 64.54 110.896 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 54.66 35.2 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 64.14 110.847 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.45 -16.23 37.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.89 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.0 20.24 16.91 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 71.21 112.48 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.52 126.71 8.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 74.35 110.864 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.49 97.53 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 72.5 111.066 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.1 t -67.71 165.18 17.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.838 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 26.1 tp -53.62 -35.94 61.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 75.52 110.875 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -77.08 -24.67 51.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 75.33 110.907 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -79.58 -53.33 6.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 71.43 110.906 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -51.98 -49.95 62.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.934 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -51.82 -47.61 64.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 73.14 110.903 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -52.8 -32.53 44.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.487 . . . . 62.25 110.904 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.5 -38.94 91.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.937 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -74.17 -24.05 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 74.43 111.11 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 45.0 mm -59.4 -55.87 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.12 111.114 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -56.24 -37.95 70.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 74.53 110.892 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.6 t -66.98 -28.48 68.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 73.23 110.869 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.3 mt -79.34 -25.42 42.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 74.53 110.956 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -59.99 -45.59 92.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.879 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -86.05 -20.37 28.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.911 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.93 -22.77 67.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.056 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 108.9 32.44 3.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.78 -0.724 . . . . 75.21 112.472 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.12 131.01 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 74.4 111.107 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -90.55 133.63 34.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.904 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.7 p -138.18 144.08 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.154 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -129.1 132.58 47.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 75.14 110.898 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -120.83 146.48 46.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 73.1 110.868 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -96.47 95.5 8.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 75.01 110.91 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -140.22 172.17 13.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 72.33 110.849 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 58.0 mt -88.42 140.69 29.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 75.22 110.898 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 16.0 m -101.7 155.77 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 74.3 111.188 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 4.1 t80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.878 179.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.9 0.381 . . . . 73.24 110.84 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 66.1 m -73.76 150.95 40.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 70.11 110.803 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 156.09 79.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 74.22 110.931 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 143.79 51.99 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.706 2.271 . . . . 74.03 112.351 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 102.6 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.845 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.07 132.85 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 64.04 110.964 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -52.02 160.49 1.17 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.623 0.725 . . . . 64.41 110.879 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -17.13 37.61 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.688 2.258 . . . . 72.51 112.34 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -82.9 -24.63 33.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.906 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.35 -63.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 75.1 111.115 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -52.15 -30.01 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 75.31 110.879 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.76 -32.69 60.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 72.14 111.123 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -87.96 -25.73 23.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 75.02 110.936 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.2 mt -77.9 -29.23 50.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.935 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -65.7 -32.59 74.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.896 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.7 p -86.05 -23.36 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 75.31 111.12 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -82.78 -35.55 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 70.01 111.108 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -24.46 57.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 75.32 110.817 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -83.17 -23.07 33.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 73.54 110.866 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.59 -24.34 33.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.899 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -65.54 -56.43 12.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 64.25 110.881 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -72.22 -24.22 61.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.88 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -52.08 -29.88 23.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 74.53 110.875 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -110.69 -21.14 12.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.901 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -75.62 69.66 2.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 52.12 110.872 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -85.14 0.51 51.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 71.33 110.895 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.39 -10.57 59.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 74.44 110.869 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.16 18.7 60.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 75.23 112.529 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 p -106.32 -22.0 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.382 . . . . 64.33 110.869 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.6 21.53 66.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 74.05 112.48 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -128.72 132.54 47.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 73.51 110.879 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 mp -90.81 104.78 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 74.52 110.923 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -88.04 177.27 6.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 72.4 110.944 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -52.04 -30.08 23.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.33 110.898 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -80.4 -55.04 5.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 74.0 110.834 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -53.95 -46.02 71.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.04 110.929 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.3 mt -57.19 -33.72 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 74.44 111.11 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.15 -48.06 61.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 73.11 111.079 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.36 -24.72 70.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 60.1 112.492 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 tp -69.42 -55.93 8.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 75.2 110.926 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 70.7 mt -51.69 -30.16 20.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 73.51 110.884 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.15 -58.57 7.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 75.01 110.915 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -71.77 -42.85 66.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 73.42 110.86 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.1 m -52.17 -34.94 47.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 62.55 111.171 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -82.11 -25.72 34.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 74.41 110.94 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.91 -25.38 43.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 74.42 111.066 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -59.68 -44.78 93.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 75.4 110.843 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.3 mtm -75.08 -18.29 60.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 70.11 110.866 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.95 17.72 36.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 75.42 112.532 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.3 ttm -66.67 175.93 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.799 0.333 . . . . 74.34 110.828 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.4 m -65.72 -14.39 61.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 63.13 110.855 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.21 73.73 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 62.33 110.841 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -78.52 152.93 31.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 75.15 110.859 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.3 m -108.03 90.88 7.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.581 0.705 . . . . 72.53 111.124 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 169.19 19.43 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.703 2.268 . . . . 74.45 112.348 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 62.7 p -108.63 -176.06 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 74.23 111.139 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -24.97 46.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 75.5 110.89 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -77.8 -55.4 5.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.13 110.895 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.57 -35.89 43.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 73.44 110.872 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 88.4 t -65.83 -36.79 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 73.14 111.144 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -59.03 -46.63 87.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 74.3 110.898 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mp -62.61 -28.01 43.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 74.41 111.111 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -83.8 -26.03 29.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.892 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.0 tt -77.3 -35.21 55.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.14 110.875 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.67 -26.62 67.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.2 110.907 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.9 ttm -87.66 -49.81 6.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 74.23 110.895 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.32 -44.37 97.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 63.01 111.107 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -58.57 98.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 72.54 110.804 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 97.4 m -86.66 -24.75 25.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 75.14 111.133 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -95.44 -12.35 26.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 71.34 110.902 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 62.27 48.16 4.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.853 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -110.31 23.81 13.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.11 110.862 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.68 14.51 58.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 53.31 112.503 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.72 158.86 40.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 74.12 110.86 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 34.4 t -117.62 122.72 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 73.51 111.141 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 -169.74 2.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.873 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -43.83 84.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 72.4 110.893 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -72.49 -34.59 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 72.15 110.878 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.7 -23.03 53.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 73.52 110.899 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -82.11 -50.33 9.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 75.12 110.959 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -53.61 -43.71 68.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 71.1 110.866 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -52.01 -29.96 23.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.22 110.885 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.35 -43.1 95.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.946 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.2 mp -69.78 -24.64 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.42 111.126 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.0 mm -59.2 -55.6 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 72.11 111.142 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -52.62 -38.07 59.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 75.21 110.876 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 p -74.57 -29.81 61.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.892 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.7 mt -68.51 -33.37 74.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 74.21 110.948 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -57.67 -47.18 83.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 73.15 110.905 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -24.68 32.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 72.51 110.909 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.88 -21.18 66.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 70.52 111.118 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.89 20.7 4.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.738 . . . . 72.25 112.535 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.73 103.85 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 74.12 111.138 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -72.12 108.45 5.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.41 110.86 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.2 p -102.55 143.9 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.3 111.168 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.45 128.21 52.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.892 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.24 151.08 42.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 75.12 110.9 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -66.12 102.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 74.53 110.906 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 12.5 t -136.37 176.5 8.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 71.31 110.897 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.5 mt -119.68 130.63 55.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.871 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.89 142.56 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 73.53 111.087 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 46.4 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 65.31 110.88 -179.97 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.881 0.372 . . . . 74.12 110.822 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.7 p -77.67 111.89 13.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 64.22 110.828 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -97.15 137.66 21.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.603 0.716 . . . . 75.41 110.918 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 119.04 6.05 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.686 2.257 . . . . 75.13 112.387 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -74.93 102.65 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 71.21 110.937 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -91.01 132.95 35.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 75.42 110.924 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -51.93 160.88 1.03 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 65.54 110.871 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -17.19 37.61 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.715 2.277 . . . . 73.44 112.301 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -82.99 -24.84 32.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 73.23 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.59 -63.35 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 74.51 111.128 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -51.88 -33.61 37.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 73.01 110.876 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.42 -36.36 54.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 75.32 111.144 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -83.06 -26.17 31.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 74.32 110.921 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 92.5 mt -74.31 -37.19 63.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.34 110.953 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.91 -57.25 11.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 75.12 110.924 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.89 -25.23 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.14 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.86 -29.7 40.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 62.35 111.139 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -60.03 -54.26 48.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.52 110.869 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 -54.24 -46.24 72.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.841 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.8 tp -56.97 -34.37 68.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 72.41 110.925 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -59.77 -62.99 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 72.45 110.907 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -62.89 -26.96 69.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 73.44 110.902 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -31.42 36.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.902 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.29 -38.08 7.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 75.24 110.943 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.88 76.23 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 74.31 110.857 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -67.2 -30.62 70.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 75.53 110.907 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.92 -10.55 59.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.32 110.869 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.74 22.49 40.56 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.733 -0.746 . . . . 64.35 112.463 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.3 m -71.42 -22.06 61.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 75.22 110.891 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.7 23.5 57.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.514 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -145.79 130.74 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.358 . . . . 73.03 110.908 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mt -103.85 101.42 11.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 75.52 110.934 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -62.89 174.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 54.02 110.901 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.14 -26.49 38.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 34.51 110.891 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.63 -54.67 5.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 70.2 110.857 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -52.22 -38.85 59.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 72.12 110.899 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.3 mt -63.32 -32.96 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 75.23 111.115 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.7 -42.13 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 73.0 111.115 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.34 -25.9 45.77 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.713 -0.756 . . . . 72.53 112.465 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.2 tp -60.88 -55.85 28.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 73.51 110.937 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.5 mt -52.03 -33.94 40.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 70.13 110.903 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -59.73 4.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 71.33 110.923 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.13 -41.42 61.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 75.4 110.832 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 89.0 m -53.44 -32.92 52.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 74.33 111.126 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -77.33 -51.23 11.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.895 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -58.19 -30.63 66.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 65.13 111.113 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.9 -46.77 64.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 71.32 110.922 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 33.1 mtm -76.8 -18.46 58.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 63.41 110.912 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 95.89 28.66 9.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.74 -0.743 . . . . 73.35 112.426 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 6.3 ttm -86.0 175.79 8.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 75.14 110.853 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.0 m -58.29 -22.97 54.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 71.32 110.848 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 63.36 60.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 60.31 110.896 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -65.62 152.51 43.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 73.33 110.864 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.0 p -108.31 90.82 7.39 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.589 0.709 . . . . 75.05 111.135 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -171.19 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.28 . . . . 71.11 112.322 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 34.3 p -126.5 -176.17 3.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.132 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -57.45 -26.36 61.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 74.34 110.918 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -72.53 -61.56 1.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 73.14 110.886 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.27 -48.82 65.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.477 . . . . 75.22 110.849 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.7 t -51.62 -34.87 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 70.35 111.115 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.27 -52.53 64.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 75.53 110.882 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 mp -57.46 -25.83 25.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 75.4 111.171 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 49.6 t90 -82.69 -37.72 24.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 74.05 110.935 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.6 tt -57.63 -46.38 84.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 72.41 110.865 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -54.7 -36.38 64.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 71.54 110.925 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.2 mtm -65.79 -54.22 29.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 73.44 110.873 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.53 -63.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 71.34 111.098 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -69.32 129.28 39.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 73.03 110.888 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 8.5 m -85.22 -24.79 27.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.123 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -89.39 -12.4 40.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 74.43 110.904 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.5 p 51.59 39.73 25.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 73.35 110.898 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -95.24 23.92 5.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.89 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 65.58 29.3 74.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.739 . . . . 53.44 112.49 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m -154.71 126.88 7.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.401 . . . . 75.22 110.828 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.71 106.38 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 73.34 111.133 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.1 t -72.1 178.32 3.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 72.43 110.86 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.67 -38.03 89.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.946 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -81.26 -25.59 36.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 63.32 110.899 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.35 -23.19 40.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 72.01 110.882 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -84.27 -51.81 6.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 74.55 110.936 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -53.1 -43.83 67.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.487 . . . . 72.24 110.888 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -52.74 -41.91 64.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.909 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.0 tt -52.42 -39.61 61.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 75.3 110.919 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -73.81 -25.85 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 73.34 111.152 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.5 mm -67.45 -38.14 80.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 73.42 111.121 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -66.28 -36.88 84.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 74.41 110.9 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 43.7 m -78.36 -37.82 43.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 73.11 110.865 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.7 mt -57.8 -35.89 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 73.14 110.919 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -56.83 -37.71 71.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.908 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -85.59 -24.88 26.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.951 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.74 67.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 75.34 111.126 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.72 24.15 3.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 65.13 112.51 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.04 102.0 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 73.11 111.135 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -69.45 101.26 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 73.24 110.915 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.9 150.38 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 75.51 111.142 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -123.41 126.27 46.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 75.4 110.876 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.97 158.94 43.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 75.31 110.889 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -83.89 84.63 7.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 71.1 110.895 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 12.4 p -74.85 167.67 21.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 72.0 110.847 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -146.77 175.94 10.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 73.25 110.886 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.7 t -58.78 109.85 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 73.3 111.091 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.845 -179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.912 0.387 . . . . 73.22 110.872 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -124.36 124.5 42.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 71.34 110.842 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -93.79 160.71 32.05 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.537 0.684 . . . . 73.53 110.933 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 131.95 22.2 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.66 2.24 . . . . 71.03 112.35 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -81.41 106.34 13.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 75.23 110.897 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -105.02 134.83 47.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 73.51 110.955 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.66 160.8 1.84 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 72.42 110.89 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -21.41 33.27 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 2.253 . . . . 75.0 112.337 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.94 -21.83 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 74.05 110.863 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -77.73 -61.17 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 75.02 111.173 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -52.08 -29.86 23.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.03 110.892 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.81 -38.73 70.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 44.44 111.132 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -83.95 -25.39 30.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.04 110.938 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 90.2 mt -75.24 -30.27 60.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.933 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.65 -56.13 25.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.472 . . . . 64.51 110.847 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.97 -26.75 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 71.01 111.142 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.83 -32.2 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 51.24 111.091 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.0 mtt180 -59.94 -45.78 91.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 75.35 110.878 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -60.71 -33.03 72.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 75.32 110.864 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.0 tp -69.48 -26.32 64.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 73.55 110.921 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -64.07 -63.72 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 62.03 110.906 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -59.43 -26.64 65.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 71.41 110.89 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -55.99 -26.92 50.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.32 110.874 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -110.35 -27.19 9.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.959 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.12 78.74 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.848 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -26.11 33.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.926 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -70.78 -10.63 59.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.858 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.99 20.66 50.18 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.761 -0.733 . . . . 70.24 112.461 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 p -86.84 -22.09 26.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 65.11 110.829 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.21 23.1 41.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 50.13 112.473 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -138.28 152.01 48.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 74.14 110.902 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.4 mt -118.81 102.69 9.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 74.12 110.895 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -70.62 173.9 6.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.875 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -55.07 -26.76 39.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 63.25 110.879 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.4 -32.34 48.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 74.52 110.865 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -84.5 -26.26 28.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 71.24 110.857 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 21.3 mt -74.51 -41.04 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 73.24 111.149 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.56 -45.11 62.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 62.05 111.117 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.22 -22.84 56.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.754 . . . . 60.03 112.496 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.9 tp -60.31 -54.41 46.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 71.42 110.953 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.91 -34.42 41.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 64.21 110.953 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -52.94 -49.21 66.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.3 110.899 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -82.25 -43.35 17.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.869 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.2 m -53.79 -30.95 47.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 64.2 111.207 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -81.04 -57.92 3.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.46 -25.6 37.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.45 111.143 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.17 -26.3 62.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.907 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 38.7 mtm -110.75 21.68 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.867 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 18.56 68.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.749 -0.739 . . . . 72.33 112.486 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.0 mmt -63.31 171.8 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 75.35 110.903 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.1 t -59.83 -20.92 59.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 75.04 110.876 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.5 t30 63.66 63.77 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 71.55 110.896 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -88.26 152.49 21.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.25 110.868 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.5 p -108.24 90.83 7.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.577 0.703 . . . . 63.21 111.148 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 157.03 61.75 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.639 2.226 . . . . 75.52 112.369 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 71.9 p -91.91 -176.94 4.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.34 111.166 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -56.44 -25.38 50.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 75.41 110.864 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.15 -59.92 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.04 110.918 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -52.99 -30.91 37.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 64.21 110.905 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.4 -32.56 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 62.31 111.111 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.15 -43.66 94.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 70.24 110.899 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mp -63.98 -34.64 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 74.01 111.144 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -81.7 -25.72 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 72.23 110.901 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 31.1 tp -83.8 -25.34 30.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 73.04 110.89 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -52.98 -58.38 7.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 74.1 110.93 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 43.5 mtm -67.09 -46.05 75.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 63.53 110.851 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -56.1 -25.04 44.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 75.03 111.127 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -88.26 95.75 10.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.21 110.883 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.8 m -87.68 -34.5 18.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 65.32 111.11 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.29 6.34 33.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 71.54 110.9 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.9 p 46.14 36.44 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 71.22 110.83 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -96.33 -16.27 21.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 74.41 110.802 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 99.29 19.44 20.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.767 -0.73 . . . . 63.52 112.476 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.2 m -142.31 -177.35 5.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.937 0.398 . . . . 73.11 110.838 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.87 106.37 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 75.22 111.155 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -77.51 -176.05 4.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.868 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.99 -38.58 86.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 75.25 110.937 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -77.75 -25.65 49.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.905 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -84.93 -23.54 28.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 72.34 110.91 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -81.87 -43.53 18.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 72.53 110.877 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -54.06 -41.86 68.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.03 110.864 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -51.7 -44.08 63.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 73.55 110.932 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 53.4 mt -51.75 -33.88 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.921 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 5.3 mp -79.43 -36.08 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 74.0 111.114 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.44 -29.62 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.117 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.58 -62.16 2.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 64.02 110.912 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 46.3 t -53.14 -37.37 61.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 71.32 110.904 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.9 mp -55.65 -24.57 34.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 74.11 110.944 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.95 -58.98 3.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 74.01 110.894 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -78.78 -5.81 54.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.892 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -91.17 13.99 15.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 61.45 111.158 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.16 33.46 85.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 62.23 112.514 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 6.5 mm -102.1 111.72 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 74.13 111.124 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 100.28 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 70.4 110.907 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.8 p -112.5 130.5 66.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 74.34 111.114 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.31 107.99 19.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 74.42 110.86 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.69 120.35 14.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.24 110.951 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -59.46 120.75 9.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 75.44 110.935 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 55.3 p -139.96 132.27 28.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.836 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mp -104.14 143.64 32.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 75.13 110.927 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.41 145.15 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 74.43 111.153 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.6 p90 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 65.44 110.853 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.878 0.371 . . . . 74.12 110.911 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.62 161.12 62.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.721 . . . . 75.22 110.9 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -18.87 36.81 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.678 2.252 . . . . 73.33 112.326 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.466 ' HB3' HG23 ' A' ' 209' ' ' ILE . 4.6 tp10 -82.04 -23.56 35.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 62.11 110.873 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.55 -63.28 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 51.25 111.119 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -51.86 -30.66 24.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 63.35 110.855 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -37.91 63.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 70.44 111.107 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.659 ' HB3' HD11 ' A' ' 204' ' ' LEU . 30.5 tptt -87.98 -25.73 23.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.45 110.926 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.692 HD22 ' HB2' ' A' ' 197' ' ' GLU . 87.3 mt -72.92 -27.27 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.895 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -66.64 -51.8 52.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.853 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.35 -25.15 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 71.5 111.121 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.25 -25.62 36.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.085 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.645 ' HG2' HD11 ' A' ' 193' ' ' LEU . 44.9 mtp180 -67.13 -47.18 71.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.3 110.842 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -63.41 -35.21 79.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 70.32 110.882 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.72 -29.48 69.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 73.23 110.896 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -65.5 -59.55 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 73.22 110.852 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -64.47 -28.07 69.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 61.23 110.882 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -55.5 -26.75 44.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 62.4 110.89 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -108.21 -30.48 8.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 65.5 110.919 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.23 84.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.892 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -85.03 -32.01 23.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.15 110.925 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.56 -10.57 59.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 53.13 110.864 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.75 23.29 43.88 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.722 -0.752 . . . . 55.14 112.476 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.9 p -75.25 -22.17 58.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 74.43 110.845 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.5 19.64 58.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.734 . . . . 64.24 112.463 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -148.34 130.75 15.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 64.35 110.918 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' HD11 ' A' ' 153' ' ' ILE . 21.7 mt -94.13 101.67 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 64.34 110.897 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -66.26 174.13 2.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 71.44 110.924 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.98 -30.15 23.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 75.05 110.868 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.73 -54.7 6.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.213 -0.448 . . . . 72.43 110.882 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -55.24 -28.36 52.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.45 110.872 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 148' ' ' LEU . 45.6 mt -79.69 -25.44 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 62.31 111.102 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.31 -53.12 48.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 72.2 111.124 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.05 -23.03 56.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.678 -0.772 . . . . 63.43 112.506 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -56.61 -52.6 64.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 62.14 110.922 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.9 mt -52.02 -41.43 62.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 72.54 110.905 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -51.93 -38.87 57.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 65.2 110.881 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -85.11 -49.58 8.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.23 110.86 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.2 m -53.09 -29.02 28.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.32 111.163 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -76.82 -33.57 57.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 74.02 110.961 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.71 -25.16 66.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 53.24 111.062 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -55.71 -26.97 47.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.44 110.9 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 19.9 mtm -109.81 16.8 21.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 71.12 110.889 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 19.46 69.47 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 35.1 112.468 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.3 tpp -63.39 168.41 4.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 73.2 110.883 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 43.2 t -71.12 -10.38 59.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 75.22 110.82 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.34 51.82 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 63.52 110.957 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -52.99 152.51 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 52.11 110.893 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 4.4 m -108.22 90.84 7.3 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.54 0.686 . . . . 71.44 111.129 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.8 Cg_endo -69.75 -177.37 1.84 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.664 2.242 . . . . 64.25 112.338 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 176' ' ' VAL . 73.1 p -123.82 -176.1 3.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 64.4 111.131 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -55.5 -27.32 47.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.9 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.622 ' O ' HD12 ' A' ' 178' ' ' ILE . 23.9 tt0 -73.15 -61.13 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 74.01 110.891 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -52.02 -44.91 64.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.823 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 172' ' ' THR . 86.7 t -57.47 -28.69 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 62.03 111.117 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -68.03 -45.69 73.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 74.32 110.904 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.622 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.4 mp -66.44 -25.98 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 44.12 111.15 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.51 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 47.9 t90 -83.21 -30.42 27.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 71.21 110.92 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.506 HD23 ' CB ' ' A' ' 184' ' ' ASP . 1.3 tt -68.71 -37.89 79.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 54.12 110.93 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -63.02 -27.39 69.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 43.04 110.903 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.0 ttm -71.93 -54.51 9.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 75.43 110.912 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.779 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -74.27 -66.27 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 73.11 111.119 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.506 ' CB ' HD23 ' A' ' 180' ' ' LEU . 48.1 t0 -53.27 129.17 30.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 53.02 110.851 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 25.1 m -85.67 -25.16 26.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 61.02 111.135 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -98.58 -12.45 21.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.936 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.3 p 51.97 37.77 22.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 52.12 110.845 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -95.42 23.96 5.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.87 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.31 31.64 74.67 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 44.3 112.478 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.44 126.98 9.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 44.12 110.858 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 184' ' ' ASP . 30.0 t -115.6 104.85 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 62.13 111.133 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 37.3 t -69.4 170.67 9.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 52.15 110.878 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.645 HD11 ' HG2' ' A' ' 134' ' ' ARG . 0.4 OUTLIER -57.81 -36.66 72.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.32 110.956 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.46 -25.64 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 74.53 110.892 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -81.77 -23.3 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 73.12 110.891 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.434 ' O ' HD12 ' A' ' 200' ' ' ILE . 31.8 t80 -83.8 -51.85 6.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 62.42 110.906 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.692 ' HB2' HD22 ' A' ' 130' ' ' LEU . 14.8 pt-20 -52.03 -43.81 63.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 71.41 110.871 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.93 -41.17 61.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 55.43 110.881 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 183' ' ' ALA . 5.0 tp -53.89 -35.68 61.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 71.35 110.916 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.3 mp -78.99 -25.12 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 61.12 111.091 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.552 ' CD1' HD21 ' A' ' 130' ' ' LEU . 44.9 mm -62.18 -50.88 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 64.34 111.163 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -55.85 -36.09 67.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 73.11 110.877 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -77.94 -35.36 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 62.3 110.841 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 129' ' ' LYS . 22.9 mt -62.32 -28.33 69.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 65.4 110.943 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -64.19 -43.49 94.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 64.2 110.928 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -85.94 -24.92 26.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 54.31 110.901 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.94 -22.58 67.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.099 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.5 31.86 1.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 71.05 112.486 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.496 HD13 ' CD2' ' A' ' 204' ' ' LEU . 5.3 mp -122.68 122.89 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 72.44 111.124 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -83.01 119.5 24.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 71.52 110.897 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.124 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.925 0.393 . . . . 71.34 110.918 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -53.18 160.55 1.61 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 65.44 110.922 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -20.1 35.44 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.705 2.27 . . . . 72.54 112.394 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -82.85 -20.33 35.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 61.25 110.908 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.513 HG11 ' CG2' ' A' ' 211' ' ' VAL . 2.7 t -81.3 -63.35 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 53.32 111.149 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -25.43 42.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 61.41 110.897 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.34 78.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 53.23 111.081 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.412 ' HG2' HD11 ' A' ' 204' ' ' LEU . 18.8 tptt -88.45 -25.37 22.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 74.1 110.903 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.835 HD22 ' HG2' ' A' ' 197' ' ' GLU . 30.9 mt -79.33 -24.06 43.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.933 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.68 -46.51 65.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.904 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.19 -23.61 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 71.22 111.106 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -77.4 -21.79 52.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 63.34 111.078 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.557 ' HG2' HD11 ' A' ' 193' ' ' LEU . 55.5 mtt85 -69.12 -52.29 29.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.889 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -52.03 -29.95 23.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 75.04 110.856 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.655 HD21 ' OD2' ' A' ' 159' ' ' ASP . 12.9 mt -71.71 -44.53 64.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 72.5 110.929 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -52.36 -48.05 65.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 52.01 110.895 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -75.93 -28.41 57.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 64.11 110.86 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -67.9 -25.91 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.11 110.886 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.527 ' HE2' HD22 ' A' ' 136' ' ' LEU . 37.2 m-85 -104.51 -26.2 12.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 65.33 110.968 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -90.43 64.45 5.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.521 . . . . 55.5 110.886 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -28.19 67.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 73.04 110.893 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -70.76 -10.52 59.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.889 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.86 25.74 53.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 42.0 112.502 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.8 p -75.85 -22.1 56.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.924 0.392 . . . . 64.43 110.882 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.62 19.57 65.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 74.35 112.513 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -149.91 130.8 14.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 63.31 110.922 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.7 mt -94.97 101.74 13.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.879 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -70.16 171.81 9.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.932 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -52.13 -30.14 25.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 51.31 110.826 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -74.61 -45.95 41.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 64.24 110.881 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.36 -38.95 88.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 64.23 110.859 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 176' ' ' VAL . 53.4 mt -65.46 -30.97 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 73.25 111.157 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.78 -45.76 63.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 62.21 111.102 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.32 -27.45 39.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 60.15 112.493 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.552 HD21 ' CE1' ' A' ' 196' ' ' TYR . 4.2 tp -54.81 -56.56 18.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 72.21 110.919 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.0 mt -51.96 -33.93 39.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.934 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -52.71 -50.5 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 74.45 110.854 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.655 ' OD2' HD21 ' A' ' 136' ' ' LEU . 10.5 t0 -82.26 -44.25 16.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 64.4 110.871 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.9 m -52.16 -29.55 22.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 63.32 111.18 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -79.33 -49.17 12.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 61.42 110.968 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.97 -24.71 55.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 72.23 111.105 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . 0.542 ' OE2' HD11 ' A' ' 136' ' ' LEU . 0.3 OUTLIER -55.04 -27.14 42.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 64.14 110.852 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.1 mtm -111.28 21.71 15.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 75.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.92 19.05 69.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 72.24 112.494 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.4 tpp -64.38 164.04 12.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 73.15 110.896 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.8 t -62.47 -17.62 59.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 74.33 110.848 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 63.52 56.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 72.43 110.9 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -65.87 152.61 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.855 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 p -108.23 90.84 7.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.544 0.688 . . . . 74.0 111.11 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -172.88 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 51.41 112.347 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.61 ' O ' HG23 ' A' ' 176' ' ' VAL . 79.9 p -120.76 -177.37 3.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 70.22 111.16 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -60.18 -25.69 65.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 55.15 110.93 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.611 ' O ' HD12 ' A' ' 178' ' ' ILE . 32.2 tt0 -72.51 -61.5 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 62.25 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -52.22 -49.0 64.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 72.32 110.871 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 172' ' ' THR . 98.1 t -52.76 -33.53 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 63.44 111.124 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -62.44 -49.9 73.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 73.12 110.92 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -61.15 -25.15 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 74.25 111.098 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.585 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 47.1 t90 -78.15 -30.29 49.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.956 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.539 ' O ' HD23 ' A' ' 180' ' ' LEU . 2.1 tt -72.54 -34.77 67.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 71.34 110.933 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -61.25 -28.74 69.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 65.01 110.923 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 5.9 ttp -86.92 -39.09 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 34.31 110.87 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . . . -68.33 -49.95 56.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 72.24 111.113 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -84.24 127.59 34.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 71.54 110.894 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 21.3 p -76.08 -42.69 46.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 61.14 111.101 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -76.32 -12.41 60.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 61.34 110.891 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.1 p 52.15 37.19 21.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 72.55 110.827 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -79.04 -16.21 57.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 75.42 110.887 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.1 22.82 8.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 54.1 112.489 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.2 p -153.6 127.14 8.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.916 0.389 . . . . 53.32 110.82 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 196' ' ' TYR . 21.9 t -106.41 124.83 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 62.3 111.096 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -174.77 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 70.32 110.897 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.557 HD11 ' HG2' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -57.11 -33.62 67.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 70.33 110.927 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.06 -62.35 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.87 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.414 ' HB3' HG13 ' A' ' 191' ' ' VAL . 6.6 mp0 -52.37 -46.16 66.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 64.12 110.878 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.552 ' CE1' HD21 ' A' ' 156' ' ' LEU . 17.2 t80 -62.04 -58.34 8.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.888 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.835 ' HG2' HD22 ' A' ' 130' ' ' LEU . 72.5 tt0 -54.89 -28.12 48.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.914 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -72.5 -29.54 63.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 75.53 110.819 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.585 HD13 ' CZ2' ' A' ' 179' ' ' TRP . 8.4 tt -64.0 -35.08 79.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 34.14 110.897 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -73.34 -24.91 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 74.33 111.116 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.464 HD13 HD21 ' A' ' 130' ' ' LEU . 50.7 mm -58.4 -43.37 86.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 54.41 111.11 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -67.81 -48.16 67.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 63.25 110.889 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 53.5 p -52.18 -40.86 62.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 51.12 110.864 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.422 ' HG ' HD13 ' A' ' 209' ' ' ILE . 6.7 mp -73.99 -33.16 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 75.21 110.926 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -43.3 89.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 64.04 110.911 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -86.11 -25.77 25.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 63.11 110.908 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.98 -22.76 67.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 72.01 111.094 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.43 20.14 5.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.739 . . . . 45.15 112.49 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.422 HD13 ' HG ' ' A' ' 204' ' ' LEU . 5.3 mp -113.15 102.75 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.815 0.341 . . . . 72.14 111.121 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -71.06 126.03 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.871 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.513 ' CG2' HG11 ' A' ' 126' ' ' VAL . 4.3 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.05 111.128 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.888 0.375 . . . . 60.13 110.944 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -78.3 160.82 72.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.615 0.721 . . . . 74.43 110.926 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -20.26 35.05 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.733 2.289 . . . . 52.11 112.329 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -82.89 -20.94 34.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 73.21 110.887 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.489 HG13 HD22 ' A' ' 204' ' ' LEU . 3.2 t -76.74 -61.99 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 53.43 111.132 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.66 -30.08 20.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 71.11 110.894 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.5 -34.52 71.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.125 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.416 ' O ' HG12 ' A' ' 132' ' ' VAL . 33.9 tptt -88.36 -23.98 23.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.53 110.954 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.554 HD22 ' HB3' ' A' ' 197' ' ' GLU . 38.7 mt -80.88 -24.31 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 72.41 110.878 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.04 -29.48 65.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 72.41 110.876 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 129' ' ' LYS . 10.1 p -85.99 -23.38 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 75.14 111.115 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.14 -37.51 20.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 73.23 111.11 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -54.65 -29.99 54.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 75.22 110.87 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -70.58 -28.98 65.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 73.54 110.872 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.64 -25.85 35.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 70.11 110.893 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.43 -63.21 1.19 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 71.33 110.89 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -60.18 -26.58 66.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 74.52 110.926 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -52.08 -30.02 24.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.852 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -101.54 -26.29 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.894 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.2 85.4 0.56 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 63.22 110.84 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -80.7 -26.29 37.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 75.24 110.892 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.79 -10.58 59.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 71.42 110.894 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.23 20.45 50.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 62.41 112.503 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 p -87.26 -22.18 25.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.945 0.402 . . . . 73.2 110.852 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.74 21.58 42.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.7 -0.762 . . . . 73.02 112.472 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -136.73 138.07 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 73.45 110.925 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.712 HD13 HD22 ' A' ' 156' ' ' LEU . 95.0 mt -103.89 112.53 25.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 65.31 110.91 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -79.83 173.66 12.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.54 110.915 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -53.07 -28.85 26.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 63.51 110.883 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -78.74 -37.85 40.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.901 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' A' ' 148' ' ' LEU . 8.5 mt-10 -75.7 -26.18 57.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 74.14 110.901 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.534 ' CG2' HG13 ' A' ' 176' ' ' VAL . 25.8 mt -76.81 -34.59 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 72.04 111.149 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.78 -46.65 64.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 70.35 111.083 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.59 -23.3 56.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 62.35 112.482 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.712 HD22 HD13 ' A' ' 148' ' ' LEU . 18.0 tp -60.7 -56.49 20.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.858 0.361 . . . . 62.45 110.917 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 45.7 mt -52.15 -36.42 51.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 65.34 110.922 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -51.88 -45.77 64.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.04 110.883 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.24 -45.05 13.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.24 110.869 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.4 m -51.85 -30.44 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.2 111.137 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -81.03 -53.62 6.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.892 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.13 -24.69 42.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 70.31 111.12 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -54.69 -31.06 57.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.896 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -107.21 21.85 16.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 71.41 110.873 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.95 21.45 71.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.727 . . . . 74.54 112.447 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.43 165.47 16.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.341 . . . . 74.31 110.86 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.1 m -60.05 -20.61 58.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.02 110.881 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 63.6 59.48 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 64.41 110.952 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -67.83 152.4 45.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 72.22 110.902 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.5 m -108.18 90.78 7.18 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.564 0.697 . . . . 53.45 111.134 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.75 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.69 2.26 . . . . 71.21 112.343 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 176' ' ' VAL . 71.3 p -126.43 -176.03 3.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 72.01 111.165 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -57.37 -25.72 59.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 65.13 110.829 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.614 ' O ' HD12 ' A' ' 178' ' ' ILE . 36.4 tt0 -74.65 -60.81 2.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 74.42 110.881 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -45.91 64.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 72.51 110.859 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 172' ' ' THR . 97.2 t -56.2 -31.02 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 75.33 111.103 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -65.38 -49.81 67.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 40.1 110.886 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -60.14 -26.76 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.11 111.153 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.679 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 87.3 t90 -82.39 -26.32 32.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 71.1 110.919 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 180' ' ' LEU . 3.9 tt -76.08 -36.46 58.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 63.41 110.892 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -52.38 -49.5 64.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.5 -26.85 65.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 74.12 110.88 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.913 ' HB2' HD11 ' A' ' 199' ' ' LEU . . . -74.69 -68.83 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.0 111.108 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -62.28 118.83 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 74.41 110.886 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.1 m -86.74 -37.54 17.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 73.52 111.146 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -78.48 -12.46 60.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 65.11 110.888 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.8 t 61.75 45.4 7.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 63.4 110.891 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -91.0 -16.17 28.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 63.42 110.835 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.25 19.46 12.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 63.14 112.515 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.52 152.4 30.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 72.24 110.876 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.1 t -108.39 114.17 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.01 111.106 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.6 t -85.08 -171.1 3.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 65.15 110.878 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.81 -57.55 10.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 72.2 110.923 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.47 -43.74 96.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 63.31 110.847 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.53 -59.85 4.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.857 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.572 ' HA ' HD12 ' A' ' 199' ' ' LEU . 34.2 t80 -53.73 -49.87 67.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 71.13 110.94 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.554 ' HB3' HD22 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -60.07 -24.35 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 73.15 110.835 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -69.67 -26.16 64.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 63.31 110.875 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.913 HD11 ' HB2' ' A' ' 183' ' ' ALA . 7.5 mt -67.17 -38.5 85.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 74.02 110.916 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.515 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.2 mp -69.49 -24.32 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 65.44 111.125 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 130' ' ' LEU . 47.7 mm -55.91 -49.63 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.211 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -51.94 -62.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.3 110.878 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.1 m -53.44 -28.6 30.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 65.32 110.836 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.683 ' HG ' HD13 ' A' ' 209' ' ' ILE . 0.6 OUTLIER -64.8 -42.68 94.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 53.43 110.903 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -52.22 -39.61 60.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.13 110.948 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -85.95 -24.24 26.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 73.12 110.89 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.89 -22.81 67.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 64.1 111.111 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.36 30.01 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.773 -0.727 . . . . 53.44 112.458 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.683 HD13 ' HG ' ' A' ' 204' ' ' LEU . 5.3 mp -126.03 137.57 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 75.21 111.151 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -98.94 113.84 26.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.904 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 64.5 111.179 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.917 0.389 . . . . 71.13 110.912 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -65.13 160.74 54.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.665 0.745 . . . . 74.32 110.848 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -20.29 35.34 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.743 2.295 . . . . 65.22 112.354 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -82.89 -21.15 34.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.31 110.859 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.69 -63.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 51.35 111.089 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.543 ' HA ' HD12 ' A' ' 130' ' ' LEU . 6.3 tt0 -52.08 -29.92 23.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 64.23 110.84 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.04 -36.13 65.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.114 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.824 ' HB3' HD11 ' A' ' 204' ' ' LEU . 16.7 tptt -82.74 -26.5 31.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 55.34 110.841 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.788 HD22 ' HB2' ' A' ' 197' ' ' GLU . 21.0 mt -78.69 -25.76 44.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 64.1 110.897 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -69.3 -32.14 71.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.854 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.6 -24.78 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.22 111.119 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.64 -43.93 36.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 55.14 111.071 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -52.08 -29.98 23.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.862 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -75.98 -35.32 59.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.02 110.913 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.4 tp -69.41 -25.66 64.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 73.22 110.911 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.01 -64.58 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 61.41 110.856 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -27.41 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.935 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -53.37 -28.64 30.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.863 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -109.11 -26.69 10.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 75.31 110.918 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -76.44 69.81 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.485 . . . . 72.35 110.881 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -67.62 -26.95 66.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.931 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.62 -10.49 59.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 54.31 110.842 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.31 24.58 52.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 52.35 112.478 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.3 t -77.65 -22.07 51.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 73.12 110.841 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.14 23.8 56.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.666 -0.778 . . . . 73.14 112.503 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -148.16 134.57 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 73.42 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.811 HD13 HD22 ' A' ' 156' ' ' LEU . 31.8 mt -106.33 101.99 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.894 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.83 174.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 74.22 110.874 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.613 ' O ' HG11 ' A' ' 176' ' ' VAL . 5.1 p-10 -54.57 -27.24 37.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 70.42 110.88 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.3 -51.01 7.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 64.24 110.866 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -54.84 -30.99 58.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 64.31 110.855 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.44 HD12 HD12 ' A' ' 180' ' ' LEU . 32.9 mt -73.89 -26.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 72.12 111.124 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.69 -47.88 63.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.074 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.35 -22.87 55.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 51.3 112.456 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.811 HD22 HD13 ' A' ' 148' ' ' LEU . 21.3 tp -58.61 -54.88 42.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 71.23 110.914 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 33.6 mt -51.91 -32.81 34.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.901 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -52.58 -60.7 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 71.11 110.954 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -73.81 -38.26 64.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.55 110.874 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.1 m -57.48 -30.19 64.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 73.31 111.117 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -82.31 -55.12 4.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 72.44 110.902 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.703 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -55.21 -25.7 34.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 32.2 111.098 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.95 -25.9 45.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 73.14 110.88 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.3 mtm -110.24 19.2 19.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 72.51 110.839 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.78 19.24 69.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 74.04 112.505 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.5 mtt -64.65 172.97 2.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 74.13 110.886 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 49.1 p -59.77 -21.03 60.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 75.14 110.868 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.703 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 5.8 t30 63.56 58.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 65.23 110.898 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -78.01 152.6 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 73.1 110.837 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 60.9 m -108.23 90.84 7.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.561 0.696 . . . . 74.04 111.141 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 168.96 19.99 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.706 2.271 . . . . 73.34 112.378 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 176' ' ' VAL . 27.8 p -108.76 -178.02 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 61.53 111.124 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -55.58 -25.89 40.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 70.41 110.891 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.581 ' O ' HD12 ' A' ' 178' ' ' ILE . 11.5 tt0 -72.88 -61.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.885 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.403 ' HA ' HD13 ' A' ' 178' ' ' ILE . 83.2 m-20 -51.91 -36.6 49.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 52.14 110.856 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 172' ' ' THR . 99.3 t -60.98 -40.87 86.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 73.24 111.103 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -54.56 -40.92 69.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 63.33 110.883 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.8 mp -69.99 -25.97 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 72.12 111.166 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -83.76 -31.12 26.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.901 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 180' ' ' LEU . 3.7 tt -78.32 -46.3 20.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 65.43 110.911 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.99 -31.55 29.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 72.11 110.9 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 53.3 ttp -90.51 -25.89 20.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 65.33 110.883 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -73.95 -52.12 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 61.44 111.095 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -85.31 127.8 34.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.43 110.864 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 3.2 m -69.39 -24.53 63.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 73.53 111.158 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -98.08 -10.4 24.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.228 -0.442 . . . . 71.13 110.872 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.4 p 52.99 36.3 21.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.86 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.0 -16.24 57.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 62.2 110.836 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.19 22.9 8.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.731 . . . . 61.43 112.532 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.14 126.93 11.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 52.32 110.828 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.8 t -109.4 112.94 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 72.3 111.12 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.04 -174.89 4.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.875 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.3 OUTLIER -66.69 -33.84 76.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 64.42 110.892 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.48 -36.8 32.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 60.31 110.931 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.19 -21.64 60.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 71.24 110.91 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.527 ' O ' HD12 ' A' ' 200' ' ' ILE . 18.7 t80 -84.48 -51.71 6.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 72.4 110.889 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.788 ' HB2' HD22 ' A' ' 130' ' ' LEU . 13.4 pt-20 -53.99 -43.69 70.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 54.42 110.859 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.84 -26.13 63.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 61.34 110.853 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 183' ' ' ALA . 7.5 tt -67.48 -38.24 84.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.881 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -73.75 -24.58 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 73.32 111.086 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.632 HD11 HD11 ' A' ' 130' ' ' LEU . 50.1 mm -56.6 -57.22 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 75.4 111.098 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -56.18 -25.14 45.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 71.24 110.903 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.4 m -83.23 -26.31 30.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 73.53 110.849 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 129' ' ' LYS . 36.2 mt -79.35 -45.0 20.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 63.3 110.956 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -51.99 -37.83 54.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.874 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -86.09 -29.07 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.32 110.901 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -18.2 65.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 72.2 111.135 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.96 23.05 4.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.774 -0.727 . . . . 42.24 112.517 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.63 101.87 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.343 . . . . 73.23 111.158 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.5 111.44 1.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 72.1 110.891 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 211' ' ' VAL . 5.5 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 70.13 111.153 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.614 ' CE2' HG11 ' A' ' 211' ' ' VAL . 2.2 m-85 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.892 0.377 . . . . 73.44 110.902 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.65 160.52 3.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 73.4 110.883 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -19.31 36.65 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 64.02 112.355 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -80.3 -24.8 39.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.896 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.693 HG21 HG13 ' A' ' 211' ' ' VAL . 3.1 t -79.39 -63.42 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 74.22 111.155 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.644 ' HA ' HD12 ' A' ' 130' ' ' LEU . 1.5 tm-20 -51.49 -30.84 21.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 71.01 110.875 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.6 -33.15 59.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 70.22 111.068 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -88.36 -30.54 19.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 75.45 110.947 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.685 HD21 HD11 ' A' ' 201' ' ' ILE . 15.1 mt -72.81 -26.28 61.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.4 110.922 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -65.41 -46.17 81.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 64.33 110.84 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.597 HG23 ' HD3' ' A' ' 135' ' ' ARG . 14.7 p -74.35 -23.73 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 55.42 111.097 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.86 -22.04 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 65.31 111.091 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -76.08 -57.19 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.869 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.597 ' HD3' HG23 ' A' ' 132' ' ' VAL . 4.5 ptm180 -58.22 -25.33 61.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.14 110.866 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.2 tp -78.3 -26.66 47.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.165 -0.471 . . . . 65.34 110.953 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -69.61 -57.51 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.842 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -65.55 -27.6 68.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 64.23 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 -54.12 -27.87 35.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 44.44 110.86 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -105.65 -40.43 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 62.45 110.909 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -73.03 84.66 1.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 71.11 110.849 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -73.03 -26.24 61.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 74.3 110.93 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.47 -10.52 59.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 73.23 110.847 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.71 22.44 40.15 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 62.34 112.536 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.5 t -76.12 -22.1 55.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 44.24 110.886 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.74 19.3 61.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 65.43 112.489 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -138.47 131.35 29.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.804 0.335 . . . . 72.5 110.933 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 55.8 mt -100.97 104.11 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.903 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.04 173.56 2.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.12 110.92 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -52.82 -29.13 26.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.897 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -80.44 -53.28 6.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 71.22 110.877 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.25 -39.17 59.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 53.11 110.889 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.1 mt -65.85 -30.51 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 62.43 111.131 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.73 -45.72 63.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.33 111.124 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.33 -23.21 55.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 62.23 112.507 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.668 HD21 ' CE1' ' A' ' 196' ' ' TYR . 5.7 tp -59.91 -54.65 43.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 65.34 110.932 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 36.0 mt -51.91 -35.24 44.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 64.13 110.923 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -52.73 -51.76 59.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.882 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -78.81 -43.7 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.5 110.85 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.2 m -54.55 -31.16 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 74.44 111.133 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -82.42 -59.56 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.25 110.934 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -53.4 -28.08 27.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 75.23 111.098 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -55.63 -26.17 42.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.45 110.91 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.2 mtm -110.54 21.79 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.924 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 18.78 68.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.768 -0.729 . . . . 74.53 112.513 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.1 mmt -60.66 172.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 73.41 110.891 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 69.4 m -62.46 -17.72 60.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 75.1 110.847 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.7 t30 63.49 48.24 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 55.23 110.888 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -68.61 152.57 45.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.861 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 p -108.21 90.83 7.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.588 0.709 . . . . 75.22 111.154 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 175.3 8.29 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.687 2.258 . . . . 73.24 112.387 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.656 ' O ' HG23 ' A' ' 176' ' ' VAL . 72.1 p -121.21 -176.14 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 62.12 111.116 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -55.66 -25.81 41.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 63.32 110.928 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.62 ' O ' HD12 ' A' ' 178' ' ' ILE . 9.2 tt0 -72.54 -61.51 1.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.938 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.51 -40.84 65.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.31 110.899 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 172' ' ' THR . 93.8 t -59.72 -31.12 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 71.35 111.09 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -65.13 -41.65 94.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.873 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.5 mp -70.39 -26.48 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 55.33 111.133 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.51 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 57.4 t90 -83.6 -40.09 19.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 75.01 110.945 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 180' ' ' LEU . 4.2 tt -58.6 -26.89 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 75.14 110.855 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -70.96 -49.38 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.923 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.6 ttp -64.9 -26.97 68.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 62.43 110.887 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . . . -83.63 -59.23 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 63.44 111.092 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -81.69 128.66 34.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 65.14 110.863 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.14 -28.87 34.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 74.41 111.135 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -89.7 -9.41 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 65.21 110.891 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.8 p 46.24 58.22 4.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.877 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -113.69 24.04 12.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 73.54 110.857 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.17 27.56 73.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 73.4 112.508 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.66 127.2 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.919 0.39 . . . . 22.44 110.858 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.7 106.17 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.1 111.171 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.53 178.09 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 61.33 110.849 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.56 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -63.66 -36.12 82.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 65.13 110.882 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -81.32 -28.58 34.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.4 110.868 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -77.57 -22.48 50.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.885 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.668 ' CE1' HD21 ' A' ' 156' ' ' LEU . 23.6 t80 -85.13 -53.36 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 63.15 110.923 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 130' ' ' LEU . 11.0 pt-20 -52.02 -43.69 63.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 75.51 110.908 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.43 -42.41 67.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 72.52 110.851 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 6.4 tt -51.9 -39.76 59.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.948 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -72.82 -29.35 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 71.05 111.138 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.685 HD11 HD21 ' A' ' 130' ' ' LEU . 51.3 mm -63.79 -44.07 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 54.54 111.136 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -67.63 -46.87 71.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.881 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 43.4 m -57.45 -37.03 72.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 52.12 110.849 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.72 -34.42 64.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.857 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -60.28 -37.54 80.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 74.43 110.941 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -24.04 26.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 54.14 110.893 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.67 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 43.21 111.088 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.82 26.18 3.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 75.45 112.486 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.3 102.17 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 73.41 111.103 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -72.93 102.78 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.874 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.693 HG13 HG21 ' A' ' 126' ' ' VAL . 22.0 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 75.25 111.066 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.905 0.383 . . . . 74.45 110.952 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -75.1 160.77 79.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.652 0.739 . . . . 72.24 110.857 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -17.88 37.25 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.704 2.269 . . . . 73.02 112.352 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -83.11 -22.55 33.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.12 110.853 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.468 HG13 HD13 ' A' ' 204' ' ' LEU . 2.9 t -79.55 -61.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 71.01 111.103 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.717 ' HA ' HD12 ' A' ' 130' ' ' LEU . 1.3 tt0 -52.18 -30.04 25.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 62.11 110.835 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.02 -32.32 67.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 61.11 111.099 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.44 ' HG3' HD21 ' A' ' 204' ' ' LEU . 0.0 OUTLIER -88.48 -22.22 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.907 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.756 HD22 ' HB3' ' A' ' 197' ' ' GLU . 16.4 mt -81.67 -32.9 31.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 71.25 110.932 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -29.28 64.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 71.33 110.826 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.5 p -85.95 -23.3 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.45 111.16 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.12 -39.28 21.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 70.12 111.11 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -54.86 -38.15 67.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 75.14 110.919 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -63.72 -25.8 68.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.829 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.56 -28.87 41.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 72.1 110.946 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -61.66 -64.55 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.1 110.876 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -54.71 -27.62 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 72.43 110.899 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -56.0 -26.16 47.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 65.45 110.812 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -110.12 -26.58 9.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 62.34 110.923 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.77 79.92 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 74.42 110.865 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -25.73 42.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 64.43 110.917 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.78 -10.57 59.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 61.43 110.904 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.57 19.99 58.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 54.32 112.487 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.4 p -82.46 -22.12 35.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 73.35 110.889 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.82 22.42 59.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 73.44 112.477 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -140.6 151.77 44.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 73.43 110.869 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 152' ' ' GLU . 71.7 mt -119.11 120.67 37.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 72.51 110.929 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -84.44 179.88 7.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 72.11 110.895 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -52.2 -29.82 24.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.24 110.839 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 19.2 t0 -77.97 -54.79 5.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 72.43 110.818 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.565 ' HB3' HD22 ' A' ' 148' ' ' LEU . 9.3 mt-10 -57.28 -51.81 67.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 71.2 110.889 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.436 HG22 HG13 ' A' ' 176' ' ' VAL . 52.2 mt -51.8 -30.93 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 72.22 111.145 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 151' ' ' ASP . . . -60.0 -56.72 18.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 72.11 111.137 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.06 -23.26 77.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.792 -0.718 . . . . 61.13 112.452 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 148' ' ' LEU . 3.3 tp -57.17 -55.99 27.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.88 0.371 . . . . 62.44 110.932 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.8 mt -54.17 -33.21 57.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 74.1 110.896 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -52.11 -53.56 41.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 74.1 110.886 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.87 -42.33 21.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 55.4 110.875 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.2 m -52.35 -30.55 29.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 74.3 111.148 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -78.56 -52.97 7.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 72.31 110.952 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.97 -24.59 58.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.056 -0.52 . . . . 72.42 111.133 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.93 -25.93 45.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 54.15 110.835 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.0 mtm -109.68 21.59 16.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 70.21 110.856 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 23.61 72.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.77 -0.728 . . . . 52.52 112.473 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.8 mmt -65.28 175.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 73.12 110.845 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 79.3 p -66.68 -14.27 62.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 72.12 110.862 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 20.8 t30 63.65 61.67 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.858 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -83.01 152.57 25.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.01 110.894 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 3.9 m -108.22 90.87 7.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.576 0.703 . . . . 71.15 111.111 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.9 Cg_endo -69.77 156.43 63.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.701 2.267 . . . . 72.12 112.31 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 176' ' ' VAL . 48.8 p -95.57 -179.34 4.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 62.22 111.146 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -56.01 -25.66 45.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.921 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.608 ' O ' HD12 ' A' ' 178' ' ' ILE . 7.7 tt0 -73.4 -57.27 4.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 75.32 110.89 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.93 -38.88 58.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.31 110.852 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 172' ' ' THR . 93.5 t -59.85 -42.55 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 71.23 111.099 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -52.46 -45.1 65.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.1 110.898 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.608 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -63.27 -27.41 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 53.44 111.145 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.512 ' HZ3' HG21 ' A' ' 191' ' ' VAL . 77.0 t90 -83.63 -32.77 25.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 73.05 110.915 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.1 tp -73.21 -37.78 66.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 75.43 110.901 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -56.18 -35.27 67.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 74.41 110.924 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.6 ttp -90.23 -39.18 12.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 64.02 110.926 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.69 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -60.31 -58.96 6.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 71.45 111.155 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.48 113.94 13.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 62.14 110.878 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.2 p -84.31 -46.34 11.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 64.51 111.1 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -74.6 -12.36 60.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 53.3 110.886 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 t 62.59 44.94 6.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 42.22 110.847 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -79.39 -16.26 56.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 75.41 110.879 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.05 -15.46 51.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 55.22 112.485 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.1 m -136.22 135.9 39.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.4 . . . . 75.42 110.835 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.512 HG21 ' HZ3' ' A' ' 179' ' ' TRP . 25.0 t -87.0 109.71 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 71.33 111.135 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.5 t -87.97 -172.77 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 63.01 110.868 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.9 tp -68.57 -28.08 66.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 60.51 110.908 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -81.2 -32.61 33.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.906 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -84.78 -26.05 27.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.24 110.925 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.535 ' O ' HD12 ' A' ' 200' ' ' ILE . 26.6 t80 -79.26 -54.41 5.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.3 110.952 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.756 ' HB3' HD22 ' A' ' 130' ' ' LEU . 4.7 mm-40 -54.96 -32.58 61.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 74.51 110.936 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -68.68 -26.12 65.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.882 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 183' ' ' ALA . 5.1 tt -68.04 -35.56 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 71.33 110.928 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.535 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -73.43 -24.73 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 73.11 111.12 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.465 ' CD1' HD21 ' A' ' 130' ' ' LEU . 50.8 mm -55.66 -50.94 63.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 72.33 111.121 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -56.26 -46.46 79.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.908 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 9.9 p -61.84 -33.0 73.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 51.43 110.861 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.727 HD23 HD13 ' A' ' 209' ' ' ILE . 5.6 mt -69.74 -31.21 69.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 65.34 110.961 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.31 -43.95 96.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 61.42 110.952 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -86.02 -24.02 26.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 65.44 110.888 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.03 -22.71 67.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.54 111.086 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.98 32.01 1.79 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 50.53 112.492 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.727 HD13 HD23 ' A' ' 204' ' ' LEU . 5.3 mp -122.86 128.58 75.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 73.43 111.142 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.7 107.37 19.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.879 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 64.44 111.173 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.929 0.395 . . . . 73.22 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -52.01 160.57 1.14 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.645 0.735 . . . . 54.21 110.854 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -19.27 36.36 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 63.45 112.356 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -82.84 -24.66 33.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 75.24 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 211' ' ' VAL . 2.9 t -78.77 -60.62 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 74.41 111.141 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -51.77 -30.12 21.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 54.22 110.875 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.84 63.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 54.11 111.076 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -88.48 -36.67 16.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.906 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 201' ' ' ILE . 43.9 mt -63.94 -30.53 71.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 71.51 110.919 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -63.45 -46.42 86.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 73.04 110.866 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.71 -23.68 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 73.24 111.132 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.79 -21.78 60.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 51.3 111.125 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -72.23 -55.64 6.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -54.81 -27.05 38.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 75.24 110.871 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.1 tp -77.77 -29.01 50.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 71.51 110.893 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -66.53 -49.77 65.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 73.14 110.852 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -72.03 -26.42 62.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 75.01 110.883 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -54.4 -27.91 40.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 73.32 110.874 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -108.12 -30.31 8.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 74.53 110.897 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -74.97 73.19 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 54.5 110.873 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -84.72 -25.03 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 65.01 110.908 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -70.66 -10.58 59.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.853 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.64 19.57 62.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 74.54 112.525 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.6 t -79.42 -22.14 44.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 52.45 110.856 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.82 18.77 76.63 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.763 . . . . 64.22 112.467 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -147.36 131.02 16.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 73.53 110.867 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.907 HD13 HD22 ' A' ' 156' ' ' LEU . 11.7 mt -92.51 101.76 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 65.54 110.908 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.56 175.65 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 74.1 110.924 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.469 ' OD1' HD23 ' A' ' 180' ' ' LEU . 15.6 m-20 -52.02 -30.13 24.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.832 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.31 -55.29 6.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.824 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -56.5 -46.57 80.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.15 110.838 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.562 HD13 ' HB2' ' A' ' 180' ' ' LEU . 29.0 mt -51.73 -43.07 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 75.4 111.146 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.96 -41.21 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.129 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.28 -24.17 52.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 43.24 112.492 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.907 HD22 HD13 ' A' ' 148' ' ' LEU . 21.7 tp -67.06 -50.33 62.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 70.24 110.919 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.511 HD21 ' CD2' ' A' ' 179' ' ' TRP . 72.5 mt -52.92 -29.55 29.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.938 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.595 ' HE2' HG22 ' A' ' 170' ' ' THR . 0.5 OUTLIER -58.71 -60.66 3.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.02 110.864 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.11 -41.35 70.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 61.11 110.888 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.6 m -51.76 -46.78 64.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 75.13 111.124 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -64.66 -29.14 70.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 72.52 110.922 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.445 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -75.9 -24.7 55.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 64.22 111.116 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -57.94 -49.51 76.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 70.33 110.865 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 29.5 mtm -79.47 -18.45 52.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.898 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.75 18.32 30.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 62.11 112.487 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 5.6 mtt -61.33 175.88 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 72.11 110.869 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.1 m -60.88 -18.95 59.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 71.15 110.818 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 1.9 t30 63.81 63.65 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 71.12 110.905 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -79.98 152.79 29.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 71.31 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.595 HG22 ' HE2' ' A' ' 158' ' ' LYS . 21.0 p -108.23 90.78 7.24 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.591 0.71 . . . . 64.4 111.134 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -175.28 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.689 2.259 . . . . 51.54 112.363 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.658 ' O ' HG23 ' A' ' 176' ' ' VAL . 23.0 p -117.23 -176.27 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 73.45 111.172 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -59.25 -24.8 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 71.13 110.88 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.631 ' O ' HD12 ' A' ' 178' ' ' ILE . 27.8 tt0 -78.04 -57.46 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.876 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -51.76 -35.15 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 64.34 110.895 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 172' ' ' THR . 85.2 t -64.77 -39.69 86.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 72.42 111.074 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -55.47 -44.45 76.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 73.44 110.918 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -62.01 -34.8 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 65.33 111.097 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.574 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 49.0 t90 -79.39 -26.13 42.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.921 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.723 HD21 ' HA2' ' A' ' 189' ' ' GLY . 10.0 tp -81.66 -39.03 24.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 62.32 110.912 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -56.9 -28.41 61.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.866 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.5 mtm -83.44 -52.61 6.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 60.21 110.893 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.494 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -52.09 -62.04 1.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 72.51 111.089 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -67.62 124.62 23.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 51.22 110.839 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.3 m -73.96 -25.44 59.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.53 111.151 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -104.01 -12.47 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 64.3 110.866 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.6 t 55.79 50.79 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 74.42 110.809 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -100.94 23.91 10.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 65.54 110.867 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.723 ' HA2' HD21 ' A' ' 180' ' ' LEU . . . 69.27 31.72 71.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.752 . . . . 53.31 112.519 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.6 157.29 43.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 73.24 110.892 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.04 101.37 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 72.35 111.148 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 40.2 t -71.08 165.74 22.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 54.42 110.872 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.92 -40.77 61.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 73.21 110.904 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -74.51 -38.18 62.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.891 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.81 -38.22 90.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 75.51 110.919 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.53 ' O ' HD12 ' A' ' 200' ' ' ILE . 30.8 t80 -75.98 -43.03 46.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 74.13 110.93 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.646 ' O ' HD12 ' A' ' 201' ' ' ILE . 5.7 mm-40 -61.72 -44.1 97.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 61.24 110.853 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -53.03 -40.91 64.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 74.51 110.908 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.574 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 1.2 tp -51.7 -52.19 50.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.927 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 200' ' ' ILE . 4.5 mp -51.42 -44.96 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 55.41 111.118 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.999 HG23 HG21 ' A' ' 211' ' ' VAL . 3.4 mp -68.9 -40.28 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 60.13 111.098 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -60.09 -38.38 82.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 65.43 110.928 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 58.1 m -84.48 -31.75 24.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 62.3 110.867 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.87 HD22 HD13 ' A' ' 209' ' ' ILE . 13.5 mt -63.73 -29.4 70.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 60.24 110.927 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -51.85 -42.3 62.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 73.12 110.923 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -86.09 -24.19 26.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.922 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.93 -22.76 67.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 42.43 111.103 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.17 19.57 5.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 71.13 112.461 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.87 HD13 HD22 ' A' ' 204' ' ' LEU . 5.2 mp -121.99 101.85 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.798 0.333 . . . . 70.2 111.12 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -74.54 128.06 34.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.847 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.999 HG21 HG23 ' A' ' 201' ' ' ILE . 42.8 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 63.44 111.121 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.456 ' CE2' HG11 ' A' ' 211' ' ' VAL . 2.6 m-85 . . . . . 0 N--CA 1.458 -0.041 0 CA-C-O 120.93 0.395 . . . . 74.42 110.902 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -58.57 160.66 9.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.588 0.709 . . . . 74.41 110.884 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -20.48 34.9 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.666 2.244 . . . . 74.32 112.367 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.0 -23.09 41.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 70.14 110.876 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.533 HG21 HG13 ' A' ' 211' ' ' VAL . 3.0 t -78.05 -62.64 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 73.05 111.133 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -51.56 -30.59 21.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 72.15 110.881 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.48 -31.04 61.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 62.33 111.146 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.735 ' HG3' HD21 ' A' ' 204' ' ' LEU . 8.3 mmmt -88.4 -21.68 24.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 72.02 110.883 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.22 -46.45 16.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 72.32 110.912 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.02 -31.34 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 75.02 110.855 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 p -85.87 -23.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 75.33 111.131 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.62 -44.43 21.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 75.5 111.103 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.83 -33.41 35.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.857 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -74.58 -40.42 61.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 75.5 110.876 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.3 tp -68.3 -25.09 64.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 74.52 110.918 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.08 -64.57 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 65.31 110.865 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -59.28 -25.97 64.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 74.23 110.868 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -52.71 -30.49 32.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.823 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -101.4 -26.52 13.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.928 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -75.75 82.92 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 75.13 110.852 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -81.52 -26.5 35.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 73.34 110.884 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -72.43 -10.56 59.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.42 . . . . 50.42 110.892 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.05 20.54 54.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 72.11 112.484 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 59.5 p -77.13 -22.06 53.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.943 0.401 . . . . 63.12 110.882 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.11 59.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 32.43 112.503 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -144.03 137.36 27.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 73.11 110.942 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.773 HD13 HD22 ' A' ' 156' ' ' LEU . 82.3 mt -100.93 105.29 16.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 71.33 110.917 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -67.8 171.38 6.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.41 110.934 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.55 ' O ' HG11 ' A' ' 176' ' ' VAL . 2.0 m-20 -52.02 -30.36 25.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 71.22 110.858 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.33 -50.87 11.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.4 110.889 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -57.28 -26.25 60.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 62.22 110.856 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 150' ' ' ASP . 26.5 mt -78.1 -26.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 65.01 111.153 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.93 -54.98 23.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 72.32 111.141 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.22 -22.86 69.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 74.22 112.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 148' ' ' LEU . 15.8 tp -57.86 -58.69 7.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 61.44 110.939 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.8 mt -51.81 -36.64 48.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.945 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -54.39 -41.93 69.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 61.15 110.942 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -85.06 -46.49 11.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 70.45 110.893 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.3 m -54.61 -33.0 59.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 74.1 111.129 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -69.13 -26.13 64.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 62.13 110.918 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.27 -30.23 71.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.499 . . . . 75.23 111.087 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.38 -26.06 64.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.858 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.8 mtm -94.05 -18.38 21.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 75.2 110.84 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 93.13 24.01 23.41 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.731 . . . . 72.51 112.443 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.3 ttm -81.95 175.81 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 74.44 110.854 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.4 m -75.73 -6.26 49.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 35.43 110.84 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.2 m120 62.9 69.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 53.33 110.886 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -68.07 152.64 45.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.906 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 1.4 m -108.18 90.82 7.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.575 0.702 . . . . 61.32 111.175 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.6 Cg_endo -69.77 175.86 7.55 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.661 2.241 . . . . 75.14 112.379 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.1 p -115.41 -176.57 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 73.4 111.154 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -52.19 -29.9 24.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.34 110.95 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -67.41 -57.65 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.864 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.02 -53.76 54.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 71.14 110.868 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 150' ' ' ASP . 90.5 t -52.66 -41.12 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.42 111.126 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -54.79 -54.51 41.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 74.14 110.895 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.35 -47.9 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.133 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -61.89 -25.95 67.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.132 -0.485 . . . . 75.4 110.904 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 180' ' ' LEU . 2.6 tt -81.61 -40.51 22.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 70.43 110.92 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.51 -28.76 70.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.903 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 43.3 ttp -91.22 -35.08 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.747 ' HA ' HD23 ' A' ' 199' ' ' LEU . . . -71.41 -48.25 50.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 51.21 111.096 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -52.55 120.3 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.851 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.87 -23.59 25.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 64.31 111.126 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.44 -10.71 18.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 72.11 110.874 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.4 p 58.99 27.19 16.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 72.35 110.852 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -78.94 -15.87 57.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 73.11 110.869 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.34 17.26 16.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 53.3 112.49 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.78 126.9 7.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 73.13 110.854 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.7 t -86.92 107.63 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 61.04 111.131 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.2 t -83.68 -176.65 6.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 71.41 110.862 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.7 tp -66.61 -36.03 81.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 74.41 110.962 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.35 -24.75 42.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 73.1 110.87 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -85.89 -20.43 29.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 74.14 110.85 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.577 ' O ' HD12 ' A' ' 200' ' ' ILE . 17.5 t80 -87.32 -40.16 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.931 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -52.68 -41.42 63.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.899 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.86 -25.16 63.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 64.35 110.828 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 183' ' ' ALA . 2.2 tm? -61.9 -40.24 94.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.466 . . . . 71.34 110.91 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.2 mp -72.22 -24.69 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.21 111.134 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.1 mm -60.81 -37.51 76.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 51.54 111.154 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -52.56 38.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 63.52 110.858 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 2.6 m -57.44 -30.67 65.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 70.32 110.885 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.735 HD21 ' HG3' ' A' ' 129' ' ' LYS . 15.9 mt -72.01 -37.93 69.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 54.42 110.925 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -58.03 -35.57 71.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.15 110.897 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -26.64 26.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 65.23 110.929 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.2 -22.65 66.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 73.02 111.13 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.75 26.45 3.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 71.43 112.491 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.52 103.12 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 74.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -71.17 110.88 6.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 71.31 110.839 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.533 HG13 HG21 ' A' ' 126' ' ' VAL . 23.3 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 55.23 111.119 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.917 0.389 . . . . 71.43 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -52.59 160.52 1.35 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.595 0.712 . . . . 74.42 110.889 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -18.81 36.92 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.72 2.28 . . . . 75.24 112.344 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -82.69 -23.63 34.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.478 HG21 HG23 ' A' ' 211' ' ' VAL . 3.0 t -77.93 -63.33 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 75.32 111.163 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -51.99 -30.9 27.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.31 110.883 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -37.5 63.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 53.12 111.116 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -88.19 -25.94 22.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.893 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.741 HD22 ' CG ' ' A' ' 197' ' ' GLU . 68.5 mt -73.94 -28.23 61.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 62.3 110.89 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.51 -59.01 4.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.449 . . . . 70.34 110.899 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 p -55.29 -26.46 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 73.12 111.152 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.91 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 74.1 111.11 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.413 ' CG ' HD11 ' A' ' 193' ' ' LEU . 25.1 mtt180 -61.39 -50.66 71.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 71.31 110.874 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -63.68 -41.48 98.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 72.31 110.863 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 tp -57.1 -38.92 74.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 71.4 110.905 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -56.47 -59.74 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.12 110.873 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.6 mmmm -66.39 -26.27 67.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 43.23 110.87 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.3 ttm-85 -54.14 -27.71 35.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.872 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -109.74 -30.55 7.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.941 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.07 84.28 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 72.11 110.862 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -84.94 -28.17 26.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.41 110.878 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -72.63 -10.57 59.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 73.14 110.899 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.96 47.12 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 64.51 112.462 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 45.4 t -75.36 -22.11 57.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.953 0.406 . . . . 72.52 110.853 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.23 19.67 60.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 75.14 112.483 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -146.04 141.75 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 70.2 110.889 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.7 mt -105.23 101.41 10.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 42.13 110.927 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -70.41 170.68 11.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 63.34 110.95 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.534 ' O ' HG11 ' A' ' 176' ' ' VAL . 10.4 p-10 -52.06 -30.02 23.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.42 110.842 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -80.41 -35.02 35.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.1 110.891 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.08 -29.19 60.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 75.33 110.896 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.66 HD12 HD12 ' A' ' 180' ' ' LEU . 54.8 mt -77.78 -26.67 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 73.23 111.145 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.76 -45.85 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 70.44 111.071 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.24 -23.04 55.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 51.21 112.495 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.15 -57.04 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 62.43 110.9 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.7 mt -51.94 -35.84 47.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.23 110.959 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -51.97 -45.68 64.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 75.34 110.834 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -84.77 -45.69 12.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 65.44 110.833 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 33.5 m -52.99 -31.23 39.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.113 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -77.07 -55.37 5.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.914 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.81 -24.81 38.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 75.3 111.081 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -53.64 -29.17 36.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 71.45 110.879 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -113.02 16.8 19.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.41 110.878 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.83 28.93 74.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 52.25 112.451 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.16 175.75 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 54.54 110.884 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 94.8 p -60.92 -21.25 63.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 72.53 110.879 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 13.4 t30 63.45 57.47 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 65.12 110.889 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -80.22 152.55 29.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.924 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.8 p -108.21 90.75 7.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.589 0.709 . . . . 73.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 174.47 9.44 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.662 2.242 . . . . 51.42 112.327 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 39.2 p -117.53 -176.06 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 60.42 111.12 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -52.14 -29.95 24.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 63.01 110.879 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -69.43 -57.36 5.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 71.54 110.918 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.415 ' HA ' HD12 ' A' ' 178' ' ' ILE . 3.3 m-20 -56.15 -52.54 64.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 75.23 110.852 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.534 HG11 ' O ' ' A' ' 150' ' ' ASP . 94.7 t -52.42 -38.15 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 73.4 111.126 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -58.11 -54.85 42.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 75.45 110.907 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 175' ' ' ASP . 3.5 mt -54.5 -47.47 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 74.12 111.143 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.546 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 50.0 t90 -57.97 -29.84 65.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 71.11 110.88 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.66 HD12 HD12 ' A' ' 153' ' ' ILE . 5.2 tt -74.88 -30.54 61.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 72.11 110.949 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -65.01 -26.17 68.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.03 110.938 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.5 ttm -90.97 -42.83 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.895 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.466 ' CA ' HD13 ' A' ' 199' ' ' LEU . . . -68.32 -50.47 53.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 74.24 111.085 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.529 ' HB2' HD23 ' A' ' 180' ' ' LEU . 35.2 t0 -51.98 105.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.836 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.5 m -87.18 -25.15 24.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 55.43 111.156 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -95.11 -12.42 26.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 61.32 110.906 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 60.74 37.93 18.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 72.24 110.855 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -102.01 23.99 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 73.03 110.855 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 65.19 19.42 66.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 70.22 112.509 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.73 160.4 41.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 61.21 110.871 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.23 124.93 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 72.02 111.11 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.28 -170.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 44.22 110.876 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -66.04 -39.01 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 74.15 110.892 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -74.11 -35.59 64.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.859 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.58 -53.4 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 75.14 110.94 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.515 ' O ' HD12 ' A' ' 200' ' ' ILE . 11.2 t80 -58.47 -47.91 82.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 74.02 110.911 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.741 ' CG ' HD22 ' A' ' 130' ' ' LEU . 26.4 tt0 -55.2 -31.04 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 41.5 110.89 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.77 -26.41 64.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 61.45 110.88 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.546 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 3.5 tp -67.46 -34.03 76.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 74.15 110.887 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.636 HG22 HD23 ' A' ' 204' ' ' LEU . 5.3 mp -75.04 -27.44 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 55.21 111.133 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.5 mm -52.11 -60.09 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 64.5 111.135 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -52.08 -30.13 24.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 73.51 110.884 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.9 m -69.98 -41.88 73.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.872 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 209' ' ' ILE . 4.1 mm? -66.83 -36.05 81.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.49 . . . . 65.41 110.936 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -57.07 -44.23 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 64.23 110.904 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -86.06 -24.83 26.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 64.33 110.91 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.05 -22.71 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 74.22 111.063 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.92 19.26 5.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.756 -0.735 . . . . 73.14 112.527 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 204' ' ' LEU . 5.3 mp -122.32 101.84 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 61.55 111.128 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.13 98.66 3.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.13 110.887 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.478 HG23 HG21 ' A' ' 126' ' ' VAL . 5.6 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 74.23 111.157 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.483 ' HB3' HG21 ' A' ' 126' ' ' VAL . 21.1 m-85 . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.913 0.387 . . . . 65.11 110.916 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -51.77 162.15 0.8 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.584 0.707 . . . . 72.5 110.883 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -16.87 37.69 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 61.34 112.346 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -83.42 -18.97 36.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.892 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.532 ' CG2' HG22 ' A' ' 211' ' ' VAL . 2.9 t -77.16 -61.44 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 45.14 111.134 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.676 ' HA ' HD12 ' A' ' 130' ' ' LEU . 4.0 tt0 -51.54 -31.38 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.45 110.891 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.03 -34.32 55.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.54 111.14 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.646 ' HB3' HD11 ' A' ' 204' ' ' LEU . 0.0 OUTLIER -88.47 -30.99 18.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.42 110.945 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.867 HD21 HD11 ' A' ' 201' ' ' ILE . 17.9 mt -69.68 -32.72 71.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.876 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -58.27 -57.58 12.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 64.31 110.857 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 129' ' ' LYS . 10.2 p -57.75 -23.79 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 70.4 111.127 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.43 -30.77 67.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 61.51 111.118 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -49.44 63.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 75.1 110.919 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -61.77 -24.65 66.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 64.42 110.885 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.7 tp -82.17 -36.67 27.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.92 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.0 -53.31 59.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.881 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -69.62 -25.97 64.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 70.44 110.906 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -52.2 -29.94 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 62.14 110.861 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -106.0 -34.18 7.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 65.22 110.895 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.75 88.95 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 72.13 110.873 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -84.72 -25.42 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.45 110.92 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -70.65 -10.61 59.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.878 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.66 22.54 40.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 61.4 112.489 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -76.38 -22.1 55.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.895 0.379 . . . . 74.04 110.844 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.76 19.04 57.24 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.752 . . . . 71.22 112.48 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -142.96 130.74 21.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 74.54 110.894 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.415 HD13 HD22 ' A' ' 156' ' ' LEU . 31.7 mt -89.03 102.57 15.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.22 110.944 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -71.6 173.11 8.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 73.32 110.894 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.407 ' HA ' HD12 ' A' ' 153' ' ' ILE . 2.9 p30 -55.54 -26.42 43.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 64.3 110.856 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -80.02 -34.28 38.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 65.21 110.85 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -80.92 -26.75 36.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 75.22 110.84 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.451 ' CG2' HG13 ' A' ' 176' ' ' VAL . 21.4 mt -74.82 -36.25 39.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 43.13 111.133 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.83 -47.27 64.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 51.43 111.067 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.42 -23.5 53.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 63.41 112.458 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.466 HD21 ' CE1' ' A' ' 196' ' ' TYR . 1.9 tp -65.48 -49.12 70.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 74.45 110.942 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.556 HD21 ' CD2' ' A' ' 179' ' ' TRP . 97.7 mt -52.12 -33.91 41.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 53.51 110.921 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -54.59 -55.2 31.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.855 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.34 -45.06 41.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 72.01 110.877 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.3 m -51.67 -30.71 22.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 62.04 111.154 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -77.85 -44.69 26.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 65.11 110.914 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.609 ' HB2' HD21 ' A' ' 168' ' ' ASN . . . -57.2 -23.24 46.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 64.54 111.087 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -55.52 -25.94 40.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 75.24 110.893 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 mtm -111.73 19.44 18.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.889 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.76 21.46 71.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 51.3 112.492 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.2 tpp -62.22 175.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.758 0.314 . . . . 64.31 110.911 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.1 t -78.3 -3.91 45.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 64.32 110.868 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.609 HD21 ' HB2' ' A' ' 162' ' ' ALA . 2.8 m120 55.72 61.74 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 74.14 110.909 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -72.86 152.63 41.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.11 110.905 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.4 m -108.11 90.77 7.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 72.35 111.136 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 171.45 14.44 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.704 2.269 . . . . 55.41 112.364 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 176' ' ' VAL . 3.4 p -102.35 177.83 4.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 73.55 111.124 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -55.19 -27.74 48.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.9 tt0 -75.23 -54.28 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 74.23 110.901 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.16 -35.87 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.823 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 172' ' ' THR . 91.2 t -63.97 -39.36 85.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 75.2 111.101 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -56.83 -52.99 62.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 61.24 110.877 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.1 mp -55.38 -30.68 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 72.22 111.118 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.592 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 90.9 t90 -79.55 -31.21 41.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 64.25 110.934 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.501 ' O ' HD23 ' A' ' 180' ' ' LEU . 1.9 tt -77.46 -39.98 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.888 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -51.92 -58.47 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.906 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 27.5 ttp -63.7 -24.46 67.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.893 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.698 ' CB ' HD11 ' A' ' 199' ' ' LEU . . . -94.51 21.89 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 61.0 111.097 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -141.73 120.93 13.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 64.34 110.864 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 14.5 m -87.17 -43.71 12.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 63.15 111.097 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.42 -12.45 60.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.868 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.0 t 57.98 48.15 13.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 65.42 110.836 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -93.27 -16.24 24.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 70.02 110.854 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.23 25.12 14.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 63.44 112.46 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.24 144.12 24.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 55.33 110.902 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 196' ' ' TYR . 22.0 t -113.89 121.95 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 74.14 111.123 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.15 -177.74 4.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 44.23 110.891 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.91 -32.67 66.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 64.14 110.949 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.53 -58.87 3.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.31 110.874 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.442 ' HB3' HG13 ' A' ' 191' ' ' VAL . 15.5 mt-10 -56.2 -25.46 47.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 71.11 110.929 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.53 ' HB2' HG12 ' A' ' 191' ' ' VAL . 31.7 t80 -85.34 -50.17 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 71.03 110.917 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.517 ' HA ' HD13 ' A' ' 200' ' ' ILE . 19.0 mt-10 -52.08 -40.98 62.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 71.45 110.877 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -53.56 -43.9 68.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 73.21 110.886 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.698 HD11 ' CB ' ' A' ' 183' ' ' ALA . 36.5 mt -51.84 -35.66 45.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 71.42 110.958 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.517 HD13 ' HA ' ' A' ' 197' ' ' GLU . 5.2 mp -77.0 -30.0 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 62.44 111.156 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.867 HD11 HD21 ' A' ' 130' ' ' LEU . 51.7 mm -64.66 -43.06 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 71.51 111.11 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -63.83 -36.05 82.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 71.21 110.905 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 62.7 m -77.66 -39.74 44.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.2 110.851 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' ' 129' ' ' LYS . 22.4 mt -57.63 -46.03 84.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.494 . . . . 73.03 110.902 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -52.59 -35.18 53.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.15 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.12 -31.33 21.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 65.14 110.88 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.425 ' HB3' ' CD1' ' A' ' 209' ' ' ILE . . . -64.91 -22.28 66.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 41.1 111.081 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.89 32.42 1.56 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.739 . . . . 42.33 112.496 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.468 HD13 ' CD2' ' A' ' 204' ' ' LEU . 5.2 mp -118.04 110.94 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 74.44 111.112 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 131.32 46.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.15 110.841 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.532 HG22 ' CG2' ' A' ' 126' ' ' VAL . 18.3 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 72.24 111.119 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.927 0.394 . . . . 71.12 110.95 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -51.73 160.97 0.95 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.661 0.743 . . . . 70.42 110.853 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -25.35 28.42 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.651 2.234 . . . . 61.33 112.318 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -79.36 -19.55 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 62.44 110.923 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.87 HG12 HD11 ' A' ' 130' ' ' LEU . 2.8 t -84.74 -61.03 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 72.1 111.111 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.521 ' HA ' HD12 ' A' ' 130' ' ' LEU . 3.6 tp10 -51.35 -30.7 19.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.9 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.37 79.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 51.34 111.089 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.442 ' O ' HG12 ' A' ' 132' ' ' VAL . 56.0 tptt -88.39 -40.73 13.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 72.33 110.914 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.87 HD11 HG12 ' A' ' 126' ' ' VAL . 13.2 mt -57.28 -25.81 59.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.928 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -70.03 -59.27 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 75.22 110.855 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 129' ' ' LYS . 10.1 p -57.87 -23.62 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 73.15 111.111 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.35 -21.69 59.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 61.54 111.137 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.8 mtt-85 -70.13 -53.41 17.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 62.41 110.885 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -54.57 -26.88 34.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 72.03 110.822 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -79.89 -35.17 38.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 62.34 110.964 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 148' ' ' LEU . 28.7 t80 -65.41 -43.02 91.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 71.5 110.885 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -79.49 -26.93 41.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.89 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -51.96 -40.44 60.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 65.32 110.889 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -94.23 -26.12 16.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.932 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.14 62.58 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 74.44 110.883 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -26.16 68.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 62.12 110.887 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -70.83 -10.56 59.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 73.12 110.875 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.04 20.89 43.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.709 -0.757 . . . . 62.32 112.464 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.5 m -78.45 -22.1 48.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 75.33 110.85 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.84 20.19 66.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 72.05 112.451 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -138.51 131.54 29.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.798 0.332 . . . . 64.23 110.935 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.597 HD13 HD22 ' A' ' 156' ' ' LEU . 24.1 mt -101.92 111.43 23.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 72.4 110.945 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -79.93 175.7 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 65.32 110.895 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -53.47 -28.51 31.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 61.23 110.87 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -77.34 -44.81 28.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.888 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.04 -33.19 73.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.928 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.64 HG22 HG13 ' A' ' 176' ' ' VAL . 30.6 mt -70.72 -37.5 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 53.35 111.201 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.84 -46.2 64.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 75.43 111.085 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.77 -23.13 56.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 65.42 112.505 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.597 HD22 HD13 ' A' ' 148' ' ' LEU . 21.3 tp -58.87 -55.95 28.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 72.05 110.902 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 25.1 mt -52.28 -35.66 50.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.931 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -43.59 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.885 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.07 -47.17 10.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.871 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.2 m -52.19 -31.16 30.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 74.22 111.142 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -76.17 -44.19 39.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.923 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.18 -25.53 64.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 74.53 111.097 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -52.25 -30.44 27.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 72.32 110.903 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -102.62 -18.45 15.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.24 110.869 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.77 27.24 9.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 53.21 112.481 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.63 175.2 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 64.54 110.873 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.1 p -55.6 -25.96 41.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 62.15 110.864 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 63.31 54.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 75.44 110.911 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -60.45 152.49 25.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 74.42 110.921 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p -108.27 90.8 7.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 72.31 111.136 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -171.02 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.643 2.228 . . . . 72.32 112.38 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 176' ' ' VAL . 70.1 p -127.86 -176.35 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 72.41 111.131 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -57.63 -25.56 60.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 72.32 110.93 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.42 -60.16 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 72.21 110.909 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.421 ' HA ' HD12 ' A' ' 178' ' ' ILE . 0.8 OUTLIER -56.84 -49.2 76.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 65.04 110.832 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.64 HG13 HG22 ' A' ' 153' ' ' ILE . 99.0 t -55.37 -43.87 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.424 . . . . 73.04 111.089 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -50.27 62.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 75.2 110.888 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 175' ' ' ASP . 3.7 mt -59.46 -49.22 84.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.22 111.173 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.527 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 53.5 t90 -54.74 -28.63 49.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 74.25 110.89 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 180' ' ' LEU . 5.8 tt -61.38 -45.64 93.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 73.11 110.906 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -72.52 -29.91 64.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.03 110.89 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.6 ttp -60.96 -31.18 70.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.25 110.871 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -101.26 -48.54 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 73.04 111.086 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -52.35 112.74 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 65.43 110.808 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 27.9 m -83.71 -33.34 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.3 111.141 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -83.51 -12.46 56.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 73.11 110.881 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.8 m 54.87 49.99 16.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 63.42 110.874 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -110.07 23.94 13.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.903 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.54 25.47 70.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 73.44 112.484 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.7 p -154.64 133.78 12.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 71.03 110.848 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.419 HG12 ' HB2' ' A' ' 196' ' ' TYR . 38.3 t -101.51 105.48 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 44.14 111.121 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -75.02 178.17 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 61.33 110.841 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.8 tp -54.79 -61.02 2.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 72.54 110.916 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -60.78 -41.54 95.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.913 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -29.38 66.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.53 110.92 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.509 ' O ' HD12 ' A' ' 200' ' ' ILE . 27.8 t80 -87.94 -47.63 8.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.955 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.418 ' HA ' HD13 ' A' ' 200' ' ' ILE . 0.3 OUTLIER -57.18 -25.84 59.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 72.42 110.905 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.9 -25.75 60.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.89 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.565 HD13 ' HB2' ' A' ' 183' ' ' ALA . 4.9 tp -69.07 -35.9 77.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.889 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -71.24 -24.5 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.13 111.135 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 1.133 HG23 HG11 ' A' ' 211' ' ' VAL . 50.0 mm -52.33 -61.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 52.05 111.073 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -49.57 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 64.2 110.919 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 49.0 m -52.15 -33.28 39.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 64.53 110.885 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.499 ' CD2' HD13 ' A' ' 209' ' ' ILE . 9.9 mt -76.59 -44.53 34.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 62.43 110.867 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -56.26 -30.1 61.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 73.11 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -16.41 38.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 70.5 110.924 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.51 ' HB3' HD12 ' A' ' 209' ' ' ILE . . . -94.72 24.81 4.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 62.11 111.102 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 66.52 32.39 81.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.763 . . . . 53.23 112.499 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 211' ' ' VAL . 18.7 mt -114.72 102.89 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.353 . . . . 64.44 111.121 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -57.0 106.31 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 73.33 110.862 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 1.133 HG11 HG23 ' A' ' 201' ' ' ILE . 85.5 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 64.12 111.142 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.547 ' CE2' HG11 ' A' ' 211' ' ' VAL . 2.4 m-85 . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.917 0.389 . . . . 73.13 110.938 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -52.23 160.62 1.2 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.587 0.708 . . . . 74.22 110.891 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -16.02 37.63 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.701 2.267 . . . . 54.45 112.37 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.61 -26.86 34.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 64.34 110.883 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.728 HG21 HG13 ' A' ' 211' ' ' VAL . 2.9 t -78.8 -61.81 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 45.43 111.107 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -51.62 -30.34 20.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 73.35 110.942 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.16 58.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 63.54 111.129 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.475 ' HG3' HD21 ' A' ' 204' ' ' LEU . 0.2 OUTLIER -84.87 -25.37 28.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.888 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.696 HD22 ' HG2' ' A' ' 197' ' ' GLU . 12.3 mt -78.67 -29.66 45.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 74.55 110.918 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.21 -48.76 69.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 70.22 110.838 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -65.47 -30.5 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 44.11 111.13 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.85 -27.89 57.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 73.53 111.086 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.463 ' HG2' HD21 ' A' ' 193' ' ' LEU . 38.4 mtp180 -66.74 -34.3 77.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.44 110.836 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -74.19 -29.83 61.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 63.12 110.878 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.52 -32.64 64.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 74.54 110.908 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.53 -63.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.13 110.874 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -58.02 -26.76 62.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.52 110.94 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -54.12 -29.24 44.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.886 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.04 -28.89 8.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 72.41 110.922 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.53 70.88 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 64.14 110.88 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -25.76 53.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 73.22 110.927 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -70.83 -10.5 59.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 72.13 110.853 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.43 19.78 58.08 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.738 -0.744 . . . . 43.12 112.463 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.4 t -82.33 -22.13 35.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.932 0.396 . . . . 45.21 110.892 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.83 22.44 63.92 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 64.43 112.523 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -140.09 148.99 42.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.858 0.361 . . . . 72.42 110.879 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.667 HD13 HD22 ' A' ' 156' ' ' LEU . 16.7 mt -120.14 119.89 34.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.33 110.912 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -85.37 177.85 7.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 74.01 110.92 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -52.0 -30.08 23.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.895 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.65 -52.14 9.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 63.32 110.856 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.25 -34.32 73.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.905 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.6 mt -68.6 -38.57 79.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 71.34 111.126 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.79 -58.35 7.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 73.03 111.114 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.22 -23.53 76.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 65.41 112.502 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.667 HD22 HD13 ' A' ' 148' ' ' LEU . 9.8 tp -67.9 -53.35 27.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 73.24 110.911 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 179' ' ' TRP . 5.6 mt -51.86 -29.86 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 72.02 110.94 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -60.28 -43.82 95.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.32 110.887 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -85.02 -38.85 18.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 64.23 110.875 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.0 m -51.75 -30.0 20.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.1 111.182 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -81.5 -50.21 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.44 110.924 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.706 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -55.29 -25.11 32.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 74.23 111.136 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -54.52 -28.99 49.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.917 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -110.74 16.93 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.51 110.906 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 29.02 74.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 74.53 112.489 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.1 mmt -69.31 175.85 3.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.821 0.344 . . . . 74.23 110.843 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 75.2 m -61.56 -18.4 59.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 72.3 110.899 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.706 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 3.5 t30 63.67 55.88 1.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 71.11 110.933 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -73.81 152.89 40.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.03 110.873 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 m -108.27 90.76 7.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 75.44 111.131 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 143.65 51.33 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.703 2.269 . . . . 71.44 112.312 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 176' ' ' VAL . 33.5 p -82.58 -178.43 7.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 51.55 111.138 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -56.32 -29.8 61.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.33 110.932 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.562 ' O ' HD12 ' A' ' 178' ' ' ILE . 3.6 tt0 -69.42 -52.44 26.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 72.02 110.895 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -54.7 -42.01 70.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.482 . . . . 63.43 110.846 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 172' ' ' THR . 47.4 t -58.57 -41.94 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 71.23 111.118 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -52.89 -48.85 66.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 62.22 110.913 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.0 mp -61.07 -25.61 36.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 72.42 111.093 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.614 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 70.8 t90 -81.87 -22.85 36.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 74.33 110.905 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' A' ' 184' ' ' ASP . 1.4 tt -78.22 -35.4 48.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 72.14 110.892 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -64.6 -31.95 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 51.3 110.933 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.5 ptp -91.72 -30.84 16.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 65.5 110.875 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.646 ' CB ' HD11 ' A' ' 199' ' ' LEU . . . -75.6 -51.27 13.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 42.45 111.128 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.585 ' HB3' HD23 ' A' ' 180' ' ' LEU . 0.5 OUTLIER -50.36 129.57 21.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 70.02 110.866 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.5 m -88.31 -48.78 7.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 64.31 111.15 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -113.86 16.69 18.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.15 110.895 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.5 t 51.78 58.67 5.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.878 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -96.17 -14.44 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.494 . . . . 62.54 110.851 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.37 16.77 17.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.728 . . . . 62.4 112.475 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.5 m -154.66 -179.26 7.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.397 . . . . 72.42 110.851 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.503 HG21 ' HZ3' ' A' ' 179' ' ' TRP . 21.5 t -135.59 101.41 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 72.14 111.159 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -76.07 -174.74 2.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 54.41 110.857 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.463 HD21 ' HG2' ' A' ' 134' ' ' ARG . 21.6 tp -65.3 -45.82 82.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 62.21 110.904 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -70.48 -26.11 63.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 74.4 110.902 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.86 -31.89 31.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 52.34 110.865 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.512 ' HA ' HD12 ' A' ' 199' ' ' LEU . 19.1 t80 -85.87 -34.96 20.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.885 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.696 ' HG2' HD22 ' A' ' 130' ' ' LEU . 24.1 tt0 -70.26 -32.15 69.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 73.31 110.868 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.83 -28.53 70.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 72.31 110.836 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.646 HD11 ' CB ' ' A' ' 183' ' ' ALA . 3.4 mt -63.9 -36.6 84.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.12 110.926 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.3 mp -74.86 -24.84 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 55.3 111.142 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.491 HD13 HD21 ' A' ' 130' ' ' LEU . 50.1 mm -58.49 -47.44 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 74.15 111.138 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -67.15 -40.4 86.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 70.34 110.912 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -47.54 65.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 74.2 110.852 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.475 HD21 ' HG3' ' A' ' 129' ' ' LYS . 6.9 mp -73.88 -29.44 62.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 73.42 110.895 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -62.9 -44.87 94.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.879 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -84.12 -24.19 30.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 52.51 110.876 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.9 -22.67 67.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 61.21 111.093 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.0 32.46 1.53 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 23.52 112.463 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.4 101.83 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.859 0.361 . . . . 54.32 111.102 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -68.76 108.07 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.872 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.728 HG13 HG21 ' A' ' 126' ' ' VAL . 21.8 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 52.53 111.126 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.882 0.372 . . . . 75.23 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -51.88 160.99 0.99 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 62.11 110.894 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -18.13 37.01 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.714 2.276 . . . . 62.1 112.335 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -83.04 -21.29 33.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.911 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.522 HG21 HG23 ' A' ' 211' ' ' VAL . 2.4 t -85.25 -51.78 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 65.12 111.128 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -51.06 -31.58 19.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.863 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.14 80.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 62.11 111.099 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HD3' HD11 ' A' ' 204' ' ' LEU . 13.8 tttp -88.58 -32.36 18.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 75.11 110.885 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.8 -25.95 68.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 74.41 110.935 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -67.59 -59.3 3.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 75.0 110.854 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 p -56.1 -24.83 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.129 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.48 -47.74 84.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 44.01 111.093 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -44.62 64.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 72.03 110.85 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -65.11 -29.14 69.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.879 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.52 -36.85 57.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 64.31 110.892 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -61.3 -41.95 97.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 72.3 110.893 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -79.1 -28.48 43.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 74.42 110.927 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -52.26 -29.88 25.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 62.21 110.834 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -108.25 -34.52 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 72.21 110.917 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -76.7 66.44 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 72.52 110.919 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -70.7 -26.09 63.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 63.44 110.885 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.9 -10.51 59.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 55.23 110.859 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.26 22.56 44.38 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 63.22 112.469 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.3 t -76.08 -22.13 55.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.915 0.388 . . . . 73.12 110.875 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.31 20.16 65.14 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 74.05 112.489 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -142.64 141.29 31.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 73.51 110.87 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.483 ' O ' HD11 ' A' ' 153' ' ' ILE . 58.0 mt -109.33 118.12 35.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 44.13 110.927 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -85.19 175.3 9.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.896 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -51.88 -30.31 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 32.3 110.883 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -81.08 -52.39 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.34 110.823 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.56 -28.36 65.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 64.44 110.874 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.483 HD11 ' O ' ' A' ' 148' ' ' LEU . 35.2 mt -81.32 -30.83 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 73.34 111.167 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.04 63.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 35.21 111.12 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.23 -22.86 56.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 72.31 112.509 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.92 -47.76 83.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 63.44 110.95 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.36 -36.41 77.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.927 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -52.62 -46.07 66.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.33 110.882 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -83.11 -47.19 11.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 72.42 110.882 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.8 m -51.79 -35.52 44.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 72.31 111.186 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -76.56 -53.69 7.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.97 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.724 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -57.06 -25.76 59.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 62.24 111.129 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -57.39 -25.68 59.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.866 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 36.9 mtm -110.01 21.74 16.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 55.15 110.873 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.69 68.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 72.52 112.435 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.6 mmt -60.79 174.98 0.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.805 0.336 . . . . 51.22 110.834 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -66.02 -14.91 62.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 64.14 110.821 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.724 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 6.7 t30 63.69 42.92 5.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 50.04 110.882 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -62.49 152.45 34.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 62.34 110.863 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 m -108.22 90.82 7.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.59 0.71 . . . . 70.42 111.152 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 159.93 51.6 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.672 2.248 . . . . 73.04 112.324 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.544 ' O ' HG23 ' A' ' 176' ' ' VAL . 79.7 p -106.87 -176.03 2.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 64.14 111.167 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -54.85 -26.57 36.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 74.51 110.932 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.431 ' O ' HD12 ' A' ' 178' ' ' ILE . 7.6 tp10 -75.42 -41.47 55.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 72.1 110.873 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.4 ' HA ' HD12 ' A' ' 178' ' ' ILE . 5.8 m-20 -74.61 -25.11 59.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 71.32 110.85 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 172' ' ' THR . 91.4 t -79.33 -32.64 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.132 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -22.73 66.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.915 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 174' ' ' GLU . 5.2 mt -87.58 -41.96 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 74.11 111.132 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -69.98 -31.27 68.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 62.14 110.951 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 180' ' ' LEU . 5.4 tt -64.25 -38.81 92.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 53.3 110.885 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -68.79 -28.18 66.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.924 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 6.1 mmm -70.47 -33.83 71.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 63.33 110.862 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.712 ' CA ' HD23 ' A' ' 199' ' ' LEU . . . -88.99 -49.34 6.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 51.12 111.111 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -75.0 119.34 19.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 54.2 110.88 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.9 m -87.59 -26.55 23.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 64.44 111.108 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.22 -12.47 56.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 70.1 110.846 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.6 m 53.61 53.65 11.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 61.14 110.834 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -106.66 -16.22 14.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 63.45 110.906 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.29 19.42 11.53 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.709 -0.758 . . . . 65.11 112.447 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.0 p -149.4 126.88 11.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 45.51 110.859 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.468 ' CG1' ' HB1' ' A' ' 183' ' ' ALA . 21.6 t -95.66 106.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 74.3 111.142 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.71 178.86 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 62.13 110.884 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 21.3 tp -63.16 -33.23 75.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 62.13 110.921 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -81.32 -40.04 24.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.858 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -65.05 -32.57 74.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.859 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.618 ' O ' HD12 ' A' ' 200' ' ' ILE . 20.2 t80 -78.89 -34.95 44.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.937 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -51.84 -56.76 12.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.499 . . . . 75.2 110.88 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -56.87 -33.28 66.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 75.03 110.931 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.712 HD23 ' CA ' ' A' ' 183' ' ' ALA . 0.7 OUTLIER -51.91 -45.1 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 63.33 110.932 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 196' ' ' TYR . 4.7 mp -72.37 -34.42 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 65.11 111.126 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.672 HG23 HG21 ' A' ' 211' ' ' VAL . 50.0 mm -52.98 -44.96 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.32 111.085 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -63.62 -44.96 92.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 70.44 110.891 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.3 m -59.44 -57.93 10.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 63.13 110.795 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.522 ' HG ' HD13 ' A' ' 209' ' ' ILE . 8.2 mp -51.97 -40.24 60.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 73.32 110.937 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -42.97 74.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 71.24 110.916 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -85.96 -6.99 58.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 61.23 110.899 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.513 ' HB3' HD12 ' A' ' 209' ' ' ILE . . . -94.94 25.48 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 73.21 111.1 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.72 32.41 83.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.719 -0.753 . . . . 73.53 112.5 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.522 HD13 ' HG ' ' A' ' 204' ' ' LEU . 17.0 mt -120.18 110.47 28.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 72.53 111.14 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.69 114.78 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 74.41 110.871 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.672 HG21 HG23 ' A' ' 201' ' ' ILE . 4.2 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 74.52 111.142 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.897 0.379 . . . . 74.3 110.917 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -51.49 161.07 0.87 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.672 0.748 . . . . 70.25 110.863 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.547 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 53.6 Cg_endo -69.8 -14.37 35.87 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.677 2.251 . . . . 64.3 112.346 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.23 -26.77 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 64.22 110.88 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.15 -63.53 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 61.21 111.103 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.64 -26.2 43.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 75.12 110.847 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 124' ' ' PRO . . . -58.66 -40.45 83.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 41.1 111.135 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.55 ' HB3' HD11 ' A' ' 204' ' ' LEU . 11.2 tptm -87.99 -26.65 22.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.43 110.928 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.689 HD22 ' CG ' ' A' ' 197' ' ' GLU . 77.1 mt -74.86 -25.57 59.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 60.12 110.931 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -76.37 -49.58 16.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 73.51 110.87 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.0 p -62.49 -25.81 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 74.11 111.143 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.81 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 54.32 111.125 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -51.91 -36.35 48.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 72.54 110.833 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -67.41 -48.31 67.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.846 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 tp -61.98 -27.91 69.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.9 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -69.54 -60.05 2.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.841 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -63.07 -28.67 70.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.874 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -52.65 -33.45 47.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 75.33 110.907 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -99.19 -29.47 12.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 62.35 110.887 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.94 85.47 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 71.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -85.06 -26.31 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.32 110.928 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.09 -10.53 59.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.885 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.58 24.47 47.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 51.43 112.523 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.2 p -90.51 -22.14 21.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 43.13 110.86 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.99 19.81 49.32 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.766 -0.731 . . . . 71.04 112.444 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -133.47 132.04 40.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 73.22 110.922 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.488 HD22 ' HB3' ' A' ' 152' ' ' GLU . 93.5 mt -99.56 110.82 23.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 64.32 110.916 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -77.94 176.94 8.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 75.21 110.893 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.94 -30.18 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.2 110.879 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.67 -51.82 15.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 60.53 110.893 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.488 ' HB3' HD22 ' A' ' 148' ' ' LEU . 35.8 mm-40 -62.26 -30.69 71.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.87 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.7 mt -77.06 -42.62 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 74.14 111.151 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.65 -49.07 63.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 61.2 111.106 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.87 -23.2 67.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 73.02 112.509 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.93 -45.7 60.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 74.01 110.9 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 179' ' ' TRP . 85.6 mt -52.86 -30.86 36.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 62.21 110.871 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.605 ' HD2' HG22 ' A' ' 170' ' ' THR . 0.0 OUTLIER -62.42 -60.81 3.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 74.14 110.881 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -27.48 67.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 73.03 110.888 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.0 m -65.05 -54.6 27.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 74.11 111.121 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -56.47 -25.99 52.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 73.23 110.933 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.86 -27.66 60.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 75.24 111.083 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -53.27 -28.68 29.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 62.13 110.858 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.3 mtm -104.26 -18.47 14.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 73.1 110.879 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.92 20.81 22.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.723 -0.751 . . . . 74.04 112.5 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 10.2 mtm -67.51 175.8 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.33 . . . . 71.04 110.852 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.7 t -60.63 -19.86 59.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 55.43 110.834 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 63.67 60.23 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 60.43 110.885 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -70.63 152.52 43.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 70.34 110.854 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.605 HG22 ' HD2' ' A' ' 158' ' ' LYS . 7.6 p -108.15 90.91 7.28 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.581 0.705 . . . . 73.41 111.151 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -178.33 2.31 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.646 2.23 . . . . 62.53 112.352 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 176' ' ' VAL . 51.5 p -118.62 179.56 4.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 52.2 111.15 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -54.74 -26.84 36.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 65.23 110.859 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.7 tp10 -72.87 -60.75 2.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.421 . . . . 73.14 110.844 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.0 -39.63 59.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 71.11 110.843 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 172' ' ' THR . 98.0 t -56.9 -43.25 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 71.5 111.136 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -52.01 -42.79 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.892 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.9 mp -68.84 -26.37 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.128 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.502 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 48.7 t90 -83.0 -26.45 31.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.471 . . . . 75.05 110.912 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.5 tt -77.14 -49.19 15.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 74.34 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -54.77 -28.79 51.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 64.43 110.895 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 31.5 ttm -72.68 -55.33 6.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.22 110.846 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.903 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -65.82 -60.81 2.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.52 111.101 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -66.26 128.72 37.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 73.42 110.904 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.26 -35.14 18.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 54.4 111.133 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -74.66 -12.46 60.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.866 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.9 p 46.24 57.42 5.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.812 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -114.17 23.56 12.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 72.11 110.851 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.06 25.89 74.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 65.42 112.467 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.8 p -152.41 135.62 15.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 65.02 110.876 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.78 111.62 36.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 74.11 111.135 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.8 t -75.37 179.95 4.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.804 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.68 -60.29 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 54.32 110.907 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -62.88 -39.21 93.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 52.4 110.88 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -61.22 -27.49 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.867 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.549 ' O ' HD12 ' A' ' 200' ' ' ILE . 36.8 t80 -89.37 -44.5 10.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 74.4 110.888 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.689 ' CG ' HD22 ' A' ' 130' ' ' LEU . 66.8 tt0 -60.46 -34.8 74.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 70.32 110.903 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -64.54 -26.18 68.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.866 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.903 HD13 ' HB2' ' A' ' 183' ' ' ALA . 2.3 tp -68.66 -44.35 74.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 75.03 110.938 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.1 mp -63.28 -24.65 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 72.33 111.122 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.644 HD13 HD21 ' A' ' 130' ' ' LEU . 48.6 mm -51.92 -48.05 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 70.04 111.124 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -69.31 -37.25 77.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 64.15 110.883 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 12.1 m -53.77 -42.19 68.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 61.02 110.842 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 129' ' ' LYS . 64.8 mt -80.14 -26.42 39.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 71.34 110.893 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -62.98 -43.63 98.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 63.5 110.917 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -85.79 -24.14 26.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 62.31 110.908 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.92 -21.55 66.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.115 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.06 21.9 4.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 52.25 112.49 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.79 101.65 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 74.51 111.157 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -68.57 98.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.32 110.851 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.9 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 72.04 111.118 179.959 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.908 0.385 . . . . 72.11 110.891 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -61.0 160.9 17.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.622 0.725 . . . . 73.12 110.915 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -27.61 26.21 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 30.42 112.34 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -75.09 -18.13 60.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 63.13 110.846 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.01 -60.42 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 55.3 111.115 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -51.59 -30.32 20.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 65.52 110.854 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.4 79.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 74.23 111.079 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -88.42 -24.59 23.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.894 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 201' ' ' ILE . 63.5 mt -76.83 -40.11 48.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.901 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -58.2 -43.24 87.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.827 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.461 HG23 HH11 ' A' ' 135' ' ' ARG . 13.3 p -71.39 -24.24 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.23 111.113 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.41 54.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 63.0 111.088 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -66.5 -50.3 63.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 72.32 110.855 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.461 HH11 HG23 ' A' ' 132' ' ' VAL . 4.1 ptm180 -55.29 -26.06 38.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 51.53 110.856 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.3 tp -79.44 -35.4 40.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 75.3 110.933 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.49 -60.54 3.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 54.23 110.876 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -60.35 -32.45 71.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 62.13 110.889 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -55.34 -26.51 41.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 61.33 110.912 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -108.24 -26.66 10.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 64.43 110.892 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.97 60.02 2.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 53.32 110.919 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -70.06 -25.91 63.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 75.21 110.918 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.74 -10.58 59.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.834 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.12 23.38 52.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.757 . . . . 63.21 112.499 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -83.07 -22.06 33.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.929 0.395 . . . . 53.02 110.87 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.32 20.69 60.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 65.13 112.527 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -150.08 131.74 14.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 64.4 110.901 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.5 mt -91.45 101.88 14.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.945 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -65.61 171.85 3.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 71.41 110.875 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.494 ' HA ' HD12 ' A' ' 153' ' ' ILE . 7.3 t70 -52.05 -29.99 23.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 62.23 110.86 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.81 -51.35 12.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 64.11 110.892 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -59.62 -26.4 65.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 73.03 110.904 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.57 ' CG2' HG13 ' A' ' 176' ' ' VAL . 23.7 mt -76.78 -36.63 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 61.24 111.112 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.72 -44.77 63.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 64.44 111.126 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.27 -25.27 48.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.741 . . . . 42.2 112.486 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.416 HD21 ' CE1' ' A' ' 196' ' ' TYR . 2.4 tp -59.23 -56.75 18.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 74.34 110.896 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.1 mt -51.95 -32.41 33.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 71.54 110.927 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -57.0 -43.97 82.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 44.23 110.885 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -84.93 -45.93 11.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 64.12 110.834 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.1 m -52.58 -36.63 56.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.174 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -67.33 -56.44 9.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 64.54 110.947 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.727 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -54.61 -26.79 34.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 61.15 111.107 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.95 -33.17 75.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 73.01 110.88 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -99.02 18.95 16.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 64.04 110.82 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.21 68.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 73.12 112.47 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.3 tpp -65.28 173.65 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 61.32 110.884 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 91.1 p -72.92 -9.07 58.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 63.11 110.831 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.727 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 0.2 OUTLIER 63.64 47.85 3.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 63.34 110.834 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -62.63 152.6 34.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 64.55 110.846 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.3 p -108.29 90.93 7.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.626 0.726 . . . . 65.53 111.1 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 -176.35 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 2.252 . . . . 71.13 112.293 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 176' ' ' VAL . 36.6 p -128.68 -176.07 3.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 70.03 111.17 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -55.07 -26.55 38.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 64.14 110.909 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.615 ' O ' HD12 ' A' ' 178' ' ' ILE . 41.2 tt0 -72.93 -61.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.861 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.05 -48.3 64.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 54.5 110.834 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 172' ' ' THR . 89.7 t -52.17 -36.62 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.44 111.152 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -59.38 -53.9 52.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.21 110.909 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -55.23 -38.4 47.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 51.33 111.137 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.702 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 88.4 t90 -75.22 -25.27 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 53.12 110.923 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 tt -74.89 -51.21 14.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.859 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -52.75 -45.17 66.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 72.04 110.887 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.0 ttm -57.92 -26.39 62.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 50.12 110.879 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.874 ' HB2' HD11 ' A' ' 199' ' ' LEU . . . -90.85 -67.28 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 73.43 111.128 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -61.25 128.49 36.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 63.13 110.872 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.1 m -84.05 -28.14 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 72.02 111.135 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -91.3 -12.46 35.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 54.34 110.883 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 58.5 58.37 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 61.11 110.83 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -117.29 23.46 11.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 60.52 110.911 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.13 31.5 81.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.718 -0.753 . . . . 64.45 112.457 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.58 129.98 17.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.922 0.391 . . . . 74.31 110.887 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.513 HG13 ' HB1' ' A' ' 183' ' ' ALA . 40.3 t -114.99 102.31 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 63.13 111.08 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.47 176.24 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.34 110.821 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.2 OUTLIER -62.52 -29.92 70.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 65.35 110.984 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -81.39 -29.5 33.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 53.34 110.933 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.7 -22.0 29.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 63.22 110.912 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.467 ' HA ' HD12 ' A' ' 199' ' ' LEU . 41.5 t80 -84.04 -35.19 24.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 73.31 110.927 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.474 ' O ' HD12 ' A' ' 201' ' ' ILE . 11.2 pt-20 -67.86 -41.81 82.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 54.12 110.891 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -55.33 -30.11 59.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.843 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' A' ' 183' ' ' ALA . 44.5 mt -62.26 -41.03 98.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 73.25 110.903 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 200' ' ' ILE . 4.6 mp -66.2 -44.25 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 72.45 111.127 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 1.036 HG23 HG11 ' A' ' 211' ' ' VAL . 2.0 mp -60.32 -35.9 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.53 111.164 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.37 -41.17 79.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 72.12 110.946 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 17.9 t -84.69 -36.05 22.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 70.34 110.881 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.63 ' CD2' HD13 ' A' ' 209' ' ' ILE . 21.4 mt -51.99 -37.9 54.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 63.14 110.929 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -51.1 -46.67 61.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 71.54 110.861 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.42 -22.62 26.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 61.32 110.885 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 204' ' ' LEU . . . -64.77 -22.79 67.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 61.33 111.117 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.52 26.59 3.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 40.52 112.472 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.63 HD13 ' CD2' ' A' ' 204' ' ' LEU . 5.2 mp -124.76 136.24 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 74.22 111.108 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -102.07 115.9 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.32 110.891 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 1.036 HG11 HG23 ' A' ' 201' ' ' ILE . 6.3 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 65.35 111.151 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.93 0.395 . . . . 71.54 110.866 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -53.73 160.57 2.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.608 0.718 . . . . 64.02 110.905 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -20.43 34.89 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.719 2.279 . . . . 61.4 112.334 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -81.63 -20.91 38.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 64.43 110.881 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.514 HG13 HD22 ' A' ' 204' ' ' LEU . 2.9 t -80.4 -59.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 63.03 111.118 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.538 ' OE2' HD12 ' A' ' 130' ' ' LEU . 2.0 tp10 -51.77 -30.66 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 62.32 110.905 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.4 -30.88 61.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 20.31 111.114 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -25.81 22.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 60.43 110.94 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.699 HD22 ' HG3' ' A' ' 197' ' ' GLU . 18.7 mt -76.32 -42.12 46.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.34 110.918 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -55.23 -51.99 64.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 52.51 110.901 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.18 -26.53 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.088 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.21 76.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 73.23 111.121 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.3 mtm-85 -56.5 -44.88 81.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 72.55 110.873 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -61.64 -37.77 85.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 50.21 110.857 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.91 -29.84 61.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 74.35 110.912 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -67.11 -55.29 14.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 62.53 110.882 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -66.82 -28.5 68.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 60.11 110.922 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -52.5 -39.91 61.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.11 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -96.55 -35.5 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 71.53 110.879 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -80.75 57.96 3.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.839 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -25.38 68.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 72.32 110.894 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -71.27 -10.62 60.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 73.05 110.857 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.4 29.68 57.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 44.03 112.484 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.8 p -70.69 -22.18 62.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 54.3 110.843 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.48 -16.39 58.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 72.23 112.491 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -141.44 155.76 45.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.359 . . . . 62.11 110.912 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.501 ' CD1' HD13 ' A' ' 156' ' ' LEU . 42.0 mt -98.62 109.74 22.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 65.52 110.893 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.55 178.34 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.21 110.948 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -57.86 -26.31 61.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 71.51 110.884 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 57.5 m-20 -82.63 -53.3 6.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.23 110.877 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HB3' HD22 ' A' ' 148' ' ' LEU . 1.7 mt-10 -51.92 -49.05 63.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.86 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.606 ' CD1' HD13 ' A' ' 180' ' ' LEU . 33.9 mt -51.63 -38.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.41 111.164 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 151' ' ' ASP . . . -51.64 -41.34 61.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 62.44 111.096 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.85 -30.41 32.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.744 -0.741 . . . . 72.32 112.514 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.501 HD13 ' CD1' ' A' ' 148' ' ' LEU . 3.8 tp -58.32 -54.02 51.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 74.1 110.904 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 179' ' ' TRP . 56.6 mt -51.85 -32.28 31.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 73.31 110.93 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -54.71 -58.13 8.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 75.43 110.852 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.96 -42.82 56.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 75.43 110.855 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 93.1 m -52.42 -32.26 38.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 54.33 111.157 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -79.16 -57.53 3.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 74.11 110.924 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.505 ' HB2' ' ND2' ' A' ' 168' ' ' ASN . . . -55.51 -26.08 40.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.45 111.102 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.64 -27.65 63.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 65.31 110.885 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 51.8 mtm -103.91 21.86 15.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 65.24 110.887 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.84 23.07 72.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 35.24 112.505 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.0 tpp -76.57 170.03 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 52.23 110.887 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -64.48 -17.46 63.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 72.54 110.848 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' A' ' 162' ' ' ALA . 48.6 t-20 63.5 56.72 1.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 64.34 110.907 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -67.69 152.65 45.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 71.23 110.902 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.5 m -108.23 90.85 7.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.555 0.693 . . . . 63.24 111.161 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 174.98 8.71 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 74.33 112.305 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 176' ' ' VAL . 68.4 p -116.15 -176.02 2.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 70.31 111.143 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -51.82 -30.42 23.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 73.31 110.902 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.62 ' O ' HD12 ' A' ' 178' ' ' ILE . 84.9 tt0 -69.38 -61.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 65.51 110.902 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.9 -45.23 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 71.03 110.875 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 172' ' ' THR . 96.6 t -58.84 -28.51 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 64.4 111.193 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -66.92 -40.0 87.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 73.04 110.911 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -70.12 -31.37 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 53.45 111.127 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.511 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 55.8 t90 -83.52 -28.34 28.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 75.12 110.912 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.667 HD21 ' HA2' ' A' ' 189' ' ' GLY . 23.0 tp -83.72 -38.2 21.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 72.53 110.958 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -61.05 -30.91 70.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 71.31 110.906 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 48.8 ttp -91.25 -40.13 11.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 61.33 110.864 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -65.38 -25.26 67.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.12 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -101.25 127.84 47.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.879 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 98.0 m -83.9 -25.03 30.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 72.15 111.167 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -97.32 -12.43 22.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.846 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.6 t 56.6 39.32 29.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 75.53 110.879 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -98.05 19.55 13.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 61.31 110.885 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.667 ' HA2' HD21 ' A' ' 180' ' ' LEU . . . 64.08 31.71 81.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.484 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.97 134.0 18.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 61.54 110.863 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 196' ' ' TYR . 22.0 t -108.26 97.72 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 71.12 111.119 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.06 162.45 24.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 32.14 110.875 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 193' ' ' LEU . 5.6 mt -53.29 -31.57 44.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.128 -0.487 . . . . 71.02 110.893 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -81.43 -28.12 34.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.887 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -78.03 -42.46 32.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.467 . . . . 74.32 110.859 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.548 ' O ' HD12 ' A' ' 200' ' ' ILE . 20.0 t80 -65.04 -52.62 54.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.917 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.699 ' HG3' HD22 ' A' ' 130' ' ' LEU . 31.3 tt0 -51.81 -48.37 63.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 70.32 110.917 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -51.93 -35.0 44.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 71.24 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.511 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 2.5 tp -61.19 -45.08 96.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.24 110.943 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.1 mp -64.95 -28.32 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 54.41 111.115 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.645 ' CD1' HD21 ' A' ' 130' ' ' LEU . 50.0 mm -63.99 -52.85 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 63.23 111.122 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -56.49 -30.75 63.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 55.22 110.903 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 22.1 m -83.08 -29.94 28.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 51.23 110.814 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.609 ' HG ' HD13 ' A' ' 209' ' ' ILE . 0.8 OUTLIER -66.81 -42.72 85.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 64.35 110.874 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -51.9 -36.53 49.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.871 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -26.02 26.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 70.43 110.938 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.72 67.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 71.42 111.108 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.81 25.09 5.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.743 . . . . 60.2 112.43 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.609 HD13 ' HG ' ' A' ' 204' ' ' LEU . 5.3 mp -116.57 108.5 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 43.14 111.124 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -64.6 118.4 8.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 72.44 110.901 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.476 ' CG2' HG11 ' A' ' 126' ' ' VAL . 5.8 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.116 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.917 0.389 . . . . 63.13 110.957 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -62.7 160.58 34.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.617 0.723 . . . . 75.23 110.912 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -17.78 37.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.714 2.276 . . . . 72.31 112.373 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.49 ' HB3' HG23 ' A' ' 209' ' ' ILE . 15.7 tp10 -82.9 -22.49 33.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.887 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.28 -61.27 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 74.11 111.114 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -51.67 -29.96 20.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 70.4 110.906 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.55 84.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 63.31 111.106 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.56 ' HB3' HD11 ' A' ' 204' ' ' LEU . 16.6 tptp -88.42 -26.61 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 72.44 110.893 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.753 HD22 ' HG3' ' A' ' 197' ' ' GLU . 61.4 mt -74.78 -26.12 59.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 72.14 110.94 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.21 -54.16 28.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 53.33 110.883 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.15 -24.95 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 61.32 111.114 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.89 -39.94 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 75.25 111.118 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -54.72 -31.09 57.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 71.45 110.891 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -85.03 -40.94 16.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.874 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.48 -27.25 67.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 64.35 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.707 ' CE1' HD13 ' A' ' 148' ' ' LEU . 87.5 t80 -72.81 -49.98 27.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 73.22 110.888 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -74.83 -25.91 59.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.901 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -57.23 -25.04 58.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.53 110.922 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -110.05 -21.31 12.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 65.43 110.919 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -77.27 61.81 2.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 75.25 110.832 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -16.72 59.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 71.12 110.952 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -70.22 -10.66 59.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 44.33 110.872 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.0 20.33 53.29 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.77 -0.729 . . . . 30.45 112.509 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.7 m -78.95 -22.12 46.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.945 0.403 . . . . 60.15 110.853 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.3 -16.06 58.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 73.42 112.533 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.63 170.71 9.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 63.43 110.891 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.707 HD13 ' CE1' ' A' ' 137' ' ' PHE . 0.8 OUTLIER -112.98 101.29 9.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 63.04 110.89 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -73.46 172.16 11.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 75.03 110.915 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.408 ' O ' HG11 ' A' ' 176' ' ' VAL . 11.8 p-10 -54.44 -27.39 36.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 74.52 110.875 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -82.23 -45.78 14.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 73.42 110.87 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -63.71 -45.18 91.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.23 110.874 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.435 ' CD1' HD12 ' A' ' 180' ' ' LEU . 21.2 mt -52.43 -31.35 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 70.12 111.123 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.95 58.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 73.43 111.111 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.75 -22.85 59.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.734 . . . . 71.13 112.501 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.682 HD13 HD21 ' A' ' 148' ' ' LEU . 3.8 tp -70.09 -59.09 3.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.808 0.337 . . . . 63.0 110.909 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 27.3 mt -52.16 -32.65 36.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 71.32 110.944 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -51.9 -57.26 9.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 51.13 110.91 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.0 -41.54 28.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 73.12 110.867 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.5 m -51.63 -30.99 23.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 70.1 111.159 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.38 -52.47 9.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 71.54 110.922 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.402 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -54.84 -25.51 28.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 63.33 111.135 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -54.29 -32.47 56.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.24 110.853 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.4 ptp -105.67 21.13 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.888 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.83 16.56 66.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 42.23 112.468 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.16 166.96 0.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.82 0.343 . . . . 70.44 110.873 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.2 m -65.36 -14.58 61.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.868 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 2.2 t30 64.21 58.32 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 72.05 110.908 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -73.29 153.08 40.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 73.01 110.919 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.406 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 10.2 m -108.09 90.91 7.2 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.685 . . . . 70.33 111.133 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.8 Cg_endo -69.74 -174.65 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.696 2.264 . . . . 75.04 112.355 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 176' ' ' VAL . 71.2 p -129.01 -176.01 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 75.51 111.135 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -54.72 -26.67 35.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 70.31 110.872 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.609 ' O ' HD12 ' A' ' 178' ' ' ILE . 8.3 tp10 -72.56 -61.64 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.89 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.07 -48.6 64.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.867 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 172' ' ' THR . 86.6 t -51.68 -42.48 31.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 45.22 111.084 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -47.0 64.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 72.13 110.918 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.9 mp -62.44 -26.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.15 111.088 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.54 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 52.3 t90 -83.78 -30.76 26.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 71.42 110.927 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 184' ' ' ASP . 3.2 tt -77.59 -47.05 20.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 72.33 110.954 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -51.95 -30.92 26.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 60.23 110.912 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 37.1 ttp -90.41 -26.43 19.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.55 110.844 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.769 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -96.09 21.91 8.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 74.13 111.133 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.534 ' HB2' HD23 ' A' ' 180' ' ' LEU . 21.1 t0 -131.8 112.2 12.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.842 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.5 m -83.74 -41.79 17.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 61.24 111.16 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.47 -12.5 59.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 64.54 110.896 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 54.66 35.2 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 64.14 110.847 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.45 -16.23 37.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.89 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.0 20.24 16.91 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 44.24 112.48 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.52 126.71 8.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 74.35 110.864 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.49 97.53 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 72.5 111.066 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.1 t -67.71 165.18 17.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.41 110.838 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 26.1 tp -53.62 -35.94 61.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 72.04 110.875 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -77.08 -24.67 51.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.907 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -79.58 -53.33 6.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 71.32 110.906 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.619 ' CE1' HD21 ' A' ' 156' ' ' LEU . 22.5 t80 -51.98 -49.95 62.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.934 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.753 ' HG3' HD22 ' A' ' 130' ' ' LEU . 3.0 tp10 -51.82 -47.61 64.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 73.14 110.903 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -52.8 -32.53 44.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.487 . . . . 54.02 110.904 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 183' ' ' ALA . 3.0 tp -62.5 -38.94 91.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.937 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -74.17 -24.05 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.11 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.455 HG22 ' NE2' ' A' ' 205' ' ' GLN . 45.0 mm -59.4 -55.87 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.12 111.114 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -56.24 -37.95 70.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.42 110.892 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.6 t -66.98 -28.48 68.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 73.23 110.869 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 129' ' ' LYS . 21.3 mt -79.34 -25.42 42.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.44 110.956 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.568 ' OE1' HG12 ' A' ' 211' ' ' VAL . 2.7 mp0 -59.99 -45.59 92.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.879 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -86.05 -20.37 28.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.911 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.93 -22.77 67.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.056 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 108.9 32.44 3.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.78 -0.724 . . . . 75.21 112.472 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 125' ' ' GLU . 5.3 mp -124.12 131.01 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 74.4 111.107 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -90.55 133.63 34.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.904 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.568 HG12 ' OE1' ' A' ' 205' ' ' GLN . 6.7 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.154 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.86 0.362 . . . . 60.13 110.964 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -52.02 160.49 1.17 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.623 0.725 . . . . 31.34 110.879 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -17.13 37.61 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.688 2.258 . . . . 72.51 112.34 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.495 ' CG ' HG23 ' A' ' 209' ' ' ILE . 18.4 pt-20 -82.9 -24.63 33.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.906 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.455 HG21 HG23 ' A' ' 211' ' ' VAL . 3.0 t -78.35 -63.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 43.44 111.115 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 130' ' ' LEU . 8.3 tt0 -52.15 -30.01 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 74.02 110.879 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.76 -32.69 60.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 62.14 111.123 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.604 ' HG2' HG21 ' A' ' 200' ' ' ILE . 24.6 tttm -87.96 -25.73 23.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 75.02 110.936 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 197' ' ' GLU . 25.2 mt -77.9 -29.23 50.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.935 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -65.7 -32.59 74.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.896 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 129' ' ' LYS . 11.7 p -86.05 -23.36 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 52.21 111.12 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -82.78 -35.55 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 33.35 111.108 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -24.46 57.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.817 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -83.17 -23.07 33.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 73.54 110.866 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.59 -24.34 33.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.899 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.681 ' CE1' HD13 ' A' ' 148' ' ' LEU . 90.3 t80 -65.54 -56.43 12.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 64.25 110.881 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -72.22 -24.22 61.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.88 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -52.08 -29.88 23.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 74.53 110.875 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -110.69 -21.14 12.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.901 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -75.62 69.66 2.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 52.12 110.872 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -85.14 0.51 51.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 71.15 110.895 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.39 -10.57 59.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.869 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.16 18.7 60.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 75.23 112.529 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 p -106.32 -22.0 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.382 . . . . 61.13 110.869 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.6 21.53 66.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 61.32 112.48 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -128.72 132.54 47.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 61.41 110.879 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.681 HD13 ' CE1' ' A' ' 137' ' ' PHE . 1.2 mp -90.81 104.78 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.923 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -88.04 177.27 6.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 72.4 110.944 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -52.04 -30.08 23.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.33 110.898 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 53.1 m-20 -80.4 -55.04 5.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 74.0 110.834 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -53.95 -46.02 71.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 61.32 110.929 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.403 ' CD1' HD12 ' A' ' 180' ' ' LEU . 39.3 mt -57.19 -33.72 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 74.32 111.11 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 151' ' ' ASP . . . -51.15 -48.06 61.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 72.32 111.079 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.36 -24.72 70.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 60.1 112.492 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.572 HD13 HD21 ' A' ' 148' ' ' LEU . 1.7 tp -69.42 -55.93 8.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 75.2 110.926 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.412 HD21 ' CE2' ' A' ' 179' ' ' TRP . 70.7 mt -51.69 -30.16 20.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 62.02 110.884 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.772 ' HE3' HG23 ' A' ' 170' ' ' THR . 0.7 OUTLIER -57.15 -58.57 7.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 55.11 110.915 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -71.77 -42.85 66.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 65.22 110.86 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.1 m -52.17 -34.94 47.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 62.55 111.171 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -82.11 -25.72 34.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.94 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -78.91 -25.38 43.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 52.1 111.066 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -59.68 -44.78 93.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 75.4 110.843 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.3 mtm -75.08 -18.29 60.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 64.53 110.866 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.95 17.72 36.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 65.22 112.532 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.3 ttm -66.67 175.93 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.799 0.333 . . . . 74.34 110.828 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.4 m -65.72 -14.39 61.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 63.13 110.855 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.553 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 0.6 OUTLIER 64.21 73.73 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 61.14 110.841 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -78.52 152.93 31.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 75.15 110.859 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.772 HG23 ' HE3' ' A' ' 158' ' ' LYS . 11.3 m -108.03 90.88 7.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.581 0.705 . . . . 63.11 111.124 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 169.19 19.43 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.703 2.268 . . . . 51.25 112.348 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 176' ' ' VAL . 62.7 p -108.63 -176.06 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 74.23 111.139 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -24.97 46.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 75.5 110.89 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.656 ' O ' HD12 ' A' ' 178' ' ' ILE . 38.7 tt0 -77.8 -55.4 5.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.13 110.895 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.57 -35.89 43.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 73.44 110.872 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 172' ' ' THR . 88.4 t -65.83 -36.79 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 62.11 111.144 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -59.03 -46.63 87.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.898 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.656 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -62.61 -28.01 43.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 74.41 111.111 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.528 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 49.5 t90 -83.8 -26.03 29.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.892 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.616 HD23 ' HB2' ' A' ' 184' ' ' ASP . 3.0 tt -77.3 -35.21 55.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.14 110.875 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.67 -26.62 67.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 72.52 110.907 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.9 ttm -87.66 -49.81 6.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 72.2 110.895 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.478 ' HB3' HG21 ' A' ' 191' ' ' VAL . . . -61.32 -44.37 97.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 63.01 111.107 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.616 ' HB2' HD23 ' A' ' 180' ' ' LEU . 29.8 t0 -58.57 98.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 51.22 110.804 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 97.4 m -86.66 -24.75 25.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 75.14 111.133 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -95.44 -12.35 26.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 71.34 110.902 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 62.27 48.16 4.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.853 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -110.31 23.81 13.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 62.1 110.862 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.68 14.51 58.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 43.54 112.503 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.72 158.86 40.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 74.12 110.86 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 183' ' ' ALA . 34.4 t -117.62 122.72 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 70.32 111.141 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 -169.74 2.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.873 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -66.4 -43.83 84.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 72.4 110.893 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -72.49 -34.59 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 71.3 110.878 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.7 -23.03 53.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 71.13 110.899 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.518 ' CE1' HD21 ' A' ' 156' ' ' LEU . 23.2 t80 -82.11 -50.33 9.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 74.03 110.959 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' A' ' 130' ' ' LEU . 10.9 pt-20 -53.61 -43.71 68.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 63.13 110.866 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -52.01 -29.96 23.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.22 110.885 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.528 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 1.7 tp -64.35 -43.1 95.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 72.42 110.946 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.604 HG21 ' HG2' ' A' ' 129' ' ' LYS . 5.2 mp -69.78 -24.64 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.42 111.126 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.607 HD11 HD11 ' A' ' 130' ' ' LEU . 50.0 mm -59.2 -55.6 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 72.11 111.142 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -52.62 -38.07 59.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 74.12 110.876 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 p -74.57 -29.81 61.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.892 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.941 HD23 HD13 ' A' ' 209' ' ' ILE . 4.7 mt -68.51 -33.37 74.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 64.44 110.948 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -57.67 -47.18 83.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 73.15 110.905 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -24.68 32.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 63.25 110.909 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.88 -21.18 66.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 44.34 111.118 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.89 20.7 4.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.738 . . . . 72.25 112.535 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.941 HD13 HD23 ' A' ' 204' ' ' LEU . 5.3 mp -119.73 103.85 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 74.12 111.138 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -72.12 108.45 5.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 71.51 110.86 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.455 HG23 HG21 ' A' ' 126' ' ' VAL . 6.2 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.3 111.168 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.897 0.379 . . . . 73.34 110.924 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -51.93 160.88 1.03 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 63.23 110.871 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -17.19 37.61 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.715 2.277 . . . . 73.44 112.301 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -82.99 -24.84 32.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 73.23 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.444 HG21 HG13 ' A' ' 211' ' ' VAL . 3.1 t -77.59 -63.35 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 74.51 111.128 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.437 ' OE2' HD12 ' A' ' 130' ' ' LEU . 4.2 tp10 -51.88 -33.61 37.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 60.04 110.876 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.42 -36.36 54.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 63.1 111.144 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.651 ' HB3' HD11 ' A' ' 204' ' ' LEU . 21.5 tptt -83.06 -26.17 31.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.53 110.921 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.771 HD11 HD11 ' A' ' 201' ' ' ILE . 92.5 mt -74.31 -37.19 63.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.34 110.953 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.91 -57.25 11.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 75.12 110.924 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.89 -25.23 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.14 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.86 -29.7 40.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 61.33 111.139 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -60.03 -54.26 48.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 70.32 110.869 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 -54.24 -46.24 72.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.841 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.8 tp -56.97 -34.37 68.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 72.41 110.925 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -59.77 -62.99 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 72.12 110.907 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -62.89 -26.96 69.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 63.44 110.902 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -31.42 36.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.902 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.29 -38.08 7.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 75.24 110.943 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.88 76.23 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 74.31 110.857 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -67.2 -30.62 70.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 75.53 110.907 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.92 -10.55 59.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.32 110.869 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.74 22.49 40.56 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.733 -0.746 . . . . 64.35 112.463 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.3 m -71.42 -22.06 61.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 62.4 110.891 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.7 23.5 57.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.514 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -145.79 130.74 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.358 . . . . 63.35 110.908 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mt -103.85 101.42 11.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 73.3 110.934 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -62.89 174.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 54.02 110.901 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.14 -26.49 38.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 34.51 110.891 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.63 -54.67 5.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 63.34 110.857 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -52.22 -38.85 59.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 61.21 110.899 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.3 mt -63.32 -32.96 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 74.11 111.115 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.7 -42.13 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 63.2 111.115 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.34 -25.9 45.77 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.713 -0.756 . . . . 72.53 112.465 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.2 tp -60.88 -55.85 28.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 73.51 110.937 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.5 mt -52.03 -33.94 40.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 65.13 110.903 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -59.73 4.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 71.33 110.923 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.13 -41.42 61.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 72.31 110.832 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 89.0 m -53.44 -32.92 52.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 74.33 111.126 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -77.33 -51.23 11.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.895 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.522 ' HB2' ' ND2' ' A' ' 168' ' ' ASN . . . -58.19 -30.63 66.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 65.13 111.113 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.9 -46.77 64.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 65.44 110.922 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 33.1 mtm -76.8 -18.46 58.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 63.41 110.912 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 95.89 28.66 9.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.74 -0.743 . . . . 73.35 112.426 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 6.3 ttm -86.0 175.79 8.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 75.14 110.853 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.0 m -58.29 -22.97 54.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 71.32 110.848 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 162' ' ' ALA . 37.8 t-20 63.36 60.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 60.31 110.896 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -65.62 152.51 43.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 73.33 110.864 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.0 p -108.31 90.82 7.39 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.589 0.709 . . . . 73.33 111.135 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -171.19 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.28 . . . . 64.35 112.322 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.627 ' O ' HG23 ' A' ' 176' ' ' VAL . 34.3 p -126.5 -176.17 3.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.132 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -57.45 -26.36 61.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 64.51 110.918 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 178' ' ' ILE . 9.8 tt0 -72.53 -61.56 1.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 73.14 110.886 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.27 -48.82 65.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.477 . . . . 75.22 110.849 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 172' ' ' THR . 85.7 t -51.62 -34.87 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 54.22 111.115 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.27 -52.53 64.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 73.42 110.882 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.551 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.8 mp -57.46 -25.83 25.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 72.14 111.171 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.513 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 49.6 t90 -82.69 -37.72 24.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 74.05 110.935 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.6 tt -57.63 -46.38 84.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 72.41 110.865 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -54.7 -36.38 64.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 61.34 110.925 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.2 mtm -65.79 -54.22 29.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 70.12 110.873 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.592 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . . . -64.53 -63.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 51.22 111.098 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -69.32 129.28 39.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 60.45 110.888 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 8.5 m -85.22 -24.79 27.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.123 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -89.39 -12.4 40.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 70.44 110.904 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.5 p 51.59 39.73 25.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 71.52 110.898 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -95.24 23.92 5.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.89 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 65.58 29.3 74.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.739 . . . . 50.13 112.49 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m -154.71 126.88 7.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.401 . . . . 63.32 110.828 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.71 106.38 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 60.24 111.133 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.1 t -72.1 178.32 3.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 72.43 110.86 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.536 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -63.67 -38.03 89.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.946 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -81.26 -25.59 36.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 63.32 110.899 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.35 -23.19 40.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 70.01 110.882 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.494 ' O ' HD12 ' A' ' 200' ' ' ILE . 19.4 t80 -84.27 -51.81 6.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 74.55 110.936 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.764 ' HB2' HD22 ' A' ' 130' ' ' LEU . 13.5 pt-20 -53.1 -43.83 67.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.487 . . . . 72.24 110.888 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -52.74 -41.91 64.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 65.22 110.909 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 9.0 tt -52.42 -39.61 61.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 72.44 110.919 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.3 mp -73.81 -25.85 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 70.34 111.152 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.771 HD11 HD11 ' A' ' 130' ' ' LEU . 50.5 mm -67.45 -38.14 80.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 73.42 111.121 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -66.28 -36.88 84.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 72.34 110.9 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 43.7 m -78.36 -37.82 43.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.865 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.651 HD11 ' HB3' ' A' ' 129' ' ' LYS . 18.7 mt -57.8 -35.89 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 73.14 110.919 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -56.83 -37.71 71.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.908 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -85.59 -24.88 26.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 65.23 110.951 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.74 67.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 75.34 111.126 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.72 24.15 3.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 65.13 112.51 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.04 102.0 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 71.33 111.135 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -69.45 101.26 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 53.51 110.915 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.444 HG13 HG21 ' A' ' 126' ' ' VAL . 21.2 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 75.51 111.142 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.886 0.374 . . . . 73.51 110.955 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.66 160.8 1.84 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 72.42 110.89 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -21.41 33.27 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 2.253 . . . . 75.0 112.337 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.94 -21.83 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 74.05 110.863 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.81 HG13 HD23 ' A' ' 204' ' ' LEU . 3.0 t -77.73 -61.17 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.23 111.173 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -52.08 -29.86 23.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.03 110.892 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.81 -38.73 70.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 44.44 111.132 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.542 ' HG2' HD11 ' A' ' 204' ' ' LEU . 16.9 tptm -83.95 -25.39 30.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.04 110.938 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 197' ' ' GLU . 90.2 mt -75.24 -30.27 60.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 70.21 110.933 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.65 -56.13 25.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.472 . . . . 64.51 110.847 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.97 -26.75 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 70.4 111.142 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.83 -32.2 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 51.02 111.091 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.711 ' HG2' HD11 ' A' ' 193' ' ' LEU . 37.0 mtt180 -59.94 -45.78 91.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 64.53 110.878 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -60.71 -33.03 72.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 73.45 110.864 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.0 tp -69.48 -26.32 64.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 41.43 110.921 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -64.07 -63.72 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 54.3 110.906 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -59.43 -26.64 65.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 64.22 110.89 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -55.99 -26.92 50.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.874 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -110.35 -27.19 9.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.959 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.12 78.74 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.848 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -26.11 33.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 73.25 110.926 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -70.78 -10.63 59.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.858 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.99 20.66 50.18 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.761 -0.733 . . . . 64.43 112.461 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 p -86.84 -22.09 26.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 65.11 110.829 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.21 23.1 41.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 31.32 112.473 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -138.28 152.01 48.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 74.14 110.902 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.4 mt -118.81 102.69 9.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 51.04 110.895 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -70.62 173.9 6.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.875 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.455 ' HA ' HD12 ' A' ' 153' ' ' ILE . 3.5 p-10 -55.07 -26.76 39.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 54.52 110.879 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.4 -32.34 48.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 74.52 110.865 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -84.5 -26.26 28.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 70.23 110.857 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.509 ' CG2' HG13 ' A' ' 176' ' ' VAL . 21.3 mt -74.51 -41.04 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 71.2 111.149 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.56 -45.11 62.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 62.05 111.117 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.22 -22.84 56.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.754 . . . . 60.03 112.496 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.9 tp -60.31 -54.41 46.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 65.34 110.953 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.91 -34.42 41.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 64.21 110.953 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -52.94 -49.21 66.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.3 110.899 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -82.25 -43.35 17.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.869 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.2 m -53.79 -30.95 47.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 54.1 111.207 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -81.04 -57.92 3.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.708 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -55.46 -25.6 37.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.45 111.143 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.17 -26.3 62.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.907 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 38.7 mtm -110.75 21.68 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.867 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 18.56 68.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.749 -0.739 . . . . 64.31 112.486 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.0 mmt -63.31 171.8 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 75.35 110.903 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.1 t -59.83 -20.92 59.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 75.04 110.876 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 6.5 t30 63.66 63.77 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 71.55 110.896 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -88.26 152.49 21.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 61.22 110.868 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.5 p -108.24 90.83 7.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.577 0.703 . . . . 60.24 111.148 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 157.03 61.75 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.639 2.226 . . . . 75.52 112.369 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.677 ' O ' HG23 ' A' ' 176' ' ' VAL . 71.9 p -91.91 -176.94 4.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.34 111.166 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -56.44 -25.38 50.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.864 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.633 ' O ' HD12 ' A' ' 178' ' ' ILE . 0.9 OUTLIER -73.15 -59.92 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.04 110.918 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -52.99 -30.91 37.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 44.41 110.905 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 172' ' ' THR . 69.7 t -69.4 -32.56 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 60.32 111.111 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.15 -43.66 94.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 65.33 110.899 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.633 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -63.98 -34.64 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 74.01 111.144 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' TRP . . . . . 0.677 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 88.9 t90 -81.7 -25.72 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 72.23 110.901 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.476 HD13 ' CD1' ' A' ' 153' ' ' ILE . 31.1 tp -83.8 -25.34 30.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 71.32 110.89 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -52.98 -58.38 7.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 60.13 110.93 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 43.5 mtm -67.09 -46.05 75.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 63.53 110.851 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.807 ' HB2' HD11 ' A' ' 199' ' ' LEU . . . -56.1 -25.04 44.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 75.03 111.127 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -88.26 95.75 10.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.21 110.883 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.8 m -87.68 -34.5 18.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 65.32 111.11 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.29 6.34 33.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 71.14 110.9 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.9 p 46.14 36.44 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 71.22 110.83 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -96.33 -16.27 21.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 74.41 110.802 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 99.29 19.44 20.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.767 -0.73 . . . . 63.4 112.476 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.2 m -142.31 -177.35 5.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.937 0.398 . . . . 62.1 110.838 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.87 106.37 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 61.41 111.155 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -77.51 -176.05 4.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.868 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.711 HD11 ' HG2' ' A' ' 134' ' ' ARG . 0.5 OUTLIER -66.99 -38.58 86.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 75.25 110.937 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -77.75 -25.65 49.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.905 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -84.93 -23.54 28.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 71.53 110.91 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.487 ' HD1' HD12 ' A' ' 199' ' ' LEU . 30.8 t80 -81.87 -43.53 18.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 71.33 110.877 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.527 ' HA ' HD13 ' A' ' 200' ' ' ILE . 10.9 pt-20 -54.06 -41.86 68.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.03 110.864 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -51.7 -44.08 63.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 73.55 110.932 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.807 HD11 ' HB2' ' A' ' 183' ' ' ALA . 53.4 mt -51.75 -33.88 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.921 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.527 HD13 ' HA ' ' A' ' 197' ' ' GLU . 5.3 mp -79.43 -36.08 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 60.45 111.114 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.44 -29.62 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.117 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.58 -62.16 2.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 64.02 110.912 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 46.3 t -53.14 -37.37 61.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 43.11 110.904 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.81 HD23 HG13 ' A' ' 126' ' ' VAL . 6.9 mp -55.65 -24.57 34.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 74.11 110.944 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.95 -58.98 3.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 74.01 110.894 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -78.78 -5.81 54.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 72.23 110.892 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.443 ' HB3' HG12 ' A' ' 209' ' ' ILE . . . -91.17 13.99 15.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 61.45 111.158 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.16 33.46 85.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 62.23 112.514 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ILE . . . . . 0.443 HG12 ' HB3' ' A' ' 207' ' ' ALA . 6.5 mm -102.1 111.72 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 54.33 111.124 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 100.28 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 63.11 110.907 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 53.01 111.114 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.3 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.864 0.364 . . . . 75.43 110.816 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 86.2 p -117.88 143.71 46.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 65.34 110.88 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -100.13 160.95 25.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.53 0.681 . . . . 70.55 110.924 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -171.27 0.46 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.658 2.239 . . . . 74.41 112.335 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -128.72 103.77 7.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 64.12 110.87 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -100.83 150.82 22.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.12 110.911 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.62 161.12 62.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.721 . . . . 75.22 110.9 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -18.87 36.81 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.678 2.252 . . . . 73.33 112.326 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.466 ' HB3' HG23 ' A' ' 209' ' ' ILE . 4.6 tp10 -82.04 -23.56 35.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 62.11 110.873 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.55 -63.28 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 51.25 111.119 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -51.86 -30.66 24.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 63.35 110.855 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -37.91 63.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 70.44 111.107 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.659 ' HB3' HD11 ' A' ' 204' ' ' LEU . 30.5 tptt -87.98 -25.73 23.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.45 110.926 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.692 HD22 ' HB2' ' A' ' 197' ' ' GLU . 87.3 mt -72.92 -27.27 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.895 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -66.64 -51.8 52.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.853 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.35 -25.15 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 71.5 111.121 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.25 -25.62 36.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.085 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.645 ' HG2' HD11 ' A' ' 193' ' ' LEU . 44.9 mtp180 -67.13 -47.18 71.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.3 110.842 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -63.41 -35.21 79.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 70.32 110.882 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.72 -29.48 69.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 73.23 110.896 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -65.5 -59.55 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 73.22 110.852 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -64.47 -28.07 69.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 61.23 110.882 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -55.5 -26.75 44.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 62.4 110.89 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -108.21 -30.48 8.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 65.5 110.919 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.23 84.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.892 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -85.03 -32.01 23.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.15 110.925 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.56 -10.57 59.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 53.13 110.864 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.75 23.29 43.88 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.722 -0.752 . . . . 55.14 112.476 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.9 p -75.25 -22.17 58.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 74.43 110.845 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.5 19.64 58.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.734 . . . . 64.24 112.463 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -148.34 130.75 15.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 64.35 110.918 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' HD11 ' A' ' 153' ' ' ILE . 21.7 mt -94.13 101.67 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 64.34 110.897 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -66.26 174.13 2.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 71.44 110.924 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.98 -30.15 23.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 75.05 110.868 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.73 -54.7 6.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.213 -0.448 . . . . 72.43 110.882 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -55.24 -28.36 52.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.45 110.872 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 148' ' ' LEU . 45.6 mt -79.69 -25.44 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 62.31 111.102 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.31 -53.12 48.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 72.2 111.124 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.05 -23.03 56.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.678 -0.772 . . . . 63.43 112.506 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -56.61 -52.6 64.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 62.14 110.922 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.9 mt -52.02 -41.43 62.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 72.54 110.905 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -51.93 -38.87 57.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 65.2 110.881 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -85.11 -49.58 8.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.23 110.86 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.2 m -53.09 -29.02 28.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.32 111.163 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -76.82 -33.57 57.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 74.02 110.961 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.71 -25.16 66.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 53.24 111.062 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -55.71 -26.97 47.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.44 110.9 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 19.9 mtm -109.81 16.8 21.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 71.12 110.889 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 19.46 69.47 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 35.1 112.468 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.3 tpp -63.39 168.41 4.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 73.2 110.883 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 43.2 t -71.12 -10.38 59.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 75.22 110.82 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.34 51.82 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 63.52 110.957 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -52.99 152.51 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 52.11 110.893 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 4.4 m -108.22 90.84 7.3 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.54 0.686 . . . . 71.44 111.129 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.8 Cg_endo -69.75 -177.37 1.84 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.664 2.242 . . . . 64.25 112.338 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 176' ' ' VAL . 73.1 p -123.82 -176.1 3.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 64.4 111.131 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -55.5 -27.32 47.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.9 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.622 ' O ' HD12 ' A' ' 178' ' ' ILE . 23.9 tt0 -73.15 -61.13 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 74.01 110.891 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -52.02 -44.91 64.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.823 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 172' ' ' THR . 86.7 t -57.47 -28.69 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 62.03 111.117 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -68.03 -45.69 73.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 74.32 110.904 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.622 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.4 mp -66.44 -25.98 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 44.12 111.15 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.51 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 47.9 t90 -83.21 -30.42 27.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 71.21 110.92 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.506 HD23 ' CB ' ' A' ' 184' ' ' ASP . 1.3 tt -68.71 -37.89 79.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 54.12 110.93 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -63.02 -27.39 69.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 43.04 110.903 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.0 ttm -71.93 -54.51 9.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 75.43 110.912 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.779 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -74.27 -66.27 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 73.11 111.119 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.506 ' CB ' HD23 ' A' ' 180' ' ' LEU . 48.1 t0 -53.27 129.17 30.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 53.02 110.851 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 25.1 m -85.67 -25.16 26.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 61.02 111.135 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -98.58 -12.45 21.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.936 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.3 p 51.97 37.77 22.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 52.12 110.845 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -95.42 23.96 5.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.87 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.31 31.64 74.67 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 44.3 112.478 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.44 126.98 9.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 44.12 110.858 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 184' ' ' ASP . 30.0 t -115.6 104.85 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 62.13 111.133 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 37.3 t -69.4 170.67 9.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 52.15 110.878 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.645 HD11 ' HG2' ' A' ' 134' ' ' ARG . 0.4 OUTLIER -57.81 -36.66 72.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.32 110.956 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.46 -25.64 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 74.53 110.892 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -81.77 -23.3 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 73.12 110.891 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.434 ' O ' HD12 ' A' ' 200' ' ' ILE . 31.8 t80 -83.8 -51.85 6.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 62.42 110.906 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.692 ' HB2' HD22 ' A' ' 130' ' ' LEU . 14.8 pt-20 -52.03 -43.81 63.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 71.41 110.871 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.93 -41.17 61.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 55.43 110.881 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 183' ' ' ALA . 5.0 tp -53.89 -35.68 61.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 71.35 110.916 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.3 mp -78.99 -25.12 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 61.12 111.091 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.552 ' CD1' HD21 ' A' ' 130' ' ' LEU . 44.9 mm -62.18 -50.88 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 64.34 111.163 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -55.85 -36.09 67.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 73.11 110.877 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -77.94 -35.36 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 62.3 110.841 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 129' ' ' LYS . 22.9 mt -62.32 -28.33 69.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 65.4 110.943 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -64.19 -43.49 94.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 64.2 110.928 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -85.94 -24.92 26.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 54.31 110.901 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.94 -22.58 67.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.099 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.5 31.86 1.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 71.05 112.486 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.496 HD13 ' CD2' ' A' ' 204' ' ' LEU . 5.3 mp -122.68 122.89 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 72.44 111.124 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -83.01 119.5 24.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 71.52 110.897 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.9 p -124.43 144.35 34.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.124 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.14 131.12 40.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 71.02 110.873 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.71 146.65 49.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 74.24 110.899 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -61.34 103.79 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 61.12 110.935 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.9 m -127.01 120.54 29.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.866 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.1 mt -106.37 165.59 11.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.154 -0.475 . . . . 70.12 110.943 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.79 124.41 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.3 111.137 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.874 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.879 0.371 . . . . 31.41 110.845 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.9 m -159.89 43.04 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 61.32 110.842 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -79.18 160.18 71.35 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.609 0.718 . . . . 52.33 110.901 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 142.35 47.39 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 71.12 112.342 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.4 tptm -90.96 112.3 24.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 70.33 110.924 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -109.89 135.08 51.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 71.34 110.918 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -53.18 160.55 1.61 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 65.44 110.922 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -20.1 35.44 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.705 2.27 . . . . 72.54 112.394 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -82.85 -20.33 35.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 61.25 110.908 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.513 HG11 ' CG2' ' A' ' 211' ' ' VAL . 2.7 t -81.3 -63.35 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 53.32 111.149 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -25.43 42.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 61.41 110.897 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.34 78.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 53.23 111.081 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.412 ' HG2' HD11 ' A' ' 204' ' ' LEU . 18.8 tptt -88.45 -25.37 22.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 74.1 110.903 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.835 HD22 ' HG2' ' A' ' 197' ' ' GLU . 30.9 mt -79.33 -24.06 43.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.933 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.68 -46.51 65.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.904 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.19 -23.61 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 71.22 111.106 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -77.4 -21.79 52.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 63.34 111.078 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.557 ' HG2' HD11 ' A' ' 193' ' ' LEU . 55.5 mtt85 -69.12 -52.29 29.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.889 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -52.03 -29.95 23.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 75.04 110.856 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.655 HD21 ' OD2' ' A' ' 159' ' ' ASP . 12.9 mt -71.71 -44.53 64.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 72.5 110.929 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -52.36 -48.05 65.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 52.01 110.895 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -75.93 -28.41 57.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 64.11 110.86 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -67.9 -25.91 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.11 110.886 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.527 ' HE2' HD22 ' A' ' 136' ' ' LEU . 37.2 m-85 -104.51 -26.2 12.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 65.33 110.968 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -90.43 64.45 5.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.521 . . . . 55.5 110.886 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -28.19 67.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 73.04 110.893 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -70.76 -10.52 59.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.889 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.86 25.74 53.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 42.0 112.502 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.8 p -75.85 -22.1 56.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.924 0.392 . . . . 64.43 110.882 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.62 19.57 65.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 74.35 112.513 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -149.91 130.8 14.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 63.31 110.922 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.7 mt -94.97 101.74 13.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.879 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -70.16 171.81 9.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.932 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -52.13 -30.14 25.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 51.31 110.826 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -74.61 -45.95 41.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 64.24 110.881 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.36 -38.95 88.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 64.23 110.859 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 176' ' ' VAL . 53.4 mt -65.46 -30.97 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 73.25 111.157 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.78 -45.76 63.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 62.21 111.102 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.32 -27.45 39.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 60.15 112.493 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.552 HD21 ' CE1' ' A' ' 196' ' ' TYR . 4.2 tp -54.81 -56.56 18.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 72.21 110.919 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.0 mt -51.96 -33.93 39.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.934 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -52.71 -50.5 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 74.45 110.854 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.655 ' OD2' HD21 ' A' ' 136' ' ' LEU . 10.5 t0 -82.26 -44.25 16.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 64.4 110.871 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.9 m -52.16 -29.55 22.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 63.32 111.18 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -79.33 -49.17 12.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 61.42 110.968 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.97 -24.71 55.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 72.23 111.105 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . 0.542 ' OE2' HD11 ' A' ' 136' ' ' LEU . 0.3 OUTLIER -55.04 -27.14 42.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 64.14 110.852 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.1 mtm -111.28 21.71 15.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 75.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.92 19.05 69.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 72.24 112.494 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.4 tpp -64.38 164.04 12.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 73.15 110.896 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.8 t -62.47 -17.62 59.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 74.33 110.848 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 63.52 56.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 72.43 110.9 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -65.87 152.61 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.855 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 p -108.23 90.84 7.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.544 0.688 . . . . 74.0 111.11 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -172.88 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 51.41 112.347 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.61 ' O ' HG23 ' A' ' 176' ' ' VAL . 79.9 p -120.76 -177.37 3.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 70.22 111.16 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -60.18 -25.69 65.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 55.15 110.93 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.611 ' O ' HD12 ' A' ' 178' ' ' ILE . 32.2 tt0 -72.51 -61.5 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 62.25 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -52.22 -49.0 64.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 72.32 110.871 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 172' ' ' THR . 98.1 t -52.76 -33.53 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 63.44 111.124 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -62.44 -49.9 73.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 73.12 110.92 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -61.15 -25.15 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 74.25 111.098 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.585 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 47.1 t90 -78.15 -30.29 49.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.956 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.539 ' O ' HD23 ' A' ' 180' ' ' LEU . 2.1 tt -72.54 -34.77 67.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 71.34 110.933 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -61.25 -28.74 69.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 65.01 110.923 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 5.9 ttp -86.92 -39.09 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 34.31 110.87 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . . . -68.33 -49.95 56.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 72.24 111.113 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -84.24 127.59 34.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 71.54 110.894 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 21.3 p -76.08 -42.69 46.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 61.14 111.101 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -76.32 -12.41 60.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 61.34 110.891 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.1 p 52.15 37.19 21.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 72.55 110.827 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -79.04 -16.21 57.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 75.42 110.887 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.1 22.82 8.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 54.1 112.489 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.2 p -153.6 127.14 8.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.916 0.389 . . . . 53.32 110.82 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 196' ' ' TYR . 21.9 t -106.41 124.83 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 62.3 111.096 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -174.77 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 70.32 110.897 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.557 HD11 ' HG2' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -57.11 -33.62 67.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 70.33 110.927 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.06 -62.35 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.87 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.414 ' HB3' HG13 ' A' ' 191' ' ' VAL . 6.6 mp0 -52.37 -46.16 66.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 64.12 110.878 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.552 ' CE1' HD21 ' A' ' 156' ' ' LEU . 17.2 t80 -62.04 -58.34 8.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.888 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.835 ' HG2' HD22 ' A' ' 130' ' ' LEU . 72.5 tt0 -54.89 -28.12 48.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.914 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -72.5 -29.54 63.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 75.53 110.819 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.585 HD13 ' CZ2' ' A' ' 179' ' ' TRP . 8.4 tt -64.0 -35.08 79.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 34.14 110.897 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -73.34 -24.91 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 74.33 111.116 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.464 HD13 HD21 ' A' ' 130' ' ' LEU . 50.7 mm -58.4 -43.37 86.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 54.41 111.11 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -67.81 -48.16 67.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 63.25 110.889 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 53.5 p -52.18 -40.86 62.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 51.12 110.864 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.422 ' HG ' HD13 ' A' ' 209' ' ' ILE . 6.7 mp -73.99 -33.16 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 75.21 110.926 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -43.3 89.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 64.04 110.911 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -86.11 -25.77 25.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 63.11 110.908 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.98 -22.76 67.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 72.01 111.094 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.43 20.14 5.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.739 . . . . 45.15 112.49 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.422 HD13 ' HG ' ' A' ' 204' ' ' LEU . 5.3 mp -113.15 102.75 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.815 0.341 . . . . 72.14 111.121 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -71.06 126.03 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.871 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.513 ' CG2' HG11 ' A' ' 126' ' ' VAL . 4.3 p -118.21 124.15 72.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.05 111.128 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.23 107.83 7.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 55.44 110.904 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -142.42 127.77 18.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.927 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -121.17 157.72 29.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 71.33 110.89 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 12.0 m -146.15 -178.76 6.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 65.33 110.889 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.6 mt -85.22 71.39 10.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 73.13 110.891 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.36 160.1 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.22 -0.445 . . . . 60.42 111.154 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.852 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.922 0.391 . . . . 72.24 110.855 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.3 p -119.32 175.5 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 61.51 110.917 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -117.06 160.68 36.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.599 0.714 . . . . 54.11 110.916 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 158.01 58.49 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.721 2.28 . . . . 63.24 112.323 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.01 111.68 20.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 64.25 110.944 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -99.81 163.59 12.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 60.13 110.944 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -78.3 160.82 72.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.615 0.721 . . . . 74.43 110.926 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -20.26 35.05 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.733 2.289 . . . . 52.11 112.329 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -82.89 -20.94 34.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 73.21 110.887 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.489 HG13 HD22 ' A' ' 204' ' ' LEU . 3.2 t -76.74 -61.99 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 53.43 111.132 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.66 -30.08 20.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 71.11 110.894 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.5 -34.52 71.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.125 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.416 ' O ' HG12 ' A' ' 132' ' ' VAL . 33.9 tptt -88.36 -23.98 23.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.53 110.954 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.554 HD22 ' HB3' ' A' ' 197' ' ' GLU . 38.7 mt -80.88 -24.31 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 72.41 110.878 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.04 -29.48 65.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 72.41 110.876 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 129' ' ' LYS . 10.1 p -85.99 -23.38 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 75.14 111.115 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.14 -37.51 20.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 73.23 111.11 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -54.65 -29.99 54.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 75.22 110.87 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -70.58 -28.98 65.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 73.54 110.872 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.64 -25.85 35.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 70.11 110.893 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.43 -63.21 1.19 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 71.33 110.89 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -60.18 -26.58 66.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 74.52 110.926 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -52.08 -30.02 24.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.852 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -101.54 -26.29 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.894 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.2 85.4 0.56 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 63.22 110.84 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -80.7 -26.29 37.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 75.24 110.892 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.79 -10.58 59.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 71.42 110.894 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.23 20.45 50.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 62.41 112.503 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 p -87.26 -22.18 25.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.945 0.402 . . . . 73.2 110.852 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.74 21.58 42.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.7 -0.762 . . . . 73.02 112.472 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -136.73 138.07 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 73.45 110.925 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.712 HD13 HD22 ' A' ' 156' ' ' LEU . 95.0 mt -103.89 112.53 25.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 65.31 110.91 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -79.83 173.66 12.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.54 110.915 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -53.07 -28.85 26.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 63.51 110.883 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -78.74 -37.85 40.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.901 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' A' ' 148' ' ' LEU . 8.5 mt-10 -75.7 -26.18 57.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 74.14 110.901 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.534 ' CG2' HG13 ' A' ' 176' ' ' VAL . 25.8 mt -76.81 -34.59 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 72.04 111.149 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.78 -46.65 64.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 70.35 111.083 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.59 -23.3 56.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 62.35 112.482 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.712 HD22 HD13 ' A' ' 148' ' ' LEU . 18.0 tp -60.7 -56.49 20.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.858 0.361 . . . . 62.45 110.917 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 45.7 mt -52.15 -36.42 51.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 65.34 110.922 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -51.88 -45.77 64.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.04 110.883 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.24 -45.05 13.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.24 110.869 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.4 m -51.85 -30.44 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.2 111.137 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -81.03 -53.62 6.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.892 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.13 -24.69 42.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 70.31 111.12 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -54.69 -31.06 57.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.896 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -107.21 21.85 16.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 71.41 110.873 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.95 21.45 71.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.727 . . . . 74.54 112.447 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.43 165.47 16.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.341 . . . . 74.31 110.86 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.1 m -60.05 -20.61 58.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.02 110.881 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 63.6 59.48 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 64.41 110.952 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -67.83 152.4 45.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 72.22 110.902 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.5 m -108.18 90.78 7.18 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.564 0.697 . . . . 53.45 111.134 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.75 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.69 2.26 . . . . 71.21 112.343 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 176' ' ' VAL . 71.3 p -126.43 -176.03 3.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 72.01 111.165 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -57.37 -25.72 59.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 65.13 110.829 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.614 ' O ' HD12 ' A' ' 178' ' ' ILE . 36.4 tt0 -74.65 -60.81 2.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 74.42 110.881 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -45.91 64.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 72.51 110.859 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 172' ' ' THR . 97.2 t -56.2 -31.02 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 75.33 111.103 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -65.38 -49.81 67.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 40.1 110.886 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -60.14 -26.76 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.11 111.153 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.679 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 87.3 t90 -82.39 -26.32 32.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 71.1 110.919 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 180' ' ' LEU . 3.9 tt -76.08 -36.46 58.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 63.41 110.892 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -52.38 -49.5 64.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.5 -26.85 65.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 74.12 110.88 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.913 ' HB2' HD11 ' A' ' 199' ' ' LEU . . . -74.69 -68.83 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.0 111.108 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -62.28 118.83 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 74.41 110.886 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.1 m -86.74 -37.54 17.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 73.52 111.146 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -78.48 -12.46 60.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 65.11 110.888 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.8 t 61.75 45.4 7.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 63.4 110.891 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -91.0 -16.17 28.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 63.42 110.835 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.25 19.46 12.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 63.14 112.515 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.52 152.4 30.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 72.24 110.876 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.1 t -108.39 114.17 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.01 111.106 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.6 t -85.08 -171.1 3.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 65.15 110.878 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.81 -57.55 10.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 72.2 110.923 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.47 -43.74 96.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 63.31 110.847 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.53 -59.85 4.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.857 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.572 ' HA ' HD12 ' A' ' 199' ' ' LEU . 34.2 t80 -53.73 -49.87 67.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 71.13 110.94 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.554 ' HB3' HD22 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -60.07 -24.35 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 73.15 110.835 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -69.67 -26.16 64.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 63.31 110.875 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.913 HD11 ' HB2' ' A' ' 183' ' ' ALA . 7.5 mt -67.17 -38.5 85.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 74.02 110.916 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.515 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.2 mp -69.49 -24.32 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 65.44 111.125 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 130' ' ' LEU . 47.7 mm -55.91 -49.63 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.211 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -51.94 -62.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.3 110.878 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.1 m -53.44 -28.6 30.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 65.32 110.836 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.683 ' HG ' HD13 ' A' ' 209' ' ' ILE . 0.6 OUTLIER -64.8 -42.68 94.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 53.43 110.903 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -52.22 -39.61 60.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.13 110.948 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -85.95 -24.24 26.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 73.12 110.89 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.89 -22.81 67.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 64.1 111.111 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.36 30.01 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.773 -0.727 . . . . 53.44 112.458 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.683 HD13 ' HG ' ' A' ' 204' ' ' LEU . 5.3 mp -126.03 137.57 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 75.21 111.151 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -98.94 113.84 26.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.904 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.72 144.36 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 64.5 111.179 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.42 125.79 41.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 55.41 110.875 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -119.46 138.08 53.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 72.51 110.848 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -137.98 105.48 5.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 71.53 110.872 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.6 t -86.41 -175.85 5.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.865 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 mt -104.77 134.4 47.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 64.42 110.901 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.79 148.08 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.12 111.122 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 3.5 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 65.41 110.854 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.868 0.366 . . . . 60.51 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.1 m -81.9 165.41 20.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 61.35 110.859 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 157.53 69.85 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.581 0.705 . . . . 73.22 110.881 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 127.93 15.26 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.74 2.294 . . . . 72.44 112.284 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -81.87 102.71 11.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 65.13 110.91 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -99.63 149.6 23.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 71.13 110.912 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -65.13 160.74 54.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.665 0.745 . . . . 74.32 110.848 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -20.29 35.34 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.743 2.295 . . . . 65.22 112.354 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -82.89 -21.15 34.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.31 110.859 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.69 -63.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 51.35 111.089 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.543 ' HA ' HD12 ' A' ' 130' ' ' LEU . 6.3 tt0 -52.08 -29.92 23.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 64.23 110.84 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.04 -36.13 65.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.114 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.824 ' HB3' HD11 ' A' ' 204' ' ' LEU . 16.7 tptt -82.74 -26.5 31.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 55.34 110.841 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.788 HD22 ' HB2' ' A' ' 197' ' ' GLU . 21.0 mt -78.69 -25.76 44.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 64.1 110.897 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -69.3 -32.14 71.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.854 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.6 -24.78 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.22 111.119 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.64 -43.93 36.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 55.14 111.071 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -52.08 -29.98 23.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.862 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -75.98 -35.32 59.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.02 110.913 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.4 tp -69.41 -25.66 64.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 73.22 110.911 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.01 -64.58 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 61.41 110.856 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -27.41 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.935 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -53.37 -28.64 30.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.863 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -109.11 -26.69 10.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 75.31 110.918 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -76.44 69.81 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.485 . . . . 72.35 110.881 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -67.62 -26.95 66.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.931 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.62 -10.49 59.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 54.31 110.842 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.31 24.58 52.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 52.35 112.478 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.3 t -77.65 -22.07 51.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 73.12 110.841 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.14 23.8 56.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.666 -0.778 . . . . 73.14 112.503 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -148.16 134.57 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 73.42 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.811 HD13 HD22 ' A' ' 156' ' ' LEU . 31.8 mt -106.33 101.99 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.894 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.83 174.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 74.22 110.874 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.613 ' O ' HG11 ' A' ' 176' ' ' VAL . 5.1 p-10 -54.57 -27.24 37.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 70.42 110.88 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.3 -51.01 7.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 64.24 110.866 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -54.84 -30.99 58.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 64.31 110.855 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.44 HD12 HD12 ' A' ' 180' ' ' LEU . 32.9 mt -73.89 -26.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 72.12 111.124 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.69 -47.88 63.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.074 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.35 -22.87 55.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 51.3 112.456 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.811 HD22 HD13 ' A' ' 148' ' ' LEU . 21.3 tp -58.61 -54.88 42.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 71.23 110.914 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 33.6 mt -51.91 -32.81 34.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.901 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -52.58 -60.7 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 71.11 110.954 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -73.81 -38.26 64.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.55 110.874 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.1 m -57.48 -30.19 64.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 73.31 111.117 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -82.31 -55.12 4.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 72.44 110.902 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.703 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -55.21 -25.7 34.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 32.2 111.098 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.95 -25.9 45.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 73.14 110.88 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.3 mtm -110.24 19.2 19.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 72.51 110.839 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.78 19.24 69.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 74.04 112.505 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.5 mtt -64.65 172.97 2.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 74.13 110.886 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 49.1 p -59.77 -21.03 60.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 75.14 110.868 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.703 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 5.8 t30 63.56 58.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 65.23 110.898 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -78.01 152.6 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 73.1 110.837 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 60.9 m -108.23 90.84 7.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.561 0.696 . . . . 74.04 111.141 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 168.96 19.99 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.706 2.271 . . . . 73.34 112.378 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 176' ' ' VAL . 27.8 p -108.76 -178.02 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 61.53 111.124 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -55.58 -25.89 40.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 70.41 110.891 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.581 ' O ' HD12 ' A' ' 178' ' ' ILE . 11.5 tt0 -72.88 -61.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.885 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.403 ' HA ' HD13 ' A' ' 178' ' ' ILE . 83.2 m-20 -51.91 -36.6 49.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 52.14 110.856 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 172' ' ' THR . 99.3 t -60.98 -40.87 86.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 73.24 111.103 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -54.56 -40.92 69.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 63.33 110.883 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.8 mp -69.99 -25.97 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 72.12 111.166 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -83.76 -31.12 26.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.901 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 180' ' ' LEU . 3.7 tt -78.32 -46.3 20.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 65.43 110.911 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.99 -31.55 29.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 72.11 110.9 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 53.3 ttp -90.51 -25.89 20.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 65.33 110.883 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -73.95 -52.12 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 61.44 111.095 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -85.31 127.8 34.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.43 110.864 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 3.2 m -69.39 -24.53 63.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 73.53 111.158 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -98.08 -10.4 24.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.228 -0.442 . . . . 71.13 110.872 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.4 p 52.99 36.3 21.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.86 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.0 -16.24 57.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 62.2 110.836 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.19 22.9 8.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.731 . . . . 61.43 112.532 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.14 126.93 11.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 52.32 110.828 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.8 t -109.4 112.94 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 72.3 111.12 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.04 -174.89 4.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.875 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.3 OUTLIER -66.69 -33.84 76.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 64.42 110.892 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.48 -36.8 32.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 60.31 110.931 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.19 -21.64 60.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 71.24 110.91 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.527 ' O ' HD12 ' A' ' 200' ' ' ILE . 18.7 t80 -84.48 -51.71 6.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 72.4 110.889 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.788 ' HB2' HD22 ' A' ' 130' ' ' LEU . 13.4 pt-20 -53.99 -43.69 70.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 54.42 110.859 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.84 -26.13 63.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 61.34 110.853 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 183' ' ' ALA . 7.5 tt -67.48 -38.24 84.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.881 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -73.75 -24.58 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 73.32 111.086 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.632 HD11 HD11 ' A' ' 130' ' ' LEU . 50.1 mm -56.6 -57.22 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 75.4 111.098 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -56.18 -25.14 45.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 71.24 110.903 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.4 m -83.23 -26.31 30.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 73.53 110.849 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 129' ' ' LYS . 36.2 mt -79.35 -45.0 20.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 63.3 110.956 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -51.99 -37.83 54.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.874 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -86.09 -29.07 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.32 110.901 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -18.2 65.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 72.2 111.135 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.96 23.05 4.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.774 -0.727 . . . . 42.24 112.517 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.63 101.87 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.343 . . . . 73.23 111.158 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.5 111.44 1.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 72.1 110.891 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 211' ' ' VAL . 5.5 p -117.67 121.07 66.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 70.13 111.153 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -103.94 150.99 23.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 71.14 110.9 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 148.4 33.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 64.31 110.904 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -56.48 106.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.905 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 12.6 p -101.6 178.45 4.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.852 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.02 142.21 24.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 63.4 110.883 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.57 144.88 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 73.41 111.114 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 72.23 110.837 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.913 0.387 . . . . 73.43 110.82 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.1 t -98.54 156.85 16.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 65.53 110.871 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.07 160.85 24.9 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 73.15 110.878 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 168.21 22.25 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.685 2.257 . . . . 63.34 112.299 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.14 105.6 15.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 73.24 110.871 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.614 ' CE2' HG11 ' A' ' 211' ' ' VAL . 2.2 m-85 -109.49 140.01 43.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.902 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.65 160.52 3.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 73.4 110.883 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -19.31 36.65 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 64.02 112.355 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -80.3 -24.8 39.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.896 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.693 HG21 HG13 ' A' ' 211' ' ' VAL . 3.1 t -79.39 -63.42 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 74.22 111.155 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.644 ' HA ' HD12 ' A' ' 130' ' ' LEU . 1.5 tm-20 -51.49 -30.84 21.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 71.01 110.875 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.6 -33.15 59.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 70.22 111.068 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -88.36 -30.54 19.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 75.45 110.947 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.685 HD21 HD11 ' A' ' 201' ' ' ILE . 15.1 mt -72.81 -26.28 61.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.4 110.922 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -65.41 -46.17 81.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 64.33 110.84 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.597 HG23 ' HD3' ' A' ' 135' ' ' ARG . 14.7 p -74.35 -23.73 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 55.42 111.097 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.86 -22.04 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 65.31 111.091 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -76.08 -57.19 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.869 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.597 ' HD3' HG23 ' A' ' 132' ' ' VAL . 4.5 ptm180 -58.22 -25.33 61.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.14 110.866 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.2 tp -78.3 -26.66 47.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.165 -0.471 . . . . 65.34 110.953 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -69.61 -57.51 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.842 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -65.55 -27.6 68.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 64.23 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 -54.12 -27.87 35.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 44.44 110.86 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -105.65 -40.43 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 62.45 110.909 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -73.03 84.66 1.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 71.11 110.849 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -73.03 -26.24 61.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 74.3 110.93 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.47 -10.52 59.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 73.23 110.847 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.71 22.44 40.15 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 62.34 112.536 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.5 t -76.12 -22.1 55.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 44.24 110.886 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.74 19.3 61.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 65.43 112.489 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -138.47 131.35 29.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.804 0.335 . . . . 72.5 110.933 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 55.8 mt -100.97 104.11 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.903 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.04 173.56 2.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.12 110.92 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -52.82 -29.13 26.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.897 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -80.44 -53.28 6.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 71.22 110.877 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.25 -39.17 59.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 53.11 110.889 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.1 mt -65.85 -30.51 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 62.43 111.131 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.73 -45.72 63.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.33 111.124 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.33 -23.21 55.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 62.23 112.507 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.668 HD21 ' CE1' ' A' ' 196' ' ' TYR . 5.7 tp -59.91 -54.65 43.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 65.34 110.932 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 36.0 mt -51.91 -35.24 44.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 64.13 110.923 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -52.73 -51.76 59.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.882 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -78.81 -43.7 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.5 110.85 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.2 m -54.55 -31.16 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 74.44 111.133 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -82.42 -59.56 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.25 110.934 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -53.4 -28.08 27.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 75.23 111.098 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -55.63 -26.17 42.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.45 110.91 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.2 mtm -110.54 21.79 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.924 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 18.78 68.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.768 -0.729 . . . . 74.53 112.513 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.1 mmt -60.66 172.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 73.41 110.891 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 69.4 m -62.46 -17.72 60.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 75.1 110.847 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.7 t30 63.49 48.24 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 55.23 110.888 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -68.61 152.57 45.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.861 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 p -108.21 90.83 7.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.588 0.709 . . . . 75.22 111.154 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 175.3 8.29 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.687 2.258 . . . . 73.24 112.387 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.656 ' O ' HG23 ' A' ' 176' ' ' VAL . 72.1 p -121.21 -176.14 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 62.12 111.116 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -55.66 -25.81 41.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 63.32 110.928 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.62 ' O ' HD12 ' A' ' 178' ' ' ILE . 9.2 tt0 -72.54 -61.51 1.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.938 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.51 -40.84 65.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.31 110.899 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 172' ' ' THR . 93.8 t -59.72 -31.12 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 71.35 111.09 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -65.13 -41.65 94.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.873 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.5 mp -70.39 -26.48 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 55.33 111.133 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.51 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 57.4 t90 -83.6 -40.09 19.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 75.01 110.945 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.652 ' O ' HD23 ' A' ' 180' ' ' LEU . 4.2 tt -58.6 -26.89 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 75.14 110.855 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -70.96 -49.38 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.923 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.6 ttp -64.9 -26.97 68.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 62.43 110.887 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . . . -83.63 -59.23 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 63.44 111.092 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -81.69 128.66 34.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 65.14 110.863 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.14 -28.87 34.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 74.41 111.135 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -89.7 -9.41 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 65.21 110.891 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.8 p 46.24 58.22 4.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.877 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -113.69 24.04 12.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 73.54 110.857 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.17 27.56 73.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 73.4 112.508 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.66 127.2 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.919 0.39 . . . . 22.44 110.858 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.7 106.17 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.1 111.171 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.53 178.09 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 61.33 110.849 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.56 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -63.66 -36.12 82.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 65.13 110.882 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -81.32 -28.58 34.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.4 110.868 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -77.57 -22.48 50.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.885 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.668 ' CE1' HD21 ' A' ' 156' ' ' LEU . 23.6 t80 -85.13 -53.36 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 63.15 110.923 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 130' ' ' LEU . 11.0 pt-20 -52.02 -43.69 63.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 75.51 110.908 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.43 -42.41 67.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 72.52 110.851 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 6.4 tt -51.9 -39.76 59.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.948 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -72.82 -29.35 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 71.05 111.138 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.685 HD11 HD21 ' A' ' 130' ' ' LEU . 51.3 mm -63.79 -44.07 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 54.54 111.136 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -67.63 -46.87 71.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.881 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 43.4 m -57.45 -37.03 72.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 52.12 110.849 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.72 -34.42 64.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.857 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -60.28 -37.54 80.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 74.43 110.941 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -24.04 26.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 54.14 110.893 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.67 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 43.21 111.088 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.82 26.18 3.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 75.45 112.486 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.3 102.17 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 73.41 111.103 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -72.93 102.78 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.874 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.693 HG13 HG21 ' A' ' 126' ' ' VAL . 22.0 t -84.23 149.93 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 75.25 111.066 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -94.14 112.58 24.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 72.32 110.89 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -149.04 132.85 16.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 61.23 110.904 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -83.38 112.66 20.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 73.4 110.851 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 91.8 p -133.96 153.76 51.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 50.51 110.863 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.454 ' H ' HD12 ' A' ' 216' ' ' LEU . 5.6 mp -67.17 168.83 9.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 70.13 110.891 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.49 144.12 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 54.21 111.095 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 35.6 p90 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 65.24 110.897 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.882 0.372 . . . . 55.02 110.849 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 64.4 m 60.43 48.94 7.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 75.4 110.88 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.94 161.49 38.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.61 0.719 . . . . 74.12 110.865 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -174.55 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 62.45 112.333 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -117.87 105.05 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.923 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -103.26 159.25 15.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 74.45 110.952 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -75.1 160.77 79.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.652 0.739 . . . . 72.24 110.857 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -17.88 37.25 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.704 2.269 . . . . 73.02 112.352 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -83.11 -22.55 33.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.12 110.853 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.468 HG13 HD13 ' A' ' 204' ' ' LEU . 2.9 t -79.55 -61.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 71.01 111.103 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.717 ' HA ' HD12 ' A' ' 130' ' ' LEU . 1.3 tt0 -52.18 -30.04 25.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 62.11 110.835 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.02 -32.32 67.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 61.11 111.099 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.44 ' HG3' HD21 ' A' ' 204' ' ' LEU . 0.0 OUTLIER -88.48 -22.22 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.907 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.756 HD22 ' HB3' ' A' ' 197' ' ' GLU . 16.4 mt -81.67 -32.9 31.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 71.25 110.932 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -29.28 64.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 71.33 110.826 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.5 p -85.95 -23.3 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.45 111.16 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.12 -39.28 21.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 70.12 111.11 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -54.86 -38.15 67.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 75.14 110.919 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -63.72 -25.8 68.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.829 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.56 -28.87 41.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 72.1 110.946 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -61.66 -64.55 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.1 110.876 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -54.71 -27.62 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 72.43 110.899 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -56.0 -26.16 47.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 65.45 110.812 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -110.12 -26.58 9.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 62.34 110.923 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.77 79.92 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 74.42 110.865 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -25.73 42.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 64.43 110.917 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.78 -10.57 59.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 61.43 110.904 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.57 19.99 58.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 54.32 112.487 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.4 p -82.46 -22.12 35.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 73.35 110.889 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.82 22.42 59.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 73.44 112.477 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -140.6 151.77 44.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 73.43 110.869 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 152' ' ' GLU . 71.7 mt -119.11 120.67 37.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 72.51 110.929 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -84.44 179.88 7.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 72.11 110.895 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -52.2 -29.82 24.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.24 110.839 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 19.2 t0 -77.97 -54.79 5.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 72.43 110.818 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.565 ' HB3' HD22 ' A' ' 148' ' ' LEU . 9.3 mt-10 -57.28 -51.81 67.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 71.2 110.889 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.436 HG22 HG13 ' A' ' 176' ' ' VAL . 52.2 mt -51.8 -30.93 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 72.22 111.145 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 151' ' ' ASP . . . -60.0 -56.72 18.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 72.11 111.137 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.06 -23.26 77.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.792 -0.718 . . . . 61.13 112.452 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 148' ' ' LEU . 3.3 tp -57.17 -55.99 27.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.88 0.371 . . . . 62.44 110.932 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.8 mt -54.17 -33.21 57.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 74.1 110.896 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -52.11 -53.56 41.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 74.1 110.886 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.87 -42.33 21.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 55.4 110.875 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.2 m -52.35 -30.55 29.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 74.3 111.148 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -78.56 -52.97 7.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 72.31 110.952 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -57.97 -24.59 58.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.056 -0.52 . . . . 72.42 111.133 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.93 -25.93 45.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 54.15 110.835 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.0 mtm -109.68 21.59 16.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 70.21 110.856 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 23.61 72.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.77 -0.728 . . . . 52.52 112.473 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.8 mmt -65.28 175.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 73.12 110.845 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 79.3 p -66.68 -14.27 62.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 72.12 110.862 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 20.8 t30 63.65 61.67 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.858 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -83.01 152.57 25.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.01 110.894 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 3.9 m -108.22 90.87 7.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.576 0.703 . . . . 71.15 111.111 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.9 Cg_endo -69.77 156.43 63.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.701 2.267 . . . . 72.12 112.31 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 176' ' ' VAL . 48.8 p -95.57 -179.34 4.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 62.22 111.146 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -56.01 -25.66 45.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.921 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.608 ' O ' HD12 ' A' ' 178' ' ' ILE . 7.7 tt0 -73.4 -57.27 4.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 75.32 110.89 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.93 -38.88 58.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.31 110.852 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 172' ' ' THR . 93.5 t -59.85 -42.55 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 71.23 111.099 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -52.46 -45.1 65.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.1 110.898 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.608 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -63.27 -27.41 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 53.44 111.145 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.512 ' HZ3' HG21 ' A' ' 191' ' ' VAL . 77.0 t90 -83.63 -32.77 25.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 73.05 110.915 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.1 tp -73.21 -37.78 66.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 75.43 110.901 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -56.18 -35.27 67.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 74.41 110.924 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.6 ttp -90.23 -39.18 12.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 64.02 110.926 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.69 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -60.31 -58.96 6.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 71.45 111.155 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.48 113.94 13.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 62.14 110.878 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.2 p -84.31 -46.34 11.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 64.51 111.1 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -74.6 -12.36 60.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 53.3 110.886 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 t 62.59 44.94 6.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 42.22 110.847 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -79.39 -16.26 56.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 75.41 110.879 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.05 -15.46 51.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 55.22 112.485 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.1 m -136.22 135.9 39.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.4 . . . . 75.42 110.835 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.512 HG21 ' HZ3' ' A' ' 179' ' ' TRP . 25.0 t -87.0 109.71 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 71.33 111.135 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.5 t -87.97 -172.77 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 63.01 110.868 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.9 tp -68.57 -28.08 66.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 60.51 110.908 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -81.2 -32.61 33.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.906 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -84.78 -26.05 27.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.24 110.925 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.535 ' O ' HD12 ' A' ' 200' ' ' ILE . 26.6 t80 -79.26 -54.41 5.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.3 110.952 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.756 ' HB3' HD22 ' A' ' 130' ' ' LEU . 4.7 mm-40 -54.96 -32.58 61.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 74.51 110.936 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -68.68 -26.12 65.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.882 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 183' ' ' ALA . 5.1 tt -68.04 -35.56 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 71.33 110.928 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.535 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -73.43 -24.73 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 73.11 111.12 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.465 ' CD1' HD21 ' A' ' 130' ' ' LEU . 50.8 mm -55.66 -50.94 63.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 72.33 111.121 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -56.26 -46.46 79.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.908 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 9.9 p -61.84 -33.0 73.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 51.43 110.861 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.727 HD23 HD13 ' A' ' 209' ' ' ILE . 5.6 mt -69.74 -31.21 69.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 65.34 110.961 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.31 -43.95 96.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 61.42 110.952 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -86.02 -24.02 26.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 65.44 110.888 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.03 -22.71 67.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.54 111.086 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.98 32.01 1.79 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 50.53 112.492 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.727 HD13 HD23 ' A' ' 204' ' ' LEU . 5.3 mp -122.86 128.58 75.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 73.43 111.142 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.7 107.37 19.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.879 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.5 p -110.3 142.4 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 64.44 111.173 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.99 131.42 49.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 74.22 110.874 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.36 145.43 50.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 74.14 110.914 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -137.8 140.29 40.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.898 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -131.03 151.82 51.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.53 110.872 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.48 147.7 24.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 72.41 110.9 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.7 m -98.08 151.93 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.33 111.169 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 35.8 p90 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 53.42 110.894 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.833 0.349 . . . . 70.42 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -94.24 123.03 37.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 61.21 110.865 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -104.64 160.67 25.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.562 0.696 . . . . 74.15 110.87 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 171.12 15.09 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.656 2.238 . . . . 63.35 112.36 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -108.99 104.44 13.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 75.12 110.878 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -106.58 140.05 40.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.922 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -52.01 160.57 1.14 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.645 0.735 . . . . 54.21 110.854 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -19.27 36.36 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 63.45 112.356 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -82.84 -24.66 33.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 75.24 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 211' ' ' VAL . 2.9 t -78.77 -60.62 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 74.41 111.141 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -51.77 -30.12 21.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 54.22 110.875 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.84 63.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 54.11 111.076 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -88.48 -36.67 16.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.906 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 201' ' ' ILE . 43.9 mt -63.94 -30.53 71.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 71.51 110.919 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -63.45 -46.42 86.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 73.04 110.866 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.71 -23.68 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 73.24 111.132 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.79 -21.78 60.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 51.3 111.125 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -72.23 -55.64 6.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -54.81 -27.05 38.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 75.24 110.871 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.1 tp -77.77 -29.01 50.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 71.51 110.893 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -66.53 -49.77 65.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 73.14 110.852 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -72.03 -26.42 62.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 75.01 110.883 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -54.4 -27.91 40.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 73.32 110.874 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -108.12 -30.31 8.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 74.53 110.897 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -74.97 73.19 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 54.5 110.873 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -84.72 -25.03 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 65.01 110.908 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -70.66 -10.58 59.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.853 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.64 19.57 62.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 74.54 112.525 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.6 t -79.42 -22.14 44.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 52.45 110.856 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.82 18.77 76.63 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.763 . . . . 64.22 112.467 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -147.36 131.02 16.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 73.53 110.867 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.907 HD13 HD22 ' A' ' 156' ' ' LEU . 11.7 mt -92.51 101.76 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 65.54 110.908 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.56 175.65 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 74.1 110.924 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.469 ' OD1' HD23 ' A' ' 180' ' ' LEU . 15.6 m-20 -52.02 -30.13 24.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.832 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.31 -55.29 6.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.824 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -56.5 -46.57 80.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.15 110.838 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.562 HD13 ' HB2' ' A' ' 180' ' ' LEU . 29.0 mt -51.73 -43.07 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 75.4 111.146 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.96 -41.21 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.129 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.28 -24.17 52.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 43.24 112.492 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.907 HD22 HD13 ' A' ' 148' ' ' LEU . 21.7 tp -67.06 -50.33 62.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 70.24 110.919 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.511 HD21 ' CD2' ' A' ' 179' ' ' TRP . 72.5 mt -52.92 -29.55 29.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.938 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.595 ' HE2' HG22 ' A' ' 170' ' ' THR . 0.5 OUTLIER -58.71 -60.66 3.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.02 110.864 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.11 -41.35 70.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 61.11 110.888 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.6 m -51.76 -46.78 64.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 75.13 111.124 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -64.66 -29.14 70.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 72.52 110.922 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.445 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -75.9 -24.7 55.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 64.22 111.116 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -57.94 -49.51 76.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 70.33 110.865 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 29.5 mtm -79.47 -18.45 52.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.898 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.75 18.32 30.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 62.11 112.487 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 5.6 mtt -61.33 175.88 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 72.11 110.869 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.1 m -60.88 -18.95 59.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 71.15 110.818 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 1.9 t30 63.81 63.65 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 71.12 110.905 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -79.98 152.79 29.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 71.31 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.595 HG22 ' HE2' ' A' ' 158' ' ' LYS . 21.0 p -108.23 90.78 7.24 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.591 0.71 . . . . 64.4 111.134 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -175.28 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.689 2.259 . . . . 51.54 112.363 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.658 ' O ' HG23 ' A' ' 176' ' ' VAL . 23.0 p -117.23 -176.27 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 73.45 111.172 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -59.25 -24.8 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 71.13 110.88 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.631 ' O ' HD12 ' A' ' 178' ' ' ILE . 27.8 tt0 -78.04 -57.46 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.876 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -51.76 -35.15 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 64.34 110.895 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 172' ' ' THR . 85.2 t -64.77 -39.69 86.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 72.42 111.074 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -55.47 -44.45 76.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 73.44 110.918 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -62.01 -34.8 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 65.33 111.097 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.574 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 49.0 t90 -79.39 -26.13 42.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.921 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.723 HD21 ' HA2' ' A' ' 189' ' ' GLY . 10.0 tp -81.66 -39.03 24.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 62.32 110.912 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -56.9 -28.41 61.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.866 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.5 mtm -83.44 -52.61 6.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 60.21 110.893 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.494 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -52.09 -62.04 1.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 72.51 111.089 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -67.62 124.62 23.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 51.22 110.839 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.3 m -73.96 -25.44 59.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.53 111.151 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -104.01 -12.47 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 64.3 110.866 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.6 t 55.79 50.79 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 74.42 110.809 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -100.94 23.91 10.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 65.54 110.867 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.723 ' HA2' HD21 ' A' ' 180' ' ' LEU . . . 69.27 31.72 71.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.752 . . . . 53.31 112.519 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.6 157.29 43.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 73.24 110.892 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.04 101.37 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 72.35 111.148 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 40.2 t -71.08 165.74 22.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 54.42 110.872 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.92 -40.77 61.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 73.21 110.904 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -74.51 -38.18 62.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.891 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.81 -38.22 90.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 75.51 110.919 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.53 ' O ' HD12 ' A' ' 200' ' ' ILE . 30.8 t80 -75.98 -43.03 46.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 74.13 110.93 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.646 ' O ' HD12 ' A' ' 201' ' ' ILE . 5.7 mm-40 -61.72 -44.1 97.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 61.24 110.853 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -53.03 -40.91 64.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 74.51 110.908 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.574 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 1.2 tp -51.7 -52.19 50.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.927 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 200' ' ' ILE . 4.5 mp -51.42 -44.96 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 55.41 111.118 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.999 HG23 HG21 ' A' ' 211' ' ' VAL . 3.4 mp -68.9 -40.28 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 60.13 111.098 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -60.09 -38.38 82.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 65.43 110.928 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 58.1 m -84.48 -31.75 24.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 62.3 110.867 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.87 HD22 HD13 ' A' ' 209' ' ' ILE . 13.5 mt -63.73 -29.4 70.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 60.24 110.927 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -51.85 -42.3 62.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 73.12 110.923 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -86.09 -24.19 26.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.922 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.93 -22.76 67.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 42.43 111.103 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.17 19.57 5.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 71.13 112.461 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.87 HD13 HD22 ' A' ' 204' ' ' LEU . 5.2 mp -121.99 101.85 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.798 0.333 . . . . 70.2 111.12 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -74.54 128.06 34.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.847 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.999 HG21 HG23 ' A' ' 201' ' ' ILE . 42.8 t -110.42 146.0 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 63.44 111.121 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -114.69 111.48 21.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 73.41 110.922 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -122.09 106.13 10.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.54 110.878 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -122.67 160.02 26.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 72.41 110.888 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.3 m -163.69 147.23 10.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 52.04 110.865 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 216' ' ' LEU . 1.3 pt? -54.61 158.91 2.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.498 . . . . 55.34 110.961 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.1 m -121.85 158.46 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 73.52 111.138 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 73.02 110.889 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.841 0.353 . . . . 73.4 110.838 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.2 m -96.1 158.47 15.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 63.34 110.919 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -111.11 160.26 29.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.54 0.686 . . . . 61.43 110.914 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 147.66 63.26 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.673 2.249 . . . . 61.01 112.35 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -107.82 103.96 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 54.14 110.827 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.456 ' CE2' HG11 ' A' ' 211' ' ' VAL . 2.6 m-85 -98.89 142.58 30.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.902 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -58.57 160.66 9.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.588 0.709 . . . . 74.41 110.884 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -20.48 34.9 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.666 2.244 . . . . 74.32 112.367 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.0 -23.09 41.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 70.14 110.876 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.533 HG21 HG13 ' A' ' 211' ' ' VAL . 3.0 t -78.05 -62.64 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 73.05 111.133 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -51.56 -30.59 21.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 72.15 110.881 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.48 -31.04 61.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 62.33 111.146 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.735 ' HG3' HD21 ' A' ' 204' ' ' LEU . 8.3 mmmt -88.4 -21.68 24.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 72.02 110.883 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.22 -46.45 16.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 72.32 110.912 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.02 -31.34 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 75.02 110.855 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 p -85.87 -23.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 75.33 111.131 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.62 -44.43 21.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 75.5 111.103 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.83 -33.41 35.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.857 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -74.58 -40.42 61.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 75.5 110.876 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.3 tp -68.3 -25.09 64.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 74.52 110.918 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.08 -64.57 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 65.31 110.865 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -59.28 -25.97 64.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 74.23 110.868 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -52.71 -30.49 32.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.823 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -101.4 -26.52 13.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.928 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -75.75 82.92 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 75.13 110.852 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -81.52 -26.5 35.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 73.34 110.884 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -72.43 -10.56 59.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.42 . . . . 50.42 110.892 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.05 20.54 54.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 72.11 112.484 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 59.5 p -77.13 -22.06 53.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.943 0.401 . . . . 63.12 110.882 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.11 59.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 32.43 112.503 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -144.03 137.36 27.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 73.11 110.942 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.773 HD13 HD22 ' A' ' 156' ' ' LEU . 82.3 mt -100.93 105.29 16.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 71.33 110.917 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -67.8 171.38 6.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.41 110.934 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.55 ' O ' HG11 ' A' ' 176' ' ' VAL . 2.0 m-20 -52.02 -30.36 25.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 71.22 110.858 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.33 -50.87 11.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.4 110.889 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -57.28 -26.25 60.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 62.22 110.856 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 150' ' ' ASP . 26.5 mt -78.1 -26.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 65.01 111.153 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.93 -54.98 23.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 72.32 111.141 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.22 -22.86 69.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 74.22 112.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 148' ' ' LEU . 15.8 tp -57.86 -58.69 7.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 61.44 110.939 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.8 mt -51.81 -36.64 48.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.945 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -54.39 -41.93 69.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 61.15 110.942 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -85.06 -46.49 11.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 70.45 110.893 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.3 m -54.61 -33.0 59.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 74.1 111.129 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -69.13 -26.13 64.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 62.13 110.918 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.27 -30.23 71.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.499 . . . . 75.23 111.087 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.38 -26.06 64.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.858 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.8 mtm -94.05 -18.38 21.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 75.2 110.84 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 93.13 24.01 23.41 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.731 . . . . 72.51 112.443 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.3 ttm -81.95 175.81 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 74.44 110.854 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.4 m -75.73 -6.26 49.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 35.43 110.84 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.2 m120 62.9 69.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 53.33 110.886 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -68.07 152.64 45.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.906 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 1.4 m -108.18 90.82 7.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.575 0.702 . . . . 61.32 111.175 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.6 Cg_endo -69.77 175.86 7.55 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.661 2.241 . . . . 75.14 112.379 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.1 p -115.41 -176.57 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 73.4 111.154 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -52.19 -29.9 24.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.34 110.95 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -67.41 -57.65 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.864 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.02 -53.76 54.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 71.14 110.868 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 150' ' ' ASP . 90.5 t -52.66 -41.12 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.42 111.126 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -54.79 -54.51 41.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 74.14 110.895 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.35 -47.9 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.133 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -61.89 -25.95 67.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.132 -0.485 . . . . 75.4 110.904 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 180' ' ' LEU . 2.6 tt -81.61 -40.51 22.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 70.43 110.92 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.51 -28.76 70.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.903 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 43.3 ttp -91.22 -35.08 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.747 ' HA ' HD23 ' A' ' 199' ' ' LEU . . . -71.41 -48.25 50.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 51.21 111.096 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -52.55 120.3 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.851 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.87 -23.59 25.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 64.31 111.126 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.44 -10.71 18.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 72.11 110.874 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.4 p 58.99 27.19 16.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 72.35 110.852 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -78.94 -15.87 57.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 73.11 110.869 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.34 17.26 16.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 53.3 112.49 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.78 126.9 7.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 73.13 110.854 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.7 t -86.92 107.63 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 61.04 111.131 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.2 t -83.68 -176.65 6.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 71.41 110.862 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.7 tp -66.61 -36.03 81.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 74.41 110.962 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.35 -24.75 42.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 73.1 110.87 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -85.89 -20.43 29.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 74.14 110.85 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.577 ' O ' HD12 ' A' ' 200' ' ' ILE . 17.5 t80 -87.32 -40.16 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.931 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -52.68 -41.42 63.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.899 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.86 -25.16 63.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 64.35 110.828 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 183' ' ' ALA . 2.2 tm? -61.9 -40.24 94.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.466 . . . . 71.34 110.91 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.2 mp -72.22 -24.69 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.21 111.134 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.1 mm -60.81 -37.51 76.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 51.54 111.154 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -52.56 38.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 63.52 110.858 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 2.6 m -57.44 -30.67 65.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 70.32 110.885 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.735 HD21 ' HG3' ' A' ' 129' ' ' LYS . 15.9 mt -72.01 -37.93 69.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 54.42 110.925 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -58.03 -35.57 71.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.15 110.897 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -26.64 26.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 65.23 110.929 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.2 -22.65 66.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 73.02 111.13 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.75 26.45 3.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 71.43 112.491 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.52 103.12 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 74.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -71.17 110.88 6.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 71.31 110.839 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.533 HG13 HG21 ' A' ' 126' ' ' VAL . 23.3 t -89.33 149.55 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 55.23 111.119 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -110.24 107.96 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 71.11 110.897 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 137.59 48.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 63.23 110.897 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -76.11 95.09 3.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 64.52 110.932 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 58.3 p -108.78 -178.51 3.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 61.22 110.826 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.62 73.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 72.32 110.914 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.5 m -52.66 140.37 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 75.23 111.13 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 41.2 p90 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 72.34 110.935 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.864 0.364 . . . . 74.53 110.914 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 p -133.15 160.25 37.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 63.24 110.834 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -116.24 81.12 10.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.586 0.708 . . . . 72.44 110.935 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 176.71 6.37 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.704 2.269 . . . . 54.15 112.346 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.1 127.24 35.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 63.0 110.9 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -109.79 133.93 52.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 71.43 110.916 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -52.59 160.52 1.35 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.595 0.712 . . . . 74.42 110.889 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -18.81 36.92 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.72 2.28 . . . . 75.24 112.344 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -82.69 -23.63 34.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.478 HG21 HG23 ' A' ' 211' ' ' VAL . 3.0 t -77.93 -63.33 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 75.32 111.163 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -51.99 -30.9 27.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.31 110.883 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -37.5 63.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 53.12 111.116 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -88.19 -25.94 22.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.893 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.741 HD22 ' CG ' ' A' ' 197' ' ' GLU . 68.5 mt -73.94 -28.23 61.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 62.3 110.89 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.51 -59.01 4.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.449 . . . . 70.34 110.899 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 p -55.29 -26.46 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 73.12 111.152 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.91 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 74.1 111.11 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.413 ' CG ' HD11 ' A' ' 193' ' ' LEU . 25.1 mtt180 -61.39 -50.66 71.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 71.31 110.874 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -63.68 -41.48 98.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 72.31 110.863 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 tp -57.1 -38.92 74.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 71.4 110.905 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -56.47 -59.74 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.12 110.873 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.6 mmmm -66.39 -26.27 67.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 43.23 110.87 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.3 ttm-85 -54.14 -27.71 35.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.872 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -109.74 -30.55 7.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.941 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.07 84.28 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 72.11 110.862 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -84.94 -28.17 26.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.41 110.878 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -72.63 -10.57 59.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 73.14 110.899 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.96 47.12 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 64.51 112.462 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 45.4 t -75.36 -22.11 57.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.953 0.406 . . . . 72.52 110.853 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.23 19.67 60.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 75.14 112.483 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -146.04 141.75 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 70.2 110.889 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.7 mt -105.23 101.41 10.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 42.13 110.927 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -70.41 170.68 11.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 63.34 110.95 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.534 ' O ' HG11 ' A' ' 176' ' ' VAL . 10.4 p-10 -52.06 -30.02 23.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.42 110.842 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -80.41 -35.02 35.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.1 110.891 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.08 -29.19 60.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 75.33 110.896 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.66 HD12 HD12 ' A' ' 180' ' ' LEU . 54.8 mt -77.78 -26.67 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 73.23 111.145 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.76 -45.85 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 70.44 111.071 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.24 -23.04 55.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 51.21 112.495 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.15 -57.04 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 62.43 110.9 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.7 mt -51.94 -35.84 47.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.23 110.959 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -51.97 -45.68 64.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 75.34 110.834 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -84.77 -45.69 12.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 65.44 110.833 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 33.5 m -52.99 -31.23 39.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.113 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -77.07 -55.37 5.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.914 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.81 -24.81 38.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 75.3 111.081 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -53.64 -29.17 36.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 71.45 110.879 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -113.02 16.8 19.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.41 110.878 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.83 28.93 74.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 52.25 112.451 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.16 175.75 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 54.54 110.884 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 94.8 p -60.92 -21.25 63.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 72.53 110.879 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 13.4 t30 63.45 57.47 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 65.12 110.889 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -80.22 152.55 29.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.924 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.8 p -108.21 90.75 7.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.589 0.709 . . . . 73.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 174.47 9.44 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.662 2.242 . . . . 51.42 112.327 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 39.2 p -117.53 -176.06 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 60.42 111.12 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -52.14 -29.95 24.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 63.01 110.879 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -69.43 -57.36 5.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 71.54 110.918 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.415 ' HA ' HD12 ' A' ' 178' ' ' ILE . 3.3 m-20 -56.15 -52.54 64.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 75.23 110.852 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.534 HG11 ' O ' ' A' ' 150' ' ' ASP . 94.7 t -52.42 -38.15 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 73.4 111.126 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -58.11 -54.85 42.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 75.45 110.907 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 175' ' ' ASP . 3.5 mt -54.5 -47.47 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 74.12 111.143 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.546 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 50.0 t90 -57.97 -29.84 65.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 71.11 110.88 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.66 HD12 HD12 ' A' ' 153' ' ' ILE . 5.2 tt -74.88 -30.54 61.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 72.11 110.949 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -65.01 -26.17 68.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.03 110.938 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.5 ttm -90.97 -42.83 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.895 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.466 ' CA ' HD13 ' A' ' 199' ' ' LEU . . . -68.32 -50.47 53.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 74.24 111.085 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.529 ' HB2' HD23 ' A' ' 180' ' ' LEU . 35.2 t0 -51.98 105.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.836 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.5 m -87.18 -25.15 24.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 55.43 111.156 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -95.11 -12.42 26.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 61.32 110.906 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 60.74 37.93 18.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 72.24 110.855 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -102.01 23.99 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 73.03 110.855 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 65.19 19.42 66.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 70.22 112.509 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.73 160.4 41.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 61.21 110.871 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.23 124.93 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 72.02 111.11 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.28 -170.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 44.22 110.876 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -66.04 -39.01 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 74.15 110.892 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -74.11 -35.59 64.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.859 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.58 -53.4 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 75.14 110.94 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.515 ' O ' HD12 ' A' ' 200' ' ' ILE . 11.2 t80 -58.47 -47.91 82.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 74.02 110.911 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.741 ' CG ' HD22 ' A' ' 130' ' ' LEU . 26.4 tt0 -55.2 -31.04 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 41.5 110.89 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.77 -26.41 64.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 61.45 110.88 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.546 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 3.5 tp -67.46 -34.03 76.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 74.15 110.887 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.636 HG22 HD23 ' A' ' 204' ' ' LEU . 5.3 mp -75.04 -27.44 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 55.21 111.133 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.5 mm -52.11 -60.09 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 64.5 111.135 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -52.08 -30.13 24.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 73.51 110.884 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.9 m -69.98 -41.88 73.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.872 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 209' ' ' ILE . 4.1 mm? -66.83 -36.05 81.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.49 . . . . 65.41 110.936 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -57.07 -44.23 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 64.23 110.904 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -86.06 -24.83 26.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 64.33 110.91 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.05 -22.71 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 74.22 111.063 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.92 19.26 5.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.756 -0.735 . . . . 73.14 112.527 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 204' ' ' LEU . 5.3 mp -122.32 101.84 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 61.55 111.128 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.13 98.66 3.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.13 110.887 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.478 HG23 HG21 ' A' ' 126' ' ' VAL . 5.6 p -77.31 138.99 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 74.23 111.157 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -91.72 108.06 19.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 71.05 110.892 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.58 134.37 22.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 73.34 110.872 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -52.73 103.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 65.31 110.931 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 19.7 p -103.36 84.53 2.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.21 110.841 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.06 134.39 57.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 71.51 110.88 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.5 m -115.4 132.94 63.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 62.2 111.193 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 22.0 p90 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.885 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.859 0.361 . . . . 33.22 110.884 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.2 p -114.98 106.9 14.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 61.01 110.846 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.69 155.98 74.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.509 0.671 . . . . 70.24 110.891 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 140.01 41.57 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.619 2.212 . . . . 72.12 112.357 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -91.39 136.57 33.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 73.44 110.926 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.483 ' HB3' HG21 ' A' ' 126' ' ' VAL . 21.1 m-85 -124.14 164.32 19.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 65.11 110.916 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -51.77 162.15 0.8 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.584 0.707 . . . . 72.5 110.883 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -16.87 37.69 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 61.34 112.346 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -83.42 -18.97 36.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.892 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.532 ' CG2' HG22 ' A' ' 211' ' ' VAL . 2.9 t -77.16 -61.44 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 45.14 111.134 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.676 ' HA ' HD12 ' A' ' 130' ' ' LEU . 4.0 tt0 -51.54 -31.38 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.45 110.891 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.03 -34.32 55.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.54 111.14 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.646 ' HB3' HD11 ' A' ' 204' ' ' LEU . 0.0 OUTLIER -88.47 -30.99 18.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.42 110.945 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.867 HD21 HD11 ' A' ' 201' ' ' ILE . 17.9 mt -69.68 -32.72 71.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.876 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -58.27 -57.58 12.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 64.31 110.857 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 129' ' ' LYS . 10.2 p -57.75 -23.79 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 70.4 111.127 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.43 -30.77 67.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 61.51 111.118 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -49.44 63.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 75.1 110.919 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -61.77 -24.65 66.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 64.42 110.885 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.7 tp -82.17 -36.67 27.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.92 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.0 -53.31 59.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.881 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -69.62 -25.97 64.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 70.44 110.906 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -52.2 -29.94 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 62.14 110.861 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -106.0 -34.18 7.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 65.22 110.895 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.75 88.95 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 72.13 110.873 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -84.72 -25.42 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.45 110.92 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -70.65 -10.61 59.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.878 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.66 22.54 40.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 61.4 112.489 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -76.38 -22.1 55.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.895 0.379 . . . . 74.04 110.844 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.76 19.04 57.24 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.752 . . . . 71.22 112.48 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -142.96 130.74 21.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 74.54 110.894 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.415 HD13 HD22 ' A' ' 156' ' ' LEU . 31.7 mt -89.03 102.57 15.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.22 110.944 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -71.6 173.11 8.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 73.32 110.894 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.407 ' HA ' HD12 ' A' ' 153' ' ' ILE . 2.9 p30 -55.54 -26.42 43.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 64.3 110.856 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -80.02 -34.28 38.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 65.21 110.85 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -80.92 -26.75 36.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 75.22 110.84 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.451 ' CG2' HG13 ' A' ' 176' ' ' VAL . 21.4 mt -74.82 -36.25 39.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 43.13 111.133 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.83 -47.27 64.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 51.43 111.067 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.42 -23.5 53.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 63.41 112.458 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.466 HD21 ' CE1' ' A' ' 196' ' ' TYR . 1.9 tp -65.48 -49.12 70.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 74.45 110.942 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.556 HD21 ' CD2' ' A' ' 179' ' ' TRP . 97.7 mt -52.12 -33.91 41.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 53.51 110.921 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -54.59 -55.2 31.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.855 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.34 -45.06 41.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 72.01 110.877 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.3 m -51.67 -30.71 22.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 62.04 111.154 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -77.85 -44.69 26.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 65.11 110.914 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.609 ' HB2' HD21 ' A' ' 168' ' ' ASN . . . -57.2 -23.24 46.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 64.54 111.087 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -55.52 -25.94 40.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 75.24 110.893 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 mtm -111.73 19.44 18.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.889 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.76 21.46 71.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 51.3 112.492 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.2 tpp -62.22 175.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.758 0.314 . . . . 64.31 110.911 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.1 t -78.3 -3.91 45.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 64.32 110.868 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.609 HD21 ' HB2' ' A' ' 162' ' ' ALA . 2.8 m120 55.72 61.74 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 74.14 110.909 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -72.86 152.63 41.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.11 110.905 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.4 m -108.11 90.77 7.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 72.35 111.136 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 171.45 14.44 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.704 2.269 . . . . 55.41 112.364 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 176' ' ' VAL . 3.4 p -102.35 177.83 4.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 73.55 111.124 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -55.19 -27.74 48.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.9 tt0 -75.23 -54.28 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 74.23 110.901 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.16 -35.87 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.823 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 172' ' ' THR . 91.2 t -63.97 -39.36 85.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 75.2 111.101 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -56.83 -52.99 62.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 61.24 110.877 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.1 mp -55.38 -30.68 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 72.22 111.118 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.592 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 90.9 t90 -79.55 -31.21 41.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 64.25 110.934 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.501 ' O ' HD23 ' A' ' 180' ' ' LEU . 1.9 tt -77.46 -39.98 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.888 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -51.92 -58.47 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.906 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 27.5 ttp -63.7 -24.46 67.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.893 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.698 ' CB ' HD11 ' A' ' 199' ' ' LEU . . . -94.51 21.89 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 61.0 111.097 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -141.73 120.93 13.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 64.34 110.864 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 14.5 m -87.17 -43.71 12.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 63.15 111.097 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.42 -12.45 60.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.868 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.0 t 57.98 48.15 13.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 65.42 110.836 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -93.27 -16.24 24.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 70.02 110.854 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.23 25.12 14.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 63.44 112.46 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.24 144.12 24.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 55.33 110.902 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 196' ' ' TYR . 22.0 t -113.89 121.95 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 74.14 111.123 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.15 -177.74 4.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 44.23 110.891 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.91 -32.67 66.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 64.14 110.949 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.53 -58.87 3.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.31 110.874 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.442 ' HB3' HG13 ' A' ' 191' ' ' VAL . 15.5 mt-10 -56.2 -25.46 47.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 71.11 110.929 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.53 ' HB2' HG12 ' A' ' 191' ' ' VAL . 31.7 t80 -85.34 -50.17 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 71.03 110.917 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.517 ' HA ' HD13 ' A' ' 200' ' ' ILE . 19.0 mt-10 -52.08 -40.98 62.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 71.45 110.877 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -53.56 -43.9 68.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 73.21 110.886 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.698 HD11 ' CB ' ' A' ' 183' ' ' ALA . 36.5 mt -51.84 -35.66 45.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 71.42 110.958 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.517 HD13 ' HA ' ' A' ' 197' ' ' GLU . 5.2 mp -77.0 -30.0 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 62.44 111.156 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.867 HD11 HD21 ' A' ' 130' ' ' LEU . 51.7 mm -64.66 -43.06 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 71.51 111.11 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -63.83 -36.05 82.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 71.21 110.905 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 62.7 m -77.66 -39.74 44.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.2 110.851 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' ' 129' ' ' LYS . 22.4 mt -57.63 -46.03 84.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.494 . . . . 73.03 110.902 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -52.59 -35.18 53.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.15 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.12 -31.33 21.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 65.14 110.88 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.425 ' HB3' ' CD1' ' A' ' 209' ' ' ILE . . . -64.91 -22.28 66.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 41.1 111.081 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.89 32.42 1.56 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.739 . . . . 42.33 112.496 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.468 HD13 ' CD2' ' A' ' 204' ' ' LEU . 5.2 mp -118.04 110.94 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 74.44 111.112 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 131.32 46.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.15 110.841 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.532 HG22 ' CG2' ' A' ' 126' ' ' VAL . 18.3 t -137.89 111.95 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 72.24 111.119 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.12 107.99 5.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 74.14 110.878 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.26 111.9 7.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 65.01 110.921 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -55.01 144.66 22.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 72.42 110.889 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 48.8 m -146.82 157.63 43.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 72.32 110.858 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 216' ' ' LEU . 0.9 OUTLIER -126.36 162.76 24.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 61.41 110.87 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.62 158.97 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 74.11 111.131 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 3.5 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 71.32 110.883 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.4 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.865 0.364 . . . . 61.25 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.65 120.01 19.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 72.33 110.882 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -111.34 81.0 2.78 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.538 0.685 . . . . 74.4 110.877 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 133.82 26.43 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.715 2.277 . . . . 73.21 112.334 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tptp -95.66 140.33 30.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.868 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -105.68 161.93 13.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 71.12 110.95 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -51.73 160.97 0.95 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.661 0.743 . . . . 70.42 110.853 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -25.35 28.42 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.651 2.234 . . . . 61.33 112.318 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -79.36 -19.55 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 62.44 110.923 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.87 HG12 HD11 ' A' ' 130' ' ' LEU . 2.8 t -84.74 -61.03 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 72.1 111.111 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.521 ' HA ' HD12 ' A' ' 130' ' ' LEU . 3.6 tp10 -51.35 -30.7 19.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.9 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.37 79.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 51.34 111.089 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.442 ' O ' HG12 ' A' ' 132' ' ' VAL . 56.0 tptt -88.39 -40.73 13.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 72.33 110.914 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.87 HD11 HG12 ' A' ' 126' ' ' VAL . 13.2 mt -57.28 -25.81 59.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.928 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -70.03 -59.27 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 75.22 110.855 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 129' ' ' LYS . 10.1 p -57.87 -23.62 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 73.15 111.111 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.35 -21.69 59.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 61.54 111.137 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.8 mtt-85 -70.13 -53.41 17.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 62.41 110.885 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -54.57 -26.88 34.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 72.03 110.822 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -79.89 -35.17 38.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 62.34 110.964 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 148' ' ' LEU . 28.7 t80 -65.41 -43.02 91.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 71.5 110.885 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -79.49 -26.93 41.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.89 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -51.96 -40.44 60.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 65.32 110.889 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -94.23 -26.12 16.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.932 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.14 62.58 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 74.44 110.883 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -26.16 68.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 62.12 110.887 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -70.83 -10.56 59.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 73.12 110.875 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.04 20.89 43.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.709 -0.757 . . . . 62.32 112.464 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.5 m -78.45 -22.1 48.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 75.33 110.85 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.84 20.19 66.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 72.05 112.451 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -138.51 131.54 29.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.798 0.332 . . . . 64.23 110.935 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.597 HD13 HD22 ' A' ' 156' ' ' LEU . 24.1 mt -101.92 111.43 23.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 72.4 110.945 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -79.93 175.7 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 65.32 110.895 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -53.47 -28.51 31.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 61.23 110.87 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -77.34 -44.81 28.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.888 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.04 -33.19 73.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.928 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.64 HG22 HG13 ' A' ' 176' ' ' VAL . 30.6 mt -70.72 -37.5 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 53.35 111.201 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.84 -46.2 64.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 75.43 111.085 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.77 -23.13 56.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 65.42 112.505 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.597 HD22 HD13 ' A' ' 148' ' ' LEU . 21.3 tp -58.87 -55.95 28.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 72.05 110.902 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 25.1 mt -52.28 -35.66 50.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.931 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -43.59 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.885 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.07 -47.17 10.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.871 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.2 m -52.19 -31.16 30.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 74.22 111.142 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -76.17 -44.19 39.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.923 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.18 -25.53 64.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 74.53 111.097 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -52.25 -30.44 27.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 72.32 110.903 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -102.62 -18.45 15.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.24 110.869 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.77 27.24 9.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 53.21 112.481 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.63 175.2 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 64.54 110.873 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.1 p -55.6 -25.96 41.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 62.15 110.864 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 63.31 54.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 75.44 110.911 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -60.45 152.49 25.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 74.42 110.921 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p -108.27 90.8 7.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 72.31 111.136 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -171.02 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.643 2.228 . . . . 72.32 112.38 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 176' ' ' VAL . 70.1 p -127.86 -176.35 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 72.41 111.131 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -57.63 -25.56 60.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 72.32 110.93 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.42 -60.16 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 72.21 110.909 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.421 ' HA ' HD12 ' A' ' 178' ' ' ILE . 0.8 OUTLIER -56.84 -49.2 76.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 65.04 110.832 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.64 HG13 HG22 ' A' ' 153' ' ' ILE . 99.0 t -55.37 -43.87 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.424 . . . . 73.04 111.089 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -50.27 62.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 75.2 110.888 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 175' ' ' ASP . 3.7 mt -59.46 -49.22 84.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.22 111.173 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.527 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 53.5 t90 -54.74 -28.63 49.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 74.25 110.89 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 180' ' ' LEU . 5.8 tt -61.38 -45.64 93.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 73.11 110.906 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -72.52 -29.91 64.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.03 110.89 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.6 ttp -60.96 -31.18 70.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.25 110.871 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -101.26 -48.54 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 73.04 111.086 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -52.35 112.74 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 65.43 110.808 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 27.9 m -83.71 -33.34 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.3 111.141 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -83.51 -12.46 56.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 73.11 110.881 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.8 m 54.87 49.99 16.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 63.42 110.874 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -110.07 23.94 13.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.903 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.54 25.47 70.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 73.44 112.484 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.7 p -154.64 133.78 12.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 71.03 110.848 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.419 HG12 ' HB2' ' A' ' 196' ' ' TYR . 38.3 t -101.51 105.48 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 44.14 111.121 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -75.02 178.17 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 61.33 110.841 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.8 tp -54.79 -61.02 2.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 72.54 110.916 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -60.78 -41.54 95.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.913 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -29.38 66.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.53 110.92 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.509 ' O ' HD12 ' A' ' 200' ' ' ILE . 27.8 t80 -87.94 -47.63 8.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.955 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.418 ' HA ' HD13 ' A' ' 200' ' ' ILE . 0.3 OUTLIER -57.18 -25.84 59.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 72.42 110.905 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.9 -25.75 60.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.89 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.565 HD13 ' HB2' ' A' ' 183' ' ' ALA . 4.9 tp -69.07 -35.9 77.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.889 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -71.24 -24.5 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.13 111.135 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 1.133 HG23 HG11 ' A' ' 211' ' ' VAL . 50.0 mm -52.33 -61.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 52.05 111.073 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -49.57 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 64.2 110.919 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 49.0 m -52.15 -33.28 39.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 64.53 110.885 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.499 ' CD2' HD13 ' A' ' 209' ' ' ILE . 9.9 mt -76.59 -44.53 34.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 62.43 110.867 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -56.26 -30.1 61.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 73.11 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -16.41 38.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 70.5 110.924 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.51 ' HB3' HD12 ' A' ' 209' ' ' ILE . . . -94.72 24.81 4.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 62.11 111.102 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 66.52 32.39 81.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.763 . . . . 53.23 112.499 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 211' ' ' VAL . 18.7 mt -114.72 102.89 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.353 . . . . 64.44 111.121 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -57.0 106.31 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 73.33 110.862 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 1.133 HG11 HG23 ' A' ' 201' ' ' ILE . 85.5 t -110.14 126.51 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 64.12 111.142 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -95.46 108.07 20.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 73.42 110.85 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.31 143.19 46.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 72.2 110.888 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -134.9 131.18 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 73.52 110.928 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.5 t -152.82 129.41 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 72.12 110.88 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 68.9 mt -59.8 130.75 48.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 71.45 110.939 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.7 m -86.24 155.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 55.53 111.17 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 46.0 p90 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.878 -179.964 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.887 0.375 . . . . 70.21 110.837 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.0 t -164.15 176.97 8.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 60.32 110.85 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 156.23 58.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 71.41 110.892 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 161.81 44.52 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.661 2.241 . . . . 61.4 112.328 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 107.75 15.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 73.32 110.895 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.547 ' CE2' HG11 ' A' ' 211' ' ' VAL . 2.4 m-85 -106.53 133.89 50.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 73.13 110.938 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -52.23 160.62 1.2 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.587 0.708 . . . . 74.22 110.891 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -16.02 37.63 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.701 2.267 . . . . 54.45 112.37 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.61 -26.86 34.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 64.34 110.883 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.728 HG21 HG13 ' A' ' 211' ' ' VAL . 2.9 t -78.8 -61.81 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 45.43 111.107 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -51.62 -30.34 20.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 73.35 110.942 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.16 58.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 63.54 111.129 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.475 ' HG3' HD21 ' A' ' 204' ' ' LEU . 0.2 OUTLIER -84.87 -25.37 28.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.888 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.696 HD22 ' HG2' ' A' ' 197' ' ' GLU . 12.3 mt -78.67 -29.66 45.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 74.55 110.918 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.21 -48.76 69.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 70.22 110.838 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -65.47 -30.5 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 44.11 111.13 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.85 -27.89 57.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 73.53 111.086 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.463 ' HG2' HD21 ' A' ' 193' ' ' LEU . 38.4 mtp180 -66.74 -34.3 77.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.44 110.836 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -74.19 -29.83 61.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 63.12 110.878 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.52 -32.64 64.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 74.54 110.908 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.53 -63.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.13 110.874 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -58.02 -26.76 62.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.52 110.94 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -54.12 -29.24 44.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.886 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.04 -28.89 8.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 72.41 110.922 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.53 70.88 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 64.14 110.88 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -25.76 53.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 73.22 110.927 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -70.83 -10.5 59.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 72.13 110.853 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.43 19.78 58.08 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.738 -0.744 . . . . 43.12 112.463 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.4 t -82.33 -22.13 35.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.932 0.396 . . . . 45.21 110.892 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.83 22.44 63.92 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 64.43 112.523 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -140.09 148.99 42.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.858 0.361 . . . . 72.42 110.879 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.667 HD13 HD22 ' A' ' 156' ' ' LEU . 16.7 mt -120.14 119.89 34.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.33 110.912 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -85.37 177.85 7.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 74.01 110.92 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -52.0 -30.08 23.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.895 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.65 -52.14 9.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 63.32 110.856 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.25 -34.32 73.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.905 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.6 mt -68.6 -38.57 79.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 71.34 111.126 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.79 -58.35 7.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 73.03 111.114 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.22 -23.53 76.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 65.41 112.502 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.667 HD22 HD13 ' A' ' 148' ' ' LEU . 9.8 tp -67.9 -53.35 27.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 73.24 110.911 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 179' ' ' TRP . 5.6 mt -51.86 -29.86 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 72.02 110.94 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -60.28 -43.82 95.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.32 110.887 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -85.02 -38.85 18.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 64.23 110.875 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.0 m -51.75 -30.0 20.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.1 111.182 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -81.5 -50.21 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.44 110.924 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.706 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -55.29 -25.11 32.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 74.23 111.136 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -54.52 -28.99 49.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.917 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -110.74 16.93 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.51 110.906 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 29.02 74.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 74.53 112.489 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.1 mmt -69.31 175.85 3.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.821 0.344 . . . . 74.23 110.843 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 75.2 m -61.56 -18.4 59.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 72.3 110.899 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.706 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 3.5 t30 63.67 55.88 1.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 71.11 110.933 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -73.81 152.89 40.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.03 110.873 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 m -108.27 90.76 7.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 75.44 111.131 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 143.65 51.33 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.703 2.269 . . . . 71.44 112.312 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 176' ' ' VAL . 33.5 p -82.58 -178.43 7.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 51.55 111.138 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -56.32 -29.8 61.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.33 110.932 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.562 ' O ' HD12 ' A' ' 178' ' ' ILE . 3.6 tt0 -69.42 -52.44 26.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 72.02 110.895 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -54.7 -42.01 70.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.482 . . . . 63.43 110.846 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 172' ' ' THR . 47.4 t -58.57 -41.94 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 71.23 111.118 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -52.89 -48.85 66.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 62.22 110.913 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.0 mp -61.07 -25.61 36.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 72.42 111.093 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.614 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 70.8 t90 -81.87 -22.85 36.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 74.33 110.905 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' A' ' 184' ' ' ASP . 1.4 tt -78.22 -35.4 48.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 72.14 110.892 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -64.6 -31.95 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 51.3 110.933 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.5 ptp -91.72 -30.84 16.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 65.5 110.875 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.646 ' CB ' HD11 ' A' ' 199' ' ' LEU . . . -75.6 -51.27 13.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 42.45 111.128 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.585 ' HB3' HD23 ' A' ' 180' ' ' LEU . 0.5 OUTLIER -50.36 129.57 21.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 70.02 110.866 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.5 m -88.31 -48.78 7.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 64.31 111.15 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -113.86 16.69 18.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.15 110.895 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.5 t 51.78 58.67 5.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.878 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -96.17 -14.44 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.494 . . . . 62.54 110.851 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.37 16.77 17.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.728 . . . . 62.4 112.475 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.5 m -154.66 -179.26 7.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.397 . . . . 72.42 110.851 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.503 HG21 ' HZ3' ' A' ' 179' ' ' TRP . 21.5 t -135.59 101.41 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 72.14 111.159 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -76.07 -174.74 2.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 54.41 110.857 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.463 HD21 ' HG2' ' A' ' 134' ' ' ARG . 21.6 tp -65.3 -45.82 82.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 62.21 110.904 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -70.48 -26.11 63.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 74.4 110.902 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.86 -31.89 31.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 52.34 110.865 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.512 ' HA ' HD12 ' A' ' 199' ' ' LEU . 19.1 t80 -85.87 -34.96 20.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.885 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.696 ' HG2' HD22 ' A' ' 130' ' ' LEU . 24.1 tt0 -70.26 -32.15 69.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 73.31 110.868 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.83 -28.53 70.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 72.31 110.836 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.646 HD11 ' CB ' ' A' ' 183' ' ' ALA . 3.4 mt -63.9 -36.6 84.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.12 110.926 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.3 mp -74.86 -24.84 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 55.3 111.142 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.491 HD13 HD21 ' A' ' 130' ' ' LEU . 50.1 mm -58.49 -47.44 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 74.15 111.138 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -67.15 -40.4 86.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 70.34 110.912 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -47.54 65.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 74.2 110.852 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.475 HD21 ' HG3' ' A' ' 129' ' ' LYS . 6.9 mp -73.88 -29.44 62.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 73.42 110.895 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -62.9 -44.87 94.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.879 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -84.12 -24.19 30.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 52.51 110.876 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.9 -22.67 67.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 61.21 111.093 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.0 32.46 1.53 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 23.52 112.463 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.4 101.83 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.859 0.361 . . . . 54.32 111.102 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -68.76 108.07 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.872 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.728 HG13 HG21 ' A' ' 126' ' ' VAL . 21.8 t -90.19 149.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 52.53 111.126 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -97.14 108.18 20.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 75.32 110.908 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.73 128.66 12.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 75.4 110.918 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -83.12 131.0 35.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 61.43 110.883 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 20.2 m -137.25 156.87 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 72.54 110.865 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 pp -99.85 142.01 31.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 65.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.15 154.06 24.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 63.35 111.112 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 73.12 110.896 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.886 0.374 . . . . 61.45 110.873 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.0 m -147.93 168.71 21.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 74.22 110.845 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -103.97 161.03 24.17 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.588 0.708 . . . . 75.15 110.931 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 169.71 18.32 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.682 2.255 . . . . 73.1 112.338 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -93.93 112.6 24.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 71.13 110.88 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -140.32 133.64 29.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 75.23 110.915 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -51.88 160.99 0.99 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 62.11 110.894 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -18.13 37.01 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.714 2.276 . . . . 62.1 112.335 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -83.04 -21.29 33.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.911 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.522 HG21 HG23 ' A' ' 211' ' ' VAL . 2.4 t -85.25 -51.78 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 65.12 111.128 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -51.06 -31.58 19.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.863 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.14 80.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 62.11 111.099 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HD3' HD11 ' A' ' 204' ' ' LEU . 13.8 tttp -88.58 -32.36 18.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 75.11 110.885 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.8 -25.95 68.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 74.41 110.935 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -67.59 -59.3 3.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 75.0 110.854 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 p -56.1 -24.83 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.129 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.48 -47.74 84.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 44.01 111.093 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -44.62 64.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 72.03 110.85 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -65.11 -29.14 69.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.879 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.52 -36.85 57.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 64.31 110.892 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -61.3 -41.95 97.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 72.3 110.893 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -79.1 -28.48 43.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 74.42 110.927 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -52.26 -29.88 25.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 62.21 110.834 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -108.25 -34.52 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 72.21 110.917 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -76.7 66.44 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 72.52 110.919 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -70.7 -26.09 63.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 63.44 110.885 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.9 -10.51 59.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 55.23 110.859 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.26 22.56 44.38 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 63.22 112.469 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.3 t -76.08 -22.13 55.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.915 0.388 . . . . 73.12 110.875 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.31 20.16 65.14 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 74.05 112.489 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -142.64 141.29 31.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 73.51 110.87 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.483 ' O ' HD11 ' A' ' 153' ' ' ILE . 58.0 mt -109.33 118.12 35.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 44.13 110.927 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -85.19 175.3 9.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.896 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -51.88 -30.31 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 32.3 110.883 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -81.08 -52.39 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.34 110.823 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.56 -28.36 65.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 64.44 110.874 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.483 HD11 ' O ' ' A' ' 148' ' ' LEU . 35.2 mt -81.32 -30.83 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 73.34 111.167 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.04 63.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 35.21 111.12 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.23 -22.86 56.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 72.31 112.509 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.92 -47.76 83.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 63.44 110.95 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.36 -36.41 77.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.927 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -52.62 -46.07 66.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.33 110.882 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -83.11 -47.19 11.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 72.42 110.882 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.8 m -51.79 -35.52 44.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 72.31 111.186 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -76.56 -53.69 7.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.97 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.724 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -57.06 -25.76 59.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 62.24 111.129 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -57.39 -25.68 59.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.866 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 36.9 mtm -110.01 21.74 16.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 55.15 110.873 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.69 68.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 72.52 112.435 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.6 mmt -60.79 174.98 0.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.805 0.336 . . . . 51.22 110.834 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -66.02 -14.91 62.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 64.14 110.821 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.724 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 6.7 t30 63.69 42.92 5.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 50.04 110.882 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -62.49 152.45 34.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 62.34 110.863 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 m -108.22 90.82 7.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.59 0.71 . . . . 70.42 111.152 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 159.93 51.6 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.672 2.248 . . . . 73.04 112.324 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.544 ' O ' HG23 ' A' ' 176' ' ' VAL . 79.7 p -106.87 -176.03 2.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 64.14 111.167 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -54.85 -26.57 36.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 74.51 110.932 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.431 ' O ' HD12 ' A' ' 178' ' ' ILE . 7.6 tp10 -75.42 -41.47 55.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 72.1 110.873 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.4 ' HA ' HD12 ' A' ' 178' ' ' ILE . 5.8 m-20 -74.61 -25.11 59.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 71.32 110.85 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 172' ' ' THR . 91.4 t -79.33 -32.64 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.132 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -22.73 66.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.915 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 174' ' ' GLU . 5.2 mt -87.58 -41.96 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 74.11 111.132 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -69.98 -31.27 68.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 62.14 110.951 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 180' ' ' LEU . 5.4 tt -64.25 -38.81 92.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 53.3 110.885 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -68.79 -28.18 66.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.924 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 6.1 mmm -70.47 -33.83 71.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 63.33 110.862 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.712 ' CA ' HD23 ' A' ' 199' ' ' LEU . . . -88.99 -49.34 6.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 51.12 111.111 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -75.0 119.34 19.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 54.2 110.88 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.9 m -87.59 -26.55 23.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 64.44 111.108 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.22 -12.47 56.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 70.1 110.846 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.6 m 53.61 53.65 11.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 61.14 110.834 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -106.66 -16.22 14.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 63.45 110.906 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.29 19.42 11.53 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.709 -0.758 . . . . 65.11 112.447 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.0 p -149.4 126.88 11.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 45.51 110.859 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.468 ' CG1' ' HB1' ' A' ' 183' ' ' ALA . 21.6 t -95.66 106.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 74.3 111.142 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.71 178.86 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 62.13 110.884 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 21.3 tp -63.16 -33.23 75.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 62.13 110.921 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -81.32 -40.04 24.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.858 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -65.05 -32.57 74.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.859 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.618 ' O ' HD12 ' A' ' 200' ' ' ILE . 20.2 t80 -78.89 -34.95 44.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.937 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -51.84 -56.76 12.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.499 . . . . 75.2 110.88 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -56.87 -33.28 66.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 75.03 110.931 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.712 HD23 ' CA ' ' A' ' 183' ' ' ALA . 0.7 OUTLIER -51.91 -45.1 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 63.33 110.932 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 196' ' ' TYR . 4.7 mp -72.37 -34.42 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 65.11 111.126 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.672 HG23 HG21 ' A' ' 211' ' ' VAL . 50.0 mm -52.98 -44.96 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.32 111.085 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -63.62 -44.96 92.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 70.44 110.891 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.3 m -59.44 -57.93 10.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 63.13 110.795 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.522 ' HG ' HD13 ' A' ' 209' ' ' ILE . 8.2 mp -51.97 -40.24 60.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 73.32 110.937 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -42.97 74.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 71.24 110.916 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -85.96 -6.99 58.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 61.23 110.899 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.513 ' HB3' HD12 ' A' ' 209' ' ' ILE . . . -94.94 25.48 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 73.21 111.1 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.72 32.41 83.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.719 -0.753 . . . . 73.53 112.5 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.522 HD13 ' HG ' ' A' ' 204' ' ' LEU . 17.0 mt -120.18 110.47 28.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 72.53 111.14 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.69 114.78 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 74.41 110.871 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.672 HG21 HG23 ' A' ' 201' ' ' ILE . 4.2 p -133.68 122.73 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 74.52 111.142 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -104.82 129.02 53.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 62.01 110.859 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.75 137.12 45.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.34 110.926 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -124.01 167.74 13.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 71.52 110.899 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 m -138.73 153.46 48.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.836 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 6.0 mt -88.21 93.21 9.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 51.51 110.948 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.57 114.79 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 75.04 111.135 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.8 p90 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 75.0 110.889 -179.995 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.898 0.38 . . . . 65.23 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.1 m -107.78 136.2 47.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 75.34 110.828 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.42 154.94 66.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.581 0.705 . . . . 55.24 110.913 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 146.84 61.74 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.691 2.26 . . . . 52.13 112.363 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -75.11 110.6 9.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 73.4 110.908 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -116.67 132.28 56.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.3 110.917 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -51.49 161.07 0.87 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.672 0.748 . . . . 70.25 110.863 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.547 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 53.6 Cg_endo -69.8 -14.37 35.87 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.677 2.251 . . . . 64.3 112.346 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.23 -26.77 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 64.22 110.88 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.15 -63.53 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 61.21 111.103 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.64 -26.2 43.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 75.12 110.847 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 124' ' ' PRO . . . -58.66 -40.45 83.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 41.1 111.135 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.55 ' HB3' HD11 ' A' ' 204' ' ' LEU . 11.2 tptm -87.99 -26.65 22.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.43 110.928 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.689 HD22 ' CG ' ' A' ' 197' ' ' GLU . 77.1 mt -74.86 -25.57 59.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 60.12 110.931 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -76.37 -49.58 16.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 73.51 110.87 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.0 p -62.49 -25.81 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 74.11 111.143 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.81 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 54.32 111.125 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -51.91 -36.35 48.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 72.54 110.833 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -67.41 -48.31 67.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.846 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 tp -61.98 -27.91 69.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.9 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -69.54 -60.05 2.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.841 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -63.07 -28.67 70.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.874 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -52.65 -33.45 47.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 75.33 110.907 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -99.19 -29.47 12.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 62.35 110.887 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.94 85.47 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 71.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -85.06 -26.31 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.32 110.928 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.09 -10.53 59.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.885 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.58 24.47 47.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 51.43 112.523 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.2 p -90.51 -22.14 21.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 43.13 110.86 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.99 19.81 49.32 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.766 -0.731 . . . . 71.04 112.444 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -133.47 132.04 40.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 73.22 110.922 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.488 HD22 ' HB3' ' A' ' 152' ' ' GLU . 93.5 mt -99.56 110.82 23.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 64.32 110.916 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -77.94 176.94 8.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 75.21 110.893 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.94 -30.18 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.2 110.879 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.67 -51.82 15.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 60.53 110.893 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.488 ' HB3' HD22 ' A' ' 148' ' ' LEU . 35.8 mm-40 -62.26 -30.69 71.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.87 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.7 mt -77.06 -42.62 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 74.14 111.151 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.65 -49.07 63.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 61.2 111.106 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.87 -23.2 67.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 73.02 112.509 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.93 -45.7 60.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 74.01 110.9 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 179' ' ' TRP . 85.6 mt -52.86 -30.86 36.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 62.21 110.871 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.605 ' HD2' HG22 ' A' ' 170' ' ' THR . 0.0 OUTLIER -62.42 -60.81 3.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 74.14 110.881 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -27.48 67.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 73.03 110.888 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.0 m -65.05 -54.6 27.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 74.11 111.121 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -56.47 -25.99 52.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 73.23 110.933 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.86 -27.66 60.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 75.24 111.083 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -53.27 -28.68 29.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 62.13 110.858 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.3 mtm -104.26 -18.47 14.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 73.1 110.879 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.92 20.81 22.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.723 -0.751 . . . . 74.04 112.5 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 10.2 mtm -67.51 175.8 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.33 . . . . 71.04 110.852 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.7 t -60.63 -19.86 59.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 55.43 110.834 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 63.67 60.23 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 60.43 110.885 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -70.63 152.52 43.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 70.34 110.854 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.605 HG22 ' HD2' ' A' ' 158' ' ' LYS . 7.6 p -108.15 90.91 7.28 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.581 0.705 . . . . 73.41 111.151 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -178.33 2.31 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.646 2.23 . . . . 62.53 112.352 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 176' ' ' VAL . 51.5 p -118.62 179.56 4.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 52.2 111.15 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -54.74 -26.84 36.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 65.23 110.859 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.7 tp10 -72.87 -60.75 2.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.421 . . . . 73.14 110.844 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.0 -39.63 59.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 71.11 110.843 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 172' ' ' THR . 98.0 t -56.9 -43.25 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 71.5 111.136 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -52.01 -42.79 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.892 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.9 mp -68.84 -26.37 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.128 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.502 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 48.7 t90 -83.0 -26.45 31.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.471 . . . . 75.05 110.912 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.5 tt -77.14 -49.19 15.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 74.34 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -54.77 -28.79 51.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 64.43 110.895 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 31.5 ttm -72.68 -55.33 6.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.22 110.846 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.903 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -65.82 -60.81 2.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.52 111.101 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -66.26 128.72 37.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 73.42 110.904 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.26 -35.14 18.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 54.4 111.133 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -74.66 -12.46 60.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.866 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.9 p 46.24 57.42 5.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.812 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -114.17 23.56 12.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 72.11 110.851 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.06 25.89 74.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 65.42 112.467 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.8 p -152.41 135.62 15.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 65.02 110.876 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.78 111.62 36.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 74.11 111.135 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.8 t -75.37 179.95 4.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.804 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.68 -60.29 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 54.32 110.907 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -62.88 -39.21 93.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 52.4 110.88 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -61.22 -27.49 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.867 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.549 ' O ' HD12 ' A' ' 200' ' ' ILE . 36.8 t80 -89.37 -44.5 10.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 74.4 110.888 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.689 ' CG ' HD22 ' A' ' 130' ' ' LEU . 66.8 tt0 -60.46 -34.8 74.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 70.32 110.903 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -64.54 -26.18 68.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.866 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.903 HD13 ' HB2' ' A' ' 183' ' ' ALA . 2.3 tp -68.66 -44.35 74.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 75.03 110.938 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.1 mp -63.28 -24.65 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 72.33 111.122 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.644 HD13 HD21 ' A' ' 130' ' ' LEU . 48.6 mm -51.92 -48.05 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 70.04 111.124 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -69.31 -37.25 77.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 64.15 110.883 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 12.1 m -53.77 -42.19 68.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 61.02 110.842 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 129' ' ' LYS . 64.8 mt -80.14 -26.42 39.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 71.34 110.893 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -62.98 -43.63 98.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 63.5 110.917 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -85.79 -24.14 26.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 62.31 110.908 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.92 -21.55 66.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.115 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.06 21.9 4.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 52.25 112.49 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.79 101.65 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 74.51 111.157 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -68.57 98.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.32 110.851 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.9 t -69.18 128.96 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 72.04 111.118 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.16 107.52 2.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 73.04 110.892 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -164.66 135.56 4.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 72.02 110.88 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -63.22 134.84 56.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 72.33 110.912 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 53.0 p -129.6 130.98 46.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.14 110.859 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.85 176.88 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 72.23 110.91 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.05 145.06 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 62.33 111.163 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 75.34 110.896 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.907 0.384 . . . . 71.03 110.807 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.5 t -142.14 113.42 7.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 62.34 110.851 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.42 157.73 53.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.612 0.72 . . . . 73.33 110.869 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 171.92 13.55 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.691 2.26 . . . . 73.13 112.349 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -91.8 106.13 18.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 73.23 110.867 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.48 147.84 27.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 72.11 110.891 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -61.0 160.9 17.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.622 0.725 . . . . 73.12 110.915 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -27.61 26.21 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 30.42 112.34 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -75.09 -18.13 60.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 63.13 110.846 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.01 -60.42 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 55.3 111.115 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -51.59 -30.32 20.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 65.52 110.854 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.4 79.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 74.23 111.079 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -88.42 -24.59 23.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.894 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 201' ' ' ILE . 63.5 mt -76.83 -40.11 48.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.901 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -58.2 -43.24 87.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.827 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.461 HG23 HH11 ' A' ' 135' ' ' ARG . 13.3 p -71.39 -24.24 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.23 111.113 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.41 54.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 63.0 111.088 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -66.5 -50.3 63.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 72.32 110.855 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.461 HH11 HG23 ' A' ' 132' ' ' VAL . 4.1 ptm180 -55.29 -26.06 38.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 51.53 110.856 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.3 tp -79.44 -35.4 40.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 75.3 110.933 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.49 -60.54 3.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 54.23 110.876 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -60.35 -32.45 71.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 62.13 110.889 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -55.34 -26.51 41.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 61.33 110.912 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -108.24 -26.66 10.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 64.43 110.892 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.97 60.02 2.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 53.32 110.919 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -70.06 -25.91 63.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 75.21 110.918 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.74 -10.58 59.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.834 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.12 23.38 52.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.757 . . . . 63.21 112.499 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -83.07 -22.06 33.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.929 0.395 . . . . 53.02 110.87 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.32 20.69 60.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 65.13 112.527 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -150.08 131.74 14.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 64.4 110.901 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.5 mt -91.45 101.88 14.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.945 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -65.61 171.85 3.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 71.41 110.875 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.494 ' HA ' HD12 ' A' ' 153' ' ' ILE . 7.3 t70 -52.05 -29.99 23.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 62.23 110.86 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.81 -51.35 12.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 64.11 110.892 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -59.62 -26.4 65.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 73.03 110.904 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.57 ' CG2' HG13 ' A' ' 176' ' ' VAL . 23.7 mt -76.78 -36.63 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 61.24 111.112 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.72 -44.77 63.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 64.44 111.126 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.27 -25.27 48.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.741 . . . . 42.2 112.486 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.416 HD21 ' CE1' ' A' ' 196' ' ' TYR . 2.4 tp -59.23 -56.75 18.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 74.34 110.896 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.1 mt -51.95 -32.41 33.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 71.54 110.927 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -57.0 -43.97 82.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 44.23 110.885 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -84.93 -45.93 11.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 64.12 110.834 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.1 m -52.58 -36.63 56.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.174 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -67.33 -56.44 9.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 64.54 110.947 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.727 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -54.61 -26.79 34.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 61.15 111.107 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.95 -33.17 75.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 73.01 110.88 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -99.02 18.95 16.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 64.04 110.82 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.21 68.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 73.12 112.47 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.3 tpp -65.28 173.65 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 61.32 110.884 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 91.1 p -72.92 -9.07 58.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 63.11 110.831 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.727 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 0.2 OUTLIER 63.64 47.85 3.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 63.34 110.834 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -62.63 152.6 34.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 64.55 110.846 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.3 p -108.29 90.93 7.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.626 0.726 . . . . 65.53 111.1 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 -176.35 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 2.252 . . . . 71.13 112.293 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 176' ' ' VAL . 36.6 p -128.68 -176.07 3.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 70.03 111.17 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -55.07 -26.55 38.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 64.14 110.909 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.615 ' O ' HD12 ' A' ' 178' ' ' ILE . 41.2 tt0 -72.93 -61.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.861 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.05 -48.3 64.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 54.5 110.834 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 172' ' ' THR . 89.7 t -52.17 -36.62 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.44 111.152 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -59.38 -53.9 52.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.21 110.909 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -55.23 -38.4 47.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 51.33 111.137 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.702 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 88.4 t90 -75.22 -25.27 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 53.12 110.923 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 tt -74.89 -51.21 14.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.859 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -52.75 -45.17 66.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 72.04 110.887 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.0 ttm -57.92 -26.39 62.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 50.12 110.879 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.874 ' HB2' HD11 ' A' ' 199' ' ' LEU . . . -90.85 -67.28 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 73.43 111.128 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -61.25 128.49 36.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 63.13 110.872 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.1 m -84.05 -28.14 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 72.02 111.135 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -91.3 -12.46 35.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 54.34 110.883 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 58.5 58.37 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 61.11 110.83 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -117.29 23.46 11.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 60.52 110.911 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.13 31.5 81.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.718 -0.753 . . . . 64.45 112.457 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.58 129.98 17.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.922 0.391 . . . . 74.31 110.887 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.513 HG13 ' HB1' ' A' ' 183' ' ' ALA . 40.3 t -114.99 102.31 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 63.13 111.08 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.47 176.24 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.34 110.821 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.2 OUTLIER -62.52 -29.92 70.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 65.35 110.984 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -81.39 -29.5 33.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 53.34 110.933 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.7 -22.0 29.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 63.22 110.912 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.467 ' HA ' HD12 ' A' ' 199' ' ' LEU . 41.5 t80 -84.04 -35.19 24.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 73.31 110.927 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.474 ' O ' HD12 ' A' ' 201' ' ' ILE . 11.2 pt-20 -67.86 -41.81 82.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 54.12 110.891 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -55.33 -30.11 59.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.843 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' A' ' 183' ' ' ALA . 44.5 mt -62.26 -41.03 98.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 73.25 110.903 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 200' ' ' ILE . 4.6 mp -66.2 -44.25 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 72.45 111.127 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 1.036 HG23 HG11 ' A' ' 211' ' ' VAL . 2.0 mp -60.32 -35.9 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.53 111.164 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.37 -41.17 79.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 72.12 110.946 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 17.9 t -84.69 -36.05 22.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 70.34 110.881 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.63 ' CD2' HD13 ' A' ' 209' ' ' ILE . 21.4 mt -51.99 -37.9 54.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 63.14 110.929 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -51.1 -46.67 61.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 71.54 110.861 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.42 -22.62 26.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 61.32 110.885 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 204' ' ' LEU . . . -64.77 -22.79 67.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 61.33 111.117 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.52 26.59 3.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 40.52 112.472 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.63 HD13 ' CD2' ' A' ' 204' ' ' LEU . 5.2 mp -124.76 136.24 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 74.22 111.108 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -102.07 115.9 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.32 110.891 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 1.036 HG11 HG23 ' A' ' 201' ' ' ILE . 6.3 p -122.68 132.46 71.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 65.35 111.151 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -113.65 135.74 53.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 65.21 110.853 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -129.03 134.49 48.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.879 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -160.29 130.61 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 73.14 110.925 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.6 t -100.24 154.68 18.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 62.43 110.86 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.0 mt -119.72 99.9 6.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 71.42 110.92 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.35 131.1 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 63.33 111.157 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 53.2 p90 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 63.52 110.906 -179.981 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.8 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.868 0.366 . . . . 74.24 110.863 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.4 p -124.41 133.74 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 43.44 110.919 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.38 159.84 32.52 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.57 0.7 . . . . 62.44 110.9 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 146.67 60.7 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.684 2.256 . . . . 74.11 112.33 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -99.88 109.02 21.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 55.34 110.894 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -109.34 135.44 50.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 71.54 110.866 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -53.73 160.57 2.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.608 0.718 . . . . 64.02 110.905 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -20.43 34.89 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.719 2.279 . . . . 61.4 112.334 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -81.63 -20.91 38.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 64.43 110.881 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.514 HG13 HD22 ' A' ' 204' ' ' LEU . 2.9 t -80.4 -59.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 63.03 111.118 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.538 ' OE2' HD12 ' A' ' 130' ' ' LEU . 2.0 tp10 -51.77 -30.66 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 62.32 110.905 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.4 -30.88 61.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 20.31 111.114 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -25.81 22.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 60.43 110.94 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.699 HD22 ' HG3' ' A' ' 197' ' ' GLU . 18.7 mt -76.32 -42.12 46.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.34 110.918 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -55.23 -51.99 64.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 52.51 110.901 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.18 -26.53 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.088 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.21 76.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 73.23 111.121 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.3 mtm-85 -56.5 -44.88 81.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 72.55 110.873 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -61.64 -37.77 85.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 50.21 110.857 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.91 -29.84 61.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 74.35 110.912 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -67.11 -55.29 14.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 62.53 110.882 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -66.82 -28.5 68.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 60.11 110.922 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -52.5 -39.91 61.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.11 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -96.55 -35.5 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 71.53 110.879 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -80.75 57.96 3.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.839 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -25.38 68.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 72.32 110.894 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -71.27 -10.62 60.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 73.05 110.857 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.4 29.68 57.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 44.03 112.484 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.8 p -70.69 -22.18 62.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 54.3 110.843 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.48 -16.39 58.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 72.23 112.491 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -141.44 155.76 45.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.359 . . . . 62.11 110.912 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.501 ' CD1' HD13 ' A' ' 156' ' ' LEU . 42.0 mt -98.62 109.74 22.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 65.52 110.893 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.55 178.34 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.21 110.948 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -57.86 -26.31 61.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 71.51 110.884 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 57.5 m-20 -82.63 -53.3 6.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.23 110.877 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HB3' HD22 ' A' ' 148' ' ' LEU . 1.7 mt-10 -51.92 -49.05 63.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.86 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.606 ' CD1' HD13 ' A' ' 180' ' ' LEU . 33.9 mt -51.63 -38.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.41 111.164 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 151' ' ' ASP . . . -51.64 -41.34 61.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 62.44 111.096 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.85 -30.41 32.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.744 -0.741 . . . . 72.32 112.514 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.501 HD13 ' CD1' ' A' ' 148' ' ' LEU . 3.8 tp -58.32 -54.02 51.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 74.1 110.904 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 179' ' ' TRP . 56.6 mt -51.85 -32.28 31.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 73.31 110.93 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -54.71 -58.13 8.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 75.43 110.852 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.96 -42.82 56.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 75.43 110.855 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 93.1 m -52.42 -32.26 38.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 54.33 111.157 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -79.16 -57.53 3.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 74.11 110.924 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.505 ' HB2' ' ND2' ' A' ' 168' ' ' ASN . . . -55.51 -26.08 40.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.45 111.102 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.64 -27.65 63.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 65.31 110.885 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 51.8 mtm -103.91 21.86 15.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 65.24 110.887 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.84 23.07 72.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 35.24 112.505 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.0 tpp -76.57 170.03 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 52.23 110.887 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -64.48 -17.46 63.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 72.54 110.848 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' A' ' 162' ' ' ALA . 48.6 t-20 63.5 56.72 1.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 64.34 110.907 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -67.69 152.65 45.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 71.23 110.902 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.5 m -108.23 90.85 7.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.555 0.693 . . . . 63.24 111.161 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 174.98 8.71 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 74.33 112.305 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 176' ' ' VAL . 68.4 p -116.15 -176.02 2.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 70.31 111.143 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -51.82 -30.42 23.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 73.31 110.902 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.62 ' O ' HD12 ' A' ' 178' ' ' ILE . 84.9 tt0 -69.38 -61.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 65.51 110.902 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.9 -45.23 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 71.03 110.875 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 172' ' ' THR . 96.6 t -58.84 -28.51 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 64.4 111.193 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -66.92 -40.0 87.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 73.04 110.911 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -70.12 -31.37 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 53.45 111.127 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.511 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 55.8 t90 -83.52 -28.34 28.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 75.12 110.912 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.667 HD21 ' HA2' ' A' ' 189' ' ' GLY . 23.0 tp -83.72 -38.2 21.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 72.53 110.958 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -61.05 -30.91 70.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 71.31 110.906 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 48.8 ttp -91.25 -40.13 11.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 61.33 110.864 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -65.38 -25.26 67.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.12 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -101.25 127.84 47.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.879 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 98.0 m -83.9 -25.03 30.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 72.15 111.167 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -97.32 -12.43 22.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.846 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.6 t 56.6 39.32 29.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 75.53 110.879 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -98.05 19.55 13.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 61.31 110.885 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.667 ' HA2' HD21 ' A' ' 180' ' ' LEU . . . 64.08 31.71 81.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.484 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.97 134.0 18.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 61.54 110.863 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 196' ' ' TYR . 22.0 t -108.26 97.72 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 71.12 111.119 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.06 162.45 24.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 32.14 110.875 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 193' ' ' LEU . 5.6 mt -53.29 -31.57 44.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.128 -0.487 . . . . 71.02 110.893 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -81.43 -28.12 34.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.887 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -78.03 -42.46 32.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.467 . . . . 74.32 110.859 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.548 ' O ' HD12 ' A' ' 200' ' ' ILE . 20.0 t80 -65.04 -52.62 54.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.917 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.699 ' HG3' HD22 ' A' ' 130' ' ' LEU . 31.3 tt0 -51.81 -48.37 63.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 70.32 110.917 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -51.93 -35.0 44.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 71.24 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.511 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 2.5 tp -61.19 -45.08 96.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.24 110.943 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.1 mp -64.95 -28.32 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 54.41 111.115 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.645 ' CD1' HD21 ' A' ' 130' ' ' LEU . 50.0 mm -63.99 -52.85 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 63.23 111.122 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -56.49 -30.75 63.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 55.22 110.903 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 22.1 m -83.08 -29.94 28.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 51.23 110.814 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.609 ' HG ' HD13 ' A' ' 209' ' ' ILE . 0.8 OUTLIER -66.81 -42.72 85.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 64.35 110.874 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -51.9 -36.53 49.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.871 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -26.02 26.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 70.43 110.938 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.72 67.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 71.42 111.108 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.81 25.09 5.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.743 . . . . 60.2 112.43 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.609 HD13 ' HG ' ' A' ' 204' ' ' LEU . 5.3 mp -116.57 108.5 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 43.14 111.124 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -64.6 118.4 8.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 72.44 110.901 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.476 ' CG2' HG11 ' A' ' 126' ' ' VAL . 5.8 p -121.34 123.05 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.116 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -78.1 108.09 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 74.22 110.882 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.4 142.58 29.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.889 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -118.21 144.22 45.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.929 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 34.4 t -142.02 167.19 22.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 74.55 110.897 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.542 ' H ' HD12 ' A' ' 216' ' ' LEU . 1.0 OUTLIER -96.8 83.25 3.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 65.22 110.914 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.66 136.02 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 60.33 111.126 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 50.6 p90 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 75.34 110.864 -179.963 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.862 0.363 . . . . 73.23 110.869 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.0 m -95.79 69.67 2.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 73.03 110.879 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.06 155.12 60.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.607 0.717 . . . . 70.41 110.898 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 166.13 28.58 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 64.44 112.377 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -122.91 103.79 8.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 72.44 110.867 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -102.26 145.54 29.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 63.13 110.957 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -62.7 160.58 34.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.617 0.723 . . . . 75.23 110.912 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -17.78 37.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.714 2.276 . . . . 72.31 112.373 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.49 ' HB3' HG23 ' A' ' 209' ' ' ILE . 15.7 tp10 -82.9 -22.49 33.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.887 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.28 -61.27 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 74.11 111.114 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -51.67 -29.96 20.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 70.4 110.906 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.55 84.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 63.31 111.106 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.56 ' HB3' HD11 ' A' ' 204' ' ' LEU . 16.6 tptp -88.42 -26.61 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 72.44 110.893 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.753 HD22 ' HG3' ' A' ' 197' ' ' GLU . 61.4 mt -74.78 -26.12 59.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 72.14 110.94 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.21 -54.16 28.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 53.33 110.883 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.15 -24.95 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 61.32 111.114 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.89 -39.94 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 75.25 111.118 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -54.72 -31.09 57.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 71.45 110.891 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -85.03 -40.94 16.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.874 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.48 -27.25 67.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 64.35 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.707 ' CE1' HD13 ' A' ' 148' ' ' LEU . 87.5 t80 -72.81 -49.98 27.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 73.22 110.888 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -74.83 -25.91 59.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.901 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -57.23 -25.04 58.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.53 110.922 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -110.05 -21.31 12.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 65.43 110.919 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -77.27 61.81 2.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 75.25 110.832 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -16.72 59.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 71.12 110.952 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -70.22 -10.66 59.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 44.33 110.872 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.0 20.33 53.29 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.77 -0.729 . . . . 30.45 112.509 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.7 m -78.95 -22.12 46.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.945 0.403 . . . . 60.15 110.853 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.3 -16.06 58.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 73.42 112.533 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.63 170.71 9.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 63.43 110.891 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.707 HD13 ' CE1' ' A' ' 137' ' ' PHE . 0.8 OUTLIER -112.98 101.29 9.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 63.04 110.89 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -73.46 172.16 11.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 75.03 110.915 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.408 ' O ' HG11 ' A' ' 176' ' ' VAL . 11.8 p-10 -54.44 -27.39 36.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 74.52 110.875 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -82.23 -45.78 14.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 73.42 110.87 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -63.71 -45.18 91.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.23 110.874 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.435 ' CD1' HD12 ' A' ' 180' ' ' LEU . 21.2 mt -52.43 -31.35 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 70.12 111.123 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.95 58.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 73.43 111.111 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.75 -22.85 59.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.734 . . . . 71.13 112.501 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.682 HD13 HD21 ' A' ' 148' ' ' LEU . 3.8 tp -70.09 -59.09 3.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.808 0.337 . . . . 63.0 110.909 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 27.3 mt -52.16 -32.65 36.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 71.32 110.944 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -51.9 -57.26 9.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 51.13 110.91 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.0 -41.54 28.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 73.12 110.867 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.5 m -51.63 -30.99 23.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 70.1 111.159 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.38 -52.47 9.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 71.54 110.922 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.402 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -54.84 -25.51 28.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 63.33 111.135 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -54.29 -32.47 56.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.24 110.853 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.4 ptp -105.67 21.13 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.888 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.83 16.56 66.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 42.23 112.468 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.16 166.96 0.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.82 0.343 . . . . 70.44 110.873 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.2 m -65.36 -14.58 61.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.868 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 2.2 t30 64.21 58.32 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 72.05 110.908 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -73.29 153.08 40.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 73.01 110.919 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.406 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 10.2 m -108.09 90.91 7.2 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.685 . . . . 70.33 111.133 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.8 Cg_endo -69.74 -174.65 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.696 2.264 . . . . 75.04 112.355 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 176' ' ' VAL . 71.2 p -129.01 -176.01 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 75.51 111.135 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -54.72 -26.67 35.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 70.31 110.872 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.609 ' O ' HD12 ' A' ' 178' ' ' ILE . 8.3 tp10 -72.56 -61.64 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.89 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.07 -48.6 64.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.867 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 172' ' ' THR . 86.6 t -51.68 -42.48 31.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 45.22 111.084 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -47.0 64.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 72.13 110.918 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.9 mp -62.44 -26.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.15 111.088 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.54 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 52.3 t90 -83.78 -30.76 26.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 71.42 110.927 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 184' ' ' ASP . 3.2 tt -77.59 -47.05 20.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 72.33 110.954 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -51.95 -30.92 26.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 60.23 110.912 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 37.1 ttp -90.41 -26.43 19.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.55 110.844 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.769 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -96.09 21.91 8.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 74.13 111.133 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.534 ' HB2' HD23 ' A' ' 180' ' ' LEU . 21.1 t0 -131.8 112.2 12.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.842 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.5 m -83.74 -41.79 17.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 61.24 111.16 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.47 -12.5 59.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 64.54 110.896 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 54.66 35.2 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 64.14 110.847 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.45 -16.23 37.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.89 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.0 20.24 16.91 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 44.24 112.48 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.52 126.71 8.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 74.35 110.864 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.49 97.53 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 72.5 111.066 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.1 t -67.71 165.18 17.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.41 110.838 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 26.1 tp -53.62 -35.94 61.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 72.04 110.875 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -77.08 -24.67 51.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.907 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -79.58 -53.33 6.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 71.32 110.906 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.619 ' CE1' HD21 ' A' ' 156' ' ' LEU . 22.5 t80 -51.98 -49.95 62.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.934 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.753 ' HG3' HD22 ' A' ' 130' ' ' LEU . 3.0 tp10 -51.82 -47.61 64.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 73.14 110.903 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -52.8 -32.53 44.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.487 . . . . 54.02 110.904 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 183' ' ' ALA . 3.0 tp -62.5 -38.94 91.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.937 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -74.17 -24.05 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.11 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.455 HG22 ' NE2' ' A' ' 205' ' ' GLN . 45.0 mm -59.4 -55.87 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.12 111.114 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -56.24 -37.95 70.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.42 110.892 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.6 t -66.98 -28.48 68.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 73.23 110.869 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 129' ' ' LYS . 21.3 mt -79.34 -25.42 42.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.44 110.956 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.568 ' OE1' HG12 ' A' ' 211' ' ' VAL . 2.7 mp0 -59.99 -45.59 92.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.879 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -86.05 -20.37 28.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.911 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.93 -22.77 67.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.056 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 108.9 32.44 3.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.78 -0.724 . . . . 75.21 112.472 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 125' ' ' GLU . 5.3 mp -124.12 131.01 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 74.4 111.107 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -90.55 133.63 34.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.904 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.568 HG12 ' OE1' ' A' ' 205' ' ' GLN . 6.7 p -138.18 144.08 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.154 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -129.1 132.58 47.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 74.13 110.898 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -120.83 146.48 46.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 73.1 110.868 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -96.47 95.5 8.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 72.14 110.91 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -140.22 172.17 13.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 72.33 110.849 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 58.0 mt -88.42 140.69 29.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 62.43 110.898 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 16.0 m -101.7 155.77 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 64.12 111.188 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 4.1 t80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.878 179.997 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.9 0.381 . . . . 73.24 110.84 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 66.1 m -73.76 150.95 40.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 70.11 110.803 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 156.09 79.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 64.32 110.931 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 143.79 51.99 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.706 2.271 . . . . 74.03 112.351 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 102.6 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.845 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.07 132.85 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 60.13 110.964 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -52.02 160.49 1.17 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.623 0.725 . . . . 31.34 110.879 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -17.13 37.61 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.688 2.258 . . . . 72.51 112.34 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.495 ' CG ' HG23 ' A' ' 209' ' ' ILE . 18.4 pt-20 -82.9 -24.63 33.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.906 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.455 HG21 HG23 ' A' ' 211' ' ' VAL . 3.0 t -78.35 -63.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 43.44 111.115 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 130' ' ' LEU . 8.3 tt0 -52.15 -30.01 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 74.02 110.879 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.76 -32.69 60.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 62.14 111.123 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.604 ' HG2' HG21 ' A' ' 200' ' ' ILE . 24.6 tttm -87.96 -25.73 23.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 75.02 110.936 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 197' ' ' GLU . 25.2 mt -77.9 -29.23 50.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.935 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -65.7 -32.59 74.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.896 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 129' ' ' LYS . 11.7 p -86.05 -23.36 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 52.21 111.12 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -82.78 -35.55 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 33.35 111.108 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -24.46 57.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.817 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -83.17 -23.07 33.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 73.54 110.866 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.59 -24.34 33.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.899 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.681 ' CE1' HD13 ' A' ' 148' ' ' LEU . 90.3 t80 -65.54 -56.43 12.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 64.25 110.881 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -72.22 -24.22 61.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.88 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -52.08 -29.88 23.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 74.53 110.875 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -110.69 -21.14 12.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.901 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -75.62 69.66 2.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 52.12 110.872 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -85.14 0.51 51.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 71.15 110.895 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.39 -10.57 59.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.869 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.16 18.7 60.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 75.23 112.529 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 p -106.32 -22.0 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.382 . . . . 61.13 110.869 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.6 21.53 66.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 61.32 112.48 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -128.72 132.54 47.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 61.41 110.879 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.681 HD13 ' CE1' ' A' ' 137' ' ' PHE . 1.2 mp -90.81 104.78 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.923 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -88.04 177.27 6.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 72.4 110.944 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -52.04 -30.08 23.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.33 110.898 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 53.1 m-20 -80.4 -55.04 5.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 74.0 110.834 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -53.95 -46.02 71.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 61.32 110.929 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.403 ' CD1' HD12 ' A' ' 180' ' ' LEU . 39.3 mt -57.19 -33.72 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 74.32 111.11 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 151' ' ' ASP . . . -51.15 -48.06 61.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 72.32 111.079 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.36 -24.72 70.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 60.1 112.492 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.572 HD13 HD21 ' A' ' 148' ' ' LEU . 1.7 tp -69.42 -55.93 8.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 75.2 110.926 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.412 HD21 ' CE2' ' A' ' 179' ' ' TRP . 70.7 mt -51.69 -30.16 20.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 62.02 110.884 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.772 ' HE3' HG23 ' A' ' 170' ' ' THR . 0.7 OUTLIER -57.15 -58.57 7.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 55.11 110.915 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -71.77 -42.85 66.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 65.22 110.86 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.1 m -52.17 -34.94 47.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 62.55 111.171 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -82.11 -25.72 34.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.94 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -78.91 -25.38 43.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 52.1 111.066 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -59.68 -44.78 93.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 75.4 110.843 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.3 mtm -75.08 -18.29 60.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 64.53 110.866 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.95 17.72 36.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 65.22 112.532 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.3 ttm -66.67 175.93 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.799 0.333 . . . . 74.34 110.828 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.4 m -65.72 -14.39 61.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 63.13 110.855 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.553 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 0.6 OUTLIER 64.21 73.73 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 61.14 110.841 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -78.52 152.93 31.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 75.15 110.859 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.772 HG23 ' HE3' ' A' ' 158' ' ' LYS . 11.3 m -108.03 90.88 7.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.581 0.705 . . . . 63.11 111.124 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 169.19 19.43 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.703 2.268 . . . . 51.25 112.348 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 176' ' ' VAL . 62.7 p -108.63 -176.06 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 74.23 111.139 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -24.97 46.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 75.5 110.89 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.656 ' O ' HD12 ' A' ' 178' ' ' ILE . 38.7 tt0 -77.8 -55.4 5.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.13 110.895 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.57 -35.89 43.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 73.44 110.872 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 172' ' ' THR . 88.4 t -65.83 -36.79 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 62.11 111.144 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -59.03 -46.63 87.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.898 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.656 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -62.61 -28.01 43.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 74.41 111.111 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.528 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 49.5 t90 -83.8 -26.03 29.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.892 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.616 HD23 ' HB2' ' A' ' 184' ' ' ASP . 3.0 tt -77.3 -35.21 55.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.14 110.875 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.67 -26.62 67.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 72.52 110.907 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.9 ttm -87.66 -49.81 6.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 72.2 110.895 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.478 ' HB3' HG21 ' A' ' 191' ' ' VAL . . . -61.32 -44.37 97.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 63.01 111.107 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.616 ' HB2' HD23 ' A' ' 180' ' ' LEU . 29.8 t0 -58.57 98.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 51.22 110.804 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 97.4 m -86.66 -24.75 25.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 75.14 111.133 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -95.44 -12.35 26.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 71.34 110.902 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 62.27 48.16 4.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.853 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -110.31 23.81 13.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 62.1 110.862 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.68 14.51 58.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 43.54 112.503 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.72 158.86 40.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 74.12 110.86 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 183' ' ' ALA . 34.4 t -117.62 122.72 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 70.32 111.141 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 -169.74 2.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.873 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -66.4 -43.83 84.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 72.4 110.893 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -72.49 -34.59 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 71.3 110.878 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.7 -23.03 53.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 71.13 110.899 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.518 ' CE1' HD21 ' A' ' 156' ' ' LEU . 23.2 t80 -82.11 -50.33 9.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 74.03 110.959 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' A' ' 130' ' ' LEU . 10.9 pt-20 -53.61 -43.71 68.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 63.13 110.866 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -52.01 -29.96 23.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.22 110.885 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.528 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 1.7 tp -64.35 -43.1 95.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 72.42 110.946 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.604 HG21 ' HG2' ' A' ' 129' ' ' LYS . 5.2 mp -69.78 -24.64 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.42 111.126 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.607 HD11 HD11 ' A' ' 130' ' ' LEU . 50.0 mm -59.2 -55.6 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 72.11 111.142 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -52.62 -38.07 59.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 74.12 110.876 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 p -74.57 -29.81 61.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.892 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.941 HD23 HD13 ' A' ' 209' ' ' ILE . 4.7 mt -68.51 -33.37 74.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 64.44 110.948 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -57.67 -47.18 83.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 73.15 110.905 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -24.68 32.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 63.25 110.909 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.88 -21.18 66.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 44.34 111.118 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.89 20.7 4.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.738 . . . . 72.25 112.535 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.941 HD13 HD23 ' A' ' 204' ' ' LEU . 5.3 mp -119.73 103.85 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 74.12 111.138 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -72.12 108.45 5.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 71.51 110.86 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.455 HG23 HG21 ' A' ' 126' ' ' VAL . 6.2 p -102.55 143.9 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.3 111.168 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.45 128.21 52.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.892 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.24 151.08 42.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 63.32 110.9 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -66.12 102.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 64.22 110.906 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 12.5 t -136.37 176.5 8.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 71.31 110.897 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.5 mt -119.68 130.63 55.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.871 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.89 142.56 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 73.53 111.087 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 46.4 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 60.32 110.88 -179.97 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.881 0.372 . . . . 74.12 110.822 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.7 p -77.67 111.89 13.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 64.22 110.828 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -97.15 137.66 21.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.603 0.716 . . . . 75.41 110.918 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 119.04 6.05 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.686 2.257 . . . . 75.13 112.387 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -74.93 102.65 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 71.21 110.937 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -91.01 132.95 35.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.924 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -51.93 160.88 1.03 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 63.23 110.871 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -17.19 37.61 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.715 2.277 . . . . 73.44 112.301 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -82.99 -24.84 32.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 73.23 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.444 HG21 HG13 ' A' ' 211' ' ' VAL . 3.1 t -77.59 -63.35 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 74.51 111.128 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.437 ' OE2' HD12 ' A' ' 130' ' ' LEU . 4.2 tp10 -51.88 -33.61 37.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 60.04 110.876 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.42 -36.36 54.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 63.1 111.144 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.651 ' HB3' HD11 ' A' ' 204' ' ' LEU . 21.5 tptt -83.06 -26.17 31.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.53 110.921 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.771 HD11 HD11 ' A' ' 201' ' ' ILE . 92.5 mt -74.31 -37.19 63.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.34 110.953 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.91 -57.25 11.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 75.12 110.924 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.89 -25.23 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.14 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.86 -29.7 40.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 61.33 111.139 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -60.03 -54.26 48.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 70.32 110.869 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 -54.24 -46.24 72.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.841 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.8 tp -56.97 -34.37 68.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 72.41 110.925 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -59.77 -62.99 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 72.12 110.907 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -62.89 -26.96 69.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 63.44 110.902 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -31.42 36.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.902 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.29 -38.08 7.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 75.24 110.943 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.88 76.23 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 74.31 110.857 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -67.2 -30.62 70.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 75.53 110.907 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.92 -10.55 59.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.32 110.869 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.74 22.49 40.56 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.733 -0.746 . . . . 64.35 112.463 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.3 m -71.42 -22.06 61.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 62.4 110.891 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.7 23.5 57.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.514 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -145.79 130.74 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.358 . . . . 63.35 110.908 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mt -103.85 101.42 11.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 73.3 110.934 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -62.89 174.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 54.02 110.901 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.14 -26.49 38.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 34.51 110.891 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.63 -54.67 5.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 63.34 110.857 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -52.22 -38.85 59.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 61.21 110.899 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.3 mt -63.32 -32.96 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 74.11 111.115 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.7 -42.13 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 63.2 111.115 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.34 -25.9 45.77 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.713 -0.756 . . . . 72.53 112.465 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.2 tp -60.88 -55.85 28.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 73.51 110.937 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.5 mt -52.03 -33.94 40.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 65.13 110.903 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -59.73 4.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 71.33 110.923 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.13 -41.42 61.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 72.31 110.832 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 89.0 m -53.44 -32.92 52.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 74.33 111.126 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -77.33 -51.23 11.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.895 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.522 ' HB2' ' ND2' ' A' ' 168' ' ' ASN . . . -58.19 -30.63 66.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 65.13 111.113 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.9 -46.77 64.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 65.44 110.922 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 33.1 mtm -76.8 -18.46 58.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 63.41 110.912 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 95.89 28.66 9.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.74 -0.743 . . . . 73.35 112.426 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 6.3 ttm -86.0 175.79 8.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 75.14 110.853 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.0 m -58.29 -22.97 54.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 71.32 110.848 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 162' ' ' ALA . 37.8 t-20 63.36 60.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 60.31 110.896 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -65.62 152.51 43.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 73.33 110.864 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.0 p -108.31 90.82 7.39 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.589 0.709 . . . . 73.33 111.135 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -171.19 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.28 . . . . 64.35 112.322 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.627 ' O ' HG23 ' A' ' 176' ' ' VAL . 34.3 p -126.5 -176.17 3.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.132 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -57.45 -26.36 61.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 64.51 110.918 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 178' ' ' ILE . 9.8 tt0 -72.53 -61.56 1.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 73.14 110.886 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.27 -48.82 65.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.477 . . . . 75.22 110.849 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 172' ' ' THR . 85.7 t -51.62 -34.87 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 54.22 111.115 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.27 -52.53 64.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 73.42 110.882 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.551 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.8 mp -57.46 -25.83 25.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 72.14 111.171 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.513 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 49.6 t90 -82.69 -37.72 24.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 74.05 110.935 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.6 tt -57.63 -46.38 84.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 72.41 110.865 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -54.7 -36.38 64.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 61.34 110.925 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.2 mtm -65.79 -54.22 29.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 70.12 110.873 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.592 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . . . -64.53 -63.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 51.22 111.098 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -69.32 129.28 39.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 60.45 110.888 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 8.5 m -85.22 -24.79 27.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.123 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -89.39 -12.4 40.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 70.44 110.904 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.5 p 51.59 39.73 25.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 71.52 110.898 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -95.24 23.92 5.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.89 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 65.58 29.3 74.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.739 . . . . 50.13 112.49 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m -154.71 126.88 7.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.401 . . . . 63.32 110.828 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.71 106.38 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 60.24 111.133 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.1 t -72.1 178.32 3.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 72.43 110.86 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.536 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -63.67 -38.03 89.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.946 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -81.26 -25.59 36.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 63.32 110.899 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.35 -23.19 40.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 70.01 110.882 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.494 ' O ' HD12 ' A' ' 200' ' ' ILE . 19.4 t80 -84.27 -51.81 6.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 74.55 110.936 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.764 ' HB2' HD22 ' A' ' 130' ' ' LEU . 13.5 pt-20 -53.1 -43.83 67.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.487 . . . . 72.24 110.888 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -52.74 -41.91 64.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 65.22 110.909 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 9.0 tt -52.42 -39.61 61.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 72.44 110.919 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.3 mp -73.81 -25.85 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 70.34 111.152 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.771 HD11 HD11 ' A' ' 130' ' ' LEU . 50.5 mm -67.45 -38.14 80.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 73.42 111.121 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -66.28 -36.88 84.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 72.34 110.9 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 43.7 m -78.36 -37.82 43.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.865 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.651 HD11 ' HB3' ' A' ' 129' ' ' LYS . 18.7 mt -57.8 -35.89 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 73.14 110.919 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -56.83 -37.71 71.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.908 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -85.59 -24.88 26.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 65.23 110.951 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.74 67.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 75.34 111.126 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.72 24.15 3.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 65.13 112.51 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.04 102.0 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 71.33 111.135 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -69.45 101.26 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 53.51 110.915 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.444 HG13 HG21 ' A' ' 126' ' ' VAL . 21.2 t -76.9 150.38 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 75.51 111.142 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -123.41 126.27 46.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 71.32 110.876 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.97 158.94 43.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 71.42 110.889 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -83.89 84.63 7.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 64.13 110.895 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 12.4 p -74.85 167.67 21.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 72.0 110.847 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.2 pt? -146.77 175.94 10.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 73.25 110.886 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.7 t -58.78 109.85 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 73.3 111.091 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.845 -179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.912 0.387 . . . . 64.44 110.872 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -124.36 124.5 42.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 71.34 110.842 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -93.79 160.71 32.05 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.537 0.684 . . . . 73.53 110.933 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 131.95 22.2 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.66 2.24 . . . . 63.25 112.35 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -81.41 106.34 13.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 71.42 110.897 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -105.02 134.83 47.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 73.51 110.955 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.66 160.8 1.84 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 72.42 110.89 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -21.41 33.27 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 2.253 . . . . 75.0 112.337 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.94 -21.83 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 74.05 110.863 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.81 HG13 HD23 ' A' ' 204' ' ' LEU . 3.0 t -77.73 -61.17 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.23 111.173 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -52.08 -29.86 23.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.03 110.892 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.81 -38.73 70.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 44.44 111.132 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.542 ' HG2' HD11 ' A' ' 204' ' ' LEU . 16.9 tptm -83.95 -25.39 30.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.04 110.938 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 197' ' ' GLU . 90.2 mt -75.24 -30.27 60.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 70.21 110.933 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.65 -56.13 25.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.472 . . . . 64.51 110.847 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.97 -26.75 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 70.4 111.142 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.83 -32.2 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 51.02 111.091 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.711 ' HG2' HD11 ' A' ' 193' ' ' LEU . 37.0 mtt180 -59.94 -45.78 91.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 64.53 110.878 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -60.71 -33.03 72.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 73.45 110.864 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.0 tp -69.48 -26.32 64.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 41.43 110.921 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -64.07 -63.72 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 54.3 110.906 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -59.43 -26.64 65.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 64.22 110.89 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -55.99 -26.92 50.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.874 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -110.35 -27.19 9.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.959 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.12 78.74 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.848 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -26.11 33.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 73.25 110.926 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -70.78 -10.63 59.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.858 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.99 20.66 50.18 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.761 -0.733 . . . . 64.43 112.461 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 p -86.84 -22.09 26.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 65.11 110.829 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.21 23.1 41.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 31.32 112.473 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -138.28 152.01 48.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 74.14 110.902 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.4 mt -118.81 102.69 9.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 51.04 110.895 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -70.62 173.9 6.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.875 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.455 ' HA ' HD12 ' A' ' 153' ' ' ILE . 3.5 p-10 -55.07 -26.76 39.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 54.52 110.879 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.4 -32.34 48.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 74.52 110.865 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -84.5 -26.26 28.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 70.23 110.857 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.509 ' CG2' HG13 ' A' ' 176' ' ' VAL . 21.3 mt -74.51 -41.04 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 71.2 111.149 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.56 -45.11 62.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 62.05 111.117 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.22 -22.84 56.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.754 . . . . 60.03 112.496 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.9 tp -60.31 -54.41 46.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 65.34 110.953 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.91 -34.42 41.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 64.21 110.953 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -52.94 -49.21 66.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.3 110.899 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -82.25 -43.35 17.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.869 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.2 m -53.79 -30.95 47.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 54.1 111.207 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -81.04 -57.92 3.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.708 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -55.46 -25.6 37.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.45 111.143 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.17 -26.3 62.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.907 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 38.7 mtm -110.75 21.68 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.867 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 18.56 68.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.749 -0.739 . . . . 64.31 112.486 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.0 mmt -63.31 171.8 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 75.35 110.903 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.1 t -59.83 -20.92 59.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 75.04 110.876 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 6.5 t30 63.66 63.77 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 71.55 110.896 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -88.26 152.49 21.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 61.22 110.868 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.5 p -108.24 90.83 7.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.577 0.703 . . . . 60.24 111.148 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 157.03 61.75 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.639 2.226 . . . . 75.52 112.369 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.677 ' O ' HG23 ' A' ' 176' ' ' VAL . 71.9 p -91.91 -176.94 4.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.34 111.166 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -56.44 -25.38 50.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.864 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.633 ' O ' HD12 ' A' ' 178' ' ' ILE . 0.9 OUTLIER -73.15 -59.92 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.04 110.918 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -52.99 -30.91 37.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 44.41 110.905 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 172' ' ' THR . 69.7 t -69.4 -32.56 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 60.32 111.111 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.15 -43.66 94.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 65.33 110.899 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.633 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -63.98 -34.64 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 74.01 111.144 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' TRP . . . . . 0.677 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 88.9 t90 -81.7 -25.72 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 72.23 110.901 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.476 HD13 ' CD1' ' A' ' 153' ' ' ILE . 31.1 tp -83.8 -25.34 30.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 71.32 110.89 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -52.98 -58.38 7.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 60.13 110.93 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 43.5 mtm -67.09 -46.05 75.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 63.53 110.851 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.807 ' HB2' HD11 ' A' ' 199' ' ' LEU . . . -56.1 -25.04 44.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 75.03 111.127 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -88.26 95.75 10.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.21 110.883 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.8 m -87.68 -34.5 18.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 65.32 111.11 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.29 6.34 33.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 71.14 110.9 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.9 p 46.14 36.44 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 71.22 110.83 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -96.33 -16.27 21.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 74.41 110.802 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 99.29 19.44 20.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.767 -0.73 . . . . 63.4 112.476 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.2 m -142.31 -177.35 5.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.937 0.398 . . . . 62.1 110.838 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.87 106.37 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 61.41 111.155 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -77.51 -176.05 4.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.868 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.711 HD11 ' HG2' ' A' ' 134' ' ' ARG . 0.5 OUTLIER -66.99 -38.58 86.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 75.25 110.937 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -77.75 -25.65 49.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.905 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -84.93 -23.54 28.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 71.53 110.91 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.487 ' HD1' HD12 ' A' ' 199' ' ' LEU . 30.8 t80 -81.87 -43.53 18.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 71.33 110.877 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.527 ' HA ' HD13 ' A' ' 200' ' ' ILE . 10.9 pt-20 -54.06 -41.86 68.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.03 110.864 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -51.7 -44.08 63.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 73.55 110.932 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.807 HD11 ' HB2' ' A' ' 183' ' ' ALA . 53.4 mt -51.75 -33.88 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.921 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.527 HD13 ' HA ' ' A' ' 197' ' ' GLU . 5.3 mp -79.43 -36.08 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 60.45 111.114 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.44 -29.62 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.117 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.58 -62.16 2.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 64.02 110.912 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 46.3 t -53.14 -37.37 61.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 43.11 110.904 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.81 HD23 HG13 ' A' ' 126' ' ' VAL . 6.9 mp -55.65 -24.57 34.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 74.11 110.944 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.95 -58.98 3.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 74.01 110.894 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -78.78 -5.81 54.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 72.23 110.892 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.443 ' HB3' HG12 ' A' ' 209' ' ' ILE . . . -91.17 13.99 15.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 61.45 111.158 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.16 33.46 85.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 62.23 112.514 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ILE . . . . . 0.443 HG12 ' HB3' ' A' ' 207' ' ' ALA . 6.5 mm -102.1 111.72 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 54.33 111.124 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 100.28 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 63.11 110.907 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.8 p -112.5 130.5 66.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 53.01 111.114 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.31 107.99 19.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 74.42 110.86 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.69 120.35 14.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 65.34 110.951 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -59.46 120.75 9.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 75.44 110.935 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 55.3 p -139.96 132.27 28.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 62.15 110.836 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mp -104.14 143.64 32.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 61.34 110.927 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.41 145.15 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 74.43 111.153 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.6 p90 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 65.44 110.853 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.878 0.371 . . . . 74.12 110.911 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.62 161.12 62.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.721 . . . . 75.22 110.9 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -18.87 36.81 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.678 2.252 . . . . 73.33 112.326 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.466 ' HB3' HG23 ' A' ' 209' ' ' ILE . 4.6 tp10 -82.04 -23.56 35.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 62.11 110.873 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.55 -63.28 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 51.25 111.119 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -51.86 -30.66 24.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 63.35 110.855 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -37.91 63.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 70.44 111.107 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.659 ' HB3' HD11 ' A' ' 204' ' ' LEU . 30.5 tptt -87.98 -25.73 23.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.45 110.926 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.692 HD22 ' HB2' ' A' ' 197' ' ' GLU . 87.3 mt -72.92 -27.27 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.895 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -66.64 -51.8 52.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.853 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.35 -25.15 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 71.5 111.121 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.25 -25.62 36.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.085 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.645 ' HG2' HD11 ' A' ' 193' ' ' LEU . 44.9 mtp180 -67.13 -47.18 71.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.3 110.842 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -63.41 -35.21 79.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 70.32 110.882 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.72 -29.48 69.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 73.23 110.896 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -65.5 -59.55 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 73.22 110.852 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -64.47 -28.07 69.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 61.23 110.882 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -55.5 -26.75 44.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 62.4 110.89 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -108.21 -30.48 8.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 65.5 110.919 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.23 84.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.892 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -85.03 -32.01 23.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.15 110.925 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.56 -10.57 59.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 53.13 110.864 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.75 23.29 43.88 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.722 -0.752 . . . . 55.14 112.476 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.9 p -75.25 -22.17 58.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 74.43 110.845 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.5 19.64 58.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.734 . . . . 64.24 112.463 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -148.34 130.75 15.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 64.35 110.918 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' HD11 ' A' ' 153' ' ' ILE . 21.7 mt -94.13 101.67 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 64.34 110.897 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -66.26 174.13 2.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 71.44 110.924 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.98 -30.15 23.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 75.05 110.868 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.73 -54.7 6.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.213 -0.448 . . . . 72.43 110.882 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -55.24 -28.36 52.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.45 110.872 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 148' ' ' LEU . 45.6 mt -79.69 -25.44 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 62.31 111.102 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.31 -53.12 48.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 72.2 111.124 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.05 -23.03 56.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.678 -0.772 . . . . 63.43 112.506 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -56.61 -52.6 64.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 62.14 110.922 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.9 mt -52.02 -41.43 62.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 72.54 110.905 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -51.93 -38.87 57.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 65.2 110.881 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -85.11 -49.58 8.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.23 110.86 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.2 m -53.09 -29.02 28.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.32 111.163 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -76.82 -33.57 57.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 74.02 110.961 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.458 ' HB2' ' ND2' ' A' ' 168' ' ' ASN . . . -60.71 -25.16 66.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 53.24 111.062 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -55.71 -26.97 47.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.44 110.9 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 19.9 mtm -109.81 16.8 21.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 71.12 110.889 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 19.46 69.47 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 35.1 112.468 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.3 tpp -63.39 168.41 4.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 73.2 110.883 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 43.2 t -71.12 -10.38 59.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 75.22 110.82 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 162' ' ' ALA . 1.2 m120 63.34 51.82 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 63.52 110.957 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -52.99 152.51 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 52.11 110.893 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 4.4 m -108.22 90.84 7.3 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.54 0.686 . . . . 71.44 111.129 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.8 Cg_endo -69.75 -177.37 1.84 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.664 2.242 . . . . 64.25 112.338 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 176' ' ' VAL . 73.1 p -123.82 -176.1 3.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 64.4 111.131 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -55.5 -27.32 47.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.9 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.622 ' O ' HD12 ' A' ' 178' ' ' ILE . 23.9 tt0 -73.15 -61.13 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 74.01 110.891 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -52.02 -44.91 64.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.823 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 172' ' ' THR . 86.7 t -57.47 -28.69 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 62.03 111.117 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -68.03 -45.69 73.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 74.32 110.904 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.622 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.4 mp -66.44 -25.98 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 44.12 111.15 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.51 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 47.9 t90 -83.21 -30.42 27.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 71.21 110.92 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.506 HD23 ' CB ' ' A' ' 184' ' ' ASP . 1.3 tt -68.71 -37.89 79.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 54.12 110.93 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -63.02 -27.39 69.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 43.04 110.903 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.0 ttm -71.93 -54.51 9.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 75.43 110.912 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.779 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -74.27 -66.27 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 73.11 111.119 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.506 ' CB ' HD23 ' A' ' 180' ' ' LEU . 48.1 t0 -53.27 129.17 30.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 53.02 110.851 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 25.1 m -85.67 -25.16 26.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 61.02 111.135 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -98.58 -12.45 21.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.936 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.3 p 51.97 37.77 22.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 52.12 110.845 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -95.42 23.96 5.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.87 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.31 31.64 74.67 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 44.3 112.478 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.44 126.98 9.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 44.12 110.858 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 184' ' ' ASP . 30.0 t -115.6 104.85 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 62.13 111.133 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 37.3 t -69.4 170.67 9.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 52.15 110.878 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.645 HD11 ' HG2' ' A' ' 134' ' ' ARG . 0.4 OUTLIER -57.81 -36.66 72.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.32 110.956 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.46 -25.64 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 74.53 110.892 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -81.77 -23.3 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 73.12 110.891 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.434 ' O ' HD12 ' A' ' 200' ' ' ILE . 31.8 t80 -83.8 -51.85 6.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 62.42 110.906 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.692 ' HB2' HD22 ' A' ' 130' ' ' LEU . 14.8 pt-20 -52.03 -43.81 63.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 71.41 110.871 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.93 -41.17 61.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 55.43 110.881 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 183' ' ' ALA . 5.0 tp -53.89 -35.68 61.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 71.35 110.916 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.3 mp -78.99 -25.12 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 61.12 111.091 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.552 ' CD1' HD21 ' A' ' 130' ' ' LEU . 44.9 mm -62.18 -50.88 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 64.34 111.163 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -55.85 -36.09 67.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 73.11 110.877 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -77.94 -35.36 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 62.3 110.841 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 129' ' ' LYS . 22.9 mt -62.32 -28.33 69.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 65.4 110.943 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -64.19 -43.49 94.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 64.2 110.928 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -85.94 -24.92 26.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 54.31 110.901 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.94 -22.58 67.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.099 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.5 31.86 1.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 71.05 112.486 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.496 HD13 ' CD2' ' A' ' 204' ' ' LEU . 5.3 mp -122.68 122.89 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 72.44 111.124 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -83.01 119.5 24.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 71.52 110.897 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.124 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.925 0.393 . . . . 71.34 110.918 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -53.18 160.55 1.61 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 65.44 110.922 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -20.1 35.44 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.705 2.27 . . . . 72.54 112.394 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -82.85 -20.33 35.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 61.25 110.908 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.513 HG11 ' CG2' ' A' ' 211' ' ' VAL . 2.7 t -81.3 -63.35 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 53.32 111.149 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -25.43 42.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 61.41 110.897 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.34 78.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 53.23 111.081 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.412 ' HG2' HD11 ' A' ' 204' ' ' LEU . 18.8 tptt -88.45 -25.37 22.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 74.1 110.903 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.835 HD22 ' HG2' ' A' ' 197' ' ' GLU . 30.9 mt -79.33 -24.06 43.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.933 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.68 -46.51 65.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.904 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.19 -23.61 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 71.22 111.106 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -77.4 -21.79 52.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 63.34 111.078 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.557 ' HG2' HD11 ' A' ' 193' ' ' LEU . 55.5 mtt85 -69.12 -52.29 29.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.889 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -52.03 -29.95 23.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 75.04 110.856 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.655 HD21 ' OD2' ' A' ' 159' ' ' ASP . 12.9 mt -71.71 -44.53 64.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 72.5 110.929 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -52.36 -48.05 65.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 52.01 110.895 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -75.93 -28.41 57.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 64.11 110.86 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -67.9 -25.91 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.11 110.886 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.527 ' HE2' HD22 ' A' ' 136' ' ' LEU . 37.2 m-85 -104.51 -26.2 12.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 65.33 110.968 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -90.43 64.45 5.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.521 . . . . 55.5 110.886 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -28.19 67.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 73.04 110.893 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -70.76 -10.52 59.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.889 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.86 25.74 53.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 42.0 112.502 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.8 p -75.85 -22.1 56.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.924 0.392 . . . . 64.43 110.882 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.62 19.57 65.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 74.35 112.513 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -149.91 130.8 14.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 63.31 110.922 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.7 mt -94.97 101.74 13.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.879 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -70.16 171.81 9.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.932 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -52.13 -30.14 25.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 51.31 110.826 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -74.61 -45.95 41.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 64.24 110.881 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.36 -38.95 88.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 64.23 110.859 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 176' ' ' VAL . 53.4 mt -65.46 -30.97 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 73.25 111.157 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.78 -45.76 63.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 62.21 111.102 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.32 -27.45 39.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 60.15 112.493 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.552 HD21 ' CE1' ' A' ' 196' ' ' TYR . 4.2 tp -54.81 -56.56 18.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 72.21 110.919 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.0 mt -51.96 -33.93 39.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.934 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -52.71 -50.5 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 74.45 110.854 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.655 ' OD2' HD21 ' A' ' 136' ' ' LEU . 10.5 t0 -82.26 -44.25 16.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 64.4 110.871 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.9 m -52.16 -29.55 22.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 63.32 111.18 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -79.33 -49.17 12.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 61.42 110.968 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.97 -24.71 55.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 72.23 111.105 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . 0.542 ' OE2' HD11 ' A' ' 136' ' ' LEU . 0.3 OUTLIER -55.04 -27.14 42.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 64.14 110.852 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.1 mtm -111.28 21.71 15.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 75.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.92 19.05 69.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 72.24 112.494 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.4 tpp -64.38 164.04 12.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 73.15 110.896 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.8 t -62.47 -17.62 59.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 74.33 110.848 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 63.52 56.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 72.43 110.9 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -65.87 152.61 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.855 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 p -108.23 90.84 7.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.544 0.688 . . . . 74.0 111.11 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -172.88 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 51.41 112.347 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.61 ' O ' HG23 ' A' ' 176' ' ' VAL . 79.9 p -120.76 -177.37 3.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 70.22 111.16 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -60.18 -25.69 65.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 55.15 110.93 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.611 ' O ' HD12 ' A' ' 178' ' ' ILE . 32.2 tt0 -72.51 -61.5 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 62.25 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -52.22 -49.0 64.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 72.32 110.871 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 172' ' ' THR . 98.1 t -52.76 -33.53 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 63.44 111.124 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -62.44 -49.9 73.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 73.12 110.92 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -61.15 -25.15 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 74.25 111.098 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.585 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 47.1 t90 -78.15 -30.29 49.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.956 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.539 ' O ' HD23 ' A' ' 180' ' ' LEU . 2.1 tt -72.54 -34.77 67.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 71.34 110.933 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -61.25 -28.74 69.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 65.01 110.923 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 5.9 ttp -86.92 -39.09 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 34.31 110.87 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . . . -68.33 -49.95 56.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 72.24 111.113 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -84.24 127.59 34.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 71.54 110.894 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 21.3 p -76.08 -42.69 46.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 61.14 111.101 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -76.32 -12.41 60.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 61.34 110.891 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.1 p 52.15 37.19 21.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 72.55 110.827 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -79.04 -16.21 57.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 75.42 110.887 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.1 22.82 8.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 54.1 112.489 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.2 p -153.6 127.14 8.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.916 0.389 . . . . 53.32 110.82 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 196' ' ' TYR . 21.9 t -106.41 124.83 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 62.3 111.096 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -174.77 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 70.32 110.897 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.557 HD11 ' HG2' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -57.11 -33.62 67.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 70.33 110.927 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.06 -62.35 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.87 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.414 ' HB3' HG13 ' A' ' 191' ' ' VAL . 6.6 mp0 -52.37 -46.16 66.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 64.12 110.878 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.552 ' CE1' HD21 ' A' ' 156' ' ' LEU . 17.2 t80 -62.04 -58.34 8.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.888 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.835 ' HG2' HD22 ' A' ' 130' ' ' LEU . 72.5 tt0 -54.89 -28.12 48.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.914 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -72.5 -29.54 63.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 75.53 110.819 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.585 HD13 ' CZ2' ' A' ' 179' ' ' TRP . 8.4 tt -64.0 -35.08 79.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 34.14 110.897 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -73.34 -24.91 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 74.33 111.116 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.464 HD13 HD21 ' A' ' 130' ' ' LEU . 50.7 mm -58.4 -43.37 86.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 54.41 111.11 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -67.81 -48.16 67.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 63.25 110.889 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 53.5 p -52.18 -40.86 62.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 51.12 110.864 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.422 ' HG ' HD13 ' A' ' 209' ' ' ILE . 6.7 mp -73.99 -33.16 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 75.21 110.926 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -43.3 89.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 64.04 110.911 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -86.11 -25.77 25.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 63.11 110.908 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.98 -22.76 67.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 72.01 111.094 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.43 20.14 5.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.739 . . . . 45.15 112.49 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.422 HD13 ' HG ' ' A' ' 204' ' ' LEU . 5.3 mp -113.15 102.75 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.815 0.341 . . . . 72.14 111.121 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -71.06 126.03 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.871 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.513 ' CG2' HG11 ' A' ' 126' ' ' VAL . 4.3 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.05 111.128 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.888 0.375 . . . . 60.13 110.944 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -78.3 160.82 72.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.615 0.721 . . . . 74.43 110.926 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -20.26 35.05 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.733 2.289 . . . . 52.11 112.329 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -82.89 -20.94 34.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 73.21 110.887 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.489 HG13 HD22 ' A' ' 204' ' ' LEU . 3.2 t -76.74 -61.99 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 53.43 111.132 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.66 -30.08 20.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 71.11 110.894 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.5 -34.52 71.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.125 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.416 ' O ' HG12 ' A' ' 132' ' ' VAL . 33.9 tptt -88.36 -23.98 23.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.53 110.954 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.554 HD22 ' HB3' ' A' ' 197' ' ' GLU . 38.7 mt -80.88 -24.31 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 72.41 110.878 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.04 -29.48 65.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 72.41 110.876 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 129' ' ' LYS . 10.1 p -85.99 -23.38 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 75.14 111.115 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.14 -37.51 20.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 73.23 111.11 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -54.65 -29.99 54.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 75.22 110.87 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -70.58 -28.98 65.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 73.54 110.872 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.64 -25.85 35.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 70.11 110.893 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.43 -63.21 1.19 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 71.33 110.89 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -60.18 -26.58 66.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 74.52 110.926 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -52.08 -30.02 24.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.852 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -101.54 -26.29 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.894 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.2 85.4 0.56 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 63.22 110.84 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -80.7 -26.29 37.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 75.24 110.892 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.79 -10.58 59.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 71.42 110.894 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.23 20.45 50.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 62.41 112.503 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 p -87.26 -22.18 25.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.945 0.402 . . . . 73.2 110.852 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.74 21.58 42.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.7 -0.762 . . . . 73.02 112.472 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -136.73 138.07 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 73.45 110.925 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.712 HD13 HD22 ' A' ' 156' ' ' LEU . 95.0 mt -103.89 112.53 25.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 65.31 110.91 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -79.83 173.66 12.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.54 110.915 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -53.07 -28.85 26.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 63.51 110.883 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -78.74 -37.85 40.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.901 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' A' ' 148' ' ' LEU . 8.5 mt-10 -75.7 -26.18 57.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 74.14 110.901 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.534 ' CG2' HG13 ' A' ' 176' ' ' VAL . 25.8 mt -76.81 -34.59 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 72.04 111.149 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.78 -46.65 64.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 70.35 111.083 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.59 -23.3 56.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 62.35 112.482 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.712 HD22 HD13 ' A' ' 148' ' ' LEU . 18.0 tp -60.7 -56.49 20.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.858 0.361 . . . . 62.45 110.917 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 45.7 mt -52.15 -36.42 51.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 65.34 110.922 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -51.88 -45.77 64.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.04 110.883 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.24 -45.05 13.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.24 110.869 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.4 m -51.85 -30.44 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.2 111.137 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -81.03 -53.62 6.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.892 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.13 -24.69 42.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 70.31 111.12 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -54.69 -31.06 57.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.896 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -107.21 21.85 16.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 71.41 110.873 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.95 21.45 71.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.727 . . . . 74.54 112.447 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.43 165.47 16.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.341 . . . . 74.31 110.86 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.1 m -60.05 -20.61 58.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.02 110.881 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 63.6 59.48 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 64.41 110.952 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -67.83 152.4 45.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 72.22 110.902 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.5 m -108.18 90.78 7.18 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.564 0.697 . . . . 53.45 111.134 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.75 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.69 2.26 . . . . 71.21 112.343 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 176' ' ' VAL . 71.3 p -126.43 -176.03 3.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 72.01 111.165 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -57.37 -25.72 59.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 65.13 110.829 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.614 ' O ' HD12 ' A' ' 178' ' ' ILE . 36.4 tt0 -74.65 -60.81 2.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 74.42 110.881 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -45.91 64.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 72.51 110.859 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 172' ' ' THR . 97.2 t -56.2 -31.02 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 75.33 111.103 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -65.38 -49.81 67.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 40.1 110.886 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -60.14 -26.76 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.11 111.153 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.679 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 87.3 t90 -82.39 -26.32 32.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 71.1 110.919 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 180' ' ' LEU . 3.9 tt -76.08 -36.46 58.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 63.41 110.892 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -52.38 -49.5 64.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.5 -26.85 65.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 74.12 110.88 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.913 ' HB2' HD11 ' A' ' 199' ' ' LEU . . . -74.69 -68.83 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.0 111.108 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -62.28 118.83 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 74.41 110.886 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.1 m -86.74 -37.54 17.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 73.52 111.146 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -78.48 -12.46 60.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 65.11 110.888 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.8 t 61.75 45.4 7.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 63.4 110.891 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -91.0 -16.17 28.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 63.42 110.835 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.25 19.46 12.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 63.14 112.515 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.52 152.4 30.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 72.24 110.876 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.1 t -108.39 114.17 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.01 111.106 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.6 t -85.08 -171.1 3.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 65.15 110.878 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.81 -57.55 10.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 72.2 110.923 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.47 -43.74 96.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 63.31 110.847 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.53 -59.85 4.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.857 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.572 ' HA ' HD12 ' A' ' 199' ' ' LEU . 34.2 t80 -53.73 -49.87 67.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 71.13 110.94 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.554 ' HB3' HD22 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -60.07 -24.35 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 73.15 110.835 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -69.67 -26.16 64.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 63.31 110.875 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.913 HD11 ' HB2' ' A' ' 183' ' ' ALA . 7.5 mt -67.17 -38.5 85.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 74.02 110.916 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.515 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.2 mp -69.49 -24.32 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 65.44 111.125 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 130' ' ' LEU . 47.7 mm -55.91 -49.63 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.211 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -51.94 -62.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.3 110.878 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.1 m -53.44 -28.6 30.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 65.32 110.836 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.683 ' HG ' HD13 ' A' ' 209' ' ' ILE . 0.6 OUTLIER -64.8 -42.68 94.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 53.43 110.903 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -52.22 -39.61 60.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.13 110.948 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -85.95 -24.24 26.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 73.12 110.89 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.89 -22.81 67.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 64.1 111.111 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.36 30.01 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.773 -0.727 . . . . 53.44 112.458 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.683 HD13 ' HG ' ' A' ' 204' ' ' LEU . 5.3 mp -126.03 137.57 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 75.21 111.151 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -98.94 113.84 26.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.904 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 64.5 111.179 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.917 0.389 . . . . 71.13 110.912 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -65.13 160.74 54.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.665 0.745 . . . . 74.32 110.848 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -20.29 35.34 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.743 2.295 . . . . 65.22 112.354 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -82.89 -21.15 34.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.31 110.859 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.69 -63.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 51.35 111.089 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.543 ' HA ' HD12 ' A' ' 130' ' ' LEU . 6.3 tt0 -52.08 -29.92 23.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 64.23 110.84 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.04 -36.13 65.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.114 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.824 ' HB3' HD11 ' A' ' 204' ' ' LEU . 16.7 tptt -82.74 -26.5 31.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 55.34 110.841 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.788 HD22 ' HB2' ' A' ' 197' ' ' GLU . 21.0 mt -78.69 -25.76 44.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 64.1 110.897 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -69.3 -32.14 71.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.854 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.6 -24.78 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.22 111.119 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.64 -43.93 36.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 55.14 111.071 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -52.08 -29.98 23.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.862 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -75.98 -35.32 59.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.02 110.913 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.4 tp -69.41 -25.66 64.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 73.22 110.911 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.01 -64.58 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 61.41 110.856 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -27.41 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.935 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -53.37 -28.64 30.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.863 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -109.11 -26.69 10.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 75.31 110.918 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -76.44 69.81 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.485 . . . . 72.35 110.881 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -67.62 -26.95 66.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.931 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.62 -10.49 59.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 54.31 110.842 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.31 24.58 52.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 52.35 112.478 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.3 t -77.65 -22.07 51.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 73.12 110.841 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.14 23.8 56.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.666 -0.778 . . . . 73.14 112.503 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -148.16 134.57 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 73.42 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.811 HD13 HD22 ' A' ' 156' ' ' LEU . 31.8 mt -106.33 101.99 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.894 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.83 174.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 74.22 110.874 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.613 ' O ' HG11 ' A' ' 176' ' ' VAL . 5.1 p-10 -54.57 -27.24 37.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 70.42 110.88 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.3 -51.01 7.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 64.24 110.866 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -54.84 -30.99 58.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 64.31 110.855 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.44 HD12 HD12 ' A' ' 180' ' ' LEU . 32.9 mt -73.89 -26.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 72.12 111.124 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.69 -47.88 63.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.074 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.35 -22.87 55.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 51.3 112.456 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.811 HD22 HD13 ' A' ' 148' ' ' LEU . 21.3 tp -58.61 -54.88 42.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 71.23 110.914 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 33.6 mt -51.91 -32.81 34.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.901 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -52.58 -60.7 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 71.11 110.954 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -73.81 -38.26 64.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.55 110.874 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.1 m -57.48 -30.19 64.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 73.31 111.117 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -82.31 -55.12 4.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 72.44 110.902 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.703 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -55.21 -25.7 34.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 32.2 111.098 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.95 -25.9 45.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 73.14 110.88 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.3 mtm -110.24 19.2 19.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 72.51 110.839 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.78 19.24 69.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 74.04 112.505 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.5 mtt -64.65 172.97 2.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 74.13 110.886 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 49.1 p -59.77 -21.03 60.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 75.14 110.868 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.703 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 5.8 t30 63.56 58.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 65.23 110.898 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -78.01 152.6 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 73.1 110.837 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 60.9 m -108.23 90.84 7.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.561 0.696 . . . . 74.04 111.141 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 168.96 19.99 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.706 2.271 . . . . 73.34 112.378 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 176' ' ' VAL . 27.8 p -108.76 -178.02 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 61.53 111.124 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -55.58 -25.89 40.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 70.41 110.891 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.581 ' O ' HD12 ' A' ' 178' ' ' ILE . 11.5 tt0 -72.88 -61.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.885 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.403 ' HA ' HD13 ' A' ' 178' ' ' ILE . 83.2 m-20 -51.91 -36.6 49.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 52.14 110.856 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 172' ' ' THR . 99.3 t -60.98 -40.87 86.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 73.24 111.103 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -54.56 -40.92 69.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 63.33 110.883 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.8 mp -69.99 -25.97 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 72.12 111.166 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -83.76 -31.12 26.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.901 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 180' ' ' LEU . 3.7 tt -78.32 -46.3 20.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 65.43 110.911 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.99 -31.55 29.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 72.11 110.9 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 53.3 ttp -90.51 -25.89 20.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 65.33 110.883 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -73.95 -52.12 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 61.44 111.095 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -85.31 127.8 34.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.43 110.864 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 3.2 m -69.39 -24.53 63.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 73.53 111.158 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -98.08 -10.4 24.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.228 -0.442 . . . . 71.13 110.872 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.4 p 52.99 36.3 21.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.86 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.0 -16.24 57.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 62.2 110.836 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.19 22.9 8.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.731 . . . . 61.43 112.532 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.14 126.93 11.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 52.32 110.828 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.8 t -109.4 112.94 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 72.3 111.12 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.04 -174.89 4.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.875 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.3 OUTLIER -66.69 -33.84 76.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 64.42 110.892 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.48 -36.8 32.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 60.31 110.931 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.19 -21.64 60.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 71.24 110.91 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.527 ' O ' HD12 ' A' ' 200' ' ' ILE . 18.7 t80 -84.48 -51.71 6.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 72.4 110.889 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.788 ' HB2' HD22 ' A' ' 130' ' ' LEU . 13.4 pt-20 -53.99 -43.69 70.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 54.42 110.859 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.84 -26.13 63.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 61.34 110.853 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 183' ' ' ALA . 7.5 tt -67.48 -38.24 84.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.881 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -73.75 -24.58 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 73.32 111.086 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.632 HD11 HD11 ' A' ' 130' ' ' LEU . 50.1 mm -56.6 -57.22 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 75.4 111.098 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -56.18 -25.14 45.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 71.24 110.903 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.4 m -83.23 -26.31 30.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 73.53 110.849 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 129' ' ' LYS . 36.2 mt -79.35 -45.0 20.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 63.3 110.956 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -51.99 -37.83 54.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.874 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -86.09 -29.07 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.32 110.901 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -18.2 65.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 72.2 111.135 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.96 23.05 4.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.774 -0.727 . . . . 42.24 112.517 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.63 101.87 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.343 . . . . 73.23 111.158 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.5 111.44 1.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 72.1 110.891 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 211' ' ' VAL . 5.5 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 70.13 111.153 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.614 ' CE2' HG11 ' A' ' 211' ' ' VAL . 2.2 m-85 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.892 0.377 . . . . 73.44 110.902 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.65 160.52 3.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 73.4 110.883 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -19.31 36.65 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 64.02 112.355 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -80.3 -24.8 39.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.896 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.693 HG21 HG13 ' A' ' 211' ' ' VAL . 3.1 t -79.39 -63.42 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 74.22 111.155 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.644 ' HA ' HD12 ' A' ' 130' ' ' LEU . 1.5 tm-20 -51.49 -30.84 21.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 71.01 110.875 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.6 -33.15 59.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 70.22 111.068 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -88.36 -30.54 19.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 75.45 110.947 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.685 HD21 HD11 ' A' ' 201' ' ' ILE . 15.1 mt -72.81 -26.28 61.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.4 110.922 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -65.41 -46.17 81.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 64.33 110.84 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.597 HG23 ' HD3' ' A' ' 135' ' ' ARG . 14.7 p -74.35 -23.73 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 55.42 111.097 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.86 -22.04 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 65.31 111.091 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -76.08 -57.19 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.869 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.597 ' HD3' HG23 ' A' ' 132' ' ' VAL . 4.5 ptm180 -58.22 -25.33 61.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.14 110.866 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.2 tp -78.3 -26.66 47.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.165 -0.471 . . . . 65.34 110.953 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -69.61 -57.51 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.842 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -65.55 -27.6 68.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 64.23 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 -54.12 -27.87 35.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 44.44 110.86 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -105.65 -40.43 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 62.45 110.909 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -73.03 84.66 1.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 71.11 110.849 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -73.03 -26.24 61.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 74.3 110.93 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.47 -10.52 59.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 73.23 110.847 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.71 22.44 40.15 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 62.34 112.536 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.5 t -76.12 -22.1 55.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 44.24 110.886 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.74 19.3 61.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 65.43 112.489 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -138.47 131.35 29.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.804 0.335 . . . . 72.5 110.933 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 55.8 mt -100.97 104.11 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.903 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.04 173.56 2.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.12 110.92 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -52.82 -29.13 26.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.897 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -80.44 -53.28 6.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 71.22 110.877 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.25 -39.17 59.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 53.11 110.889 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.1 mt -65.85 -30.51 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 62.43 111.131 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.73 -45.72 63.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.33 111.124 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.33 -23.21 55.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 62.23 112.507 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.668 HD21 ' CE1' ' A' ' 196' ' ' TYR . 5.7 tp -59.91 -54.65 43.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 65.34 110.932 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 36.0 mt -51.91 -35.24 44.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 64.13 110.923 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -52.73 -51.76 59.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.882 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -78.81 -43.7 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.5 110.85 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.2 m -54.55 -31.16 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 74.44 111.133 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -82.42 -59.56 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.25 110.934 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -53.4 -28.08 27.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 75.23 111.098 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -55.63 -26.17 42.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.45 110.91 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.2 mtm -110.54 21.79 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.924 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 18.78 68.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.768 -0.729 . . . . 74.53 112.513 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.1 mmt -60.66 172.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 73.41 110.891 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 69.4 m -62.46 -17.72 60.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 75.1 110.847 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 63.49 48.24 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 55.23 110.888 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -68.61 152.57 45.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.861 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 p -108.21 90.83 7.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.588 0.709 . . . . 75.22 111.154 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 175.3 8.29 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.687 2.258 . . . . 73.24 112.387 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.656 ' O ' HG23 ' A' ' 176' ' ' VAL . 72.1 p -121.21 -176.14 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 62.12 111.116 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -55.66 -25.81 41.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 63.32 110.928 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.62 ' O ' HD12 ' A' ' 178' ' ' ILE . 9.2 tt0 -72.54 -61.51 1.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.938 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.51 -40.84 65.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.31 110.899 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 172' ' ' THR . 93.8 t -59.72 -31.12 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 71.35 111.09 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -65.13 -41.65 94.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.873 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.5 mp -70.39 -26.48 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 55.33 111.133 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.51 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 57.4 t90 -83.6 -40.09 19.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 75.01 110.945 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 180' ' ' LEU . 4.2 tt -58.6 -26.89 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 75.14 110.855 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -70.96 -49.38 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.923 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.6 ttp -64.9 -26.97 68.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 62.43 110.887 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . . . -83.63 -59.23 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 63.44 111.092 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -81.69 128.66 34.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 65.14 110.863 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.14 -28.87 34.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 74.41 111.135 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -89.7 -9.41 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 65.21 110.891 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.8 p 46.24 58.22 4.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.877 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -113.69 24.04 12.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 73.54 110.857 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.17 27.56 73.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 73.4 112.508 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.66 127.2 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.919 0.39 . . . . 22.44 110.858 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.7 106.17 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.1 111.171 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.53 178.09 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 61.33 110.849 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.56 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -63.66 -36.12 82.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 65.13 110.882 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -81.32 -28.58 34.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.4 110.868 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -77.57 -22.48 50.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.885 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.668 ' CE1' HD21 ' A' ' 156' ' ' LEU . 23.6 t80 -85.13 -53.36 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 63.15 110.923 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 130' ' ' LEU . 11.0 pt-20 -52.02 -43.69 63.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 75.51 110.908 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.43 -42.41 67.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 72.52 110.851 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 6.4 tt -51.9 -39.76 59.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.948 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -72.82 -29.35 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 71.05 111.138 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.685 HD11 HD21 ' A' ' 130' ' ' LEU . 51.3 mm -63.79 -44.07 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 54.54 111.136 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -67.63 -46.87 71.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.881 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 43.4 m -57.45 -37.03 72.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 52.12 110.849 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.72 -34.42 64.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.857 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -60.28 -37.54 80.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 74.43 110.941 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -24.04 26.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 54.14 110.893 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.67 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 43.21 111.088 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.82 26.18 3.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 75.45 112.486 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.3 102.17 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 73.41 111.103 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -72.93 102.78 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.874 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.693 HG13 HG21 ' A' ' 126' ' ' VAL . 22.0 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 75.25 111.066 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.905 0.383 . . . . 74.45 110.952 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -75.1 160.77 79.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.652 0.739 . . . . 72.24 110.857 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -17.88 37.25 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.704 2.269 . . . . 73.02 112.352 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -83.11 -22.55 33.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.12 110.853 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.468 HG13 HD13 ' A' ' 204' ' ' LEU . 2.9 t -79.55 -61.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 71.01 111.103 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.717 ' HA ' HD12 ' A' ' 130' ' ' LEU . 1.3 tt0 -52.18 -30.04 25.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 62.11 110.835 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.02 -32.32 67.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 61.11 111.099 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.44 ' HG3' HD21 ' A' ' 204' ' ' LEU . 0.0 OUTLIER -88.48 -22.22 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.907 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.756 HD22 ' HB3' ' A' ' 197' ' ' GLU . 16.4 mt -81.67 -32.9 31.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 71.25 110.932 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -29.28 64.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 71.33 110.826 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.5 p -85.95 -23.3 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.45 111.16 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.12 -39.28 21.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 70.12 111.11 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -54.86 -38.15 67.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 75.14 110.919 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -63.72 -25.8 68.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.829 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.56 -28.87 41.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 72.1 110.946 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -61.66 -64.55 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.1 110.876 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -54.71 -27.62 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 72.43 110.899 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -56.0 -26.16 47.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 65.45 110.812 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -110.12 -26.58 9.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 62.34 110.923 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.77 79.92 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 74.42 110.865 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -25.73 42.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 64.43 110.917 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.78 -10.57 59.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 61.43 110.904 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.57 19.99 58.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 54.32 112.487 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.4 p -82.46 -22.12 35.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 73.35 110.889 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.82 22.42 59.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 73.44 112.477 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -140.6 151.77 44.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 73.43 110.869 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 152' ' ' GLU . 71.7 mt -119.11 120.67 37.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 72.51 110.929 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -84.44 179.88 7.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 72.11 110.895 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -52.2 -29.82 24.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.24 110.839 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 19.2 t0 -77.97 -54.79 5.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 72.43 110.818 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.565 ' HB3' HD22 ' A' ' 148' ' ' LEU . 9.3 mt-10 -57.28 -51.81 67.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 71.2 110.889 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.436 HG22 HG13 ' A' ' 176' ' ' VAL . 52.2 mt -51.8 -30.93 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 72.22 111.145 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 151' ' ' ASP . . . -60.0 -56.72 18.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 72.11 111.137 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.06 -23.26 77.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.792 -0.718 . . . . 61.13 112.452 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 148' ' ' LEU . 3.3 tp -57.17 -55.99 27.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.88 0.371 . . . . 62.44 110.932 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.8 mt -54.17 -33.21 57.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 74.1 110.896 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -52.11 -53.56 41.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 74.1 110.886 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.87 -42.33 21.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 55.4 110.875 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.2 m -52.35 -30.55 29.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 74.3 111.148 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -78.56 -52.97 7.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 72.31 110.952 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.672 ' HB2' HD22 ' A' ' 168' ' ' ASN . . . -57.97 -24.59 58.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.056 -0.52 . . . . 72.42 111.133 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.93 -25.93 45.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 54.15 110.835 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.0 mtm -109.68 21.59 16.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 70.21 110.856 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 23.61 72.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.77 -0.728 . . . . 52.52 112.473 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.8 mmt -65.28 175.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 73.12 110.845 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 79.3 p -66.68 -14.27 62.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 72.12 110.862 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.672 HD22 ' HB2' ' A' ' 162' ' ' ALA . 11.5 t-20 63.65 61.67 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.858 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -83.01 152.57 25.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.01 110.894 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 3.9 m -108.22 90.87 7.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.576 0.703 . . . . 71.15 111.111 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.9 Cg_endo -69.77 156.43 63.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.701 2.267 . . . . 72.12 112.31 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 176' ' ' VAL . 48.8 p -95.57 -179.34 4.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 62.22 111.146 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -56.01 -25.66 45.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.921 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.608 ' O ' HD12 ' A' ' 178' ' ' ILE . 7.7 tt0 -73.4 -57.27 4.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 75.32 110.89 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.93 -38.88 58.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.31 110.852 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 172' ' ' THR . 93.5 t -59.85 -42.55 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 71.23 111.099 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -52.46 -45.1 65.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.1 110.898 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.608 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -63.27 -27.41 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 53.44 111.145 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.512 ' HZ3' HG21 ' A' ' 191' ' ' VAL . 77.0 t90 -83.63 -32.77 25.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 73.05 110.915 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.1 tp -73.21 -37.78 66.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 75.43 110.901 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -56.18 -35.27 67.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 74.41 110.924 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.6 ttp -90.23 -39.18 12.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 64.02 110.926 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.69 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -60.31 -58.96 6.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 71.45 111.155 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.48 113.94 13.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 62.14 110.878 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.2 p -84.31 -46.34 11.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 64.51 111.1 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -74.6 -12.36 60.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 53.3 110.886 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 t 62.59 44.94 6.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 42.22 110.847 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -79.39 -16.26 56.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 75.41 110.879 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.05 -15.46 51.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 55.22 112.485 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.1 m -136.22 135.9 39.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.4 . . . . 75.42 110.835 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.512 HG21 ' HZ3' ' A' ' 179' ' ' TRP . 25.0 t -87.0 109.71 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 71.33 111.135 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.5 t -87.97 -172.77 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 63.01 110.868 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.9 tp -68.57 -28.08 66.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 60.51 110.908 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -81.2 -32.61 33.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.906 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -84.78 -26.05 27.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.24 110.925 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.535 ' O ' HD12 ' A' ' 200' ' ' ILE . 26.6 t80 -79.26 -54.41 5.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.3 110.952 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.756 ' HB3' HD22 ' A' ' 130' ' ' LEU . 4.7 mm-40 -54.96 -32.58 61.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 74.51 110.936 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -68.68 -26.12 65.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.882 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 183' ' ' ALA . 5.1 tt -68.04 -35.56 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 71.33 110.928 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.535 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -73.43 -24.73 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 73.11 111.12 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.465 ' CD1' HD21 ' A' ' 130' ' ' LEU . 50.8 mm -55.66 -50.94 63.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 72.33 111.121 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -56.26 -46.46 79.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.908 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 9.9 p -61.84 -33.0 73.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 51.43 110.861 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.727 HD23 HD13 ' A' ' 209' ' ' ILE . 5.6 mt -69.74 -31.21 69.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 65.34 110.961 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.31 -43.95 96.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 61.42 110.952 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -86.02 -24.02 26.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 65.44 110.888 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.03 -22.71 67.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.54 111.086 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.98 32.01 1.79 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 50.53 112.492 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.727 HD13 HD23 ' A' ' 204' ' ' LEU . 5.3 mp -122.86 128.58 75.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 73.43 111.142 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.7 107.37 19.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.879 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 64.44 111.173 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.929 0.395 . . . . 73.22 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -52.01 160.57 1.14 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.645 0.735 . . . . 54.21 110.854 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -19.27 36.36 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 63.45 112.356 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -82.84 -24.66 33.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 75.24 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 211' ' ' VAL . 2.9 t -78.77 -60.62 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 74.41 111.141 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -51.77 -30.12 21.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 54.22 110.875 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.84 63.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 54.11 111.076 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -88.48 -36.67 16.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.906 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 201' ' ' ILE . 43.9 mt -63.94 -30.53 71.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 71.51 110.919 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -63.45 -46.42 86.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 73.04 110.866 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.71 -23.68 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 73.24 111.132 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.79 -21.78 60.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 51.3 111.125 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -72.23 -55.64 6.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -54.81 -27.05 38.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 75.24 110.871 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.1 tp -77.77 -29.01 50.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 71.51 110.893 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -66.53 -49.77 65.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 73.14 110.852 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -72.03 -26.42 62.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 75.01 110.883 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -54.4 -27.91 40.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 73.32 110.874 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -108.12 -30.31 8.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 74.53 110.897 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -74.97 73.19 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 54.5 110.873 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -84.72 -25.03 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 65.01 110.908 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -70.66 -10.58 59.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.853 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.64 19.57 62.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 74.54 112.525 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.6 t -79.42 -22.14 44.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 52.45 110.856 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.82 18.77 76.63 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.763 . . . . 64.22 112.467 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -147.36 131.02 16.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 73.53 110.867 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.907 HD13 HD22 ' A' ' 156' ' ' LEU . 11.7 mt -92.51 101.76 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 65.54 110.908 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.56 175.65 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 74.1 110.924 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.469 ' OD1' HD23 ' A' ' 180' ' ' LEU . 15.6 m-20 -52.02 -30.13 24.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.832 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.31 -55.29 6.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.824 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -56.5 -46.57 80.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.15 110.838 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.562 HD13 ' HB2' ' A' ' 180' ' ' LEU . 29.0 mt -51.73 -43.07 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 75.4 111.146 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.96 -41.21 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.129 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.28 -24.17 52.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 43.24 112.492 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.907 HD22 HD13 ' A' ' 148' ' ' LEU . 21.7 tp -67.06 -50.33 62.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 70.24 110.919 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.511 HD21 ' CD2' ' A' ' 179' ' ' TRP . 72.5 mt -52.92 -29.55 29.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.938 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.595 ' HE2' HG22 ' A' ' 170' ' ' THR . 0.5 OUTLIER -58.71 -60.66 3.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.02 110.864 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.11 -41.35 70.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 61.11 110.888 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.6 m -51.76 -46.78 64.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 75.13 111.124 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -64.66 -29.14 70.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 72.52 110.922 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.445 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -75.9 -24.7 55.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 64.22 111.116 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -57.94 -49.51 76.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 70.33 110.865 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 29.5 mtm -79.47 -18.45 52.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.898 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.75 18.32 30.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 62.11 112.487 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 5.6 mtt -61.33 175.88 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 72.11 110.869 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.1 m -60.88 -18.95 59.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 71.15 110.818 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 1.9 t30 63.81 63.65 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 71.12 110.905 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -79.98 152.79 29.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 71.31 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.595 HG22 ' HE2' ' A' ' 158' ' ' LYS . 21.0 p -108.23 90.78 7.24 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.591 0.71 . . . . 64.4 111.134 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -175.28 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.689 2.259 . . . . 51.54 112.363 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.658 ' O ' HG23 ' A' ' 176' ' ' VAL . 23.0 p -117.23 -176.27 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 73.45 111.172 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -59.25 -24.8 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 71.13 110.88 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.631 ' O ' HD12 ' A' ' 178' ' ' ILE . 27.8 tt0 -78.04 -57.46 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.876 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -51.76 -35.15 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 64.34 110.895 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 172' ' ' THR . 85.2 t -64.77 -39.69 86.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 72.42 111.074 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -55.47 -44.45 76.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 73.44 110.918 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -62.01 -34.8 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 65.33 111.097 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.574 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 49.0 t90 -79.39 -26.13 42.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.921 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.723 HD21 ' HA2' ' A' ' 189' ' ' GLY . 10.0 tp -81.66 -39.03 24.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 62.32 110.912 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -56.9 -28.41 61.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.866 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.5 mtm -83.44 -52.61 6.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 60.21 110.893 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.494 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -52.09 -62.04 1.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 72.51 111.089 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -67.62 124.62 23.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 51.22 110.839 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.3 m -73.96 -25.44 59.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.53 111.151 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -104.01 -12.47 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 64.3 110.866 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.6 t 55.79 50.79 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 74.42 110.809 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -100.94 23.91 10.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 65.54 110.867 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.723 ' HA2' HD21 ' A' ' 180' ' ' LEU . . . 69.27 31.72 71.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.752 . . . . 53.31 112.519 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.6 157.29 43.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 73.24 110.892 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.04 101.37 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 72.35 111.148 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 40.2 t -71.08 165.74 22.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 54.42 110.872 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.92 -40.77 61.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 73.21 110.904 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -74.51 -38.18 62.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.891 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.81 -38.22 90.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 75.51 110.919 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.53 ' O ' HD12 ' A' ' 200' ' ' ILE . 30.8 t80 -75.98 -43.03 46.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 74.13 110.93 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.646 ' O ' HD12 ' A' ' 201' ' ' ILE . 5.7 mm-40 -61.72 -44.1 97.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 61.24 110.853 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -53.03 -40.91 64.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 74.51 110.908 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.574 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 1.2 tp -51.7 -52.19 50.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.927 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 200' ' ' ILE . 4.5 mp -51.42 -44.96 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 55.41 111.118 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.999 HG23 HG21 ' A' ' 211' ' ' VAL . 3.4 mp -68.9 -40.28 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 60.13 111.098 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -60.09 -38.38 82.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 65.43 110.928 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 58.1 m -84.48 -31.75 24.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 62.3 110.867 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.87 HD22 HD13 ' A' ' 209' ' ' ILE . 13.5 mt -63.73 -29.4 70.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 60.24 110.927 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -51.85 -42.3 62.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 73.12 110.923 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -86.09 -24.19 26.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.922 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.93 -22.76 67.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 42.43 111.103 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.17 19.57 5.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 71.13 112.461 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.87 HD13 HD22 ' A' ' 204' ' ' LEU . 5.2 mp -121.99 101.85 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.798 0.333 . . . . 70.2 111.12 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -74.54 128.06 34.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.847 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.999 HG21 HG23 ' A' ' 201' ' ' ILE . 42.8 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 63.44 111.121 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.456 ' CE2' HG11 ' A' ' 211' ' ' VAL . 2.6 m-85 . . . . . 0 N--CA 1.458 -0.041 0 CA-C-O 120.93 0.395 . . . . 74.42 110.902 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -58.57 160.66 9.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.588 0.709 . . . . 74.41 110.884 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -20.48 34.9 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.666 2.244 . . . . 74.32 112.367 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.0 -23.09 41.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 70.14 110.876 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.533 HG21 HG13 ' A' ' 211' ' ' VAL . 3.0 t -78.05 -62.64 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 73.05 111.133 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -51.56 -30.59 21.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 72.15 110.881 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.48 -31.04 61.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 62.33 111.146 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.735 ' HG3' HD21 ' A' ' 204' ' ' LEU . 8.3 mmmt -88.4 -21.68 24.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 72.02 110.883 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.22 -46.45 16.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 72.32 110.912 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.02 -31.34 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 75.02 110.855 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 p -85.87 -23.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 75.33 111.131 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.62 -44.43 21.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 75.5 111.103 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.83 -33.41 35.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.857 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -74.58 -40.42 61.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 75.5 110.876 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.3 tp -68.3 -25.09 64.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 74.52 110.918 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.08 -64.57 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 65.31 110.865 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -59.28 -25.97 64.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 74.23 110.868 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -52.71 -30.49 32.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.823 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -101.4 -26.52 13.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.928 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -75.75 82.92 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 75.13 110.852 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -81.52 -26.5 35.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 73.34 110.884 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -72.43 -10.56 59.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.42 . . . . 50.42 110.892 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.05 20.54 54.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 72.11 112.484 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 59.5 p -77.13 -22.06 53.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.943 0.401 . . . . 63.12 110.882 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.11 59.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 32.43 112.503 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -144.03 137.36 27.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 73.11 110.942 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.773 HD13 HD22 ' A' ' 156' ' ' LEU . 82.3 mt -100.93 105.29 16.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 71.33 110.917 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -67.8 171.38 6.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.41 110.934 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.55 ' O ' HG11 ' A' ' 176' ' ' VAL . 2.0 m-20 -52.02 -30.36 25.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 71.22 110.858 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.33 -50.87 11.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.4 110.889 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -57.28 -26.25 60.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 62.22 110.856 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 150' ' ' ASP . 26.5 mt -78.1 -26.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 65.01 111.153 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.93 -54.98 23.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 72.32 111.141 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.22 -22.86 69.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 74.22 112.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 148' ' ' LEU . 15.8 tp -57.86 -58.69 7.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 61.44 110.939 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.8 mt -51.81 -36.64 48.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.945 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -54.39 -41.93 69.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 61.15 110.942 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -85.06 -46.49 11.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 70.45 110.893 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.3 m -54.61 -33.0 59.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 74.1 111.129 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -69.13 -26.13 64.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 62.13 110.918 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.27 -30.23 71.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.499 . . . . 75.23 111.087 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.38 -26.06 64.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.858 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.8 mtm -94.05 -18.38 21.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 75.2 110.84 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 93.13 24.01 23.41 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.731 . . . . 72.51 112.443 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.3 ttm -81.95 175.81 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 74.44 110.854 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.4 m -75.73 -6.26 49.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 35.43 110.84 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.2 m120 62.9 69.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 53.33 110.886 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -68.07 152.64 45.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.906 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 1.4 m -108.18 90.82 7.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.575 0.702 . . . . 61.32 111.175 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.6 Cg_endo -69.77 175.86 7.55 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.661 2.241 . . . . 75.14 112.379 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.1 p -115.41 -176.57 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 73.4 111.154 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -52.19 -29.9 24.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.34 110.95 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -67.41 -57.65 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.864 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.02 -53.76 54.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 71.14 110.868 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 150' ' ' ASP . 90.5 t -52.66 -41.12 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.42 111.126 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -54.79 -54.51 41.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 74.14 110.895 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.35 -47.9 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.133 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -61.89 -25.95 67.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.132 -0.485 . . . . 75.4 110.904 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 180' ' ' LEU . 2.6 tt -81.61 -40.51 22.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 70.43 110.92 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.51 -28.76 70.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.903 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 43.3 ttp -91.22 -35.08 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.747 ' HA ' HD23 ' A' ' 199' ' ' LEU . . . -71.41 -48.25 50.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 51.21 111.096 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -52.55 120.3 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.851 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.87 -23.59 25.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 64.31 111.126 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.44 -10.71 18.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 72.11 110.874 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.4 p 58.99 27.19 16.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 72.35 110.852 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -78.94 -15.87 57.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 73.11 110.869 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.34 17.26 16.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 53.3 112.49 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.78 126.9 7.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 73.13 110.854 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.7 t -86.92 107.63 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 61.04 111.131 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.2 t -83.68 -176.65 6.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 71.41 110.862 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.7 tp -66.61 -36.03 81.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 74.41 110.962 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.35 -24.75 42.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 73.1 110.87 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -85.89 -20.43 29.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 74.14 110.85 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.577 ' O ' HD12 ' A' ' 200' ' ' ILE . 17.5 t80 -87.32 -40.16 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.931 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -52.68 -41.42 63.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.899 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.86 -25.16 63.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 64.35 110.828 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 183' ' ' ALA . 2.2 tm? -61.9 -40.24 94.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.466 . . . . 71.34 110.91 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.2 mp -72.22 -24.69 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.21 111.134 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.1 mm -60.81 -37.51 76.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 51.54 111.154 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -52.56 38.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 63.52 110.858 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 2.6 m -57.44 -30.67 65.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 70.32 110.885 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.735 HD21 ' HG3' ' A' ' 129' ' ' LYS . 15.9 mt -72.01 -37.93 69.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 54.42 110.925 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -58.03 -35.57 71.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.15 110.897 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -26.64 26.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 65.23 110.929 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.2 -22.65 66.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 73.02 111.13 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.75 26.45 3.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 71.43 112.491 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.52 103.12 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 74.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -71.17 110.88 6.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 71.31 110.839 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.533 HG13 HG21 ' A' ' 126' ' ' VAL . 23.3 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 55.23 111.119 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.917 0.389 . . . . 71.43 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -52.59 160.52 1.35 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.595 0.712 . . . . 74.42 110.889 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -18.81 36.92 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.72 2.28 . . . . 75.24 112.344 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -82.69 -23.63 34.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.478 HG21 HG23 ' A' ' 211' ' ' VAL . 3.0 t -77.93 -63.33 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 75.32 111.163 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -51.99 -30.9 27.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.31 110.883 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -37.5 63.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 53.12 111.116 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -88.19 -25.94 22.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.893 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.741 HD22 ' CG ' ' A' ' 197' ' ' GLU . 68.5 mt -73.94 -28.23 61.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 62.3 110.89 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.51 -59.01 4.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.449 . . . . 70.34 110.899 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 p -55.29 -26.46 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 73.12 111.152 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.91 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 74.1 111.11 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.413 ' CG ' HD11 ' A' ' 193' ' ' LEU . 25.1 mtt180 -61.39 -50.66 71.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 71.31 110.874 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -63.68 -41.48 98.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 72.31 110.863 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 tp -57.1 -38.92 74.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 71.4 110.905 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -56.47 -59.74 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.12 110.873 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.6 mmmm -66.39 -26.27 67.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 43.23 110.87 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.3 ttm-85 -54.14 -27.71 35.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.872 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -109.74 -30.55 7.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.941 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.07 84.28 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 72.11 110.862 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -84.94 -28.17 26.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.41 110.878 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -72.63 -10.57 59.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 73.14 110.899 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.96 47.12 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 64.51 112.462 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 45.4 t -75.36 -22.11 57.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.953 0.406 . . . . 72.52 110.853 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.23 19.67 60.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 75.14 112.483 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -146.04 141.75 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 70.2 110.889 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.7 mt -105.23 101.41 10.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 42.13 110.927 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -70.41 170.68 11.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 63.34 110.95 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.534 ' O ' HG11 ' A' ' 176' ' ' VAL . 10.4 p-10 -52.06 -30.02 23.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.42 110.842 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -80.41 -35.02 35.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.1 110.891 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.08 -29.19 60.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 75.33 110.896 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.66 HD12 HD12 ' A' ' 180' ' ' LEU . 54.8 mt -77.78 -26.67 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 73.23 111.145 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.76 -45.85 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 70.44 111.071 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.24 -23.04 55.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 51.21 112.495 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.15 -57.04 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 62.43 110.9 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.7 mt -51.94 -35.84 47.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.23 110.959 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -51.97 -45.68 64.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 75.34 110.834 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -84.77 -45.69 12.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 65.44 110.833 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 33.5 m -52.99 -31.23 39.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.113 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -77.07 -55.37 5.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.914 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.81 -24.81 38.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 75.3 111.081 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -53.64 -29.17 36.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 71.45 110.879 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -113.02 16.8 19.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.41 110.878 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.83 28.93 74.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 52.25 112.451 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.16 175.75 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 54.54 110.884 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 94.8 p -60.92 -21.25 63.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 72.53 110.879 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 63.45 57.47 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 65.12 110.889 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -80.22 152.55 29.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.924 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.8 p -108.21 90.75 7.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.589 0.709 . . . . 73.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 174.47 9.44 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.662 2.242 . . . . 51.42 112.327 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 39.2 p -117.53 -176.06 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 60.42 111.12 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -52.14 -29.95 24.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 63.01 110.879 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -69.43 -57.36 5.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 71.54 110.918 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.415 ' HA ' HD12 ' A' ' 178' ' ' ILE . 3.3 m-20 -56.15 -52.54 64.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 75.23 110.852 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.534 HG11 ' O ' ' A' ' 150' ' ' ASP . 94.7 t -52.42 -38.15 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 73.4 111.126 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -58.11 -54.85 42.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 75.45 110.907 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 175' ' ' ASP . 3.5 mt -54.5 -47.47 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 74.12 111.143 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.546 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 50.0 t90 -57.97 -29.84 65.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 71.11 110.88 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.66 HD12 HD12 ' A' ' 153' ' ' ILE . 5.2 tt -74.88 -30.54 61.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 72.11 110.949 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -65.01 -26.17 68.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.03 110.938 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.5 ttm -90.97 -42.83 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.895 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.466 ' CA ' HD13 ' A' ' 199' ' ' LEU . . . -68.32 -50.47 53.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 74.24 111.085 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.529 ' HB2' HD23 ' A' ' 180' ' ' LEU . 35.2 t0 -51.98 105.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.836 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.5 m -87.18 -25.15 24.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 55.43 111.156 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -95.11 -12.42 26.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 61.32 110.906 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 60.74 37.93 18.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 72.24 110.855 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -102.01 23.99 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 73.03 110.855 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 65.19 19.42 66.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 70.22 112.509 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.73 160.4 41.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 61.21 110.871 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.23 124.93 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 72.02 111.11 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.28 -170.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 44.22 110.876 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -66.04 -39.01 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 74.15 110.892 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -74.11 -35.59 64.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.859 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.58 -53.4 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 75.14 110.94 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.515 ' O ' HD12 ' A' ' 200' ' ' ILE . 11.2 t80 -58.47 -47.91 82.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 74.02 110.911 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.741 ' CG ' HD22 ' A' ' 130' ' ' LEU . 26.4 tt0 -55.2 -31.04 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 41.5 110.89 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.77 -26.41 64.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 61.45 110.88 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.546 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 3.5 tp -67.46 -34.03 76.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 74.15 110.887 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.636 HG22 HD23 ' A' ' 204' ' ' LEU . 5.3 mp -75.04 -27.44 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 55.21 111.133 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.5 mm -52.11 -60.09 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 64.5 111.135 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -52.08 -30.13 24.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 73.51 110.884 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.9 m -69.98 -41.88 73.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.872 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 209' ' ' ILE . 4.1 mm? -66.83 -36.05 81.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.49 . . . . 65.41 110.936 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -57.07 -44.23 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 64.23 110.904 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -86.06 -24.83 26.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 64.33 110.91 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.05 -22.71 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 74.22 111.063 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.92 19.26 5.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.756 -0.735 . . . . 73.14 112.527 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 204' ' ' LEU . 5.3 mp -122.32 101.84 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 61.55 111.128 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.13 98.66 3.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.13 110.887 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.478 HG23 HG21 ' A' ' 126' ' ' VAL . 5.6 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 74.23 111.157 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.483 ' HB3' HG21 ' A' ' 126' ' ' VAL . 21.1 m-85 . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.913 0.387 . . . . 65.11 110.916 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -51.77 162.15 0.8 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.584 0.707 . . . . 72.5 110.883 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -16.87 37.69 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 61.34 112.346 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -83.42 -18.97 36.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.892 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.532 ' CG2' HG22 ' A' ' 211' ' ' VAL . 2.9 t -77.16 -61.44 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 45.14 111.134 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.676 ' HA ' HD12 ' A' ' 130' ' ' LEU . 4.0 tt0 -51.54 -31.38 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.45 110.891 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.03 -34.32 55.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.54 111.14 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.646 ' HB3' HD11 ' A' ' 204' ' ' LEU . 0.0 OUTLIER -88.47 -30.99 18.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.42 110.945 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.867 HD21 HD11 ' A' ' 201' ' ' ILE . 17.9 mt -69.68 -32.72 71.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.876 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -58.27 -57.58 12.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 64.31 110.857 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 129' ' ' LYS . 10.2 p -57.75 -23.79 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 70.4 111.127 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.43 -30.77 67.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 61.51 111.118 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -49.44 63.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 75.1 110.919 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -61.77 -24.65 66.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 64.42 110.885 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.7 tp -82.17 -36.67 27.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.92 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.0 -53.31 59.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.881 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -69.62 -25.97 64.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 70.44 110.906 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -52.2 -29.94 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 62.14 110.861 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -106.0 -34.18 7.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 65.22 110.895 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.75 88.95 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 72.13 110.873 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -84.72 -25.42 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.45 110.92 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -70.65 -10.61 59.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.878 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.66 22.54 40.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 61.4 112.489 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -76.38 -22.1 55.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.895 0.379 . . . . 74.04 110.844 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.76 19.04 57.24 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.752 . . . . 71.22 112.48 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -142.96 130.74 21.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 74.54 110.894 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.415 HD13 HD22 ' A' ' 156' ' ' LEU . 31.7 mt -89.03 102.57 15.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.22 110.944 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -71.6 173.11 8.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 73.32 110.894 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.407 ' HA ' HD12 ' A' ' 153' ' ' ILE . 2.9 p30 -55.54 -26.42 43.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 64.3 110.856 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -80.02 -34.28 38.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 65.21 110.85 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -80.92 -26.75 36.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 75.22 110.84 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.451 ' CG2' HG13 ' A' ' 176' ' ' VAL . 21.4 mt -74.82 -36.25 39.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 43.13 111.133 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.83 -47.27 64.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 51.43 111.067 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.42 -23.5 53.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 63.41 112.458 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.466 HD21 ' CE1' ' A' ' 196' ' ' TYR . 1.9 tp -65.48 -49.12 70.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 74.45 110.942 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.556 HD21 ' CD2' ' A' ' 179' ' ' TRP . 97.7 mt -52.12 -33.91 41.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 53.51 110.921 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -54.59 -55.2 31.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.855 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.34 -45.06 41.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 72.01 110.877 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.3 m -51.67 -30.71 22.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 62.04 111.154 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -77.85 -44.69 26.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 65.11 110.914 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.609 ' HB2' HD21 ' A' ' 168' ' ' ASN . . . -57.2 -23.24 46.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 64.54 111.087 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -55.52 -25.94 40.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 75.24 110.893 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 mtm -111.73 19.44 18.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.889 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.76 21.46 71.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 51.3 112.492 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.2 tpp -62.22 175.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.758 0.314 . . . . 64.31 110.911 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.1 t -78.3 -3.91 45.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 64.32 110.868 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.609 HD21 ' HB2' ' A' ' 162' ' ' ALA . 2.8 m120 55.72 61.74 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 74.14 110.909 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -72.86 152.63 41.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.11 110.905 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.4 m -108.11 90.77 7.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 72.35 111.136 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 171.45 14.44 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.704 2.269 . . . . 55.41 112.364 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 176' ' ' VAL . 3.4 p -102.35 177.83 4.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 73.55 111.124 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -55.19 -27.74 48.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.9 tt0 -75.23 -54.28 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 74.23 110.901 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.16 -35.87 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.823 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 172' ' ' THR . 91.2 t -63.97 -39.36 85.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 75.2 111.101 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -56.83 -52.99 62.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 61.24 110.877 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.1 mp -55.38 -30.68 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 72.22 111.118 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.592 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 90.9 t90 -79.55 -31.21 41.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 64.25 110.934 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.501 ' O ' HD23 ' A' ' 180' ' ' LEU . 1.9 tt -77.46 -39.98 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.888 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -51.92 -58.47 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.906 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 27.5 ttp -63.7 -24.46 67.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.893 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.698 ' CB ' HD11 ' A' ' 199' ' ' LEU . . . -94.51 21.89 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 61.0 111.097 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -141.73 120.93 13.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 64.34 110.864 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 14.5 m -87.17 -43.71 12.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 63.15 111.097 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.42 -12.45 60.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.868 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.0 t 57.98 48.15 13.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 65.42 110.836 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -93.27 -16.24 24.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 70.02 110.854 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.23 25.12 14.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 63.44 112.46 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.24 144.12 24.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 55.33 110.902 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 196' ' ' TYR . 22.0 t -113.89 121.95 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 74.14 111.123 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.15 -177.74 4.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 44.23 110.891 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.91 -32.67 66.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 64.14 110.949 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.53 -58.87 3.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.31 110.874 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.442 ' HB3' HG13 ' A' ' 191' ' ' VAL . 15.5 mt-10 -56.2 -25.46 47.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 71.11 110.929 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.53 ' HB2' HG12 ' A' ' 191' ' ' VAL . 31.7 t80 -85.34 -50.17 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 71.03 110.917 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.517 ' HA ' HD13 ' A' ' 200' ' ' ILE . 19.0 mt-10 -52.08 -40.98 62.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 71.45 110.877 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -53.56 -43.9 68.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 73.21 110.886 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.698 HD11 ' CB ' ' A' ' 183' ' ' ALA . 36.5 mt -51.84 -35.66 45.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 71.42 110.958 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.517 HD13 ' HA ' ' A' ' 197' ' ' GLU . 5.2 mp -77.0 -30.0 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 62.44 111.156 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.867 HD11 HD21 ' A' ' 130' ' ' LEU . 51.7 mm -64.66 -43.06 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 71.51 111.11 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -63.83 -36.05 82.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 71.21 110.905 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 62.7 m -77.66 -39.74 44.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.2 110.851 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' ' 129' ' ' LYS . 22.4 mt -57.63 -46.03 84.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.494 . . . . 73.03 110.902 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -52.59 -35.18 53.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.15 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.12 -31.33 21.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 65.14 110.88 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.425 ' HB3' ' CD1' ' A' ' 209' ' ' ILE . . . -64.91 -22.28 66.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 41.1 111.081 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.89 32.42 1.56 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.739 . . . . 42.33 112.496 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.468 HD13 ' CD2' ' A' ' 204' ' ' LEU . 5.2 mp -118.04 110.94 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 74.44 111.112 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 131.32 46.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.15 110.841 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.532 HG22 ' CG2' ' A' ' 126' ' ' VAL . 18.3 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 72.24 111.119 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.927 0.394 . . . . 71.12 110.95 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -51.73 160.97 0.95 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.661 0.743 . . . . 70.42 110.853 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -25.35 28.42 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.651 2.234 . . . . 61.33 112.318 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -79.36 -19.55 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 62.44 110.923 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.87 HG12 HD11 ' A' ' 130' ' ' LEU . 2.8 t -84.74 -61.03 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 72.1 111.111 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.521 ' HA ' HD12 ' A' ' 130' ' ' LEU . 3.6 tp10 -51.35 -30.7 19.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.9 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.37 79.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 51.34 111.089 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.442 ' O ' HG12 ' A' ' 132' ' ' VAL . 56.0 tptt -88.39 -40.73 13.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 72.33 110.914 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.87 HD11 HG12 ' A' ' 126' ' ' VAL . 13.2 mt -57.28 -25.81 59.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.928 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -70.03 -59.27 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 75.22 110.855 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 129' ' ' LYS . 10.1 p -57.87 -23.62 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 73.15 111.111 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.35 -21.69 59.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 61.54 111.137 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.8 mtt-85 -70.13 -53.41 17.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 62.41 110.885 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -54.57 -26.88 34.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 72.03 110.822 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -79.89 -35.17 38.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 62.34 110.964 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 148' ' ' LEU . 28.7 t80 -65.41 -43.02 91.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 71.5 110.885 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -79.49 -26.93 41.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.89 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -51.96 -40.44 60.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 65.32 110.889 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -94.23 -26.12 16.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.932 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.14 62.58 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 74.44 110.883 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -26.16 68.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 62.12 110.887 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -70.83 -10.56 59.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 73.12 110.875 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.04 20.89 43.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.709 -0.757 . . . . 62.32 112.464 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.5 m -78.45 -22.1 48.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 75.33 110.85 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.84 20.19 66.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 72.05 112.451 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -138.51 131.54 29.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.798 0.332 . . . . 64.23 110.935 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.597 HD13 HD22 ' A' ' 156' ' ' LEU . 24.1 mt -101.92 111.43 23.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 72.4 110.945 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -79.93 175.7 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 65.32 110.895 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -53.47 -28.51 31.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 61.23 110.87 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -77.34 -44.81 28.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.888 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.04 -33.19 73.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.928 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.64 HG22 HG13 ' A' ' 176' ' ' VAL . 30.6 mt -70.72 -37.5 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 53.35 111.201 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.84 -46.2 64.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 75.43 111.085 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.77 -23.13 56.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 65.42 112.505 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.597 HD22 HD13 ' A' ' 148' ' ' LEU . 21.3 tp -58.87 -55.95 28.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 72.05 110.902 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 25.1 mt -52.28 -35.66 50.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.931 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -43.59 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.885 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.07 -47.17 10.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.871 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.2 m -52.19 -31.16 30.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 74.22 111.142 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -76.17 -44.19 39.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.923 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.18 -25.53 64.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 74.53 111.097 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -52.25 -30.44 27.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 72.32 110.903 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -102.62 -18.45 15.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.24 110.869 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.77 27.24 9.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 53.21 112.481 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.63 175.2 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 64.54 110.873 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.1 p -55.6 -25.96 41.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 62.15 110.864 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 63.31 54.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 75.44 110.911 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -60.45 152.49 25.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 74.42 110.921 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p -108.27 90.8 7.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 72.31 111.136 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -171.02 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.643 2.228 . . . . 72.32 112.38 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 176' ' ' VAL . 70.1 p -127.86 -176.35 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 72.41 111.131 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -57.63 -25.56 60.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 72.32 110.93 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.42 -60.16 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 72.21 110.909 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.421 ' HA ' HD12 ' A' ' 178' ' ' ILE . 0.8 OUTLIER -56.84 -49.2 76.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 65.04 110.832 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.64 HG13 HG22 ' A' ' 153' ' ' ILE . 99.0 t -55.37 -43.87 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.424 . . . . 73.04 111.089 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -50.27 62.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 75.2 110.888 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 175' ' ' ASP . 3.7 mt -59.46 -49.22 84.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.22 111.173 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.527 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 53.5 t90 -54.74 -28.63 49.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 74.25 110.89 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 180' ' ' LEU . 5.8 tt -61.38 -45.64 93.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 73.11 110.906 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -72.52 -29.91 64.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.03 110.89 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.6 ttp -60.96 -31.18 70.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.25 110.871 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -101.26 -48.54 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 73.04 111.086 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -52.35 112.74 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 65.43 110.808 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 27.9 m -83.71 -33.34 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.3 111.141 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -83.51 -12.46 56.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 73.11 110.881 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.8 m 54.87 49.99 16.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 63.42 110.874 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -110.07 23.94 13.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.903 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.54 25.47 70.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 73.44 112.484 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.7 p -154.64 133.78 12.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 71.03 110.848 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.419 HG12 ' HB2' ' A' ' 196' ' ' TYR . 38.3 t -101.51 105.48 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 44.14 111.121 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -75.02 178.17 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 61.33 110.841 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.8 tp -54.79 -61.02 2.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 72.54 110.916 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -60.78 -41.54 95.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.913 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -29.38 66.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.53 110.92 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.509 ' O ' HD12 ' A' ' 200' ' ' ILE . 27.8 t80 -87.94 -47.63 8.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.955 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.418 ' HA ' HD13 ' A' ' 200' ' ' ILE . 0.3 OUTLIER -57.18 -25.84 59.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 72.42 110.905 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.9 -25.75 60.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.89 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.565 HD13 ' HB2' ' A' ' 183' ' ' ALA . 4.9 tp -69.07 -35.9 77.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.889 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -71.24 -24.5 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.13 111.135 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 1.133 HG23 HG11 ' A' ' 211' ' ' VAL . 50.0 mm -52.33 -61.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 52.05 111.073 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -49.57 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 64.2 110.919 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 49.0 m -52.15 -33.28 39.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 64.53 110.885 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.499 ' CD2' HD13 ' A' ' 209' ' ' ILE . 9.9 mt -76.59 -44.53 34.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 62.43 110.867 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -56.26 -30.1 61.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 73.11 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -16.41 38.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 70.5 110.924 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.51 ' HB3' HD12 ' A' ' 209' ' ' ILE . . . -94.72 24.81 4.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 62.11 111.102 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 66.52 32.39 81.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.763 . . . . 53.23 112.499 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 211' ' ' VAL . 18.7 mt -114.72 102.89 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.353 . . . . 64.44 111.121 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -57.0 106.31 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 73.33 110.862 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 1.133 HG11 HG23 ' A' ' 201' ' ' ILE . 85.5 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 64.12 111.142 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.547 ' CE2' HG11 ' A' ' 211' ' ' VAL . 2.4 m-85 . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.917 0.389 . . . . 73.13 110.938 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -52.23 160.62 1.2 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.587 0.708 . . . . 74.22 110.891 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -16.02 37.63 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.701 2.267 . . . . 54.45 112.37 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.61 -26.86 34.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 64.34 110.883 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.728 HG21 HG13 ' A' ' 211' ' ' VAL . 2.9 t -78.8 -61.81 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 45.43 111.107 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -51.62 -30.34 20.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 73.35 110.942 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.16 58.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 63.54 111.129 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.475 ' HG3' HD21 ' A' ' 204' ' ' LEU . 0.2 OUTLIER -84.87 -25.37 28.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.888 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.696 HD22 ' HG2' ' A' ' 197' ' ' GLU . 12.3 mt -78.67 -29.66 45.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 74.55 110.918 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.21 -48.76 69.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 70.22 110.838 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -65.47 -30.5 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 44.11 111.13 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.85 -27.89 57.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 73.53 111.086 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.463 ' HG2' HD21 ' A' ' 193' ' ' LEU . 38.4 mtp180 -66.74 -34.3 77.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.44 110.836 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -74.19 -29.83 61.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 63.12 110.878 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.52 -32.64 64.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 74.54 110.908 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.53 -63.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.13 110.874 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -58.02 -26.76 62.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.52 110.94 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -54.12 -29.24 44.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.886 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.04 -28.89 8.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 72.41 110.922 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.53 70.88 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 64.14 110.88 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -25.76 53.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 73.22 110.927 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -70.83 -10.5 59.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 72.13 110.853 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.43 19.78 58.08 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.738 -0.744 . . . . 43.12 112.463 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.4 t -82.33 -22.13 35.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.932 0.396 . . . . 45.21 110.892 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.83 22.44 63.92 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 64.43 112.523 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -140.09 148.99 42.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.858 0.361 . . . . 72.42 110.879 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.667 HD13 HD22 ' A' ' 156' ' ' LEU . 16.7 mt -120.14 119.89 34.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.33 110.912 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -85.37 177.85 7.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 74.01 110.92 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -52.0 -30.08 23.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.895 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.65 -52.14 9.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 63.32 110.856 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.25 -34.32 73.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.905 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.6 mt -68.6 -38.57 79.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 71.34 111.126 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.79 -58.35 7.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 73.03 111.114 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.22 -23.53 76.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 65.41 112.502 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.667 HD22 HD13 ' A' ' 148' ' ' LEU . 9.8 tp -67.9 -53.35 27.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 73.24 110.911 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 179' ' ' TRP . 5.6 mt -51.86 -29.86 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 72.02 110.94 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -60.28 -43.82 95.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.32 110.887 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -85.02 -38.85 18.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 64.23 110.875 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.0 m -51.75 -30.0 20.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.1 111.182 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -81.5 -50.21 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.44 110.924 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.706 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -55.29 -25.11 32.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 74.23 111.136 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -54.52 -28.99 49.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.917 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -110.74 16.93 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.51 110.906 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 29.02 74.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 74.53 112.489 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.1 mmt -69.31 175.85 3.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.821 0.344 . . . . 74.23 110.843 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 75.2 m -61.56 -18.4 59.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 72.3 110.899 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.706 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 3.5 t30 63.67 55.88 1.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 71.11 110.933 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -73.81 152.89 40.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.03 110.873 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 m -108.27 90.76 7.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 75.44 111.131 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 143.65 51.33 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.703 2.269 . . . . 71.44 112.312 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 176' ' ' VAL . 33.5 p -82.58 -178.43 7.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 51.55 111.138 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -56.32 -29.8 61.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.33 110.932 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.562 ' O ' HD12 ' A' ' 178' ' ' ILE . 3.6 tt0 -69.42 -52.44 26.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 72.02 110.895 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -54.7 -42.01 70.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.482 . . . . 63.43 110.846 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 172' ' ' THR . 47.4 t -58.57 -41.94 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 71.23 111.118 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -52.89 -48.85 66.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 62.22 110.913 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.0 mp -61.07 -25.61 36.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 72.42 111.093 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.614 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 70.8 t90 -81.87 -22.85 36.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 74.33 110.905 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' A' ' 184' ' ' ASP . 1.4 tt -78.22 -35.4 48.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 72.14 110.892 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -64.6 -31.95 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 51.3 110.933 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.5 ptp -91.72 -30.84 16.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 65.5 110.875 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.646 ' CB ' HD11 ' A' ' 199' ' ' LEU . . . -75.6 -51.27 13.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 42.45 111.128 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.585 ' HB3' HD23 ' A' ' 180' ' ' LEU . 0.5 OUTLIER -50.36 129.57 21.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 70.02 110.866 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.5 m -88.31 -48.78 7.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 64.31 111.15 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -113.86 16.69 18.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.15 110.895 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.5 t 51.78 58.67 5.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.878 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -96.17 -14.44 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.494 . . . . 62.54 110.851 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.37 16.77 17.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.728 . . . . 62.4 112.475 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.5 m -154.66 -179.26 7.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.397 . . . . 72.42 110.851 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.503 HG21 ' HZ3' ' A' ' 179' ' ' TRP . 21.5 t -135.59 101.41 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 72.14 111.159 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -76.07 -174.74 2.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 54.41 110.857 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.463 HD21 ' HG2' ' A' ' 134' ' ' ARG . 21.6 tp -65.3 -45.82 82.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 62.21 110.904 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -70.48 -26.11 63.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 74.4 110.902 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.86 -31.89 31.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 52.34 110.865 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.512 ' HA ' HD12 ' A' ' 199' ' ' LEU . 19.1 t80 -85.87 -34.96 20.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.885 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.696 ' HG2' HD22 ' A' ' 130' ' ' LEU . 24.1 tt0 -70.26 -32.15 69.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 73.31 110.868 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.83 -28.53 70.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 72.31 110.836 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.646 HD11 ' CB ' ' A' ' 183' ' ' ALA . 3.4 mt -63.9 -36.6 84.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.12 110.926 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.3 mp -74.86 -24.84 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 55.3 111.142 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.491 HD13 HD21 ' A' ' 130' ' ' LEU . 50.1 mm -58.49 -47.44 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 74.15 111.138 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -67.15 -40.4 86.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 70.34 110.912 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -47.54 65.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 74.2 110.852 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.475 HD21 ' HG3' ' A' ' 129' ' ' LYS . 6.9 mp -73.88 -29.44 62.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 73.42 110.895 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -62.9 -44.87 94.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.879 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -84.12 -24.19 30.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 52.51 110.876 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.9 -22.67 67.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 61.21 111.093 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.0 32.46 1.53 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 23.52 112.463 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.4 101.83 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.859 0.361 . . . . 54.32 111.102 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -68.76 108.07 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.872 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.728 HG13 HG21 ' A' ' 126' ' ' VAL . 21.8 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 52.53 111.126 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.882 0.372 . . . . 75.23 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -51.88 160.99 0.99 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 62.11 110.894 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -18.13 37.01 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.714 2.276 . . . . 62.1 112.335 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -83.04 -21.29 33.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.911 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.522 HG21 HG23 ' A' ' 211' ' ' VAL . 2.4 t -85.25 -51.78 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 65.12 111.128 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -51.06 -31.58 19.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.863 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.14 80.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 62.11 111.099 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HD3' HD11 ' A' ' 204' ' ' LEU . 13.8 tttp -88.58 -32.36 18.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 75.11 110.885 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.8 -25.95 68.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 74.41 110.935 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -67.59 -59.3 3.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 75.0 110.854 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 p -56.1 -24.83 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.129 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.48 -47.74 84.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 44.01 111.093 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -44.62 64.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 72.03 110.85 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -65.11 -29.14 69.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.879 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.52 -36.85 57.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 64.31 110.892 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -61.3 -41.95 97.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 72.3 110.893 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -79.1 -28.48 43.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 74.42 110.927 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -52.26 -29.88 25.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 62.21 110.834 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -108.25 -34.52 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 72.21 110.917 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -76.7 66.44 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 72.52 110.919 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -70.7 -26.09 63.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 63.44 110.885 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.9 -10.51 59.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 55.23 110.859 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.26 22.56 44.38 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 63.22 112.469 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.3 t -76.08 -22.13 55.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.915 0.388 . . . . 73.12 110.875 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.31 20.16 65.14 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 74.05 112.489 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -142.64 141.29 31.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 73.51 110.87 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.483 ' O ' HD11 ' A' ' 153' ' ' ILE . 58.0 mt -109.33 118.12 35.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 44.13 110.927 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -85.19 175.3 9.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.896 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -51.88 -30.31 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 32.3 110.883 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -81.08 -52.39 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.34 110.823 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.56 -28.36 65.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 64.44 110.874 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.483 HD11 ' O ' ' A' ' 148' ' ' LEU . 35.2 mt -81.32 -30.83 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 73.34 111.167 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.04 63.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 35.21 111.12 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.23 -22.86 56.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 72.31 112.509 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.92 -47.76 83.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 63.44 110.95 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.36 -36.41 77.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.927 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -52.62 -46.07 66.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.33 110.882 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -83.11 -47.19 11.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 72.42 110.882 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.8 m -51.79 -35.52 44.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 72.31 111.186 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -76.56 -53.69 7.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.97 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.724 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -57.06 -25.76 59.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 62.24 111.129 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -57.39 -25.68 59.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.866 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 36.9 mtm -110.01 21.74 16.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 55.15 110.873 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.69 68.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 72.52 112.435 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.6 mmt -60.79 174.98 0.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.805 0.336 . . . . 51.22 110.834 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -66.02 -14.91 62.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 64.14 110.821 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.724 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 6.7 t30 63.69 42.92 5.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 50.04 110.882 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -62.49 152.45 34.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 62.34 110.863 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 m -108.22 90.82 7.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.59 0.71 . . . . 70.42 111.152 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 159.93 51.6 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.672 2.248 . . . . 73.04 112.324 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.544 ' O ' HG23 ' A' ' 176' ' ' VAL . 79.7 p -106.87 -176.03 2.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 64.14 111.167 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -54.85 -26.57 36.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 74.51 110.932 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.431 ' O ' HD12 ' A' ' 178' ' ' ILE . 7.6 tp10 -75.42 -41.47 55.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 72.1 110.873 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.4 ' HA ' HD12 ' A' ' 178' ' ' ILE . 5.8 m-20 -74.61 -25.11 59.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 71.32 110.85 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 172' ' ' THR . 91.4 t -79.33 -32.64 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.132 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -22.73 66.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.915 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 174' ' ' GLU . 5.2 mt -87.58 -41.96 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 74.11 111.132 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -69.98 -31.27 68.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 62.14 110.951 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 180' ' ' LEU . 5.4 tt -64.25 -38.81 92.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 53.3 110.885 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -68.79 -28.18 66.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.924 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 6.1 mmm -70.47 -33.83 71.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 63.33 110.862 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.712 ' CA ' HD23 ' A' ' 199' ' ' LEU . . . -88.99 -49.34 6.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 51.12 111.111 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -75.0 119.34 19.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 54.2 110.88 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.9 m -87.59 -26.55 23.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 64.44 111.108 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.22 -12.47 56.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 70.1 110.846 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.6 m 53.61 53.65 11.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 61.14 110.834 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -106.66 -16.22 14.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 63.45 110.906 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.29 19.42 11.53 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.709 -0.758 . . . . 65.11 112.447 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.0 p -149.4 126.88 11.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 45.51 110.859 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.468 ' CG1' ' HB1' ' A' ' 183' ' ' ALA . 21.6 t -95.66 106.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 74.3 111.142 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.71 178.86 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 62.13 110.884 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 21.3 tp -63.16 -33.23 75.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 62.13 110.921 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -81.32 -40.04 24.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.858 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -65.05 -32.57 74.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.859 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.618 ' O ' HD12 ' A' ' 200' ' ' ILE . 20.2 t80 -78.89 -34.95 44.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.937 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -51.84 -56.76 12.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.499 . . . . 75.2 110.88 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -56.87 -33.28 66.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 75.03 110.931 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.712 HD23 ' CA ' ' A' ' 183' ' ' ALA . 0.7 OUTLIER -51.91 -45.1 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 63.33 110.932 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 196' ' ' TYR . 4.7 mp -72.37 -34.42 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 65.11 111.126 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.672 HG23 HG21 ' A' ' 211' ' ' VAL . 50.0 mm -52.98 -44.96 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.32 111.085 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -63.62 -44.96 92.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 70.44 110.891 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.3 m -59.44 -57.93 10.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 63.13 110.795 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.522 ' HG ' HD13 ' A' ' 209' ' ' ILE . 8.2 mp -51.97 -40.24 60.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 73.32 110.937 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -42.97 74.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 71.24 110.916 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -85.96 -6.99 58.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 61.23 110.899 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.513 ' HB3' HD12 ' A' ' 209' ' ' ILE . . . -94.94 25.48 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 73.21 111.1 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.72 32.41 83.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.719 -0.753 . . . . 73.53 112.5 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.522 HD13 ' HG ' ' A' ' 204' ' ' LEU . 17.0 mt -120.18 110.47 28.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 72.53 111.14 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.69 114.78 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 74.41 110.871 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.672 HG21 HG23 ' A' ' 201' ' ' ILE . 4.2 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 74.52 111.142 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.897 0.379 . . . . 74.3 110.917 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -51.49 161.07 0.87 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.672 0.748 . . . . 70.25 110.863 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.547 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 53.6 Cg_endo -69.8 -14.37 35.87 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.677 2.251 . . . . 64.3 112.346 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.23 -26.77 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 64.22 110.88 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.15 -63.53 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 61.21 111.103 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.64 -26.2 43.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 75.12 110.847 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 124' ' ' PRO . . . -58.66 -40.45 83.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 41.1 111.135 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.55 ' HB3' HD11 ' A' ' 204' ' ' LEU . 11.2 tptm -87.99 -26.65 22.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.43 110.928 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.689 HD22 ' CG ' ' A' ' 197' ' ' GLU . 77.1 mt -74.86 -25.57 59.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 60.12 110.931 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -76.37 -49.58 16.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 73.51 110.87 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.0 p -62.49 -25.81 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 74.11 111.143 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.81 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 54.32 111.125 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -51.91 -36.35 48.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 72.54 110.833 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -67.41 -48.31 67.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.846 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 tp -61.98 -27.91 69.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.9 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -69.54 -60.05 2.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.841 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -63.07 -28.67 70.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.874 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -52.65 -33.45 47.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 75.33 110.907 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -99.19 -29.47 12.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 62.35 110.887 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.94 85.47 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 71.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -85.06 -26.31 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.32 110.928 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.09 -10.53 59.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.885 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.58 24.47 47.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 51.43 112.523 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.2 p -90.51 -22.14 21.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 43.13 110.86 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.99 19.81 49.32 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.766 -0.731 . . . . 71.04 112.444 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -133.47 132.04 40.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 73.22 110.922 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.488 HD22 ' HB3' ' A' ' 152' ' ' GLU . 93.5 mt -99.56 110.82 23.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 64.32 110.916 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -77.94 176.94 8.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 75.21 110.893 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.94 -30.18 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.2 110.879 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.67 -51.82 15.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 60.53 110.893 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.488 ' HB3' HD22 ' A' ' 148' ' ' LEU . 35.8 mm-40 -62.26 -30.69 71.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.87 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.7 mt -77.06 -42.62 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 74.14 111.151 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.65 -49.07 63.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 61.2 111.106 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.87 -23.2 67.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 73.02 112.509 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.93 -45.7 60.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 74.01 110.9 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 179' ' ' TRP . 85.6 mt -52.86 -30.86 36.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 62.21 110.871 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.605 ' HD2' HG22 ' A' ' 170' ' ' THR . 0.0 OUTLIER -62.42 -60.81 3.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 74.14 110.881 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -27.48 67.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 73.03 110.888 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.0 m -65.05 -54.6 27.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 74.11 111.121 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -56.47 -25.99 52.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 73.23 110.933 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.86 -27.66 60.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 75.24 111.083 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -53.27 -28.68 29.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 62.13 110.858 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.3 mtm -104.26 -18.47 14.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 73.1 110.879 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.92 20.81 22.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.723 -0.751 . . . . 74.04 112.5 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 10.2 mtm -67.51 175.8 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.33 . . . . 71.04 110.852 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.7 t -60.63 -19.86 59.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 55.43 110.834 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 63.67 60.23 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 60.43 110.885 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -70.63 152.52 43.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 70.34 110.854 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.605 HG22 ' HD2' ' A' ' 158' ' ' LYS . 7.6 p -108.15 90.91 7.28 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.581 0.705 . . . . 73.41 111.151 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -178.33 2.31 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.646 2.23 . . . . 62.53 112.352 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 176' ' ' VAL . 51.5 p -118.62 179.56 4.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 52.2 111.15 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -54.74 -26.84 36.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 65.23 110.859 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.7 tp10 -72.87 -60.75 2.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.421 . . . . 73.14 110.844 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.0 -39.63 59.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 71.11 110.843 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 172' ' ' THR . 98.0 t -56.9 -43.25 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 71.5 111.136 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -52.01 -42.79 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.892 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.9 mp -68.84 -26.37 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.128 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.502 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 48.7 t90 -83.0 -26.45 31.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.471 . . . . 75.05 110.912 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.5 tt -77.14 -49.19 15.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 74.34 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -54.77 -28.79 51.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 64.43 110.895 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 31.5 ttm -72.68 -55.33 6.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.22 110.846 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.903 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -65.82 -60.81 2.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.52 111.101 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -66.26 128.72 37.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 73.42 110.904 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.26 -35.14 18.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 54.4 111.133 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -74.66 -12.46 60.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.866 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.9 p 46.24 57.42 5.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.812 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -114.17 23.56 12.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 72.11 110.851 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.06 25.89 74.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 65.42 112.467 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.8 p -152.41 135.62 15.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 65.02 110.876 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.78 111.62 36.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 74.11 111.135 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.8 t -75.37 179.95 4.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.804 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.68 -60.29 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 54.32 110.907 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -62.88 -39.21 93.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 52.4 110.88 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -61.22 -27.49 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.867 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.549 ' O ' HD12 ' A' ' 200' ' ' ILE . 36.8 t80 -89.37 -44.5 10.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 74.4 110.888 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.689 ' CG ' HD22 ' A' ' 130' ' ' LEU . 66.8 tt0 -60.46 -34.8 74.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 70.32 110.903 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -64.54 -26.18 68.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.866 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.903 HD13 ' HB2' ' A' ' 183' ' ' ALA . 2.3 tp -68.66 -44.35 74.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 75.03 110.938 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.1 mp -63.28 -24.65 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 72.33 111.122 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.644 HD13 HD21 ' A' ' 130' ' ' LEU . 48.6 mm -51.92 -48.05 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 70.04 111.124 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -69.31 -37.25 77.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 64.15 110.883 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 12.1 m -53.77 -42.19 68.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 61.02 110.842 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 129' ' ' LYS . 64.8 mt -80.14 -26.42 39.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 71.34 110.893 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -62.98 -43.63 98.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 63.5 110.917 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -85.79 -24.14 26.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 62.31 110.908 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.92 -21.55 66.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.115 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.06 21.9 4.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 52.25 112.49 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.79 101.65 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 74.51 111.157 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -68.57 98.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.32 110.851 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.9 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 72.04 111.118 179.959 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.908 0.385 . . . . 72.11 110.891 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -61.0 160.9 17.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.622 0.725 . . . . 73.12 110.915 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -27.61 26.21 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 30.42 112.34 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -75.09 -18.13 60.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 63.13 110.846 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.01 -60.42 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 55.3 111.115 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -51.59 -30.32 20.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 65.52 110.854 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.4 79.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 74.23 111.079 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -88.42 -24.59 23.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.894 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 201' ' ' ILE . 63.5 mt -76.83 -40.11 48.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.901 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -58.2 -43.24 87.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.827 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.461 HG23 HH11 ' A' ' 135' ' ' ARG . 13.3 p -71.39 -24.24 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.23 111.113 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.41 54.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 63.0 111.088 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -66.5 -50.3 63.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 72.32 110.855 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.461 HH11 HG23 ' A' ' 132' ' ' VAL . 4.1 ptm180 -55.29 -26.06 38.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 51.53 110.856 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.3 tp -79.44 -35.4 40.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 75.3 110.933 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.49 -60.54 3.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 54.23 110.876 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -60.35 -32.45 71.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 62.13 110.889 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -55.34 -26.51 41.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 61.33 110.912 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -108.24 -26.66 10.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 64.43 110.892 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.97 60.02 2.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 53.32 110.919 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -70.06 -25.91 63.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 75.21 110.918 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.74 -10.58 59.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.834 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.12 23.38 52.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.757 . . . . 63.21 112.499 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -83.07 -22.06 33.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.929 0.395 . . . . 53.02 110.87 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.32 20.69 60.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 65.13 112.527 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -150.08 131.74 14.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 64.4 110.901 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.5 mt -91.45 101.88 14.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.945 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -65.61 171.85 3.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 71.41 110.875 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.494 ' HA ' HD12 ' A' ' 153' ' ' ILE . 7.3 t70 -52.05 -29.99 23.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 62.23 110.86 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.81 -51.35 12.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 64.11 110.892 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -59.62 -26.4 65.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 73.03 110.904 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.57 ' CG2' HG13 ' A' ' 176' ' ' VAL . 23.7 mt -76.78 -36.63 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 61.24 111.112 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.72 -44.77 63.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 64.44 111.126 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.27 -25.27 48.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.741 . . . . 42.2 112.486 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.416 HD21 ' CE1' ' A' ' 196' ' ' TYR . 2.4 tp -59.23 -56.75 18.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 74.34 110.896 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.1 mt -51.95 -32.41 33.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 71.54 110.927 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -57.0 -43.97 82.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 44.23 110.885 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -84.93 -45.93 11.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 64.12 110.834 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.1 m -52.58 -36.63 56.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.174 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -67.33 -56.44 9.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 64.54 110.947 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.727 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -54.61 -26.79 34.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 61.15 111.107 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.95 -33.17 75.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 73.01 110.88 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -99.02 18.95 16.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 64.04 110.82 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.21 68.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 73.12 112.47 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.3 tpp -65.28 173.65 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 61.32 110.884 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 91.1 p -72.92 -9.07 58.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 63.11 110.831 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.727 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 0.2 OUTLIER 63.64 47.85 3.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 63.34 110.834 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -62.63 152.6 34.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 64.55 110.846 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.3 p -108.29 90.93 7.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.626 0.726 . . . . 65.53 111.1 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 -176.35 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 2.252 . . . . 71.13 112.293 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 176' ' ' VAL . 36.6 p -128.68 -176.07 3.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 70.03 111.17 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -55.07 -26.55 38.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 64.14 110.909 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.615 ' O ' HD12 ' A' ' 178' ' ' ILE . 41.2 tt0 -72.93 -61.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.861 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.05 -48.3 64.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 54.5 110.834 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 172' ' ' THR . 89.7 t -52.17 -36.62 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.44 111.152 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -59.38 -53.9 52.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.21 110.909 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -55.23 -38.4 47.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 51.33 111.137 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.702 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 88.4 t90 -75.22 -25.27 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 53.12 110.923 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 tt -74.89 -51.21 14.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.859 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -52.75 -45.17 66.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 72.04 110.887 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.0 ttm -57.92 -26.39 62.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 50.12 110.879 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.874 ' HB2' HD11 ' A' ' 199' ' ' LEU . . . -90.85 -67.28 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 73.43 111.128 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -61.25 128.49 36.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 63.13 110.872 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.1 m -84.05 -28.14 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 72.02 111.135 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -91.3 -12.46 35.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 54.34 110.883 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 58.5 58.37 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 61.11 110.83 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -117.29 23.46 11.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 60.52 110.911 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.13 31.5 81.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.718 -0.753 . . . . 64.45 112.457 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.58 129.98 17.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.922 0.391 . . . . 74.31 110.887 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.513 HG13 ' HB1' ' A' ' 183' ' ' ALA . 40.3 t -114.99 102.31 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 63.13 111.08 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.47 176.24 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.34 110.821 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.2 OUTLIER -62.52 -29.92 70.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 65.35 110.984 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -81.39 -29.5 33.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 53.34 110.933 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.7 -22.0 29.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 63.22 110.912 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.467 ' HA ' HD12 ' A' ' 199' ' ' LEU . 41.5 t80 -84.04 -35.19 24.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 73.31 110.927 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.474 ' O ' HD12 ' A' ' 201' ' ' ILE . 11.2 pt-20 -67.86 -41.81 82.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 54.12 110.891 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -55.33 -30.11 59.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.843 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' A' ' 183' ' ' ALA . 44.5 mt -62.26 -41.03 98.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 73.25 110.903 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 200' ' ' ILE . 4.6 mp -66.2 -44.25 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 72.45 111.127 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 1.036 HG23 HG11 ' A' ' 211' ' ' VAL . 2.0 mp -60.32 -35.9 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.53 111.164 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.37 -41.17 79.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 72.12 110.946 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 17.9 t -84.69 -36.05 22.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 70.34 110.881 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.63 ' CD2' HD13 ' A' ' 209' ' ' ILE . 21.4 mt -51.99 -37.9 54.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 63.14 110.929 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -51.1 -46.67 61.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 71.54 110.861 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.42 -22.62 26.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 61.32 110.885 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 204' ' ' LEU . . . -64.77 -22.79 67.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 61.33 111.117 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.52 26.59 3.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 40.52 112.472 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.63 HD13 ' CD2' ' A' ' 204' ' ' LEU . 5.2 mp -124.76 136.24 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 74.22 111.108 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -102.07 115.9 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.32 110.891 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 1.036 HG11 HG23 ' A' ' 201' ' ' ILE . 6.3 p . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 65.35 111.151 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.93 0.395 . . . . 71.54 110.866 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -53.73 160.57 2.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.608 0.718 . . . . 64.02 110.905 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -20.43 34.89 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.719 2.279 . . . . 61.4 112.334 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -81.63 -20.91 38.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 64.43 110.881 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.514 HG13 HD22 ' A' ' 204' ' ' LEU . 2.9 t -80.4 -59.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 63.03 111.118 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.538 ' OE2' HD12 ' A' ' 130' ' ' LEU . 2.0 tp10 -51.77 -30.66 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 62.32 110.905 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.4 -30.88 61.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 20.31 111.114 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -25.81 22.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 60.43 110.94 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.699 HD22 ' HG3' ' A' ' 197' ' ' GLU . 18.7 mt -76.32 -42.12 46.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.34 110.918 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -55.23 -51.99 64.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 52.51 110.901 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.18 -26.53 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.088 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.21 76.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 73.23 111.121 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.3 mtm-85 -56.5 -44.88 81.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 72.55 110.873 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -61.64 -37.77 85.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 50.21 110.857 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.91 -29.84 61.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 74.35 110.912 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -67.11 -55.29 14.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 62.53 110.882 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -66.82 -28.5 68.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 60.11 110.922 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -52.5 -39.91 61.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.11 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -96.55 -35.5 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 71.53 110.879 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -80.75 57.96 3.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.839 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -25.38 68.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 72.32 110.894 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -71.27 -10.62 60.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 73.05 110.857 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.4 29.68 57.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 44.03 112.484 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.8 p -70.69 -22.18 62.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 54.3 110.843 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.48 -16.39 58.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 72.23 112.491 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -141.44 155.76 45.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.359 . . . . 62.11 110.912 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.501 ' CD1' HD13 ' A' ' 156' ' ' LEU . 42.0 mt -98.62 109.74 22.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 65.52 110.893 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.55 178.34 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.21 110.948 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -57.86 -26.31 61.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 71.51 110.884 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 57.5 m-20 -82.63 -53.3 6.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.23 110.877 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HB3' HD22 ' A' ' 148' ' ' LEU . 1.7 mt-10 -51.92 -49.05 63.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.86 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.606 ' CD1' HD13 ' A' ' 180' ' ' LEU . 33.9 mt -51.63 -38.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.41 111.164 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 151' ' ' ASP . . . -51.64 -41.34 61.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 62.44 111.096 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.85 -30.41 32.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.744 -0.741 . . . . 72.32 112.514 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.501 HD13 ' CD1' ' A' ' 148' ' ' LEU . 3.8 tp -58.32 -54.02 51.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 74.1 110.904 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 179' ' ' TRP . 56.6 mt -51.85 -32.28 31.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 73.31 110.93 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -54.71 -58.13 8.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 75.43 110.852 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.96 -42.82 56.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 75.43 110.855 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 93.1 m -52.42 -32.26 38.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 54.33 111.157 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -79.16 -57.53 3.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 74.11 110.924 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.505 ' HB2' ' ND2' ' A' ' 168' ' ' ASN . . . -55.51 -26.08 40.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.45 111.102 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.64 -27.65 63.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 65.31 110.885 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 51.8 mtm -103.91 21.86 15.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 65.24 110.887 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.84 23.07 72.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 35.24 112.505 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.0 tpp -76.57 170.03 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 52.23 110.887 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -64.48 -17.46 63.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 72.54 110.848 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' A' ' 162' ' ' ALA . 48.6 t-20 63.5 56.72 1.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 64.34 110.907 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -67.69 152.65 45.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 71.23 110.902 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.5 m -108.23 90.85 7.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.555 0.693 . . . . 63.24 111.161 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 174.98 8.71 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 74.33 112.305 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 176' ' ' VAL . 68.4 p -116.15 -176.02 2.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 70.31 111.143 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -51.82 -30.42 23.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 73.31 110.902 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.62 ' O ' HD12 ' A' ' 178' ' ' ILE . 84.9 tt0 -69.38 -61.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 65.51 110.902 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.9 -45.23 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 71.03 110.875 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 172' ' ' THR . 96.6 t -58.84 -28.51 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 64.4 111.193 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -66.92 -40.0 87.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 73.04 110.911 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -70.12 -31.37 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 53.45 111.127 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.511 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 55.8 t90 -83.52 -28.34 28.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 75.12 110.912 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.667 HD21 ' HA2' ' A' ' 189' ' ' GLY . 23.0 tp -83.72 -38.2 21.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 72.53 110.958 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -61.05 -30.91 70.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 71.31 110.906 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 48.8 ttp -91.25 -40.13 11.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 61.33 110.864 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -65.38 -25.26 67.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.12 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -101.25 127.84 47.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.879 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 98.0 m -83.9 -25.03 30.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 72.15 111.167 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -97.32 -12.43 22.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.846 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.6 t 56.6 39.32 29.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 75.53 110.879 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -98.05 19.55 13.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 61.31 110.885 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.667 ' HA2' HD21 ' A' ' 180' ' ' LEU . . . 64.08 31.71 81.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.484 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.97 134.0 18.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 61.54 110.863 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 196' ' ' TYR . 22.0 t -108.26 97.72 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 71.12 111.119 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.06 162.45 24.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 32.14 110.875 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 193' ' ' LEU . 5.6 mt -53.29 -31.57 44.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.128 -0.487 . . . . 71.02 110.893 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -81.43 -28.12 34.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.887 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -78.03 -42.46 32.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.467 . . . . 74.32 110.859 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.548 ' O ' HD12 ' A' ' 200' ' ' ILE . 20.0 t80 -65.04 -52.62 54.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.917 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.699 ' HG3' HD22 ' A' ' 130' ' ' LEU . 31.3 tt0 -51.81 -48.37 63.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 70.32 110.917 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -51.93 -35.0 44.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 71.24 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.511 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 2.5 tp -61.19 -45.08 96.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.24 110.943 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.1 mp -64.95 -28.32 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 54.41 111.115 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.645 ' CD1' HD21 ' A' ' 130' ' ' LEU . 50.0 mm -63.99 -52.85 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 63.23 111.122 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -56.49 -30.75 63.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 55.22 110.903 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 22.1 m -83.08 -29.94 28.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 51.23 110.814 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.609 ' HG ' HD13 ' A' ' 209' ' ' ILE . 0.8 OUTLIER -66.81 -42.72 85.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 64.35 110.874 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -51.9 -36.53 49.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.871 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -26.02 26.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 70.43 110.938 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.72 67.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 71.42 111.108 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.81 25.09 5.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.743 . . . . 60.2 112.43 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.609 HD13 ' HG ' ' A' ' 204' ' ' LEU . 5.3 mp -116.57 108.5 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 43.14 111.124 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -64.6 118.4 8.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 72.44 110.901 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.476 ' CG2' HG11 ' A' ' 126' ' ' VAL . 5.8 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.116 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.917 0.389 . . . . 63.13 110.957 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -62.7 160.58 34.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.617 0.723 . . . . 75.23 110.912 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -17.78 37.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.714 2.276 . . . . 72.31 112.373 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.49 ' HB3' HG23 ' A' ' 209' ' ' ILE . 15.7 tp10 -82.9 -22.49 33.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.887 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.28 -61.27 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 74.11 111.114 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -51.67 -29.96 20.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 70.4 110.906 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.55 84.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 63.31 111.106 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.56 ' HB3' HD11 ' A' ' 204' ' ' LEU . 16.6 tptp -88.42 -26.61 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 72.44 110.893 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.753 HD22 ' HG3' ' A' ' 197' ' ' GLU . 61.4 mt -74.78 -26.12 59.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 72.14 110.94 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.21 -54.16 28.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 53.33 110.883 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.15 -24.95 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 61.32 111.114 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.89 -39.94 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 75.25 111.118 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -54.72 -31.09 57.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 71.45 110.891 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -85.03 -40.94 16.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.874 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.48 -27.25 67.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 64.35 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.707 ' CE1' HD13 ' A' ' 148' ' ' LEU . 87.5 t80 -72.81 -49.98 27.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 73.22 110.888 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -74.83 -25.91 59.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.901 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -57.23 -25.04 58.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.53 110.922 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -110.05 -21.31 12.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 65.43 110.919 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -77.27 61.81 2.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 75.25 110.832 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -16.72 59.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 71.12 110.952 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -70.22 -10.66 59.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 44.33 110.872 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.0 20.33 53.29 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.77 -0.729 . . . . 30.45 112.509 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.7 m -78.95 -22.12 46.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.945 0.403 . . . . 60.15 110.853 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.3 -16.06 58.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 73.42 112.533 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.63 170.71 9.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 63.43 110.891 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.707 HD13 ' CE1' ' A' ' 137' ' ' PHE . 0.8 OUTLIER -112.98 101.29 9.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 63.04 110.89 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -73.46 172.16 11.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 75.03 110.915 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.408 ' O ' HG11 ' A' ' 176' ' ' VAL . 11.8 p-10 -54.44 -27.39 36.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 74.52 110.875 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -82.23 -45.78 14.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 73.42 110.87 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -63.71 -45.18 91.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.23 110.874 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.435 ' CD1' HD12 ' A' ' 180' ' ' LEU . 21.2 mt -52.43 -31.35 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 70.12 111.123 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.95 58.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 73.43 111.111 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.75 -22.85 59.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.734 . . . . 71.13 112.501 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.682 HD13 HD21 ' A' ' 148' ' ' LEU . 3.8 tp -70.09 -59.09 3.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.808 0.337 . . . . 63.0 110.909 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 27.3 mt -52.16 -32.65 36.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 71.32 110.944 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -51.9 -57.26 9.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 51.13 110.91 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.0 -41.54 28.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 73.12 110.867 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.5 m -51.63 -30.99 23.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 70.1 111.159 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.38 -52.47 9.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 71.54 110.922 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.402 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -54.84 -25.51 28.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 63.33 111.135 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -54.29 -32.47 56.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.24 110.853 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.4 ptp -105.67 21.13 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.888 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.83 16.56 66.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 42.23 112.468 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.16 166.96 0.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.82 0.343 . . . . 70.44 110.873 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.2 m -65.36 -14.58 61.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.868 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 2.2 t30 64.21 58.32 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 72.05 110.908 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -73.29 153.08 40.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 73.01 110.919 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.406 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 10.2 m -108.09 90.91 7.2 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.685 . . . . 70.33 111.133 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.8 Cg_endo -69.74 -174.65 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.696 2.264 . . . . 75.04 112.355 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 176' ' ' VAL . 71.2 p -129.01 -176.01 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 75.51 111.135 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -54.72 -26.67 35.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 70.31 110.872 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.609 ' O ' HD12 ' A' ' 178' ' ' ILE . 8.3 tp10 -72.56 -61.64 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.89 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.07 -48.6 64.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.867 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 172' ' ' THR . 86.6 t -51.68 -42.48 31.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 45.22 111.084 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -47.0 64.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 72.13 110.918 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.9 mp -62.44 -26.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.15 111.088 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.54 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 52.3 t90 -83.78 -30.76 26.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 71.42 110.927 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 184' ' ' ASP . 3.2 tt -77.59 -47.05 20.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 72.33 110.954 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -51.95 -30.92 26.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 60.23 110.912 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 37.1 ttp -90.41 -26.43 19.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.55 110.844 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.769 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -96.09 21.91 8.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 74.13 111.133 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.534 ' HB2' HD23 ' A' ' 180' ' ' LEU . 21.1 t0 -131.8 112.2 12.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.842 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.5 m -83.74 -41.79 17.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 61.24 111.16 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.47 -12.5 59.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 64.54 110.896 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 54.66 35.2 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 64.14 110.847 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.45 -16.23 37.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.89 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.0 20.24 16.91 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 44.24 112.48 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.52 126.71 8.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 74.35 110.864 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.49 97.53 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 72.5 111.066 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.1 t -67.71 165.18 17.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.41 110.838 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 26.1 tp -53.62 -35.94 61.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 72.04 110.875 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -77.08 -24.67 51.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.907 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -79.58 -53.33 6.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 71.32 110.906 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.619 ' CE1' HD21 ' A' ' 156' ' ' LEU . 22.5 t80 -51.98 -49.95 62.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.934 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.753 ' HG3' HD22 ' A' ' 130' ' ' LEU . 3.0 tp10 -51.82 -47.61 64.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 73.14 110.903 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -52.8 -32.53 44.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.487 . . . . 54.02 110.904 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 183' ' ' ALA . 3.0 tp -62.5 -38.94 91.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.937 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -74.17 -24.05 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.11 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.455 HG22 ' NE2' ' A' ' 205' ' ' GLN . 45.0 mm -59.4 -55.87 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.12 111.114 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -56.24 -37.95 70.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.42 110.892 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.6 t -66.98 -28.48 68.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 73.23 110.869 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 129' ' ' LYS . 21.3 mt -79.34 -25.42 42.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.44 110.956 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.568 ' OE1' HG12 ' A' ' 211' ' ' VAL . 2.7 mp0 -59.99 -45.59 92.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.879 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -86.05 -20.37 28.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.911 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.93 -22.77 67.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.056 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 108.9 32.44 3.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.78 -0.724 . . . . 75.21 112.472 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 125' ' ' GLU . 5.3 mp -124.12 131.01 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 74.4 111.107 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -90.55 133.63 34.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.904 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.568 HG12 ' OE1' ' A' ' 205' ' ' GLN . 6.7 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.154 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.86 0.362 . . . . 60.13 110.964 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -52.02 160.49 1.17 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.623 0.725 . . . . 31.34 110.879 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -17.13 37.61 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.688 2.258 . . . . 72.51 112.34 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.495 ' CG ' HG23 ' A' ' 209' ' ' ILE . 18.4 pt-20 -82.9 -24.63 33.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.906 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.455 HG21 HG23 ' A' ' 211' ' ' VAL . 3.0 t -78.35 -63.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 43.44 111.115 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 130' ' ' LEU . 8.3 tt0 -52.15 -30.01 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 74.02 110.879 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.76 -32.69 60.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 62.14 111.123 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.604 ' HG2' HG21 ' A' ' 200' ' ' ILE . 24.6 tttm -87.96 -25.73 23.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 75.02 110.936 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 197' ' ' GLU . 25.2 mt -77.9 -29.23 50.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.935 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -65.7 -32.59 74.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.896 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 129' ' ' LYS . 11.7 p -86.05 -23.36 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 52.21 111.12 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -82.78 -35.55 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 33.35 111.108 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -24.46 57.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.817 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -83.17 -23.07 33.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 73.54 110.866 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.59 -24.34 33.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.899 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.681 ' CE1' HD13 ' A' ' 148' ' ' LEU . 90.3 t80 -65.54 -56.43 12.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 64.25 110.881 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -72.22 -24.22 61.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.88 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -52.08 -29.88 23.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 74.53 110.875 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -110.69 -21.14 12.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.901 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -75.62 69.66 2.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 52.12 110.872 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -85.14 0.51 51.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 71.15 110.895 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.39 -10.57 59.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.869 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.16 18.7 60.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 75.23 112.529 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 p -106.32 -22.0 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.382 . . . . 61.13 110.869 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.6 21.53 66.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 61.32 112.48 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -128.72 132.54 47.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 61.41 110.879 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.681 HD13 ' CE1' ' A' ' 137' ' ' PHE . 1.2 mp -90.81 104.78 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.923 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -88.04 177.27 6.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 72.4 110.944 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -52.04 -30.08 23.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.33 110.898 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 53.1 m-20 -80.4 -55.04 5.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 74.0 110.834 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -53.95 -46.02 71.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 61.32 110.929 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.403 ' CD1' HD12 ' A' ' 180' ' ' LEU . 39.3 mt -57.19 -33.72 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 74.32 111.11 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 151' ' ' ASP . . . -51.15 -48.06 61.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 72.32 111.079 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.36 -24.72 70.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 60.1 112.492 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.572 HD13 HD21 ' A' ' 148' ' ' LEU . 1.7 tp -69.42 -55.93 8.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 75.2 110.926 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.412 HD21 ' CE2' ' A' ' 179' ' ' TRP . 70.7 mt -51.69 -30.16 20.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 62.02 110.884 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.772 ' HE3' HG23 ' A' ' 170' ' ' THR . 0.7 OUTLIER -57.15 -58.57 7.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 55.11 110.915 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -71.77 -42.85 66.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 65.22 110.86 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.1 m -52.17 -34.94 47.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 62.55 111.171 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -82.11 -25.72 34.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.94 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -78.91 -25.38 43.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 52.1 111.066 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -59.68 -44.78 93.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 75.4 110.843 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.3 mtm -75.08 -18.29 60.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 64.53 110.866 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.95 17.72 36.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 65.22 112.532 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.3 ttm -66.67 175.93 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.799 0.333 . . . . 74.34 110.828 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.4 m -65.72 -14.39 61.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 63.13 110.855 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.553 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 0.6 OUTLIER 64.21 73.73 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 61.14 110.841 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -78.52 152.93 31.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 75.15 110.859 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.772 HG23 ' HE3' ' A' ' 158' ' ' LYS . 11.3 m -108.03 90.88 7.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.581 0.705 . . . . 63.11 111.124 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 169.19 19.43 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.703 2.268 . . . . 51.25 112.348 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 176' ' ' VAL . 62.7 p -108.63 -176.06 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 74.23 111.139 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -24.97 46.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 75.5 110.89 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.656 ' O ' HD12 ' A' ' 178' ' ' ILE . 38.7 tt0 -77.8 -55.4 5.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.13 110.895 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.57 -35.89 43.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 73.44 110.872 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 172' ' ' THR . 88.4 t -65.83 -36.79 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 62.11 111.144 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -59.03 -46.63 87.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.898 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.656 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -62.61 -28.01 43.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 74.41 111.111 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.528 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 49.5 t90 -83.8 -26.03 29.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.892 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.616 HD23 ' HB2' ' A' ' 184' ' ' ASP . 3.0 tt -77.3 -35.21 55.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.14 110.875 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.67 -26.62 67.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 72.52 110.907 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.9 ttm -87.66 -49.81 6.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 72.2 110.895 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.478 ' HB3' HG21 ' A' ' 191' ' ' VAL . . . -61.32 -44.37 97.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 63.01 111.107 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.616 ' HB2' HD23 ' A' ' 180' ' ' LEU . 29.8 t0 -58.57 98.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 51.22 110.804 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 97.4 m -86.66 -24.75 25.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 75.14 111.133 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -95.44 -12.35 26.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 71.34 110.902 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 62.27 48.16 4.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.853 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -110.31 23.81 13.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 62.1 110.862 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.68 14.51 58.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 43.54 112.503 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.72 158.86 40.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 74.12 110.86 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 183' ' ' ALA . 34.4 t -117.62 122.72 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 70.32 111.141 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 -169.74 2.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.873 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -66.4 -43.83 84.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 72.4 110.893 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -72.49 -34.59 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 71.3 110.878 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.7 -23.03 53.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 71.13 110.899 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.518 ' CE1' HD21 ' A' ' 156' ' ' LEU . 23.2 t80 -82.11 -50.33 9.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 74.03 110.959 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' A' ' 130' ' ' LEU . 10.9 pt-20 -53.61 -43.71 68.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 63.13 110.866 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -52.01 -29.96 23.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.22 110.885 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.528 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 1.7 tp -64.35 -43.1 95.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 72.42 110.946 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.604 HG21 ' HG2' ' A' ' 129' ' ' LYS . 5.2 mp -69.78 -24.64 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.42 111.126 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.607 HD11 HD11 ' A' ' 130' ' ' LEU . 50.0 mm -59.2 -55.6 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 72.11 111.142 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -52.62 -38.07 59.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 74.12 110.876 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 p -74.57 -29.81 61.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.892 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.941 HD23 HD13 ' A' ' 209' ' ' ILE . 4.7 mt -68.51 -33.37 74.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 64.44 110.948 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -57.67 -47.18 83.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 73.15 110.905 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -24.68 32.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 63.25 110.909 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.88 -21.18 66.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 44.34 111.118 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.89 20.7 4.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.738 . . . . 72.25 112.535 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.941 HD13 HD23 ' A' ' 204' ' ' LEU . 5.3 mp -119.73 103.85 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 74.12 111.138 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -72.12 108.45 5.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 71.51 110.86 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.455 HG23 HG21 ' A' ' 126' ' ' VAL . 6.2 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.3 111.168 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 120.897 0.379 . . . . 73.34 110.924 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -51.93 160.88 1.03 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 63.23 110.871 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -17.19 37.61 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.715 2.277 . . . . 73.44 112.301 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -82.99 -24.84 32.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 73.23 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.444 HG21 HG13 ' A' ' 211' ' ' VAL . 3.1 t -77.59 -63.35 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 74.51 111.128 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.437 ' OE2' HD12 ' A' ' 130' ' ' LEU . 4.2 tp10 -51.88 -33.61 37.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 60.04 110.876 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.42 -36.36 54.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 63.1 111.144 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.651 ' HB3' HD11 ' A' ' 204' ' ' LEU . 21.5 tptt -83.06 -26.17 31.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.53 110.921 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.771 HD11 HD11 ' A' ' 201' ' ' ILE . 92.5 mt -74.31 -37.19 63.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.34 110.953 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.91 -57.25 11.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 75.12 110.924 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.89 -25.23 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.14 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.86 -29.7 40.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 61.33 111.139 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -60.03 -54.26 48.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 70.32 110.869 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 -54.24 -46.24 72.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.841 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.8 tp -56.97 -34.37 68.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 72.41 110.925 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -59.77 -62.99 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 72.12 110.907 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -62.89 -26.96 69.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 63.44 110.902 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -31.42 36.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.902 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.29 -38.08 7.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 75.24 110.943 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.88 76.23 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 74.31 110.857 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -67.2 -30.62 70.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 75.53 110.907 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.92 -10.55 59.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.32 110.869 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.74 22.49 40.56 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.733 -0.746 . . . . 64.35 112.463 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.3 m -71.42 -22.06 61.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 62.4 110.891 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.7 23.5 57.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.514 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -145.79 130.74 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.358 . . . . 63.35 110.908 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mt -103.85 101.42 11.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 73.3 110.934 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -62.89 174.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 54.02 110.901 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.14 -26.49 38.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 34.51 110.891 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.63 -54.67 5.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 63.34 110.857 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -52.22 -38.85 59.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 61.21 110.899 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.3 mt -63.32 -32.96 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 74.11 111.115 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.7 -42.13 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 63.2 111.115 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.34 -25.9 45.77 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.713 -0.756 . . . . 72.53 112.465 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.2 tp -60.88 -55.85 28.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 73.51 110.937 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.5 mt -52.03 -33.94 40.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 65.13 110.903 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -59.73 4.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 71.33 110.923 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.13 -41.42 61.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 72.31 110.832 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 89.0 m -53.44 -32.92 52.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 74.33 111.126 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -77.33 -51.23 11.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.895 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.522 ' HB2' ' ND2' ' A' ' 168' ' ' ASN . . . -58.19 -30.63 66.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 65.13 111.113 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.9 -46.77 64.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 65.44 110.922 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 33.1 mtm -76.8 -18.46 58.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 63.41 110.912 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 95.89 28.66 9.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.74 -0.743 . . . . 73.35 112.426 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 6.3 ttm -86.0 175.79 8.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 75.14 110.853 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.0 m -58.29 -22.97 54.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 71.32 110.848 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 162' ' ' ALA . 37.8 t-20 63.36 60.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 60.31 110.896 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -65.62 152.51 43.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 73.33 110.864 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.0 p -108.31 90.82 7.39 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.589 0.709 . . . . 73.33 111.135 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -171.19 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.28 . . . . 64.35 112.322 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.627 ' O ' HG23 ' A' ' 176' ' ' VAL . 34.3 p -126.5 -176.17 3.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.132 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -57.45 -26.36 61.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 64.51 110.918 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 178' ' ' ILE . 9.8 tt0 -72.53 -61.56 1.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 73.14 110.886 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.27 -48.82 65.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.477 . . . . 75.22 110.849 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 172' ' ' THR . 85.7 t -51.62 -34.87 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 54.22 111.115 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.27 -52.53 64.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 73.42 110.882 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.551 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.8 mp -57.46 -25.83 25.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 72.14 111.171 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.513 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 49.6 t90 -82.69 -37.72 24.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 74.05 110.935 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.6 tt -57.63 -46.38 84.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 72.41 110.865 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -54.7 -36.38 64.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 61.34 110.925 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.2 mtm -65.79 -54.22 29.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 70.12 110.873 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.592 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . . . -64.53 -63.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 51.22 111.098 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -69.32 129.28 39.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 60.45 110.888 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 8.5 m -85.22 -24.79 27.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.123 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -89.39 -12.4 40.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 70.44 110.904 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.5 p 51.59 39.73 25.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 71.52 110.898 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -95.24 23.92 5.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.89 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 65.58 29.3 74.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.739 . . . . 50.13 112.49 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m -154.71 126.88 7.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.401 . . . . 63.32 110.828 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.71 106.38 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 60.24 111.133 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.1 t -72.1 178.32 3.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 72.43 110.86 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.536 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -63.67 -38.03 89.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.946 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -81.26 -25.59 36.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 63.32 110.899 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.35 -23.19 40.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 70.01 110.882 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.494 ' O ' HD12 ' A' ' 200' ' ' ILE . 19.4 t80 -84.27 -51.81 6.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 74.55 110.936 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.764 ' HB2' HD22 ' A' ' 130' ' ' LEU . 13.5 pt-20 -53.1 -43.83 67.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.487 . . . . 72.24 110.888 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -52.74 -41.91 64.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 65.22 110.909 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 9.0 tt -52.42 -39.61 61.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 72.44 110.919 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.3 mp -73.81 -25.85 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 70.34 111.152 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.771 HD11 HD11 ' A' ' 130' ' ' LEU . 50.5 mm -67.45 -38.14 80.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 73.42 111.121 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -66.28 -36.88 84.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 72.34 110.9 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 43.7 m -78.36 -37.82 43.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.865 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.651 HD11 ' HB3' ' A' ' 129' ' ' LYS . 18.7 mt -57.8 -35.89 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 73.14 110.919 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -56.83 -37.71 71.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.908 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -85.59 -24.88 26.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 65.23 110.951 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.74 67.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 75.34 111.126 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.72 24.15 3.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 65.13 112.51 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.04 102.0 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 71.33 111.135 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -69.45 101.26 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 53.51 110.915 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.444 HG13 HG21 ' A' ' 126' ' ' VAL . 21.2 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 75.51 111.142 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.886 0.374 . . . . 73.51 110.955 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.66 160.8 1.84 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 72.42 110.89 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -21.41 33.27 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 2.253 . . . . 75.0 112.337 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.94 -21.83 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 74.05 110.863 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.81 HG13 HD23 ' A' ' 204' ' ' LEU . 3.0 t -77.73 -61.17 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.23 111.173 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -52.08 -29.86 23.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.03 110.892 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.81 -38.73 70.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 44.44 111.132 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.542 ' HG2' HD11 ' A' ' 204' ' ' LEU . 16.9 tptm -83.95 -25.39 30.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.04 110.938 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 197' ' ' GLU . 90.2 mt -75.24 -30.27 60.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 70.21 110.933 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.65 -56.13 25.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.472 . . . . 64.51 110.847 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.97 -26.75 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 70.4 111.142 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.83 -32.2 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 51.02 111.091 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.711 ' HG2' HD11 ' A' ' 193' ' ' LEU . 37.0 mtt180 -59.94 -45.78 91.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 64.53 110.878 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -60.71 -33.03 72.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 73.45 110.864 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.0 tp -69.48 -26.32 64.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 41.43 110.921 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -64.07 -63.72 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 54.3 110.906 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -59.43 -26.64 65.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 64.22 110.89 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -55.99 -26.92 50.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.874 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -110.35 -27.19 9.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.959 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.12 78.74 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.848 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -26.11 33.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 73.25 110.926 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -70.78 -10.63 59.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.858 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.99 20.66 50.18 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.761 -0.733 . . . . 64.43 112.461 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 p -86.84 -22.09 26.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 65.11 110.829 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.21 23.1 41.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 31.32 112.473 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -138.28 152.01 48.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 74.14 110.902 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.4 mt -118.81 102.69 9.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 51.04 110.895 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -70.62 173.9 6.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.875 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.455 ' HA ' HD12 ' A' ' 153' ' ' ILE . 3.5 p-10 -55.07 -26.76 39.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 54.52 110.879 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.4 -32.34 48.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 74.52 110.865 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -84.5 -26.26 28.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 70.23 110.857 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.509 ' CG2' HG13 ' A' ' 176' ' ' VAL . 21.3 mt -74.51 -41.04 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 71.2 111.149 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.56 -45.11 62.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 62.05 111.117 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.22 -22.84 56.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.754 . . . . 60.03 112.496 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.9 tp -60.31 -54.41 46.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 65.34 110.953 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.91 -34.42 41.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 64.21 110.953 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -52.94 -49.21 66.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.3 110.899 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -82.25 -43.35 17.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.869 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.2 m -53.79 -30.95 47.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 54.1 111.207 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -81.04 -57.92 3.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.708 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -55.46 -25.6 37.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.45 111.143 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.17 -26.3 62.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.907 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 38.7 mtm -110.75 21.68 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.867 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 18.56 68.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.749 -0.739 . . . . 64.31 112.486 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.0 mmt -63.31 171.8 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 75.35 110.903 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.1 t -59.83 -20.92 59.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 75.04 110.876 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 6.5 t30 63.66 63.77 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 71.55 110.896 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -88.26 152.49 21.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 61.22 110.868 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.5 p -108.24 90.83 7.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.577 0.703 . . . . 60.24 111.148 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 157.03 61.75 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.639 2.226 . . . . 75.52 112.369 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.677 ' O ' HG23 ' A' ' 176' ' ' VAL . 71.9 p -91.91 -176.94 4.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.34 111.166 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -56.44 -25.38 50.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.864 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.633 ' O ' HD12 ' A' ' 178' ' ' ILE . 0.9 OUTLIER -73.15 -59.92 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.04 110.918 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -52.99 -30.91 37.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 44.41 110.905 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 172' ' ' THR . 69.7 t -69.4 -32.56 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 60.32 111.111 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.15 -43.66 94.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 65.33 110.899 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.633 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -63.98 -34.64 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 74.01 111.144 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' TRP . . . . . 0.677 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 88.9 t90 -81.7 -25.72 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 72.23 110.901 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.476 HD13 ' CD1' ' A' ' 153' ' ' ILE . 31.1 tp -83.8 -25.34 30.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 71.32 110.89 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -52.98 -58.38 7.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 60.13 110.93 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 43.5 mtm -67.09 -46.05 75.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 63.53 110.851 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.807 ' HB2' HD11 ' A' ' 199' ' ' LEU . . . -56.1 -25.04 44.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 75.03 111.127 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -88.26 95.75 10.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.21 110.883 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.8 m -87.68 -34.5 18.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 65.32 111.11 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.29 6.34 33.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 71.14 110.9 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.9 p 46.14 36.44 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 71.22 110.83 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -96.33 -16.27 21.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 74.41 110.802 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 99.29 19.44 20.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.767 -0.73 . . . . 63.4 112.476 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.2 m -142.31 -177.35 5.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.937 0.398 . . . . 62.1 110.838 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.87 106.37 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 61.41 111.155 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -77.51 -176.05 4.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.868 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.711 HD11 ' HG2' ' A' ' 134' ' ' ARG . 0.5 OUTLIER -66.99 -38.58 86.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 75.25 110.937 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -77.75 -25.65 49.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.905 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -84.93 -23.54 28.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 71.53 110.91 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.487 ' HD1' HD12 ' A' ' 199' ' ' LEU . 30.8 t80 -81.87 -43.53 18.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 71.33 110.877 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.527 ' HA ' HD13 ' A' ' 200' ' ' ILE . 10.9 pt-20 -54.06 -41.86 68.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.03 110.864 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -51.7 -44.08 63.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 73.55 110.932 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.807 HD11 ' HB2' ' A' ' 183' ' ' ALA . 53.4 mt -51.75 -33.88 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.921 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.527 HD13 ' HA ' ' A' ' 197' ' ' GLU . 5.3 mp -79.43 -36.08 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 60.45 111.114 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.44 -29.62 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.117 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.58 -62.16 2.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 64.02 110.912 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 46.3 t -53.14 -37.37 61.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 43.11 110.904 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.81 HD23 HG13 ' A' ' 126' ' ' VAL . 6.9 mp -55.65 -24.57 34.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 74.11 110.944 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.95 -58.98 3.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 74.01 110.894 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -78.78 -5.81 54.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 72.23 110.892 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.443 ' HB3' HG12 ' A' ' 209' ' ' ILE . . . -91.17 13.99 15.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 61.45 111.158 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.16 33.46 85.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 62.23 112.514 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ILE . . . . . 0.443 HG12 ' HB3' ' A' ' 207' ' ' ALA . 6.5 mm -102.1 111.72 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 54.33 111.124 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 100.28 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 63.11 110.907 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 53.01 111.114 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.3 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.864 0.364 . . . . 75.43 110.816 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 86.2 p -117.88 143.71 46.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 65.34 110.88 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -100.13 160.95 25.76 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.53 0.681 . . . . 70.55 110.924 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -171.27 0.46 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.658 2.239 . . . . 74.41 112.335 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -128.72 103.77 7.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 64.12 110.87 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -100.83 150.82 22.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 74.12 110.911 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -66.62 161.12 62.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.721 . . . . 75.22 110.9 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -18.87 36.81 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.678 2.252 . . . . 73.33 112.326 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.466 ' HB3' HG23 ' A' ' 209' ' ' ILE . 4.6 tp10 -82.04 -23.56 35.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 62.11 110.873 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.55 -63.28 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 51.25 111.119 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -51.86 -30.66 24.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 63.35 110.855 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -37.91 63.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 70.44 111.107 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.659 ' HB3' HD11 ' A' ' 204' ' ' LEU . 30.5 tptt -87.98 -25.73 23.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.45 110.926 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.692 HD22 ' HB2' ' A' ' 197' ' ' GLU . 87.3 mt -72.92 -27.27 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 72.32 110.895 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -66.64 -51.8 52.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 72.31 110.853 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.35 -25.15 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 71.5 111.121 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.25 -25.62 36.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 75.23 111.085 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.645 ' HG2' HD11 ' A' ' 193' ' ' LEU . 44.9 mtp180 -67.13 -47.18 71.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.3 110.842 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -63.41 -35.21 79.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 70.32 110.882 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.72 -29.48 69.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 73.23 110.896 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -65.5 -59.55 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 73.22 110.852 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -64.47 -28.07 69.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 61.23 110.882 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -55.5 -26.75 44.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 62.4 110.89 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -108.21 -30.48 8.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 65.5 110.919 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.23 84.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.892 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -85.03 -32.01 23.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.15 110.925 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.56 -10.57 59.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 53.13 110.864 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.75 23.29 43.88 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.722 -0.752 . . . . 55.14 112.476 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 69.9 p -75.25 -22.17 58.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 74.43 110.845 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.5 19.64 58.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.758 -0.734 . . . . 64.24 112.463 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -148.34 130.75 15.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 64.35 110.918 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.407 ' O ' HD11 ' A' ' 153' ' ' ILE . 21.7 mt -94.13 101.67 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 64.34 110.897 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -66.26 174.13 2.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 71.44 110.924 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.98 -30.15 23.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 75.05 110.868 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.73 -54.7 6.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.213 -0.448 . . . . 72.43 110.882 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -55.24 -28.36 52.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 74.45 110.872 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 148' ' ' LEU . 45.6 mt -79.69 -25.44 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 62.31 111.102 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.31 -53.12 48.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 72.2 111.124 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.05 -23.03 56.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.678 -0.772 . . . . 63.43 112.506 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 tp -56.61 -52.6 64.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 62.14 110.922 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.9 mt -52.02 -41.43 62.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 72.54 110.905 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -51.93 -38.87 57.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 65.2 110.881 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -85.11 -49.58 8.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.23 110.86 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.2 m -53.09 -29.02 28.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 73.32 111.163 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -76.82 -33.57 57.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 74.02 110.961 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.458 ' HB2' ' ND2' ' A' ' 168' ' ' ASN . . . -60.71 -25.16 66.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 53.24 111.062 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -55.71 -26.97 47.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.44 110.9 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 19.9 mtm -109.81 16.8 21.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 71.12 110.889 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 19.46 69.47 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.721 -0.752 . . . . 35.1 112.468 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.3 tpp -63.39 168.41 4.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 73.2 110.883 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 43.2 t -71.12 -10.38 59.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 75.22 110.82 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 162' ' ' ALA . 1.2 m120 63.34 51.82 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 63.52 110.957 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -52.99 152.51 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 52.11 110.893 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 4.4 m -108.22 90.84 7.3 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.54 0.686 . . . . 71.44 111.129 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.8 Cg_endo -69.75 -177.37 1.84 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.664 2.242 . . . . 64.25 112.338 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 176' ' ' VAL . 73.1 p -123.82 -176.1 3.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 64.4 111.131 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -55.5 -27.32 47.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.9 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.622 ' O ' HD12 ' A' ' 178' ' ' ILE . 23.9 tt0 -73.15 -61.13 1.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 74.01 110.891 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -52.02 -44.91 64.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.823 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 172' ' ' THR . 86.7 t -57.47 -28.69 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 62.03 111.117 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -68.03 -45.69 73.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 74.32 110.904 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.622 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.4 mp -66.44 -25.98 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 44.12 111.15 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.51 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 47.9 t90 -83.21 -30.42 27.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 71.21 110.92 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.506 HD23 ' CB ' ' A' ' 184' ' ' ASP . 1.3 tt -68.71 -37.89 79.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 54.12 110.93 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -63.02 -27.39 69.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 43.04 110.903 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 26.0 ttm -71.93 -54.51 9.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 75.43 110.912 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.779 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -74.27 -66.27 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 73.11 111.119 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.506 ' CB ' HD23 ' A' ' 180' ' ' LEU . 48.1 t0 -53.27 129.17 30.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 53.02 110.851 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 25.1 m -85.67 -25.16 26.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 61.02 111.135 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -98.58 -12.45 21.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.936 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.3 p 51.97 37.77 22.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 52.12 110.845 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -95.42 23.96 5.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.87 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.31 31.64 74.67 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 44.3 112.478 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.44 126.98 9.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.938 0.399 . . . . 44.12 110.858 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 184' ' ' ASP . 30.0 t -115.6 104.85 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 62.13 111.133 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 37.3 t -69.4 170.67 9.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.459 . . . . 52.15 110.878 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.645 HD11 ' HG2' ' A' ' 134' ' ' ARG . 0.4 OUTLIER -57.81 -36.66 72.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 72.32 110.956 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.46 -25.64 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 74.53 110.892 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -81.77 -23.3 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 73.12 110.891 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.434 ' O ' HD12 ' A' ' 200' ' ' ILE . 31.8 t80 -83.8 -51.85 6.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 62.42 110.906 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.692 ' HB2' HD22 ' A' ' 130' ' ' LEU . 14.8 pt-20 -52.03 -43.81 63.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 71.41 110.871 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -51.93 -41.17 61.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 55.43 110.881 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 183' ' ' ALA . 5.0 tp -53.89 -35.68 61.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 71.35 110.916 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.3 mp -78.99 -25.12 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 61.12 111.091 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.552 ' CD1' HD21 ' A' ' 130' ' ' LEU . 44.9 mm -62.18 -50.88 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 64.34 111.163 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -55.85 -36.09 67.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 73.11 110.877 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -77.94 -35.36 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 62.3 110.841 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.659 HD11 ' HB3' ' A' ' 129' ' ' LYS . 22.9 mt -62.32 -28.33 69.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 65.4 110.943 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -64.19 -43.49 94.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 64.2 110.928 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -85.94 -24.92 26.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 54.31 110.901 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.94 -22.58 67.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.099 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.5 31.86 1.9 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 71.05 112.486 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.496 HD13 ' CD2' ' A' ' 204' ' ' LEU . 5.3 mp -122.68 122.89 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 72.44 111.124 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -83.01 119.5 24.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 71.52 110.897 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.9 p -124.43 144.35 34.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.124 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.14 131.12 40.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 71.02 110.873 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.71 146.65 49.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 74.24 110.899 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -61.34 103.79 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 61.12 110.935 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.9 m -127.01 120.54 29.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.866 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.1 mt -106.37 165.59 11.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.154 -0.475 . . . . 70.12 110.943 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.79 124.41 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 74.3 111.137 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.874 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.879 0.371 . . . . 31.41 110.845 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.9 m -159.89 43.04 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 61.32 110.842 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -79.18 160.18 71.35 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.609 0.718 . . . . 52.33 110.901 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 142.35 47.39 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 71.12 112.342 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.4 tptm -90.96 112.3 24.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 70.33 110.924 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -109.89 135.08 51.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 71.34 110.918 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -53.18 160.55 1.61 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.574 0.702 . . . . 65.44 110.922 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -20.1 35.44 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.705 2.27 . . . . 72.54 112.394 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -82.85 -20.33 35.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 61.25 110.908 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.513 HG11 ' CG2' ' A' ' 211' ' ' VAL . 2.7 t -81.3 -63.35 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 53.32 111.149 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -25.43 42.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 61.41 110.897 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.34 78.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 53.23 111.081 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.412 ' HG2' HD11 ' A' ' 204' ' ' LEU . 18.8 tptt -88.45 -25.37 22.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 74.1 110.903 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.835 HD22 ' HG2' ' A' ' 197' ' ' GLU . 30.9 mt -79.33 -24.06 43.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.933 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -69.68 -46.51 65.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.904 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.19 -23.61 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 71.22 111.106 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -77.4 -21.79 52.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 63.34 111.078 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.557 ' HG2' HD11 ' A' ' 193' ' ' LEU . 55.5 mtt85 -69.12 -52.29 29.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 75.52 110.889 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -52.03 -29.95 23.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 75.04 110.856 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.655 HD21 ' OD2' ' A' ' 159' ' ' ASP . 12.9 mt -71.71 -44.53 64.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 72.5 110.929 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -52.36 -48.05 65.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 52.01 110.895 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -75.93 -28.41 57.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 64.11 110.86 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 60.6 ttt-85 -67.9 -25.91 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 72.11 110.886 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.527 ' HE2' HD22 ' A' ' 136' ' ' LEU . 37.2 m-85 -104.51 -26.2 12.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 65.33 110.968 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -90.43 64.45 5.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.521 . . . . 55.5 110.886 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -28.19 67.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 73.04 110.893 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -70.76 -10.52 59.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.889 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.86 25.74 53.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 42.0 112.502 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.8 p -75.85 -22.1 56.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.924 0.392 . . . . 64.43 110.882 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.62 19.57 65.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.735 -0.745 . . . . 74.35 112.513 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -149.91 130.8 14.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 63.31 110.922 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.7 mt -94.97 101.74 13.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.879 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -70.16 171.81 9.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.43 110.932 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -52.13 -30.14 25.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 51.31 110.826 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -74.61 -45.95 41.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 64.24 110.881 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.36 -38.95 88.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 64.23 110.859 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 176' ' ' VAL . 53.4 mt -65.46 -30.97 51.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 73.25 111.157 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.78 -45.76 63.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 62.21 111.102 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.32 -27.45 39.84 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.75 -0.738 . . . . 60.15 112.493 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.552 HD21 ' CE1' ' A' ' 196' ' ' TYR . 4.2 tp -54.81 -56.56 18.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 72.21 110.919 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.0 mt -51.96 -33.93 39.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.934 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -52.71 -50.5 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 74.45 110.854 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.655 ' OD2' HD21 ' A' ' 136' ' ' LEU . 10.5 t0 -82.26 -44.25 16.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 64.4 110.871 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.9 m -52.16 -29.55 22.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 63.32 111.18 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -79.33 -49.17 12.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 61.42 110.968 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.97 -24.71 55.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.075 -0.511 . . . . 72.23 111.105 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . 0.542 ' OE2' HD11 ' A' ' 136' ' ' LEU . 0.3 OUTLIER -55.04 -27.14 42.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 64.14 110.852 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 35.1 mtm -111.28 21.71 15.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 75.0 110.886 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.92 19.05 69.35 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 72.24 112.494 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.4 tpp -64.38 164.04 12.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 73.15 110.896 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.8 t -62.47 -17.62 59.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 74.33 110.848 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 63.52 56.97 1.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 72.43 110.9 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -65.87 152.61 44.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.855 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 p -108.23 90.84 7.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.544 0.688 . . . . 74.0 111.11 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -172.88 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 51.41 112.347 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.61 ' O ' HG23 ' A' ' 176' ' ' VAL . 79.9 p -120.76 -177.37 3.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 70.22 111.16 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -60.18 -25.69 65.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 55.15 110.93 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.611 ' O ' HD12 ' A' ' 178' ' ' ILE . 32.2 tt0 -72.51 -61.5 1.78 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 62.25 110.9 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -52.22 -49.0 64.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 72.32 110.871 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 172' ' ' THR . 98.1 t -52.76 -33.53 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 63.44 111.124 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -62.44 -49.9 73.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 73.12 110.92 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -61.15 -25.15 35.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 74.25 111.098 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.585 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 47.1 t90 -78.15 -30.29 49.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.956 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.539 ' O ' HD23 ' A' ' 180' ' ' LEU . 2.1 tt -72.54 -34.77 67.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 71.34 110.933 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -61.25 -28.74 69.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 65.01 110.923 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 5.9 ttp -86.92 -39.09 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 34.31 110.87 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.535 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . . . -68.33 -49.95 56.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 72.24 111.113 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -84.24 127.59 34.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.438 . . . . 71.54 110.894 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 21.3 p -76.08 -42.69 46.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 61.14 111.101 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -76.32 -12.41 60.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 61.34 110.891 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.1 p 52.15 37.19 21.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 72.55 110.827 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -79.04 -16.21 57.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 75.42 110.887 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.1 22.82 8.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 54.1 112.489 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.2 p -153.6 127.14 8.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.916 0.389 . . . . 53.32 110.82 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 196' ' ' TYR . 21.9 t -106.41 124.83 62.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 62.3 111.096 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.32 -174.77 2.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 70.32 110.897 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.557 HD11 ' HG2' ' A' ' 134' ' ' ARG . 0.2 OUTLIER -57.11 -33.62 67.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 70.33 110.927 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.06 -62.35 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.87 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.414 ' HB3' HG13 ' A' ' 191' ' ' VAL . 6.6 mp0 -52.37 -46.16 66.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 64.12 110.878 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.552 ' CE1' HD21 ' A' ' 156' ' ' LEU . 17.2 t80 -62.04 -58.34 8.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.888 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.835 ' HG2' HD22 ' A' ' 130' ' ' LEU . 72.5 tt0 -54.89 -28.12 48.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.914 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -72.5 -29.54 63.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 75.53 110.819 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.585 HD13 ' CZ2' ' A' ' 179' ' ' TRP . 8.4 tt -64.0 -35.08 79.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 34.14 110.897 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -73.34 -24.91 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 74.33 111.116 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.464 HD13 HD21 ' A' ' 130' ' ' LEU . 50.7 mm -58.4 -43.37 86.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 54.41 111.11 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -67.81 -48.16 67.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 63.25 110.889 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 53.5 p -52.18 -40.86 62.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 51.12 110.864 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.422 ' HG ' HD13 ' A' ' 209' ' ' ILE . 6.7 mp -73.99 -33.16 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 75.21 110.926 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -43.3 89.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 64.04 110.911 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -86.11 -25.77 25.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 63.11 110.908 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.98 -22.76 67.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 72.01 111.094 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.43 20.14 5.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.739 . . . . 45.15 112.49 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.422 HD13 ' HG ' ' A' ' 204' ' ' LEU . 5.3 mp -113.15 102.75 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.815 0.341 . . . . 72.14 111.121 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -71.06 126.03 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.871 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.513 ' CG2' HG11 ' A' ' 126' ' ' VAL . 4.3 p -118.21 124.15 72.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.05 111.128 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.23 107.83 7.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 55.44 110.904 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -142.42 127.77 18.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.927 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -121.17 157.72 29.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 71.33 110.89 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 12.0 m -146.15 -178.76 6.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 65.33 110.889 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.6 mt -85.22 71.39 10.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 73.13 110.891 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.3 m -66.36 160.1 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.22 -0.445 . . . . 60.42 111.154 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.852 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.922 0.391 . . . . 72.24 110.855 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.3 p -119.32 175.5 5.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 61.51 110.917 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -117.06 160.68 36.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.599 0.714 . . . . 54.11 110.916 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 158.01 58.49 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.721 2.28 . . . . 63.24 112.323 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.01 111.68 20.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 64.25 110.944 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -99.81 163.59 12.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 60.13 110.944 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -78.3 160.82 72.24 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.615 0.721 . . . . 74.43 110.926 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -20.26 35.05 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.733 2.289 . . . . 52.11 112.329 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -82.89 -20.94 34.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 73.21 110.887 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.489 HG13 HD22 ' A' ' 204' ' ' LEU . 3.2 t -76.74 -61.99 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 53.43 111.132 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.66 -30.08 20.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 71.11 110.894 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.5 -34.52 71.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.125 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.416 ' O ' HG12 ' A' ' 132' ' ' VAL . 33.9 tptt -88.36 -23.98 23.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.53 110.954 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.554 HD22 ' HB3' ' A' ' 197' ' ' GLU . 38.7 mt -80.88 -24.31 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 72.41 110.878 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.04 -29.48 65.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 72.41 110.876 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 129' ' ' LYS . 10.1 p -85.99 -23.38 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 75.14 111.115 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.14 -37.51 20.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 73.23 111.11 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -54.65 -29.99 54.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 75.22 110.87 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -70.58 -28.98 65.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 73.54 110.872 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.64 -25.85 35.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 70.11 110.893 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -64.43 -63.21 1.19 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 71.33 110.89 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -60.18 -26.58 66.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 74.52 110.926 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -52.08 -30.02 24.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 72.13 110.852 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -101.54 -26.29 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.894 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.2 85.4 0.56 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 63.22 110.84 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -80.7 -26.29 37.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 75.24 110.892 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.79 -10.58 59.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 71.42 110.894 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.23 20.45 50.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 62.41 112.503 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.0 p -87.26 -22.18 25.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.945 0.402 . . . . 73.2 110.852 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.74 21.58 42.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.7 -0.762 . . . . 73.02 112.472 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -136.73 138.07 40.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.361 . . . . 73.45 110.925 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.712 HD13 HD22 ' A' ' 156' ' ' LEU . 95.0 mt -103.89 112.53 25.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 65.31 110.91 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -79.83 173.66 12.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.54 110.915 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -53.07 -28.85 26.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 63.51 110.883 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -78.74 -37.85 40.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.901 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' A' ' 148' ' ' LEU . 8.5 mt-10 -75.7 -26.18 57.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.462 . . . . 74.14 110.901 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.534 ' CG2' HG13 ' A' ' 176' ' ' VAL . 25.8 mt -76.81 -34.59 23.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 72.04 111.149 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.78 -46.65 64.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 70.35 111.083 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.59 -23.3 56.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.772 -0.728 . . . . 62.35 112.482 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.712 HD22 HD13 ' A' ' 148' ' ' LEU . 18.0 tp -60.7 -56.49 20.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.858 0.361 . . . . 62.45 110.917 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 45.7 mt -52.15 -36.42 51.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 65.34 110.922 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -51.88 -45.77 64.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 72.04 110.883 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.24 -45.05 13.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 64.24 110.869 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.4 m -51.85 -30.44 23.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.2 111.137 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -81.03 -53.62 6.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.892 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -56.13 -24.69 42.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 70.31 111.12 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -54.69 -31.06 57.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 75.22 110.896 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -107.21 21.85 16.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 71.41 110.873 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.95 21.45 71.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.727 . . . . 74.54 112.447 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.43 165.47 16.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.341 . . . . 74.31 110.86 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 14.1 m -60.05 -20.61 58.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.02 110.881 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 63.6 59.48 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 64.41 110.952 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -67.83 152.4 45.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 72.22 110.902 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.5 m -108.18 90.78 7.18 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.564 0.697 . . . . 53.45 111.134 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.75 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.69 2.26 . . . . 71.21 112.343 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 176' ' ' VAL . 71.3 p -126.43 -176.03 3.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 72.01 111.165 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -57.37 -25.72 59.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 65.13 110.829 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.614 ' O ' HD12 ' A' ' 178' ' ' ILE . 36.4 tt0 -74.65 -60.81 2.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 74.42 110.881 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -45.91 64.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 72.51 110.859 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 172' ' ' THR . 97.2 t -56.2 -31.02 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 75.33 111.103 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -65.38 -49.81 67.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 40.1 110.886 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -60.14 -26.76 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 73.11 111.153 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.679 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 87.3 t90 -82.39 -26.32 32.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 71.1 110.919 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 180' ' ' LEU . 3.9 tt -76.08 -36.46 58.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 63.41 110.892 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -52.38 -49.5 64.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.5 -26.85 65.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 74.12 110.88 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.913 ' HB2' HD11 ' A' ' 199' ' ' LEU . . . -74.69 -68.83 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.0 111.108 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -62.28 118.83 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 74.41 110.886 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 12.1 m -86.74 -37.54 17.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 73.52 111.146 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -78.48 -12.46 60.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 65.11 110.888 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.8 t 61.75 45.4 7.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 63.4 110.891 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -91.0 -16.17 28.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 63.42 110.835 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.25 19.46 12.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 63.14 112.515 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.52 152.4 30.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 72.24 110.876 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 33.1 t -108.39 114.17 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 73.01 111.106 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.6 t -85.08 -171.1 3.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 65.15 110.878 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.81 -57.55 10.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 72.2 110.923 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.47 -43.74 96.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 63.31 110.847 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.53 -59.85 4.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.857 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.572 ' HA ' HD12 ' A' ' 199' ' ' LEU . 34.2 t80 -53.73 -49.87 67.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 71.13 110.94 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.554 ' HB3' HD22 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -60.07 -24.35 64.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 73.15 110.835 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -69.67 -26.16 64.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 63.31 110.875 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.913 HD11 ' HB2' ' A' ' 183' ' ' ALA . 7.5 mt -67.17 -38.5 85.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 74.02 110.916 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.515 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.2 mp -69.49 -24.32 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 65.44 111.125 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.405 HD11 HD11 ' A' ' 130' ' ' LEU . 47.7 mm -55.91 -49.63 73.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.211 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -51.94 -62.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.3 110.878 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.1 m -53.44 -28.6 30.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 65.32 110.836 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.683 ' HG ' HD13 ' A' ' 209' ' ' ILE . 0.6 OUTLIER -64.8 -42.68 94.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 53.43 110.903 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -52.22 -39.61 60.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.13 110.948 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -85.95 -24.24 26.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 73.12 110.89 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.89 -22.81 67.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 64.1 111.111 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.36 30.01 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.773 -0.727 . . . . 53.44 112.458 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.683 HD13 ' HG ' ' A' ' 204' ' ' LEU . 5.3 mp -126.03 137.57 57.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.799 0.333 . . . . 75.21 111.151 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -98.94 113.84 26.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 73.21 110.904 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.72 144.36 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 64.5 111.179 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.42 125.79 41.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 55.41 110.875 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -119.46 138.08 53.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 72.51 110.848 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -137.98 105.48 5.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 71.53 110.872 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 7.6 t -86.41 -175.85 5.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.865 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 mt -104.77 134.4 47.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 64.42 110.901 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.79 148.08 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.12 111.122 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 3.5 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 65.41 110.854 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.868 0.366 . . . . 60.51 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 26.1 m -81.9 165.41 20.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 61.35 110.859 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 157.53 69.85 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.581 0.705 . . . . 73.22 110.881 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 127.93 15.26 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.74 2.294 . . . . 72.44 112.284 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -81.87 102.71 11.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 65.13 110.91 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -99.63 149.6 23.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 71.13 110.912 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -65.13 160.74 54.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.665 0.745 . . . . 74.32 110.848 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -20.29 35.34 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.743 2.295 . . . . 65.22 112.354 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -82.89 -21.15 34.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.31 110.859 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.69 -63.4 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 51.35 111.089 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.543 ' HA ' HD12 ' A' ' 130' ' ' LEU . 6.3 tt0 -52.08 -29.92 23.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 64.23 110.84 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.04 -36.13 65.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.114 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.824 ' HB3' HD11 ' A' ' 204' ' ' LEU . 16.7 tptt -82.74 -26.5 31.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 55.34 110.841 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.788 HD22 ' HB2' ' A' ' 197' ' ' GLU . 21.0 mt -78.69 -25.76 44.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 64.1 110.897 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -69.3 -32.14 71.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.854 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.6 -24.78 6.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.22 111.119 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.64 -43.93 36.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 55.14 111.071 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -52.08 -29.98 23.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.862 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -75.98 -35.32 59.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 72.02 110.913 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.4 tp -69.41 -25.66 64.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 73.22 110.911 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.01 -64.58 0.87 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 61.41 110.856 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -27.41 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.935 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -53.37 -28.64 30.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.863 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -109.11 -26.69 10.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 75.31 110.918 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -76.44 69.81 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.485 . . . . 72.35 110.881 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -67.62 -26.95 66.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.931 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.62 -10.49 59.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 54.31 110.842 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.31 24.58 52.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 52.35 112.478 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.3 t -77.65 -22.07 51.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 73.12 110.841 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.14 23.8 56.27 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.666 -0.778 . . . . 73.14 112.503 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -148.16 134.57 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 73.42 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.811 HD13 HD22 ' A' ' 156' ' ' LEU . 31.8 mt -106.33 101.99 11.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 74.02 110.894 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.83 174.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 74.22 110.874 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.613 ' O ' HG11 ' A' ' 176' ' ' VAL . 5.1 p-10 -54.57 -27.24 37.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 70.42 110.88 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -83.3 -51.01 7.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 64.24 110.866 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -54.84 -30.99 58.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 64.31 110.855 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.44 HD12 HD12 ' A' ' 180' ' ' LEU . 32.9 mt -73.89 -26.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 72.12 111.124 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.69 -47.88 63.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.074 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.35 -22.87 55.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 51.3 112.456 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.811 HD22 HD13 ' A' ' 148' ' ' LEU . 21.3 tp -58.61 -54.88 42.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.84 0.352 . . . . 71.23 110.914 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 33.6 mt -51.91 -32.81 34.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.901 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -52.58 -60.7 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 71.11 110.954 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -73.81 -38.26 64.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.55 110.874 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 72.1 m -57.48 -30.19 64.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 73.31 111.117 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -82.31 -55.12 4.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.254 -0.43 . . . . 72.44 110.902 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.703 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -55.21 -25.7 34.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 32.2 111.098 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.95 -25.9 45.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 73.14 110.88 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.3 mtm -110.24 19.2 19.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 72.51 110.839 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.78 19.24 69.23 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 74.04 112.505 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.5 mtt -64.65 172.97 2.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 74.13 110.886 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 49.1 p -59.77 -21.03 60.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 75.14 110.868 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.703 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 5.8 t30 63.56 58.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 65.23 110.898 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -78.01 152.6 32.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 73.1 110.837 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 60.9 m -108.23 90.84 7.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.561 0.696 . . . . 74.04 111.141 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 168.96 19.99 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.706 2.271 . . . . 73.34 112.378 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.687 ' O ' HG23 ' A' ' 176' ' ' VAL . 27.8 p -108.76 -178.02 3.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 61.53 111.124 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -55.58 -25.89 40.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 70.41 110.891 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.581 ' O ' HD12 ' A' ' 178' ' ' ILE . 11.5 tt0 -72.88 -61.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.885 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.403 ' HA ' HD13 ' A' ' 178' ' ' ILE . 83.2 m-20 -51.91 -36.6 49.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 52.14 110.856 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 172' ' ' THR . 99.3 t -60.98 -40.87 86.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 73.24 111.103 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -54.56 -40.92 69.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 63.33 110.883 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.8 mp -69.99 -25.97 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 72.12 111.166 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -83.76 -31.12 26.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.901 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 180' ' ' LEU . 3.7 tt -78.32 -46.3 20.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 65.43 110.911 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -51.99 -31.55 29.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 72.11 110.9 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 53.3 ttp -90.51 -25.89 20.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 65.33 110.883 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -73.95 -52.12 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 61.44 111.095 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -85.31 127.8 34.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 74.43 110.864 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 3.2 m -69.39 -24.53 63.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 73.53 111.158 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -98.08 -10.4 24.36 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.228 -0.442 . . . . 71.13 110.872 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.4 p 52.99 36.3 21.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.86 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.0 -16.24 57.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 62.2 110.836 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.19 22.9 8.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.764 -0.731 . . . . 61.43 112.532 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.14 126.93 11.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 52.32 110.828 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.8 t -109.4 112.94 42.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.489 . . . . 72.3 111.12 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.04 -174.89 4.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.875 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.3 OUTLIER -66.69 -33.84 76.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 64.42 110.892 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.48 -36.8 32.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 60.31 110.931 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -73.19 -21.64 60.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 71.24 110.91 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.527 ' O ' HD12 ' A' ' 200' ' ' ILE . 18.7 t80 -84.48 -51.71 6.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 72.4 110.889 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.788 ' HB2' HD22 ' A' ' 130' ' ' LEU . 13.4 pt-20 -53.99 -43.69 70.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 54.42 110.859 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.84 -26.13 63.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 61.34 110.853 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 183' ' ' ALA . 7.5 tt -67.48 -38.24 84.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.881 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -73.75 -24.58 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 73.32 111.086 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.632 HD11 HD11 ' A' ' 130' ' ' LEU . 50.1 mm -56.6 -57.22 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 75.4 111.098 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -56.18 -25.14 45.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 71.24 110.903 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.4 m -83.23 -26.31 30.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 73.53 110.849 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.824 HD11 ' HB3' ' A' ' 129' ' ' LYS . 36.2 mt -79.35 -45.0 20.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 63.3 110.956 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -51.99 -37.83 54.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.874 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -86.09 -29.07 23.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.32 110.901 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -18.2 65.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.456 . . . . 72.2 111.135 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.96 23.05 4.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.774 -0.727 . . . . 42.24 112.517 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.63 101.87 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.343 . . . . 73.23 111.158 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.5 111.44 1.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 72.1 110.891 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 211' ' ' VAL . 5.5 p -117.67 121.07 66.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 70.13 111.153 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -103.94 150.99 23.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 71.14 110.9 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 148.4 33.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 64.31 110.904 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -56.48 106.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 73.24 110.905 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 12.6 p -101.6 178.45 4.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.34 110.852 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.02 142.21 24.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 63.4 110.883 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.57 144.88 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 73.41 111.114 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 72.23 110.837 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.913 0.387 . . . . 73.43 110.82 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.1 t -98.54 156.85 16.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 65.53 110.871 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.07 160.85 24.9 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 73.15 110.878 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 168.21 22.25 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.685 2.257 . . . . 63.34 112.299 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.14 105.6 15.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 73.24 110.871 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.614 ' CE2' HG11 ' A' ' 211' ' ' VAL . 2.2 m-85 -109.49 140.01 43.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.902 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.65 160.52 3.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.631 0.729 . . . . 73.4 110.883 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 -19.31 36.65 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 64.02 112.355 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -80.3 -24.8 39.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 73.34 110.896 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.693 HG21 HG13 ' A' ' 211' ' ' VAL . 3.1 t -79.39 -63.42 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 74.22 111.155 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.644 ' HA ' HD12 ' A' ' 130' ' ' LEU . 1.5 tm-20 -51.49 -30.84 21.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 71.01 110.875 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.6 -33.15 59.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 70.22 111.068 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -88.36 -30.54 19.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 75.45 110.947 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.685 HD21 HD11 ' A' ' 201' ' ' ILE . 15.1 mt -72.81 -26.28 61.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.4 110.922 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -65.41 -46.17 81.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 64.33 110.84 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.597 HG23 ' HD3' ' A' ' 135' ' ' ARG . 14.7 p -74.35 -23.73 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 55.42 111.097 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.86 -22.04 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 65.31 111.091 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -76.08 -57.19 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.869 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.597 ' HD3' HG23 ' A' ' 132' ' ' VAL . 4.5 ptm180 -58.22 -25.33 61.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.14 110.866 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.2 tp -78.3 -26.66 47.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.165 -0.471 . . . . 65.34 110.953 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -69.61 -57.51 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.842 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -65.55 -27.6 68.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 64.23 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.0 ttt85 -54.12 -27.87 35.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 44.44 110.86 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -105.65 -40.43 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 62.45 110.909 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -73.03 84.66 1.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 71.11 110.849 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.5 tttm -73.03 -26.24 61.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 74.3 110.93 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -72.47 -10.52 59.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 73.23 110.847 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.71 22.44 40.15 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 62.34 112.536 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.5 t -76.12 -22.1 55.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.925 0.393 . . . . 44.24 110.886 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.74 19.3 61.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 65.43 112.489 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -138.47 131.35 29.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.804 0.335 . . . . 72.5 110.933 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 55.8 mt -100.97 104.11 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.903 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -66.04 173.56 2.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.12 110.92 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -52.82 -29.13 26.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.897 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -80.44 -53.28 6.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 71.22 110.877 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.25 -39.17 59.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 53.11 110.889 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.1 mt -65.85 -30.51 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 62.43 111.131 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.73 -45.72 63.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.33 111.124 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.33 -23.21 55.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.746 -0.74 . . . . 62.23 112.507 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.668 HD21 ' CE1' ' A' ' 196' ' ' TYR . 5.7 tp -59.91 -54.65 43.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 65.34 110.932 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 36.0 mt -51.91 -35.24 44.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 64.13 110.923 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -52.73 -51.76 59.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.882 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -78.81 -43.7 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.5 110.85 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.2 m -54.55 -31.16 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 74.44 111.133 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -82.42 -59.56 2.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.25 110.934 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -53.4 -28.08 27.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 75.23 111.098 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -55.63 -26.17 42.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.45 110.91 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.2 mtm -110.54 21.79 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.924 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 18.78 68.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.768 -0.729 . . . . 74.53 112.513 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 4.1 mmt -60.66 172.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 73.41 110.891 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 69.4 m -62.46 -17.72 60.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 75.1 110.847 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 63.49 48.24 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 55.23 110.888 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -68.61 152.57 45.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.861 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 p -108.21 90.83 7.27 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.588 0.709 . . . . 75.22 111.154 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 175.3 8.29 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.687 2.258 . . . . 73.24 112.387 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.656 ' O ' HG23 ' A' ' 176' ' ' VAL . 72.1 p -121.21 -176.14 3.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 62.12 111.116 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -55.66 -25.81 41.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 63.32 110.928 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.62 ' O ' HD12 ' A' ' 178' ' ' ILE . 9.2 tt0 -72.54 -61.51 1.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.938 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.51 -40.84 65.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.31 110.899 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 172' ' ' THR . 93.8 t -59.72 -31.12 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 71.35 111.09 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -65.13 -41.65 94.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.873 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.5 mp -70.39 -26.48 29.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 55.33 111.133 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.51 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 57.4 t90 -83.6 -40.09 19.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 75.01 110.945 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.652 ' O ' HD23 ' A' ' 180' ' ' LEU . 4.2 tt -58.6 -26.89 64.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 75.14 110.855 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -70.96 -49.38 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.923 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.6 ttp -64.9 -26.97 68.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 62.43 110.887 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . . . -83.63 -59.23 2.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 63.44 111.092 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -81.69 128.66 34.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 65.14 110.863 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.14 -28.87 34.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 74.41 111.135 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -89.7 -9.41 49.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 65.21 110.891 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.8 p 46.24 58.22 4.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.877 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -113.69 24.04 12.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 73.54 110.857 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.17 27.56 73.51 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 73.4 112.508 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.66 127.2 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.919 0.39 . . . . 22.44 110.858 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.7 106.17 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.1 111.171 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.53 178.09 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 61.33 110.849 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.56 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -63.66 -36.12 82.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 65.13 110.882 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -81.32 -28.58 34.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.4 110.868 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -77.57 -22.48 50.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.885 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.668 ' CE1' HD21 ' A' ' 156' ' ' LEU . 23.6 t80 -85.13 -53.36 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 63.15 110.923 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.472 ' HB2' HD22 ' A' ' 130' ' ' LEU . 11.0 pt-20 -52.02 -43.69 63.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 75.51 110.908 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -53.43 -42.41 67.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.149 -0.478 . . . . 72.52 110.851 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 6.4 tt -51.9 -39.76 59.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.948 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -72.82 -29.35 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 71.05 111.138 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.685 HD11 HD21 ' A' ' 130' ' ' LEU . 51.3 mm -63.79 -44.07 98.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 54.54 111.136 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -67.63 -46.87 71.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.881 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 43.4 m -57.45 -37.03 72.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 52.12 110.849 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.72 -34.42 64.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.857 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -60.28 -37.54 80.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 74.43 110.941 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -24.04 26.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 54.14 110.893 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.92 -22.67 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 43.21 111.088 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.82 26.18 3.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.79 -0.719 . . . . 75.45 112.486 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.3 102.17 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 73.41 111.103 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -72.93 102.78 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.874 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.693 HG13 HG21 ' A' ' 126' ' ' VAL . 22.0 t -84.23 149.93 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 75.25 111.066 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -94.14 112.58 24.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 72.32 110.89 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -149.04 132.85 16.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 61.23 110.904 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -83.38 112.66 20.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 73.4 110.851 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 91.8 p -133.96 153.76 51.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 50.51 110.863 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.454 ' H ' HD12 ' A' ' 216' ' ' LEU . 5.6 mp -67.17 168.83 9.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 70.13 110.891 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.49 144.12 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 54.21 111.095 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 35.6 p90 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 65.24 110.897 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.882 0.372 . . . . 55.02 110.849 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 64.4 m 60.43 48.94 7.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 75.4 110.88 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.94 161.49 38.02 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.61 0.719 . . . . 74.12 110.865 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -174.55 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.684 2.256 . . . . 62.45 112.333 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -117.87 105.05 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.923 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -103.26 159.25 15.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 74.45 110.952 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -75.1 160.77 79.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.652 0.739 . . . . 72.24 110.857 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -17.88 37.25 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.704 2.269 . . . . 73.02 112.352 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -83.11 -22.55 33.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.12 110.853 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.468 HG13 HD13 ' A' ' 204' ' ' LEU . 2.9 t -79.55 -61.24 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 71.01 111.103 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.717 ' HA ' HD12 ' A' ' 130' ' ' LEU . 1.3 tt0 -52.18 -30.04 25.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 62.11 110.835 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.02 -32.32 67.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 61.11 111.099 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.44 ' HG3' HD21 ' A' ' 204' ' ' LEU . 0.0 OUTLIER -88.48 -22.22 23.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 75.25 110.907 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.756 HD22 ' HB3' ' A' ' 197' ' ' GLU . 16.4 mt -81.67 -32.9 31.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.434 . . . . 71.25 110.932 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.34 -29.28 64.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 71.33 110.826 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.5 p -85.95 -23.3 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.45 111.16 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.12 -39.28 21.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 70.12 111.11 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -54.86 -38.15 67.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 75.14 110.919 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -63.72 -25.8 68.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.829 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.0 tp -79.56 -28.87 41.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 72.1 110.946 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -61.66 -64.55 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.1 110.876 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -54.71 -27.62 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 72.43 110.899 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -56.0 -26.16 47.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 65.45 110.812 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -110.12 -26.58 9.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 62.34 110.923 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -79.77 79.92 6.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.083 -0.508 . . . . 74.42 110.865 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -25.73 42.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 64.43 110.917 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.78 -10.57 59.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 61.43 110.904 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.57 19.99 58.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.723 -0.751 . . . . 54.32 112.487 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.4 p -82.46 -22.12 35.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 73.35 110.889 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.82 22.42 59.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.765 -0.731 . . . . 73.44 112.477 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -140.6 151.77 44.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 73.43 110.869 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.565 HD22 ' HB3' ' A' ' 152' ' ' GLU . 71.7 mt -119.11 120.67 37.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 72.51 110.929 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -84.44 179.88 7.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 72.11 110.895 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -52.2 -29.82 24.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.24 110.839 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 19.2 t0 -77.97 -54.79 5.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 72.43 110.818 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.565 ' HB3' HD22 ' A' ' 148' ' ' LEU . 9.3 mt-10 -57.28 -51.81 67.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 71.2 110.889 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.436 HG22 HG13 ' A' ' 176' ' ' VAL . 52.2 mt -51.8 -30.93 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 72.22 111.145 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 151' ' ' ASP . . . -60.0 -56.72 18.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 72.11 111.137 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.06 -23.26 77.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.792 -0.718 . . . . 61.13 112.452 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 148' ' ' LEU . 3.3 tp -57.17 -55.99 27.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.88 0.371 . . . . 62.44 110.932 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.8 mt -54.17 -33.21 57.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 74.1 110.896 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -52.11 -53.56 41.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 74.1 110.886 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.87 -42.33 21.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 55.4 110.875 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.2 m -52.35 -30.55 29.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 74.3 111.148 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -78.56 -52.97 7.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 72.31 110.952 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.672 ' HB2' HD22 ' A' ' 168' ' ' ASN . . . -57.97 -24.59 58.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.056 -0.52 . . . . 72.42 111.133 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -55.93 -25.93 45.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 54.15 110.835 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.0 mtm -109.68 21.59 16.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.462 . . . . 70.21 110.856 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 23.61 72.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.77 -0.728 . . . . 52.52 112.473 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.8 mmt -65.28 175.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 73.12 110.845 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 79.3 p -66.68 -14.27 62.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 72.12 110.862 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.672 HD22 ' HB2' ' A' ' 162' ' ' ALA . 11.5 t-20 63.65 61.67 0.98 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.858 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -83.01 152.57 25.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.01 110.894 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 3.9 m -108.22 90.87 7.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.576 0.703 . . . . 71.15 111.111 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.9 Cg_endo -69.77 156.43 63.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.701 2.267 . . . . 72.12 112.31 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 176' ' ' VAL . 48.8 p -95.57 -179.34 4.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 62.22 111.146 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -56.01 -25.66 45.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.921 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.608 ' O ' HD12 ' A' ' 178' ' ' ILE . 7.7 tt0 -73.4 -57.27 4.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 75.32 110.89 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.93 -38.88 58.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.31 110.852 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 172' ' ' THR . 93.5 t -59.85 -42.55 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 71.23 111.099 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -52.46 -45.1 65.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 75.1 110.898 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.608 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -63.27 -27.41 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 53.44 111.145 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.512 ' HZ3' HG21 ' A' ' 191' ' ' VAL . 77.0 t90 -83.63 -32.77 25.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 73.05 110.915 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 57.1 tp -73.21 -37.78 66.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 75.43 110.901 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -56.18 -35.27 67.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 74.41 110.924 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.6 ttp -90.23 -39.18 12.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 64.02 110.926 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.69 ' HA ' HD12 ' A' ' 199' ' ' LEU . . . -60.31 -58.96 6.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 71.45 111.155 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.48 113.94 13.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 62.14 110.878 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 82.2 p -84.31 -46.34 11.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 64.51 111.1 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -74.6 -12.36 60.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 53.3 110.886 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.1 t 62.59 44.94 6.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 42.22 110.847 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -79.39 -16.26 56.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 75.41 110.879 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.05 -15.46 51.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 55.22 112.485 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.1 m -136.22 135.9 39.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.4 . . . . 75.42 110.835 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.512 HG21 ' HZ3' ' A' ' 179' ' ' TRP . 25.0 t -87.0 109.71 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 71.33 111.135 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.5 t -87.97 -172.77 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 63.01 110.868 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 29.9 tp -68.57 -28.08 66.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 60.51 110.908 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -81.2 -32.61 33.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.906 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -84.78 -26.05 27.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 73.24 110.925 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.535 ' O ' HD12 ' A' ' 200' ' ' ILE . 26.6 t80 -79.26 -54.41 5.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.3 110.952 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.756 ' HB3' HD22 ' A' ' 130' ' ' LEU . 4.7 mm-40 -54.96 -32.58 61.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 74.51 110.936 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -68.68 -26.12 65.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.882 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 183' ' ' ALA . 5.1 tt -68.04 -35.56 78.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 71.33 110.928 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.535 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -73.43 -24.73 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 73.11 111.12 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.465 ' CD1' HD21 ' A' ' 130' ' ' LEU . 50.8 mm -55.66 -50.94 63.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 72.33 111.121 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -56.26 -46.46 79.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 74.11 110.908 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 9.9 p -61.84 -33.0 73.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 51.43 110.861 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.727 HD23 HD13 ' A' ' 209' ' ' ILE . 5.6 mt -69.74 -31.21 69.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 65.34 110.961 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -63.31 -43.95 96.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 61.42 110.952 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -86.02 -24.02 26.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 65.44 110.888 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.03 -22.71 67.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.54 111.086 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.98 32.01 1.79 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 50.53 112.492 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.727 HD13 HD23 ' A' ' 204' ' ' LEU . 5.3 mp -122.86 128.58 75.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 73.43 111.142 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.7 107.37 19.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.879 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 6.5 p -110.3 142.4 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 64.44 111.173 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.99 131.42 49.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 74.22 110.874 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.36 145.43 50.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 74.14 110.914 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -137.8 140.29 40.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.898 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -131.03 151.82 51.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 71.53 110.872 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.9 pp -88.48 147.7 24.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 72.41 110.9 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.7 m -98.08 151.93 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.33 111.169 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 35.8 p90 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 53.42 110.894 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.833 0.349 . . . . 70.42 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -94.24 123.03 37.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 61.21 110.865 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -104.64 160.67 25.22 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.562 0.696 . . . . 74.15 110.87 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 171.12 15.09 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.656 2.238 . . . . 63.35 112.36 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -108.99 104.44 13.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 75.12 110.878 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -106.58 140.05 40.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.922 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -52.01 160.57 1.14 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.645 0.735 . . . . 54.21 110.854 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -19.27 36.36 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 63.45 112.356 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -82.84 -24.66 33.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 75.24 110.901 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 211' ' ' VAL . 2.9 t -78.77 -60.62 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 74.41 111.141 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -51.77 -30.12 21.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 54.22 110.875 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.84 63.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 54.11 111.076 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -88.48 -36.67 16.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 74.33 110.906 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.758 HD21 HD11 ' A' ' 201' ' ' ILE . 43.9 mt -63.94 -30.53 71.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 71.51 110.919 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -63.45 -46.42 86.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 73.04 110.866 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.6 p -81.71 -23.68 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 73.24 111.132 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.79 -21.78 60.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 51.3 111.125 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 10.2 mtt-85 -72.23 -55.64 6.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -54.81 -27.05 38.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 75.24 110.871 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.1 tp -77.77 -29.01 50.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 71.51 110.893 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -66.53 -49.77 65.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 73.14 110.852 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.0 mtpp -72.03 -26.42 62.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 75.01 110.883 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -54.4 -27.91 40.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 73.32 110.874 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -108.12 -30.31 8.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 74.53 110.897 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -74.97 73.19 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 54.5 110.873 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -84.72 -25.03 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 65.01 110.908 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -70.66 -10.58 59.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.853 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.64 19.57 62.87 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 74.54 112.525 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.6 t -79.42 -22.14 44.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 52.45 110.856 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.82 18.77 76.63 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.763 . . . . 64.22 112.467 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -147.36 131.02 16.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.827 0.346 . . . . 73.53 110.867 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.907 HD13 HD22 ' A' ' 156' ' ' LEU . 11.7 mt -92.51 101.76 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 65.54 110.908 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -65.56 175.65 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 74.1 110.924 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.469 ' OD1' HD23 ' A' ' 180' ' ' LEU . 15.6 m-20 -52.02 -30.13 24.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.832 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -74.31 -55.29 6.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 75.35 110.824 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -56.5 -46.57 80.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.15 110.838 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.562 HD13 ' HB2' ' A' ' 180' ' ' LEU . 29.0 mt -51.73 -43.07 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 75.4 111.146 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.96 -41.21 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 72.2 111.129 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.28 -24.17 52.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 43.24 112.492 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.907 HD22 HD13 ' A' ' 148' ' ' LEU . 21.7 tp -67.06 -50.33 62.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 70.24 110.919 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.511 HD21 ' CD2' ' A' ' 179' ' ' TRP . 72.5 mt -52.92 -29.55 29.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 71.43 110.938 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.595 ' HE2' HG22 ' A' ' 170' ' ' THR . 0.5 OUTLIER -58.71 -60.66 3.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.02 110.864 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.11 -41.35 70.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 61.11 110.888 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.6 m -51.76 -46.78 64.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 75.13 111.124 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -64.66 -29.14 70.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 72.52 110.922 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.445 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -75.9 -24.7 55.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 64.22 111.116 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -57.94 -49.51 76.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 70.33 110.865 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 29.5 mtm -79.47 -18.45 52.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 72.34 110.898 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.75 18.32 30.34 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 62.11 112.487 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 5.6 mtt -61.33 175.88 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 72.11 110.869 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.1 m -60.88 -18.95 59.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 71.15 110.818 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 1.9 t30 63.81 63.65 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 71.12 110.905 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -79.98 152.79 29.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 71.31 110.874 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.595 HG22 ' HE2' ' A' ' 158' ' ' LYS . 21.0 p -108.23 90.78 7.24 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.591 0.71 . . . . 64.4 111.134 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -175.28 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.689 2.259 . . . . 51.54 112.363 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.658 ' O ' HG23 ' A' ' 176' ' ' VAL . 23.0 p -117.23 -176.27 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 73.45 111.172 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -59.25 -24.8 63.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 71.13 110.88 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.631 ' O ' HD12 ' A' ' 178' ' ' ILE . 27.8 tt0 -78.04 -57.46 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.52 110.876 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -51.76 -35.15 42.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 64.34 110.895 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 172' ' ' THR . 85.2 t -64.77 -39.69 86.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 72.42 111.074 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -55.47 -44.45 76.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 73.44 110.918 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -62.01 -34.8 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 65.33 111.097 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.574 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 49.0 t90 -79.39 -26.13 42.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.921 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.723 HD21 ' HA2' ' A' ' 189' ' ' GLY . 10.0 tp -81.66 -39.03 24.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 62.32 110.912 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -56.9 -28.41 61.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.866 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 17.5 mtm -83.44 -52.61 6.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 60.21 110.893 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.494 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -52.09 -62.04 1.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 72.51 111.089 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -67.62 124.62 23.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 51.22 110.839 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.3 m -73.96 -25.44 59.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 74.53 111.151 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -104.01 -12.47 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 64.3 110.866 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 7.6 t 55.79 50.79 13.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 74.42 110.809 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -100.94 23.91 10.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 65.54 110.867 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.723 ' HA2' HD21 ' A' ' 180' ' ' LEU . . . 69.27 31.72 71.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.72 -0.752 . . . . 53.31 112.519 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.6 157.29 43.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 73.24 110.892 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.3 t -140.04 101.37 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 72.35 111.148 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 40.2 t -71.08 165.74 22.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 54.42 110.872 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.92 -40.77 61.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 73.21 110.904 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -74.51 -38.18 62.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.891 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.81 -38.22 90.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 75.51 110.919 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.53 ' O ' HD12 ' A' ' 200' ' ' ILE . 30.8 t80 -75.98 -43.03 46.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 74.13 110.93 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.646 ' O ' HD12 ' A' ' 201' ' ' ILE . 5.7 mm-40 -61.72 -44.1 97.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 61.24 110.853 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -53.03 -40.91 64.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 74.51 110.908 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.574 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 1.2 tp -51.7 -52.19 50.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.927 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 200' ' ' ILE . 4.5 mp -51.42 -44.96 33.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 55.41 111.118 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.999 HG23 HG21 ' A' ' 211' ' ' VAL . 3.4 mp -68.9 -40.28 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 60.13 111.098 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -60.09 -38.38 82.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 65.43 110.928 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 58.1 m -84.48 -31.75 24.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 62.3 110.867 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.87 HD22 HD13 ' A' ' 209' ' ' ILE . 13.5 mt -63.73 -29.4 70.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 60.24 110.927 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -51.85 -42.3 62.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 73.12 110.923 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -86.09 -24.19 26.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.922 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.93 -22.76 67.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 42.43 111.103 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.17 19.57 5.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 71.13 112.461 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.87 HD13 HD22 ' A' ' 204' ' ' LEU . 5.2 mp -121.99 101.85 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.798 0.333 . . . . 70.2 111.12 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -74.54 128.06 34.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.847 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.999 HG21 HG23 ' A' ' 201' ' ' ILE . 42.8 t -110.42 146.0 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 63.44 111.121 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -114.69 111.48 21.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 73.41 110.922 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -122.09 106.13 10.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 74.54 110.878 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -122.67 160.02 26.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 72.41 110.888 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.3 m -163.69 147.23 10.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 52.04 110.865 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.417 ' H ' HD23 ' A' ' 216' ' ' LEU . 1.3 pt? -54.61 158.91 2.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.498 . . . . 55.34 110.961 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 31.1 m -121.85 158.46 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 73.52 111.138 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 73.02 110.889 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.841 0.353 . . . . 73.4 110.838 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.2 m -96.1 158.47 15.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 63.34 110.919 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -111.11 160.26 29.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.54 0.686 . . . . 61.43 110.914 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 147.66 63.26 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.673 2.249 . . . . 61.01 112.35 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -107.82 103.96 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 54.14 110.827 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.456 ' CE2' HG11 ' A' ' 211' ' ' VAL . 2.6 m-85 -98.89 142.58 30.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.902 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -58.57 160.66 9.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.588 0.709 . . . . 74.41 110.884 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -20.48 34.9 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.666 2.244 . . . . 74.32 112.367 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.0 -23.09 41.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 70.14 110.876 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.533 HG21 HG13 ' A' ' 211' ' ' VAL . 3.0 t -78.05 -62.64 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 73.05 111.133 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -51.56 -30.59 21.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 72.15 110.881 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.48 -31.04 61.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 62.33 111.146 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.735 ' HG3' HD21 ' A' ' 204' ' ' LEU . 8.3 mmmt -88.4 -21.68 24.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 72.02 110.883 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.22 -46.45 16.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.431 . . . . 72.32 110.912 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.02 -31.34 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 75.02 110.855 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 p -85.87 -23.96 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 75.33 111.131 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.62 -44.43 21.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 75.5 111.103 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.83 -33.41 35.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.857 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 41.3 mtp85 -74.58 -40.42 61.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 75.5 110.876 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.3 tp -68.3 -25.09 64.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 74.52 110.918 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.08 -64.57 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 65.31 110.865 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -59.28 -25.97 64.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 74.23 110.868 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -52.71 -30.49 32.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.823 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -101.4 -26.52 13.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 73.13 110.928 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -75.75 82.92 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 75.13 110.852 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -81.52 -26.5 35.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 73.34 110.884 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -72.43 -10.56 59.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.42 . . . . 50.42 110.892 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.05 20.54 54.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 72.11 112.484 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 59.5 p -77.13 -22.06 53.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.943 0.401 . . . . 63.12 110.882 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.11 59.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 32.43 112.503 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -144.03 137.36 27.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 73.11 110.942 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.773 HD13 HD22 ' A' ' 156' ' ' LEU . 82.3 mt -100.93 105.29 16.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 71.33 110.917 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -67.8 171.38 6.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.41 110.934 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.55 ' O ' HG11 ' A' ' 176' ' ' VAL . 2.0 m-20 -52.02 -30.36 25.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 71.22 110.858 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.33 -50.87 11.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.4 110.889 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -57.28 -26.25 60.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 62.22 110.856 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 150' ' ' ASP . 26.5 mt -78.1 -26.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 65.01 111.153 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.93 -54.98 23.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 72.32 111.141 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.22 -22.86 69.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 74.22 112.524 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 148' ' ' LEU . 15.8 tp -57.86 -58.69 7.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.909 0.385 . . . . 61.44 110.939 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.8 mt -51.81 -36.64 48.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.945 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -54.39 -41.93 69.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 61.15 110.942 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -85.06 -46.49 11.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 70.45 110.893 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 87.3 m -54.61 -33.0 59.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 74.1 111.129 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -69.13 -26.13 64.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 62.13 110.918 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.27 -30.23 71.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.101 -0.499 . . . . 75.23 111.087 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.38 -26.06 64.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.858 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 30.8 mtm -94.05 -18.38 21.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 75.2 110.84 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 93.13 24.01 23.41 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.764 -0.731 . . . . 72.51 112.443 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.3 ttm -81.95 175.81 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 74.44 110.854 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.4 m -75.73 -6.26 49.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 35.43 110.84 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.2 m120 62.9 69.66 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 53.33 110.886 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -68.07 152.64 45.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.906 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 1.4 m -108.18 90.82 7.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.575 0.702 . . . . 61.32 111.175 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.6 Cg_endo -69.77 175.86 7.55 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.661 2.241 . . . . 75.14 112.379 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 81.1 p -115.41 -176.57 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 73.4 111.154 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -52.19 -29.9 24.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.34 110.95 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -67.41 -57.65 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.864 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.02 -53.76 54.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 71.14 110.868 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 150' ' ' ASP . 90.5 t -52.66 -41.12 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.42 111.126 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -54.79 -54.51 41.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 74.14 110.895 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.35 -47.9 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 74.32 111.133 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 64.4 t90 -61.89 -25.95 67.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.132 -0.485 . . . . 75.4 110.904 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 180' ' ' LEU . 2.6 tt -81.61 -40.51 22.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.426 . . . . 70.43 110.92 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.51 -28.76 70.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.903 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 43.3 ttp -91.22 -35.08 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 74.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.747 ' HA ' HD23 ' A' ' 199' ' ' LEU . . . -71.41 -48.25 50.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 51.21 111.096 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -52.55 120.3 5.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.851 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.87 -23.59 25.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 64.31 111.126 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -103.44 -10.71 18.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 72.11 110.874 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.4 p 58.99 27.19 16.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 72.35 110.852 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -78.94 -15.87 57.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 73.11 110.869 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.34 17.26 16.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 53.3 112.49 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.78 126.9 7.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 73.13 110.854 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.7 t -86.92 107.63 17.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 61.04 111.131 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.2 t -83.68 -176.65 6.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 71.41 110.862 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.7 tp -66.61 -36.03 81.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 74.41 110.962 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -79.35 -24.75 42.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 73.1 110.87 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -85.89 -20.43 29.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 74.14 110.85 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.577 ' O ' HD12 ' A' ' 200' ' ' ILE . 17.5 t80 -87.32 -40.16 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.931 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -52.68 -41.42 63.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.899 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.86 -25.16 63.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 64.35 110.828 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 183' ' ' ALA . 2.2 tm? -61.9 -40.24 94.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.466 . . . . 71.34 110.91 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.2 mp -72.22 -24.69 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.21 111.134 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 51.1 mm -60.81 -37.51 76.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 51.54 111.154 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.45 -52.56 38.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 63.52 110.858 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 2.6 m -57.44 -30.67 65.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 70.32 110.885 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.735 HD21 ' HG3' ' A' ' 129' ' ' LYS . 15.9 mt -72.01 -37.93 69.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 54.42 110.925 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -58.03 -35.57 71.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 71.15 110.897 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.36 -26.64 26.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 65.23 110.929 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.2 -22.65 66.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 73.02 111.13 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.75 26.45 3.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 71.43 112.491 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -119.52 103.12 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.854 0.359 . . . . 74.0 111.13 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -71.17 110.88 6.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 71.31 110.839 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.533 HG13 HG21 ' A' ' 126' ' ' VAL . 23.3 t -89.33 149.55 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 55.23 111.119 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -110.24 107.96 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 71.11 110.897 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 137.59 48.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 63.23 110.897 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -76.11 95.09 3.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 64.52 110.932 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 58.3 p -108.78 -178.51 3.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 61.22 110.826 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.62 73.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 72.32 110.914 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.5 m -52.66 140.37 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 75.23 111.13 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 41.2 p90 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 72.34 110.935 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.864 0.364 . . . . 74.53 110.914 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 p -133.15 160.25 37.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 63.24 110.834 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -116.24 81.12 10.25 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.586 0.708 . . . . 72.44 110.935 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 176.71 6.37 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.704 2.269 . . . . 54.15 112.346 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.1 127.24 35.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 63.0 110.9 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -109.79 133.93 52.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 71.43 110.916 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -52.59 160.52 1.35 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.595 0.712 . . . . 74.42 110.889 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -18.81 36.92 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.72 2.28 . . . . 75.24 112.344 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -82.69 -23.63 34.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 73.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.478 HG21 HG23 ' A' ' 211' ' ' VAL . 3.0 t -77.93 -63.33 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 75.32 111.163 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -51.99 -30.9 27.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.31 110.883 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.71 -37.5 63.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 53.12 111.116 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -88.19 -25.94 22.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.893 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.741 HD22 ' CG ' ' A' ' 197' ' ' GLU . 68.5 mt -73.94 -28.23 61.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 62.3 110.89 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.51 -59.01 4.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.449 . . . . 70.34 110.899 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.8 p -55.29 -26.46 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 73.12 111.152 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.91 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 74.1 111.11 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.413 ' CG ' HD11 ' A' ' 193' ' ' LEU . 25.1 mtt180 -61.39 -50.66 71.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 71.31 110.874 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -63.68 -41.48 98.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 72.31 110.863 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 24.6 tp -57.1 -38.92 74.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 71.4 110.905 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -56.47 -59.74 4.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.12 110.873 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.6 mmmm -66.39 -26.27 67.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 43.23 110.87 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.3 ttm-85 -54.14 -27.71 35.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.872 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -109.74 -30.55 7.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.941 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -70.07 84.28 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 72.11 110.862 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -84.94 -28.17 26.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.41 110.878 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -72.63 -10.57 59.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 73.14 110.899 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.96 47.12 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.738 . . . . 64.51 112.462 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 45.4 t -75.36 -22.11 57.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.953 0.406 . . . . 72.52 110.853 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 84.23 19.67 60.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.79 -0.719 . . . . 75.14 112.483 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -146.04 141.75 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 70.2 110.889 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.7 mt -105.23 101.41 10.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 42.13 110.927 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -70.41 170.68 11.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 63.34 110.95 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.534 ' O ' HG11 ' A' ' 176' ' ' VAL . 10.4 p-10 -52.06 -30.02 23.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.42 110.842 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -80.41 -35.02 35.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 75.1 110.891 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -75.08 -29.19 60.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 75.33 110.896 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.66 HD12 HD12 ' A' ' 180' ' ' LEU . 54.8 mt -77.78 -26.67 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 73.23 111.145 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.76 -45.85 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 70.44 111.071 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.24 -23.04 55.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.789 -0.72 . . . . 51.21 112.495 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.1 tp -59.15 -57.04 14.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 62.43 110.9 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.7 mt -51.94 -35.84 47.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.23 110.959 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -51.97 -45.68 64.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 75.34 110.834 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -84.77 -45.69 12.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 65.44 110.833 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 33.5 m -52.99 -31.23 39.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.113 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -77.07 -55.37 5.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.914 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.81 -24.81 38.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 75.3 111.081 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -53.64 -29.17 36.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 71.45 110.879 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -113.02 16.8 19.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.41 110.878 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.83 28.93 74.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 52.25 112.451 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.16 175.75 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 54.54 110.884 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 94.8 p -60.92 -21.25 63.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 72.53 110.879 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 63.45 57.47 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 65.12 110.889 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -80.22 152.55 29.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.924 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.8 p -108.21 90.75 7.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.589 0.709 . . . . 73.0 111.179 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 174.47 9.44 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.662 2.242 . . . . 51.42 112.327 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 39.2 p -117.53 -176.06 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 60.42 111.12 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -52.14 -29.95 24.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 63.01 110.879 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -69.43 -57.36 5.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 71.54 110.918 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.415 ' HA ' HD12 ' A' ' 178' ' ' ILE . 3.3 m-20 -56.15 -52.54 64.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 75.23 110.852 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.534 HG11 ' O ' ' A' ' 150' ' ' ASP . 94.7 t -52.42 -38.15 25.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 73.4 111.126 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -58.11 -54.85 42.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 75.45 110.907 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 175' ' ' ASP . 3.5 mt -54.5 -47.47 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 74.12 111.143 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.546 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 50.0 t90 -57.97 -29.84 65.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 71.11 110.88 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.66 HD12 HD12 ' A' ' 153' ' ' ILE . 5.2 tt -74.88 -30.54 61.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 72.11 110.949 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -65.01 -26.17 68.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.03 110.938 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.5 ttm -90.97 -42.83 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 64.11 110.895 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.466 ' CA ' HD13 ' A' ' 199' ' ' LEU . . . -68.32 -50.47 53.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 74.24 111.085 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.529 ' HB2' HD23 ' A' ' 180' ' ' LEU . 35.2 t0 -51.98 105.45 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.836 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.5 m -87.18 -25.15 24.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 55.43 111.156 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -95.11 -12.42 26.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 61.32 110.906 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 60.74 37.93 18.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 72.24 110.855 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -102.01 23.99 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 73.03 110.855 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 65.19 19.42 66.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 70.22 112.509 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.73 160.4 41.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 61.21 110.871 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.23 124.93 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 72.02 111.11 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.28 -170.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 44.22 110.876 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -66.04 -39.01 89.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 74.15 110.892 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -74.11 -35.59 64.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.859 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.58 -53.4 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 75.14 110.94 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.515 ' O ' HD12 ' A' ' 200' ' ' ILE . 11.2 t80 -58.47 -47.91 82.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 74.02 110.911 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.741 ' CG ' HD22 ' A' ' 130' ' ' LEU . 26.4 tt0 -55.2 -31.04 61.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 41.5 110.89 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -69.77 -26.41 64.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 61.45 110.88 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.546 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 3.5 tp -67.46 -34.03 76.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 74.15 110.887 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.636 HG22 HD23 ' A' ' 204' ' ' LEU . 5.3 mp -75.04 -27.44 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 55.21 111.133 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.5 mm -52.11 -60.09 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 64.5 111.135 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -52.08 -30.13 24.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 73.51 110.884 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.9 m -69.98 -41.88 73.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.872 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 209' ' ' ILE . 4.1 mm? -66.83 -36.05 81.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.49 . . . . 65.41 110.936 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -57.07 -44.23 82.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 64.23 110.904 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -86.06 -24.83 26.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 64.33 110.91 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.05 -22.71 67.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 74.22 111.063 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.92 19.26 5.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.756 -0.735 . . . . 73.14 112.527 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 204' ' ' LEU . 5.3 mp -122.32 101.84 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 61.55 111.128 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.13 98.66 3.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.13 110.887 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.478 HG23 HG21 ' A' ' 126' ' ' VAL . 5.6 p -77.31 138.99 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 74.23 111.157 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -91.72 108.06 19.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 71.05 110.892 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.58 134.37 22.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 73.34 110.872 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -52.73 103.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 65.31 110.931 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 19.7 p -103.36 84.53 2.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 75.21 110.841 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.06 134.39 57.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 71.51 110.88 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 12.5 m -115.4 132.94 63.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 62.2 111.193 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 22.0 p90 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.885 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.859 0.361 . . . . 33.22 110.884 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.2 p -114.98 106.9 14.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 61.01 110.846 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.69 155.98 74.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.509 0.671 . . . . 70.24 110.891 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 140.01 41.57 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.619 2.212 . . . . 72.12 112.357 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -91.39 136.57 33.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 73.44 110.926 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.483 ' HB3' HG21 ' A' ' 126' ' ' VAL . 21.1 m-85 -124.14 164.32 19.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 65.11 110.916 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -51.77 162.15 0.8 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.584 0.707 . . . . 72.5 110.883 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -16.87 37.69 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.676 2.251 . . . . 61.34 112.346 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -83.42 -18.97 36.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.892 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.532 ' CG2' HG22 ' A' ' 211' ' ' VAL . 2.9 t -77.16 -61.44 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 45.14 111.134 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.676 ' HA ' HD12 ' A' ' 130' ' ' LEU . 4.0 tt0 -51.54 -31.38 24.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.45 110.891 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.03 -34.32 55.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.54 111.14 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.646 ' HB3' HD11 ' A' ' 204' ' ' LEU . 0.0 OUTLIER -88.47 -30.99 18.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.42 110.945 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.867 HD21 HD11 ' A' ' 201' ' ' ILE . 17.9 mt -69.68 -32.72 71.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.876 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -58.27 -57.58 12.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 64.31 110.857 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 129' ' ' LYS . 10.2 p -57.75 -23.79 21.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 70.4 111.127 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.43 -30.77 67.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 61.51 111.118 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -49.44 63.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 75.1 110.919 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -61.77 -24.65 66.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 64.42 110.885 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.7 tp -82.17 -36.67 27.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.04 110.92 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.0 -53.31 59.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.881 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -69.62 -25.97 64.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 70.44 110.906 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -52.2 -29.94 24.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 62.14 110.861 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -106.0 -34.18 7.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 65.22 110.895 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -74.75 88.95 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 72.13 110.873 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -84.72 -25.42 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.45 110.92 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -70.65 -10.61 59.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.878 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.66 22.54 40.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.717 -0.754 . . . . 61.4 112.489 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.5 m -76.38 -22.1 55.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.895 0.379 . . . . 74.04 110.844 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.76 19.04 57.24 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.752 . . . . 71.22 112.48 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -142.96 130.74 21.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 74.54 110.894 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.415 HD13 HD22 ' A' ' 156' ' ' LEU . 31.7 mt -89.03 102.57 15.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 72.22 110.944 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -71.6 173.11 8.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 73.32 110.894 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.407 ' HA ' HD12 ' A' ' 153' ' ' ILE . 2.9 p30 -55.54 -26.42 43.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 64.3 110.856 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -80.02 -34.28 38.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 65.21 110.85 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -80.92 -26.75 36.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 75.22 110.84 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.451 ' CG2' HG13 ' A' ' 176' ' ' VAL . 21.4 mt -74.82 -36.25 39.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 43.13 111.133 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.83 -47.27 64.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 51.43 111.067 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.42 -23.5 53.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 63.41 112.458 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.466 HD21 ' CE1' ' A' ' 196' ' ' TYR . 1.9 tp -65.48 -49.12 70.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 74.45 110.942 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.556 HD21 ' CD2' ' A' ' 179' ' ' TRP . 97.7 mt -52.12 -33.91 41.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 53.51 110.921 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -54.59 -55.2 31.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.855 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.34 -45.06 41.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 72.01 110.877 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.3 m -51.67 -30.71 22.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 62.04 111.154 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -77.85 -44.69 26.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 65.11 110.914 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.609 ' HB2' HD21 ' A' ' 168' ' ' ASN . . . -57.2 -23.24 46.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 64.54 111.087 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -55.52 -25.94 40.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 75.24 110.893 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.6 mtm -111.73 19.44 18.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.889 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.76 21.46 71.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 51.3 112.492 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.2 tpp -62.22 175.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.758 0.314 . . . . 64.31 110.911 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.1 t -78.3 -3.91 45.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 64.32 110.868 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.609 HD21 ' HB2' ' A' ' 162' ' ' ALA . 2.8 m120 55.72 61.74 2.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 74.14 110.909 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -72.86 152.63 41.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.11 110.905 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.4 m -108.11 90.77 7.08 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.572 0.701 . . . . 72.35 111.136 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 171.45 14.44 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.704 2.269 . . . . 55.41 112.364 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 176' ' ' VAL . 3.4 p -102.35 177.83 4.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 73.55 111.124 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -55.19 -27.74 48.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 74.4 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.9 tt0 -75.23 -54.28 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 74.23 110.901 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.16 -35.87 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.823 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 172' ' ' THR . 91.2 t -63.97 -39.36 85.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 75.2 111.101 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 26.8 mmtm -56.83 -52.99 62.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 61.24 110.877 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.1 mp -55.38 -30.68 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 72.22 111.118 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.592 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 90.9 t90 -79.55 -31.21 41.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 64.25 110.934 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.501 ' O ' HD23 ' A' ' 180' ' ' LEU . 1.9 tt -77.46 -39.98 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.888 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -51.92 -58.47 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.906 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 27.5 ttp -63.7 -24.46 67.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.893 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.698 ' CB ' HD11 ' A' ' 199' ' ' LEU . . . -94.51 21.89 6.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 61.0 111.097 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -141.73 120.93 13.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 64.34 110.864 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 14.5 m -87.17 -43.71 12.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 63.15 111.097 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -78.42 -12.45 60.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.868 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 46.0 t 57.98 48.15 13.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 65.42 110.836 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -93.27 -16.24 24.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 70.02 110.854 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.23 25.12 14.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 63.44 112.46 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.24 144.12 24.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.894 0.378 . . . . 55.33 110.902 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 196' ' ' TYR . 22.0 t -113.89 121.95 67.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 74.14 111.123 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.15 -177.74 4.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 44.23 110.891 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.91 -32.67 66.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 64.14 110.949 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.53 -58.87 3.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.31 110.874 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.442 ' HB3' HG13 ' A' ' 191' ' ' VAL . 15.5 mt-10 -56.2 -25.46 47.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 71.11 110.929 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.53 ' HB2' HG12 ' A' ' 191' ' ' VAL . 31.7 t80 -85.34 -50.17 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 71.03 110.917 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.517 ' HA ' HD13 ' A' ' 200' ' ' ILE . 19.0 mt-10 -52.08 -40.98 62.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 71.45 110.877 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -53.56 -43.9 68.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 73.21 110.886 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.698 HD11 ' CB ' ' A' ' 183' ' ' ALA . 36.5 mt -51.84 -35.66 45.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 71.42 110.958 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.517 HD13 ' HA ' ' A' ' 197' ' ' GLU . 5.2 mp -77.0 -30.0 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 62.44 111.156 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.867 HD11 HD21 ' A' ' 130' ' ' LEU . 51.7 mm -64.66 -43.06 96.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 71.51 111.11 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -63.83 -36.05 82.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 71.21 110.905 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 62.7 m -77.66 -39.74 44.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.2 110.851 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' ' 129' ' ' LYS . 22.4 mt -57.63 -46.03 84.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.494 . . . . 73.03 110.902 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -52.59 -35.18 53.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.15 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.12 -31.33 21.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 65.14 110.88 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.425 ' HB3' ' CD1' ' A' ' 209' ' ' ILE . . . -64.91 -22.28 66.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 41.1 111.081 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.89 32.42 1.56 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.739 . . . . 42.33 112.496 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.468 HD13 ' CD2' ' A' ' 204' ' ' LEU . 5.2 mp -118.04 110.94 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 74.44 111.112 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 131.32 46.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.15 110.841 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.532 HG22 ' CG2' ' A' ' 126' ' ' VAL . 18.3 t -137.89 111.95 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 72.24 111.119 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.12 107.99 5.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 74.14 110.878 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.26 111.9 7.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 65.01 110.921 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -55.01 144.66 22.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 72.42 110.889 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 48.8 m -146.82 157.63 43.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 72.32 110.858 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 216' ' ' LEU . 0.9 OUTLIER -126.36 162.76 24.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 61.41 110.87 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 27.8 m -115.62 158.97 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 74.11 111.131 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 3.5 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 71.32 110.883 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.4 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.865 0.364 . . . . 61.25 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.65 120.01 19.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 72.33 110.882 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -111.34 81.0 2.78 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.538 0.685 . . . . 74.4 110.877 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 133.82 26.43 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.715 2.277 . . . . 73.21 112.334 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tptp -95.66 140.33 30.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.868 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -105.68 161.93 13.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 71.12 110.95 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -51.73 160.97 0.95 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.661 0.743 . . . . 70.42 110.853 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -25.35 28.42 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.651 2.234 . . . . 61.33 112.318 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -79.36 -19.55 49.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 62.44 110.923 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.87 HG12 HD11 ' A' ' 130' ' ' LEU . 2.8 t -84.74 -61.03 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 72.1 111.111 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.521 ' HA ' HD12 ' A' ' 130' ' ' LEU . 3.6 tp10 -51.35 -30.7 19.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.9 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.37 79.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 51.34 111.089 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.442 ' O ' HG12 ' A' ' 132' ' ' VAL . 56.0 tptt -88.39 -40.73 13.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 72.33 110.914 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.87 HD11 HG12 ' A' ' 126' ' ' VAL . 13.2 mt -57.28 -25.81 59.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.21 110.928 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -70.03 -59.27 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 75.22 110.855 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 129' ' ' LYS . 10.1 p -57.87 -23.62 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 73.15 111.111 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.35 -21.69 59.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 61.54 111.137 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.8 mtt-85 -70.13 -53.41 17.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 62.41 110.885 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -54.57 -26.88 34.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 72.03 110.822 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.5 tp -79.89 -35.17 38.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 62.34 110.964 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' A' ' 148' ' ' LEU . 28.7 t80 -65.41 -43.02 91.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 71.5 110.885 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -79.49 -26.93 41.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.89 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -51.96 -40.44 60.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 65.32 110.889 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -94.23 -26.12 16.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.932 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.14 62.58 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 74.44 110.883 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -26.16 68.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 62.12 110.887 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -70.83 -10.56 59.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 73.12 110.875 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.04 20.89 43.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.709 -0.757 . . . . 62.32 112.464 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.5 m -78.45 -22.1 48.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 75.33 110.85 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.84 20.19 66.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 72.05 112.451 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -138.51 131.54 29.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.798 0.332 . . . . 64.23 110.935 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.597 HD13 HD22 ' A' ' 156' ' ' LEU . 24.1 mt -101.92 111.43 23.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 72.4 110.945 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -79.93 175.7 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 65.32 110.895 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -53.47 -28.51 31.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 61.23 110.87 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -77.34 -44.81 28.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.888 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.04 -33.19 73.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 74.14 110.928 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.64 HG22 HG13 ' A' ' 176' ' ' VAL . 30.6 mt -70.72 -37.5 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 53.35 111.201 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.84 -46.2 64.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 75.43 111.085 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.77 -23.13 56.71 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 65.42 112.505 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.597 HD22 HD13 ' A' ' 148' ' ' LEU . 21.3 tp -58.87 -55.95 28.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 72.05 110.902 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 25.1 mt -52.28 -35.66 50.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.931 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 -43.59 68.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.885 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -85.07 -47.17 10.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.871 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.2 m -52.19 -31.16 30.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 74.22 111.142 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -76.17 -44.19 39.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.923 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.18 -25.53 64.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 74.53 111.097 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -52.25 -30.44 27.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 72.32 110.903 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -102.62 -18.45 15.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.24 110.869 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 97.77 27.24 9.13 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 53.21 112.481 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.63 175.2 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 64.54 110.873 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.1 p -55.6 -25.96 41.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 62.15 110.864 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 63.31 54.66 1.97 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 75.44 110.911 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -60.45 152.49 25.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 74.42 110.921 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p -108.27 90.8 7.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 72.31 111.136 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -171.02 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.643 2.228 . . . . 72.32 112.38 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 176' ' ' VAL . 70.1 p -127.86 -176.35 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 72.41 111.131 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -57.63 -25.56 60.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 72.32 110.93 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.42 -60.16 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 72.21 110.909 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.421 ' HA ' HD12 ' A' ' 178' ' ' ILE . 0.8 OUTLIER -56.84 -49.2 76.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 65.04 110.832 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.64 HG13 HG22 ' A' ' 153' ' ' ILE . 99.0 t -55.37 -43.87 73.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.424 . . . . 73.04 111.089 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -50.27 62.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 75.2 110.888 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 175' ' ' ASP . 3.7 mt -59.46 -49.22 84.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.22 111.173 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.527 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 53.5 t90 -54.74 -28.63 49.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 74.25 110.89 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 180' ' ' LEU . 5.8 tt -61.38 -45.64 93.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 73.11 110.906 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -72.52 -29.91 64.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.03 110.89 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.6 ttp -60.96 -31.18 70.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.25 110.871 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -101.26 -48.54 4.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 73.04 111.086 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -52.35 112.74 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 65.43 110.808 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 27.9 m -83.71 -33.34 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 64.3 111.141 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -83.51 -12.46 56.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 73.11 110.881 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 21.8 m 54.87 49.99 16.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 63.42 110.874 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -110.07 23.94 13.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 72.43 110.903 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.54 25.47 70.2 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 73.44 112.484 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.7 p -154.64 133.78 12.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 71.03 110.848 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.419 HG12 ' HB2' ' A' ' 196' ' ' TYR . 38.3 t -101.51 105.48 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 44.14 111.121 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -75.02 178.17 5.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 61.33 110.841 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.8 tp -54.79 -61.02 2.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 72.54 110.916 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -60.78 -41.54 95.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 73.23 110.913 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -29.38 66.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.53 110.92 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.509 ' O ' HD12 ' A' ' 200' ' ' ILE . 27.8 t80 -87.94 -47.63 8.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 74.22 110.955 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.418 ' HA ' HD13 ' A' ' 200' ' ' ILE . 0.3 OUTLIER -57.18 -25.84 59.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 72.42 110.905 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.9 -25.75 60.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 73.4 110.89 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.565 HD13 ' HB2' ' A' ' 183' ' ' ALA . 4.9 tp -69.07 -35.9 77.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.889 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -71.24 -24.5 24.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.13 111.135 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 1.133 HG23 HG11 ' A' ' 211' ' ' VAL . 50.0 mm -52.33 -61.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 52.05 111.073 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.86 -49.57 62.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 64.2 110.919 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 49.0 m -52.15 -33.28 39.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 64.53 110.885 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.499 ' CD2' HD13 ' A' ' 209' ' ' ILE . 9.9 mt -76.59 -44.53 34.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 62.43 110.867 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -56.26 -30.1 61.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 73.11 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.1 -16.41 38.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 70.5 110.924 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.51 ' HB3' HD12 ' A' ' 209' ' ' ILE . . . -94.72 24.81 4.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 62.11 111.102 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 66.52 32.39 81.54 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.763 . . . . 53.23 112.499 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 211' ' ' VAL . 18.7 mt -114.72 102.89 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.353 . . . . 64.44 111.121 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -57.0 106.31 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 73.33 110.862 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 1.133 HG11 HG23 ' A' ' 201' ' ' ILE . 85.5 t -110.14 126.51 67.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 64.12 111.142 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -95.46 108.07 20.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 73.42 110.85 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.31 143.19 46.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 72.2 110.888 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -134.9 131.18 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 73.52 110.928 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.5 t -152.82 129.41 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 72.12 110.88 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 68.9 mt -59.8 130.75 48.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 71.45 110.939 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.7 m -86.24 155.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 55.53 111.17 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 46.0 p90 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.878 -179.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.887 0.375 . . . . 70.21 110.837 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.0 t -164.15 176.97 8.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 60.32 110.85 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.58 156.23 58.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.595 0.712 . . . . 71.41 110.892 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 161.81 44.52 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.661 2.241 . . . . 61.4 112.328 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 107.75 15.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 73.32 110.895 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.547 ' CE2' HG11 ' A' ' 211' ' ' VAL . 2.4 m-85 -106.53 133.89 50.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 73.13 110.938 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -52.23 160.62 1.2 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.587 0.708 . . . . 74.22 110.891 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -16.02 37.63 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.701 2.267 . . . . 54.45 112.37 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.61 -26.86 34.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 64.34 110.883 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.728 HG21 HG13 ' A' ' 211' ' ' VAL . 2.9 t -78.8 -61.81 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 45.43 111.107 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -51.62 -30.34 20.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 73.35 110.942 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.16 58.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 63.54 111.129 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.475 ' HG3' HD21 ' A' ' 204' ' ' LEU . 0.2 OUTLIER -84.87 -25.37 28.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.888 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.696 HD22 ' HG2' ' A' ' 197' ' ' GLU . 12.3 mt -78.67 -29.66 45.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 74.55 110.918 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.21 -48.76 69.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 70.22 110.838 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 p -65.47 -30.5 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 44.11 111.13 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.85 -27.89 57.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 73.53 111.086 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.463 ' HG2' HD21 ' A' ' 193' ' ' LEU . 38.4 mtp180 -66.74 -34.3 77.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.44 110.836 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -74.19 -29.83 61.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 63.12 110.878 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 tp -73.52 -32.64 64.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 74.54 110.908 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.53 -63.43 1.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.13 110.874 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -58.02 -26.76 62.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 75.52 110.94 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -54.12 -29.24 44.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.886 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -109.04 -28.89 8.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 72.41 110.922 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.53 70.88 2.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 64.14 110.88 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -25.76 53.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 73.22 110.927 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -70.83 -10.5 59.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 72.13 110.853 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.43 19.78 58.08 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.738 -0.744 . . . . 43.12 112.463 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.4 t -82.33 -22.13 35.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.932 0.396 . . . . 45.21 110.892 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.83 22.44 63.92 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.734 -0.746 . . . . 64.43 112.523 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -140.09 148.99 42.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.858 0.361 . . . . 72.42 110.879 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.667 HD13 HD22 ' A' ' 156' ' ' LEU . 16.7 mt -120.14 119.89 34.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.33 110.912 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -85.37 177.85 7.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.446 . . . . 74.01 110.92 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -52.0 -30.08 23.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 72.33 110.895 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.65 -52.14 9.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 63.32 110.856 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.25 -34.32 73.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 74.04 110.905 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.6 mt -68.6 -38.57 79.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 71.34 111.126 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.79 -58.35 7.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 73.03 111.114 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.22 -23.53 76.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 65.41 112.502 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.667 HD22 HD13 ' A' ' 148' ' ' LEU . 9.8 tp -67.9 -53.35 27.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 73.24 110.911 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.577 HD21 ' CD1' ' A' ' 179' ' ' TRP . 5.6 mt -51.86 -29.86 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 72.02 110.94 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -60.28 -43.82 95.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 72.32 110.887 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -85.02 -38.85 18.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 64.23 110.875 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.0 m -51.75 -30.0 20.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.1 111.182 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -81.5 -50.21 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 75.44 110.924 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.706 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -55.29 -25.11 32.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 74.23 111.136 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -54.52 -28.99 49.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.917 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -110.74 16.93 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.51 110.906 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 29.02 74.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.704 -0.76 . . . . 74.53 112.489 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.1 mmt -69.31 175.85 3.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.821 0.344 . . . . 74.23 110.843 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 75.2 m -61.56 -18.4 59.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 72.3 110.899 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.706 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 3.5 t30 63.67 55.88 1.63 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 71.11 110.933 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -73.81 152.89 40.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.03 110.873 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.4 m -108.27 90.76 7.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.553 0.692 . . . . 75.44 111.131 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 143.65 51.33 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.703 2.269 . . . . 71.44 112.312 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 176' ' ' VAL . 33.5 p -82.58 -178.43 7.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 51.55 111.138 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -56.32 -29.8 61.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.33 110.932 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.562 ' O ' HD12 ' A' ' 178' ' ' ILE . 3.6 tt0 -69.42 -52.44 26.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 72.02 110.895 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -54.7 -42.01 70.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.482 . . . . 63.43 110.846 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 172' ' ' THR . 47.4 t -58.57 -41.94 83.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 71.23 111.118 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -52.89 -48.85 66.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 62.22 110.913 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.0 mp -61.07 -25.61 36.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 72.42 111.093 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.614 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 70.8 t90 -81.87 -22.85 36.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 74.33 110.905 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' A' ' 184' ' ' ASP . 1.4 tt -78.22 -35.4 48.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 72.14 110.892 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -64.6 -31.95 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 51.3 110.933 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.5 ptp -91.72 -30.84 16.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 65.5 110.875 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.646 ' CB ' HD11 ' A' ' 199' ' ' LEU . . . -75.6 -51.27 13.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 42.45 111.128 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.585 ' HB3' HD23 ' A' ' 180' ' ' LEU . 0.5 OUTLIER -50.36 129.57 21.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 70.02 110.866 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.5 m -88.31 -48.78 7.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 64.31 111.15 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -113.86 16.69 18.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.15 110.895 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.5 t 51.78 58.67 5.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.878 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -96.17 -14.44 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.494 . . . . 62.54 110.851 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.37 16.77 17.23 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.728 . . . . 62.4 112.475 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.5 m -154.66 -179.26 7.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.397 . . . . 72.42 110.851 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.503 HG21 ' HZ3' ' A' ' 179' ' ' TRP . 21.5 t -135.59 101.41 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 72.14 111.159 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.4 t -76.07 -174.74 2.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 54.41 110.857 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.463 HD21 ' HG2' ' A' ' 134' ' ' ARG . 21.6 tp -65.3 -45.82 82.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 62.21 110.904 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -70.48 -26.11 63.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 74.4 110.902 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -81.86 -31.89 31.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 52.34 110.865 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.512 ' HA ' HD12 ' A' ' 199' ' ' LEU . 19.1 t80 -85.87 -34.96 20.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 75.43 110.885 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.696 ' HG2' HD22 ' A' ' 130' ' ' LEU . 24.1 tt0 -70.26 -32.15 69.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 73.31 110.868 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.83 -28.53 70.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 72.31 110.836 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.646 HD11 ' CB ' ' A' ' 183' ' ' ALA . 3.4 mt -63.9 -36.6 84.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.12 110.926 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.3 mp -74.86 -24.84 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 55.3 111.142 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.491 HD13 HD21 ' A' ' 130' ' ' LEU . 50.1 mm -58.49 -47.44 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 74.15 111.138 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -67.15 -40.4 86.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 70.34 110.912 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -47.54 65.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 74.2 110.852 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.475 HD21 ' HG3' ' A' ' 129' ' ' LYS . 6.9 mp -73.88 -29.44 62.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 73.42 110.895 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -62.9 -44.87 94.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.879 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -84.12 -24.19 30.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 52.51 110.876 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.9 -22.67 67.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 61.21 111.093 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.0 32.46 1.53 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 23.52 112.463 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -121.4 101.83 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.859 0.361 . . . . 54.32 111.102 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -68.76 108.07 3.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.872 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.728 HG13 HG21 ' A' ' 126' ' ' VAL . 21.8 t -90.19 149.79 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 52.53 111.126 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -97.14 108.18 20.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 75.32 110.908 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.73 128.66 12.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 75.4 110.918 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -83.12 131.0 35.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 61.43 110.883 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 20.2 m -137.25 156.87 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 72.54 110.865 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 pp -99.85 142.01 31.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 65.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.15 154.06 24.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 63.35 111.112 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 73.12 110.896 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.886 0.374 . . . . 61.45 110.873 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.0 m -147.93 168.71 21.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 74.22 110.845 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -103.97 161.03 24.17 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.588 0.708 . . . . 75.15 110.931 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 169.71 18.32 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.682 2.255 . . . . 73.1 112.338 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -93.93 112.6 24.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 71.13 110.88 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -140.32 133.64 29.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 75.23 110.915 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -51.88 160.99 0.99 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 62.11 110.894 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -18.13 37.01 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.714 2.276 . . . . 62.1 112.335 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -83.04 -21.29 33.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.911 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.522 HG21 HG23 ' A' ' 211' ' ' VAL . 2.4 t -85.25 -51.78 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 65.12 111.128 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -51.06 -31.58 19.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.863 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.14 80.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 62.11 111.099 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HD3' HD11 ' A' ' 204' ' ' LEU . 13.8 tttp -88.58 -32.36 18.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 75.11 110.885 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.8 -25.95 68.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 74.41 110.935 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -67.59 -59.3 3.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 75.0 110.854 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 p -56.1 -24.83 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.12 111.129 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.48 -47.74 84.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 44.01 111.093 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -44.62 64.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 72.03 110.85 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -65.11 -29.14 69.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 75.31 110.879 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.52 -36.85 57.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 64.31 110.892 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -61.3 -41.95 97.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 72.3 110.893 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -79.1 -28.48 43.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 74.42 110.927 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -52.26 -29.88 25.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 62.21 110.834 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -108.25 -34.52 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 72.21 110.917 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -76.7 66.44 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 72.52 110.919 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -70.7 -26.09 63.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 63.44 110.885 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.9 -10.51 59.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 55.23 110.859 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 57.26 22.56 44.38 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 63.22 112.469 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.3 t -76.08 -22.13 55.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.915 0.388 . . . . 73.12 110.875 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.31 20.16 65.14 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 74.05 112.489 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -142.64 141.29 31.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 73.51 110.87 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.483 ' O ' HD11 ' A' ' 153' ' ' ILE . 58.0 mt -109.33 118.12 35.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 44.13 110.927 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -85.19 175.3 9.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 64.52 110.896 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -51.88 -30.31 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 32.3 110.883 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -81.08 -52.39 7.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 71.34 110.823 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.56 -28.36 65.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 64.44 110.874 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.483 HD11 ' O ' ' A' ' 148' ' ' LEU . 35.2 mt -81.32 -30.83 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 73.34 111.167 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.67 -45.04 63.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 35.21 111.12 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.23 -22.86 56.24 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 72.31 112.509 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.92 -47.76 83.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 63.44 110.95 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.36 -36.41 77.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.927 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -52.62 -46.07 66.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.33 110.882 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -83.11 -47.19 11.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 72.42 110.882 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.8 m -51.79 -35.52 44.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 72.31 111.186 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -76.56 -53.69 7.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 74.44 110.97 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.724 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -57.06 -25.76 59.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 62.24 111.129 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -57.39 -25.68 59.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.866 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 36.9 mtm -110.01 21.74 16.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.464 . . . . 55.15 110.873 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.69 68.81 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 72.52 112.435 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.6 mmt -60.79 174.98 0.53 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.805 0.336 . . . . 51.22 110.834 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.4 t -66.02 -14.91 62.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 64.14 110.821 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.724 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 6.7 t30 63.69 42.92 5.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 50.04 110.882 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -62.49 152.45 34.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 62.34 110.863 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 m -108.22 90.82 7.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.59 0.71 . . . . 70.42 111.152 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 159.93 51.6 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.672 2.248 . . . . 73.04 112.324 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.544 ' O ' HG23 ' A' ' 176' ' ' VAL . 79.7 p -106.87 -176.03 2.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 64.14 111.167 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -54.85 -26.57 36.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 74.51 110.932 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.431 ' O ' HD12 ' A' ' 178' ' ' ILE . 7.6 tp10 -75.42 -41.47 55.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 72.1 110.873 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.4 ' HA ' HD12 ' A' ' 178' ' ' ILE . 5.8 m-20 -74.61 -25.11 59.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 71.32 110.85 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 172' ' ' THR . 91.4 t -79.33 -32.64 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 73.32 111.132 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -22.73 66.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.915 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 174' ' ' GLU . 5.2 mt -87.58 -41.96 14.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 74.11 111.132 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -69.98 -31.27 68.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 62.14 110.951 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.557 ' O ' HD23 ' A' ' 180' ' ' LEU . 5.4 tt -64.25 -38.81 92.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 53.3 110.885 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -68.79 -28.18 66.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.924 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 6.1 mmm -70.47 -33.83 71.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 63.33 110.862 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.712 ' CA ' HD23 ' A' ' 199' ' ' LEU . . . -88.99 -49.34 6.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 51.12 111.111 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -75.0 119.34 19.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 54.2 110.88 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 95.9 m -87.59 -26.55 23.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 64.44 111.108 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.22 -12.47 56.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 70.1 110.846 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.6 m 53.61 53.65 11.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 61.14 110.834 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -106.66 -16.22 14.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 63.45 110.906 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.29 19.42 11.53 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.709 -0.758 . . . . 65.11 112.447 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.0 p -149.4 126.88 11.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 45.51 110.859 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.468 ' CG1' ' HB1' ' A' ' 183' ' ' ALA . 21.6 t -95.66 106.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 74.3 111.142 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.71 178.86 4.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 62.13 110.884 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 21.3 tp -63.16 -33.23 75.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 62.13 110.921 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -81.32 -40.04 24.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.858 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -65.05 -32.57 74.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.859 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.618 ' O ' HD12 ' A' ' 200' ' ' ILE . 20.2 t80 -78.89 -34.95 44.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.937 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -51.84 -56.76 12.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.499 . . . . 75.2 110.88 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -56.87 -33.28 66.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 75.03 110.931 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.712 HD23 ' CA ' ' A' ' 183' ' ' ALA . 0.7 OUTLIER -51.91 -45.1 64.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 63.33 110.932 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 196' ' ' TYR . 4.7 mp -72.37 -34.42 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 65.11 111.126 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.672 HG23 HG21 ' A' ' 211' ' ' VAL . 50.0 mm -52.98 -44.96 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.32 111.085 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -63.62 -44.96 92.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 70.44 110.891 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.3 m -59.44 -57.93 10.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 63.13 110.795 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.522 ' HG ' HD13 ' A' ' 209' ' ' ILE . 8.2 mp -51.97 -40.24 60.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 73.32 110.937 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -42.97 74.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 71.24 110.916 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -85.96 -6.99 58.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 61.23 110.899 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.513 ' HB3' HD12 ' A' ' 209' ' ' ILE . . . -94.94 25.48 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 73.21 111.1 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.72 32.41 83.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.719 -0.753 . . . . 73.53 112.5 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.522 HD13 ' HG ' ' A' ' 204' ' ' LEU . 17.0 mt -120.18 110.47 28.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 72.53 111.14 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.69 114.78 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 74.41 110.871 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.672 HG21 HG23 ' A' ' 201' ' ' ILE . 4.2 p -133.68 122.73 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 74.52 111.142 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -104.82 129.02 53.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 62.01 110.859 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.75 137.12 45.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 73.34 110.926 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -124.01 167.74 13.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 71.52 110.899 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.0 m -138.73 153.46 48.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 62.41 110.836 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 6.0 mt -88.21 93.21 9.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.098 -0.501 . . . . 51.51 110.948 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.57 114.79 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 75.04 111.135 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 25.8 p90 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 75.0 110.889 -179.995 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.898 0.38 . . . . 65.23 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.1 m -107.78 136.2 47.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 75.34 110.828 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.42 154.94 66.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.581 0.705 . . . . 55.24 110.913 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 146.84 61.74 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.691 2.26 . . . . 52.13 112.363 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -75.11 110.6 9.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 73.4 110.908 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -116.67 132.28 56.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.3 110.917 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -51.49 161.07 0.87 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.672 0.748 . . . . 70.25 110.863 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.547 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 53.6 Cg_endo -69.8 -14.37 35.87 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.677 2.251 . . . . 64.3 112.346 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.23 -26.77 30.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 64.22 110.88 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.15 -63.53 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 61.21 111.103 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.64 -26.2 43.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 75.12 110.847 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 124' ' ' PRO . . . -58.66 -40.45 83.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 41.1 111.135 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.55 ' HB3' HD11 ' A' ' 204' ' ' LEU . 11.2 tptm -87.99 -26.65 22.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.43 110.928 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.689 HD22 ' CG ' ' A' ' 197' ' ' GLU . 77.1 mt -74.86 -25.57 59.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 60.12 110.931 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -76.37 -49.58 16.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 73.51 110.87 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.0 p -62.49 -25.81 38.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 74.11 111.143 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.81 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 54.32 111.125 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -51.91 -36.35 48.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 72.54 110.833 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -67.41 -48.31 67.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.846 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.7 tp -61.98 -27.91 69.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.9 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -69.54 -60.05 2.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.841 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -63.07 -28.67 70.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.874 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -52.65 -33.45 47.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 75.33 110.907 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -99.19 -29.47 12.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 62.35 110.887 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.94 85.47 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 71.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -85.06 -26.31 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.32 110.928 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.09 -10.53 59.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.885 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.58 24.47 47.33 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 51.43 112.523 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.2 p -90.51 -22.14 21.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 43.13 110.86 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.99 19.81 49.32 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.766 -0.731 . . . . 71.04 112.444 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -133.47 132.04 40.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 73.22 110.922 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.488 HD22 ' HB3' ' A' ' 152' ' ' GLU . 93.5 mt -99.56 110.82 23.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 64.32 110.916 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -77.94 176.94 8.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 75.21 110.893 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.94 -30.18 23.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.2 110.879 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.67 -51.82 15.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 60.53 110.893 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.488 ' HB3' HD22 ' A' ' 148' ' ' LEU . 35.8 mm-40 -62.26 -30.69 71.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.87 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.7 mt -77.06 -42.62 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 74.14 111.151 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.65 -49.07 63.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 61.2 111.106 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -77.87 -23.2 67.28 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 73.02 112.509 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.93 -45.7 60.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 74.01 110.9 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 179' ' ' TRP . 85.6 mt -52.86 -30.86 36.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.448 . . . . 62.21 110.871 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.605 ' HD2' HG22 ' A' ' 170' ' ' THR . 0.0 OUTLIER -62.42 -60.81 3.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.435 . . . . 74.14 110.881 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -27.48 67.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 73.03 110.888 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.0 m -65.05 -54.6 27.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 74.11 111.121 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -56.47 -25.99 52.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.438 . . . . 73.23 110.933 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.86 -27.66 60.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 75.24 111.083 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -53.27 -28.68 29.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 62.13 110.858 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 20.3 mtm -104.26 -18.47 14.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 73.1 110.879 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.92 20.81 22.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.723 -0.751 . . . . 74.04 112.5 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 10.2 mtm -67.51 175.8 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.33 . . . . 71.04 110.852 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.7 t -60.63 -19.86 59.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 55.43 110.834 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 63.67 60.23 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 60.43 110.885 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -70.63 152.52 43.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 70.34 110.854 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.605 HG22 ' HD2' ' A' ' 158' ' ' LYS . 7.6 p -108.15 90.91 7.28 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.581 0.705 . . . . 73.41 111.151 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -178.33 2.31 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.646 2.23 . . . . 62.53 112.352 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 176' ' ' VAL . 51.5 p -118.62 179.56 4.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 52.2 111.15 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -54.74 -26.84 36.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 65.23 110.859 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.7 tp10 -72.87 -60.75 2.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.421 . . . . 73.14 110.844 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.0 -39.63 59.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 71.11 110.843 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 172' ' ' THR . 98.0 t -56.9 -43.25 80.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 71.5 111.136 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -52.01 -42.79 63.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.892 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.9 mp -68.84 -26.37 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.13 111.128 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.502 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 48.7 t90 -83.0 -26.45 31.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.471 . . . . 75.05 110.912 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.5 tt -77.14 -49.19 15.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 74.34 110.88 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -54.77 -28.79 51.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 64.43 110.895 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 31.5 ttm -72.68 -55.33 6.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.22 110.846 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.903 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -65.82 -60.81 2.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.52 111.101 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -66.26 128.72 37.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 73.42 110.904 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.26 -35.14 18.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 54.4 111.133 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -74.66 -12.46 60.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.866 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.9 p 46.24 57.42 5.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.812 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -114.17 23.56 12.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 72.11 110.851 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 68.06 25.89 74.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 65.42 112.467 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.8 p -152.41 135.62 15.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.929 0.395 . . . . 65.02 110.876 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.78 111.62 36.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 74.11 111.135 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.8 t -75.37 179.95 4.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.804 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.68 -60.29 3.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 54.32 110.907 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -62.88 -39.21 93.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 52.4 110.88 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -61.22 -27.49 68.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.867 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.549 ' O ' HD12 ' A' ' 200' ' ' ILE . 36.8 t80 -89.37 -44.5 10.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 74.4 110.888 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.689 ' CG ' HD22 ' A' ' 130' ' ' LEU . 66.8 tt0 -60.46 -34.8 74.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 70.32 110.903 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -64.54 -26.18 68.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 71.52 110.866 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.903 HD13 ' HB2' ' A' ' 183' ' ' ALA . 2.3 tp -68.66 -44.35 74.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 75.03 110.938 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.1 mp -63.28 -24.65 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 72.33 111.122 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.644 HD13 HD21 ' A' ' 130' ' ' LEU . 48.6 mm -51.92 -48.05 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 70.04 111.124 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -69.31 -37.25 77.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.201 -0.454 . . . . 64.15 110.883 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 12.1 m -53.77 -42.19 68.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 61.02 110.842 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 129' ' ' LYS . 64.8 mt -80.14 -26.42 39.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 71.34 110.893 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -62.98 -43.63 98.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 63.5 110.917 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -85.79 -24.14 26.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 62.31 110.908 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.92 -21.55 66.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.115 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 117.06 21.9 4.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 52.25 112.49 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 mp -113.79 101.65 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 74.51 111.157 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -68.57 98.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.32 110.851 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.9 t -69.18 128.96 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 72.04 111.118 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.16 107.52 2.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 73.04 110.892 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -164.66 135.56 4.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 72.02 110.88 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -63.22 134.84 56.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 72.33 110.912 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 53.0 p -129.6 130.98 46.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.14 110.859 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.85 176.88 7.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 72.23 110.91 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.6 t -123.05 145.06 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 62.33 111.163 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 75.34 110.896 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.907 0.384 . . . . 71.03 110.807 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.5 t -142.14 113.42 7.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 62.34 110.851 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.42 157.73 53.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.612 0.72 . . . . 73.33 110.869 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 171.92 13.55 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.691 2.26 . . . . 73.13 112.349 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -91.8 106.13 18.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 73.23 110.867 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.48 147.84 27.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 72.11 110.891 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -61.0 160.9 17.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.622 0.725 . . . . 73.12 110.915 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -27.61 26.21 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 30.42 112.34 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -75.09 -18.13 60.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 63.13 110.846 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.01 -60.42 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 55.3 111.115 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -51.59 -30.32 20.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 65.52 110.854 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.4 79.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 74.23 111.079 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -88.42 -24.59 23.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.894 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 201' ' ' ILE . 63.5 mt -76.83 -40.11 48.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.901 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -58.2 -43.24 87.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.827 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.461 HG23 HH11 ' A' ' 135' ' ' ARG . 13.3 p -71.39 -24.24 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.23 111.113 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.41 54.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 63.0 111.088 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.8 mtm180 -66.5 -50.3 63.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.443 . . . . 72.32 110.855 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.461 HH11 HG23 ' A' ' 132' ' ' VAL . 4.1 ptm180 -55.29 -26.06 38.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 51.53 110.856 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.3 tp -79.44 -35.4 40.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 75.3 110.933 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.49 -60.54 3.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 54.23 110.876 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -60.35 -32.45 71.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 62.13 110.889 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -55.34 -26.51 41.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 61.33 110.912 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -108.24 -26.66 10.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 64.43 110.892 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -77.97 60.02 2.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 53.32 110.919 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -70.06 -25.91 63.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 75.21 110.918 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.74 -10.58 59.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.834 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.12 23.38 52.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.757 . . . . 63.21 112.499 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -83.07 -22.06 33.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.929 0.395 . . . . 53.02 110.87 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.32 20.69 60.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.752 -0.737 . . . . 65.13 112.527 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -150.08 131.74 14.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 64.4 110.901 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.5 mt -91.45 101.88 14.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.945 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -65.61 171.85 3.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 71.41 110.875 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.494 ' HA ' HD12 ' A' ' 153' ' ' ILE . 7.3 t70 -52.05 -29.99 23.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 62.23 110.86 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.81 -51.35 12.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.232 -0.44 . . . . 64.11 110.892 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -59.62 -26.4 65.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 73.03 110.904 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.57 ' CG2' HG13 ' A' ' 176' ' ' VAL . 23.7 mt -76.78 -36.63 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 61.24 111.112 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.72 -44.77 63.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 64.44 111.126 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.27 -25.27 48.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.741 . . . . 42.2 112.486 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.416 HD21 ' CE1' ' A' ' 196' ' ' TYR . 2.4 tp -59.23 -56.75 18.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 74.34 110.896 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 38.1 mt -51.95 -32.41 33.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 71.54 110.927 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -57.0 -43.97 82.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 44.23 110.885 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -84.93 -45.93 11.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 64.12 110.834 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.1 m -52.58 -36.63 56.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.174 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -67.33 -56.44 9.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 64.54 110.947 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.727 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -54.61 -26.79 34.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 61.15 111.107 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.95 -33.17 75.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 73.01 110.88 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -99.02 18.95 16.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 64.04 110.82 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 18.21 68.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 73.12 112.47 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.3 tpp -65.28 173.65 2.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 61.32 110.884 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 91.1 p -72.92 -9.07 58.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 63.11 110.831 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.727 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 0.2 OUTLIER 63.64 47.85 3.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 63.34 110.834 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -62.63 152.6 34.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 64.55 110.846 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.3 p -108.29 90.93 7.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.626 0.726 . . . . 65.53 111.1 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 -176.35 1.48 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.678 2.252 . . . . 71.13 112.293 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 176' ' ' VAL . 36.6 p -128.68 -176.07 3.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 70.03 111.17 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -55.07 -26.55 38.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 64.14 110.909 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.615 ' O ' HD12 ' A' ' 178' ' ' ILE . 41.2 tt0 -72.93 -61.45 1.81 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.861 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.05 -48.3 64.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 54.5 110.834 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 172' ' ' THR . 89.7 t -52.17 -36.62 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.44 111.152 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -59.38 -53.9 52.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.21 110.909 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.615 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.0 mp -55.23 -38.4 47.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 51.33 111.137 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.702 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 88.4 t90 -75.22 -25.27 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 53.12 110.923 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.6 tt -74.89 -51.21 14.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.859 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -52.75 -45.17 66.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 72.04 110.887 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.0 ttm -57.92 -26.39 62.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 50.12 110.879 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.874 ' HB2' HD11 ' A' ' 199' ' ' LEU . . . -90.85 -67.28 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 73.43 111.128 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -61.25 128.49 36.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 63.13 110.872 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 13.1 m -84.05 -28.14 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 72.02 111.135 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -91.3 -12.46 35.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 54.34 110.883 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t 58.5 58.37 3.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 61.11 110.83 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -117.29 23.46 11.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 60.52 110.911 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.13 31.5 81.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.718 -0.753 . . . . 64.45 112.457 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.58 129.98 17.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.922 0.391 . . . . 74.31 110.887 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.513 HG13 ' HB1' ' A' ' 183' ' ' ALA . 40.3 t -114.99 102.31 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 63.13 111.08 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.47 176.24 2.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 63.34 110.821 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.2 OUTLIER -62.52 -29.92 70.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 65.35 110.984 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -81.39 -29.5 33.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 53.34 110.933 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.7 -22.0 29.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 63.22 110.912 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.467 ' HA ' HD12 ' A' ' 199' ' ' LEU . 41.5 t80 -84.04 -35.19 24.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 73.31 110.927 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.474 ' O ' HD12 ' A' ' 201' ' ' ILE . 11.2 pt-20 -67.86 -41.81 82.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 54.12 110.891 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -55.33 -30.11 59.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.843 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' A' ' 183' ' ' ALA . 44.5 mt -62.26 -41.03 98.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 73.25 110.903 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 200' ' ' ILE . 4.6 mp -66.2 -44.25 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 72.45 111.127 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 1.036 HG23 HG11 ' A' ' 211' ' ' VAL . 2.0 mp -60.32 -35.9 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.53 111.164 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.37 -41.17 79.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 72.12 110.946 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 17.9 t -84.69 -36.05 22.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 70.34 110.881 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.63 ' CD2' HD13 ' A' ' 209' ' ' ILE . 21.4 mt -51.99 -37.9 54.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 63.14 110.929 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -51.1 -46.67 61.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 71.54 110.861 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.42 -22.62 26.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 61.32 110.885 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 204' ' ' LEU . . . -64.77 -22.79 67.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 61.33 111.117 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.52 26.59 3.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.739 -0.743 . . . . 40.52 112.472 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.63 HD13 ' CD2' ' A' ' 204' ' ' LEU . 5.2 mp -124.76 136.24 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 74.22 111.108 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -102.07 115.9 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.32 110.891 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 1.036 HG11 HG23 ' A' ' 201' ' ' ILE . 6.3 p -122.68 132.46 71.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 65.35 111.151 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -113.65 135.74 53.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 65.21 110.853 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -129.03 134.49 48.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.879 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -160.29 130.61 5.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 73.14 110.925 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.6 t -100.24 154.68 18.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 62.43 110.86 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.0 mt -119.72 99.9 6.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 71.42 110.92 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.35 131.1 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 63.33 111.157 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 53.2 p90 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 63.52 110.906 -179.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.8 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.868 0.366 . . . . 74.24 110.863 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.4 p -124.41 133.74 53.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 43.44 110.919 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -112.38 159.84 32.52 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.57 0.7 . . . . 62.44 110.9 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 146.67 60.7 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.684 2.256 . . . . 74.11 112.33 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -99.88 109.02 21.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 55.34 110.894 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -109.34 135.44 50.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 71.54 110.866 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -53.73 160.57 2.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.608 0.718 . . . . 64.02 110.905 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -20.43 34.89 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.719 2.279 . . . . 61.4 112.334 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -81.63 -20.91 38.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 64.43 110.881 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.514 HG13 HD22 ' A' ' 204' ' ' LEU . 2.9 t -80.4 -59.93 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 63.03 111.118 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.538 ' OE2' HD12 ' A' ' 130' ' ' LEU . 2.0 tp10 -51.77 -30.66 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 62.32 110.905 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.4 -30.88 61.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 20.31 111.114 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.52 -25.81 22.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 60.43 110.94 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.699 HD22 ' HG3' ' A' ' 197' ' ' GLU . 18.7 mt -76.32 -42.12 46.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.34 110.918 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -55.23 -51.99 64.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 52.51 110.901 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.18 -26.53 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 75.34 111.088 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.09 -35.21 76.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 73.23 111.121 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.3 mtm-85 -56.5 -44.88 81.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 72.55 110.873 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -61.64 -37.77 85.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 50.21 110.857 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.5 tp -74.91 -29.84 61.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 74.35 110.912 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -67.11 -55.29 14.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 62.53 110.882 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -66.82 -28.5 68.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 60.11 110.922 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -52.5 -39.91 61.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.11 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -96.55 -35.5 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 71.53 110.879 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -80.75 57.96 3.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 74.44 110.839 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -25.38 68.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 72.32 110.894 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -71.27 -10.62 60.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 73.05 110.857 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.4 29.68 57.4 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.748 -0.739 . . . . 44.03 112.484 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.8 p -70.69 -22.18 62.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 54.3 110.843 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.48 -16.39 58.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 72.23 112.491 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -141.44 155.76 45.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.359 . . . . 62.11 110.912 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.501 ' CD1' HD13 ' A' ' 156' ' ' LEU . 42.0 mt -98.62 109.74 22.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 65.52 110.893 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -61.55 178.34 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.21 110.948 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -57.86 -26.31 61.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 71.51 110.884 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 57.5 m-20 -82.63 -53.3 6.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.23 110.877 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HB3' HD22 ' A' ' 148' ' ' LEU . 1.7 mt-10 -51.92 -49.05 63.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.86 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.606 ' CD1' HD13 ' A' ' 180' ' ' LEU . 33.9 mt -51.63 -38.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.41 111.164 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 151' ' ' ASP . . . -51.64 -41.34 61.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 62.44 111.096 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.85 -30.41 32.12 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.744 -0.741 . . . . 72.32 112.514 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.501 HD13 ' CD1' ' A' ' 148' ' ' LEU . 3.8 tp -58.32 -54.02 51.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.859 0.361 . . . . 74.1 110.904 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 179' ' ' TRP . 56.6 mt -51.85 -32.28 31.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 73.31 110.93 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -54.71 -58.13 8.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 75.43 110.852 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.96 -42.82 56.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 75.43 110.855 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 93.1 m -52.42 -32.26 38.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 54.33 111.157 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -79.16 -57.53 3.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 74.11 110.924 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.505 ' HB2' ' ND2' ' A' ' 168' ' ' ASN . . . -55.51 -26.08 40.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 74.45 111.102 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.64 -27.65 63.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 65.31 110.885 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 51.8 mtm -103.91 21.86 15.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 65.24 110.887 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.84 23.07 72.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 35.24 112.505 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.0 tpp -76.57 170.03 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 52.23 110.887 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -64.48 -17.46 63.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 72.54 110.848 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' A' ' 162' ' ' ALA . 48.6 t-20 63.5 56.72 1.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 64.34 110.907 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -67.69 152.65 45.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 71.23 110.902 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.5 m -108.23 90.85 7.32 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.555 0.693 . . . . 63.24 111.161 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 174.98 8.71 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 74.33 112.305 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 176' ' ' VAL . 68.4 p -116.15 -176.02 2.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 70.31 111.143 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -51.82 -30.42 23.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 73.31 110.902 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.62 ' O ' HD12 ' A' ' 178' ' ' ILE . 84.9 tt0 -69.38 -61.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 65.51 110.902 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.9 -45.23 64.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 71.03 110.875 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 172' ' ' THR . 96.6 t -58.84 -28.51 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 64.4 111.193 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -66.92 -40.0 87.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 73.04 110.911 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -70.12 -31.37 47.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 53.45 111.127 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.511 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 55.8 t90 -83.52 -28.34 28.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 75.12 110.912 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.667 HD21 ' HA2' ' A' ' 189' ' ' GLY . 23.0 tp -83.72 -38.2 21.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 72.53 110.958 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -61.05 -30.91 70.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 71.31 110.906 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 48.8 ttp -91.25 -40.13 11.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 61.33 110.864 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -65.38 -25.26 67.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.12 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -101.25 127.84 47.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.879 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 98.0 m -83.9 -25.03 30.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 72.15 111.167 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -97.32 -12.43 22.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.846 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.6 t 56.6 39.32 29.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 75.53 110.879 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -98.05 19.55 13.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 61.31 110.885 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.667 ' HA2' HD21 ' A' ' 180' ' ' LEU . . . 64.08 31.71 81.76 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.714 -0.755 . . . . 73.33 112.484 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.97 134.0 18.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 61.54 110.863 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 196' ' ' TYR . 22.0 t -108.26 97.72 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 71.12 111.119 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.06 162.45 24.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 32.14 110.875 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 193' ' ' LEU . 5.6 mt -53.29 -31.57 44.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.128 -0.487 . . . . 71.02 110.893 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -81.43 -28.12 34.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.887 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -78.03 -42.46 32.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.467 . . . . 74.32 110.859 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.548 ' O ' HD12 ' A' ' 200' ' ' ILE . 20.0 t80 -65.04 -52.62 54.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.917 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.699 ' HG3' HD22 ' A' ' 130' ' ' LEU . 31.3 tt0 -51.81 -48.37 63.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 70.32 110.917 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -51.93 -35.0 44.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 71.24 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.511 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 2.5 tp -61.19 -45.08 96.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.24 110.943 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.1 mp -64.95 -28.32 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 54.41 111.115 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.645 ' CD1' HD21 ' A' ' 130' ' ' LEU . 50.0 mm -63.99 -52.85 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 63.23 111.122 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -56.49 -30.75 63.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 55.22 110.903 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 22.1 m -83.08 -29.94 28.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 51.23 110.814 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.609 ' HG ' HD13 ' A' ' 209' ' ' ILE . 0.8 OUTLIER -66.81 -42.72 85.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 64.35 110.874 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -51.9 -36.53 49.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 74.44 110.871 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -26.02 26.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 70.43 110.938 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.72 67.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 71.42 111.108 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 110.81 25.09 5.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.743 . . . . 60.2 112.43 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.609 HD13 ' HG ' ' A' ' 204' ' ' LEU . 5.3 mp -116.57 108.5 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 43.14 111.124 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -64.6 118.4 8.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 72.44 110.901 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.476 ' CG2' HG11 ' A' ' 126' ' ' VAL . 5.8 p -121.34 123.05 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.116 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -78.1 108.09 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 74.22 110.882 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.4 142.58 29.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.889 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -118.21 144.22 45.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.929 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 34.4 t -142.02 167.19 22.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 74.55 110.897 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.542 ' H ' HD12 ' A' ' 216' ' ' LEU . 1.0 OUTLIER -96.8 83.25 3.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 65.22 110.914 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.66 136.02 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 60.33 111.126 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 50.6 p90 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 75.34 110.864 -179.963 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.862 0.363 . . . . 73.23 110.869 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.0 m -95.79 69.67 2.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 73.03 110.879 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.06 155.12 60.87 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.607 0.717 . . . . 70.41 110.898 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 166.13 28.58 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.239 . . . . 64.44 112.377 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -122.91 103.79 8.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 72.44 110.867 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -102.26 145.54 29.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 63.13 110.957 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -62.7 160.58 34.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.617 0.723 . . . . 75.23 110.912 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -17.78 37.86 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.714 2.276 . . . . 72.31 112.373 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.49 ' HB3' HG23 ' A' ' 209' ' ' ILE . 15.7 tp10 -82.9 -22.49 33.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.31 110.887 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.28 -61.27 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 74.11 111.114 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -51.67 -29.96 20.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 70.4 110.906 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.93 -40.55 84.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.137 -0.483 . . . . 63.31 111.106 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.56 ' HB3' HD11 ' A' ' 204' ' ' LEU . 16.6 tptp -88.42 -26.61 22.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 72.44 110.893 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.753 HD22 ' HG3' ' A' ' 197' ' ' GLU . 61.4 mt -74.78 -26.12 59.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 72.14 110.94 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.21 -54.16 28.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 53.33 110.883 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.15 -24.95 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 61.32 111.114 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.89 -39.94 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 75.25 111.118 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -54.72 -31.09 57.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 71.45 110.891 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -85.03 -40.94 16.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.874 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.48 -27.25 67.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 64.35 110.897 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.707 ' CE1' HD13 ' A' ' 148' ' ' LEU . 87.5 t80 -72.81 -49.98 27.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 73.22 110.888 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -74.83 -25.91 59.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 75.02 110.901 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -57.23 -25.04 58.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.53 110.922 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -110.05 -21.31 12.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 65.43 110.919 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -77.27 61.81 2.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.101 -0.5 . . . . 75.25 110.832 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.32 -16.72 59.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 71.12 110.952 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -70.22 -10.66 59.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 44.33 110.872 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.0 20.33 53.29 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.77 -0.729 . . . . 30.45 112.509 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.7 m -78.95 -22.12 46.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.945 0.403 . . . . 60.15 110.853 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 90.3 -16.06 58.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 73.42 112.533 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.63 170.71 9.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 63.43 110.891 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.707 HD13 ' CE1' ' A' ' 137' ' ' PHE . 0.8 OUTLIER -112.98 101.29 9.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 63.04 110.89 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -73.46 172.16 11.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 75.03 110.915 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.408 ' O ' HG11 ' A' ' 176' ' ' VAL . 11.8 p-10 -54.44 -27.39 36.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 74.52 110.875 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -82.23 -45.78 14.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 73.42 110.87 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -63.71 -45.18 91.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.23 110.874 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.435 ' CD1' HD12 ' A' ' 180' ' ' LEU . 21.2 mt -52.43 -31.35 15.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 70.12 111.123 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.95 58.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 73.43 111.111 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.75 -22.85 59.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.734 . . . . 71.13 112.501 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.682 HD13 HD21 ' A' ' 148' ' ' LEU . 3.8 tp -70.09 -59.09 3.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.808 0.337 . . . . 63.0 110.909 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 27.3 mt -52.16 -32.65 36.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 71.32 110.944 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -51.9 -57.26 9.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 51.13 110.91 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.0 -41.54 28.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 73.12 110.867 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.5 m -51.63 -30.99 23.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 70.1 111.159 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -77.38 -52.47 9.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.192 -0.458 . . . . 71.54 110.922 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.402 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -54.84 -25.51 28.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 63.33 111.135 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -54.29 -32.47 56.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.24 110.853 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.4 ptp -105.67 21.13 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.888 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.83 16.56 66.21 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 42.23 112.468 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.16 166.96 0.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.82 0.343 . . . . 70.44 110.873 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.2 m -65.36 -14.58 61.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.868 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 2.2 t30 64.21 58.32 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 72.05 110.908 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -73.29 153.08 40.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 73.01 110.919 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.406 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 10.2 m -108.09 90.91 7.2 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.685 . . . . 70.33 111.133 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 170' ' ' THR . 53.8 Cg_endo -69.74 -174.65 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.696 2.264 . . . . 75.04 112.355 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 176' ' ' VAL . 71.2 p -129.01 -176.01 3.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 75.51 111.135 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -54.72 -26.67 35.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 70.31 110.872 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.609 ' O ' HD12 ' A' ' 178' ' ' ILE . 8.3 tp10 -72.56 -61.64 1.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 75.41 110.89 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.07 -48.6 64.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.867 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 172' ' ' THR . 86.6 t -51.68 -42.48 31.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 45.22 111.084 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -47.0 64.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 72.13 110.918 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.9 mp -62.44 -26.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.15 111.088 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.54 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 52.3 t90 -83.78 -30.76 26.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 71.42 110.927 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 184' ' ' ASP . 3.2 tt -77.59 -47.05 20.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 72.33 110.954 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -51.95 -30.92 26.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 60.23 110.912 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 37.1 ttp -90.41 -26.43 19.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.55 110.844 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.769 ' HB2' HD13 ' A' ' 199' ' ' LEU . . . -96.09 21.91 8.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 74.13 111.133 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.534 ' HB2' HD23 ' A' ' 180' ' ' LEU . 21.1 t0 -131.8 112.2 12.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.842 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 2.5 m -83.74 -41.79 17.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 61.24 111.16 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.47 -12.5 59.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 64.54 110.896 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 54.66 35.2 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 64.14 110.847 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.45 -16.23 37.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.89 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.0 20.24 16.91 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 44.24 112.48 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.52 126.71 8.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 74.35 110.864 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.49 97.53 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 72.5 111.066 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 6.1 t -67.71 165.18 17.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.41 110.838 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 26.1 tp -53.62 -35.94 61.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 72.04 110.875 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -77.08 -24.67 51.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.907 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -79.58 -53.33 6.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 71.32 110.906 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.619 ' CE1' HD21 ' A' ' 156' ' ' LEU . 22.5 t80 -51.98 -49.95 62.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.934 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.753 ' HG3' HD22 ' A' ' 130' ' ' LEU . 3.0 tp10 -51.82 -47.61 64.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 73.14 110.903 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -52.8 -32.53 44.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.487 . . . . 54.02 110.904 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 183' ' ' ALA . 3.0 tp -62.5 -38.94 91.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.937 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 196' ' ' TYR . 5.3 mp -74.17 -24.05 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.11 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.455 HG22 ' NE2' ' A' ' 205' ' ' GLN . 45.0 mm -59.4 -55.87 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.12 111.114 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.7 tptm -56.24 -37.95 70.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.42 110.892 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.6 t -66.98 -28.48 68.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 73.23 110.869 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' A' ' 129' ' ' LYS . 21.3 mt -79.34 -25.42 42.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 72.44 110.956 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.568 ' OE1' HG12 ' A' ' 211' ' ' VAL . 2.7 mp0 -59.99 -45.59 92.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.879 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -86.05 -20.37 28.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.911 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.93 -22.77 67.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 74.44 111.056 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 108.9 32.44 3.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.78 -0.724 . . . . 75.21 112.472 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 125' ' ' GLU . 5.3 mp -124.12 131.01 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.806 0.336 . . . . 74.4 111.107 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -90.55 133.63 34.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.54 110.904 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.568 HG12 ' OE1' ' A' ' 205' ' ' GLN . 6.7 p -138.18 144.08 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.154 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -129.1 132.58 47.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 74.13 110.898 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -120.83 146.48 46.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 73.1 110.868 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -96.47 95.5 8.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 72.14 110.91 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -140.22 172.17 13.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 72.33 110.849 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 58.0 mt -88.42 140.69 29.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 62.43 110.898 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 16.0 m -101.7 155.77 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 64.12 111.188 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 4.1 t80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.878 179.997 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.9 0.381 . . . . 73.24 110.84 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 66.1 m -73.76 150.95 40.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 70.11 110.803 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.27 156.09 79.91 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.553 0.692 . . . . 64.32 110.931 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 143.79 51.99 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.706 2.271 . . . . 74.03 112.351 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 102.6 14.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.845 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.07 132.85 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 60.13 110.964 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -52.02 160.49 1.17 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.623 0.725 . . . . 31.34 110.879 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -17.13 37.61 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.688 2.258 . . . . 72.51 112.34 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.495 ' CG ' HG23 ' A' ' 209' ' ' ILE . 18.4 pt-20 -82.9 -24.63 33.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.906 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.455 HG21 HG23 ' A' ' 211' ' ' VAL . 3.0 t -78.35 -63.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 43.44 111.115 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 130' ' ' LEU . 8.3 tt0 -52.15 -30.01 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 74.02 110.879 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.76 -32.69 60.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 62.14 111.123 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.604 ' HG2' HG21 ' A' ' 200' ' ' ILE . 24.6 tttm -87.96 -25.73 23.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 75.02 110.936 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 197' ' ' GLU . 25.2 mt -77.9 -29.23 50.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 73.13 110.935 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -65.7 -32.59 74.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.896 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 129' ' ' LYS . 11.7 p -86.05 -23.36 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 52.21 111.12 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -82.78 -35.55 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 33.35 111.108 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -24.46 57.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 74.21 110.817 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -83.17 -23.07 33.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 73.54 110.866 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -82.59 -24.34 33.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.899 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.681 ' CE1' HD13 ' A' ' 148' ' ' LEU . 90.3 t80 -65.54 -56.43 12.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 64.25 110.881 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -72.22 -24.22 61.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.88 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -52.08 -29.88 23.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 74.53 110.875 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -110.69 -21.14 12.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.901 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -75.62 69.66 2.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 52.12 110.872 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -85.14 0.51 51.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 71.15 110.895 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -70.39 -10.57 59.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.869 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 63.16 18.7 60.75 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 75.23 112.529 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.6 p -106.32 -22.0 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.382 . . . . 61.13 110.869 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.6 21.53 66.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 61.32 112.48 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -128.72 132.54 47.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 61.41 110.879 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.681 HD13 ' CE1' ' A' ' 137' ' ' PHE . 1.2 mp -90.81 104.78 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.923 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -88.04 177.27 6.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 72.4 110.944 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -52.04 -30.08 23.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.33 110.898 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 53.1 m-20 -80.4 -55.04 5.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 74.0 110.834 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -53.95 -46.02 71.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 61.32 110.929 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.403 ' CD1' HD12 ' A' ' 180' ' ' LEU . 39.3 mt -57.19 -33.72 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 74.32 111.11 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 151' ' ' ASP . . . -51.15 -48.06 61.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 72.32 111.079 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.36 -24.72 70.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 60.1 112.492 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.572 HD13 HD21 ' A' ' 148' ' ' LEU . 1.7 tp -69.42 -55.93 8.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 75.2 110.926 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.412 HD21 ' CE2' ' A' ' 179' ' ' TRP . 70.7 mt -51.69 -30.16 20.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 62.02 110.884 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.772 ' HE3' HG23 ' A' ' 170' ' ' THR . 0.7 OUTLIER -57.15 -58.57 7.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 55.11 110.915 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -71.77 -42.85 66.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 65.22 110.86 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.1 m -52.17 -34.94 47.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 62.55 111.171 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -82.11 -25.72 34.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.94 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -78.91 -25.38 43.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 52.1 111.066 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -59.68 -44.78 93.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 75.4 110.843 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.3 mtm -75.08 -18.29 60.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 64.53 110.866 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.95 17.72 36.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 65.22 112.532 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.3 ttm -66.67 175.93 2.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.799 0.333 . . . . 74.34 110.828 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.4 m -65.72 -14.39 61.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 63.13 110.855 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.553 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 0.6 OUTLIER 64.21 73.73 0.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 61.14 110.841 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -78.52 152.93 31.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 75.15 110.859 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.772 HG23 ' HE3' ' A' ' 158' ' ' LYS . 11.3 m -108.03 90.88 7.1 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.581 0.705 . . . . 63.11 111.124 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 169.19 19.43 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.703 2.268 . . . . 51.25 112.348 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 176' ' ' VAL . 62.7 p -108.63 -176.06 2.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 74.23 111.139 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.28 -24.97 46.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 75.5 110.89 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.656 ' O ' HD12 ' A' ' 178' ' ' ILE . 38.7 tt0 -77.8 -55.4 5.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.13 110.895 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.57 -35.89 43.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 73.44 110.872 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 172' ' ' THR . 88.4 t -65.83 -36.79 78.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 62.11 111.144 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -59.03 -46.63 87.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.898 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.656 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -62.61 -28.01 43.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 74.41 111.111 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.528 ' CZ2' HD22 ' A' ' 199' ' ' LEU . 49.5 t90 -83.8 -26.03 29.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.892 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.616 HD23 ' HB2' ' A' ' 184' ' ' ASP . 3.0 tt -77.3 -35.21 55.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.14 110.875 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.67 -26.62 67.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 72.52 110.907 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.9 ttm -87.66 -49.81 6.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 72.2 110.895 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.478 ' HB3' HG21 ' A' ' 191' ' ' VAL . . . -61.32 -44.37 97.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 63.01 111.107 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.616 ' HB2' HD23 ' A' ' 180' ' ' LEU . 29.8 t0 -58.57 98.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 51.22 110.804 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 97.4 m -86.66 -24.75 25.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 75.14 111.133 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -95.44 -12.35 26.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 71.34 110.902 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m 62.27 48.16 4.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.484 . . . . 75.44 110.853 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -110.31 23.81 13.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 62.1 110.862 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 64.68 14.51 58.12 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 43.54 112.503 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.72 158.86 40.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 74.12 110.86 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 183' ' ' ALA . 34.4 t -117.62 122.72 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 70.32 111.141 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.68 -169.74 2.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.873 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -66.4 -43.83 84.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 72.4 110.893 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -72.49 -34.59 67.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 71.3 110.878 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.7 -23.03 53.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 71.13 110.899 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.518 ' CE1' HD21 ' A' ' 156' ' ' LEU . 23.2 t80 -82.11 -50.33 9.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 74.03 110.959 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.827 ' HB2' HD22 ' A' ' 130' ' ' LEU . 10.9 pt-20 -53.61 -43.71 68.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 63.13 110.866 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -52.01 -29.96 23.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.22 110.885 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.528 HD22 ' CZ2' ' A' ' 179' ' ' TRP . 1.7 tp -64.35 -43.1 95.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 72.42 110.946 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.604 HG21 ' HG2' ' A' ' 129' ' ' LYS . 5.2 mp -69.78 -24.64 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.42 111.126 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.607 HD11 HD11 ' A' ' 130' ' ' LEU . 50.0 mm -59.2 -55.6 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 72.11 111.142 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -52.62 -38.07 59.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 74.12 110.876 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 p -74.57 -29.81 61.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.892 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.941 HD23 HD13 ' A' ' 209' ' ' ILE . 4.7 mt -68.51 -33.37 74.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 64.44 110.948 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -57.67 -47.18 83.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 73.15 110.905 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -24.68 32.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 63.25 110.909 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.88 -21.18 66.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 44.34 111.118 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.89 20.7 4.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.751 -0.738 . . . . 72.25 112.535 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.941 HD13 HD23 ' A' ' 204' ' ' LEU . 5.3 mp -119.73 103.85 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 74.12 111.138 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -72.12 108.45 5.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 71.51 110.86 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.455 HG23 HG21 ' A' ' 126' ' ' VAL . 6.2 p -102.55 143.9 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.3 111.168 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.45 128.21 52.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.892 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.24 151.08 42.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 63.32 110.9 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -66.12 102.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 64.22 110.906 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 12.5 t -136.37 176.5 8.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 71.31 110.897 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.5 mt -119.68 130.63 55.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 73.22 110.871 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 26.9 m -77.89 142.56 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 73.53 111.087 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 46.4 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 60.32 110.88 -179.97 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.881 0.372 . . . . 74.12 110.822 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.7 p -77.67 111.89 13.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 64.22 110.828 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -97.15 137.66 21.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.603 0.716 . . . . 75.41 110.918 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 119.04 6.05 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.686 2.257 . . . . 75.13 112.387 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -74.93 102.65 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 71.21 110.937 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -91.01 132.95 35.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 73.34 110.924 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -51.93 160.88 1.03 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.645 0.736 . . . . 63.23 110.871 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -17.19 37.61 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.715 2.277 . . . . 73.44 112.301 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -82.99 -24.84 32.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 73.23 110.903 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.444 HG21 HG13 ' A' ' 211' ' ' VAL . 3.1 t -77.59 -63.35 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 74.51 111.128 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.437 ' OE2' HD12 ' A' ' 130' ' ' LEU . 4.2 tp10 -51.88 -33.61 37.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 60.04 110.876 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.42 -36.36 54.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 63.1 111.144 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.651 ' HB3' HD11 ' A' ' 204' ' ' LEU . 21.5 tptt -83.06 -26.17 31.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.53 110.921 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.771 HD11 HD11 ' A' ' 201' ' ' ILE . 92.5 mt -74.31 -37.19 63.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.34 110.953 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.91 -57.25 11.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 75.12 110.924 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.89 -25.23 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.14 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.86 -29.7 40.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 61.33 111.139 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -60.03 -54.26 48.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 70.32 110.869 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 -54.24 -46.24 72.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.841 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.8 tp -56.97 -34.37 68.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 72.41 110.925 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -59.77 -62.99 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 72.12 110.907 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -62.89 -26.96 69.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 63.44 110.902 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.59 -31.42 36.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.902 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.29 -38.08 7.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 75.24 110.943 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.88 76.23 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 74.31 110.857 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -67.2 -30.62 70.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 75.53 110.907 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -70.92 -10.55 59.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.32 110.869 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.74 22.49 40.56 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.733 -0.746 . . . . 64.35 112.463 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.3 m -71.42 -22.06 61.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 62.4 110.891 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.7 23.5 57.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.514 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -145.79 130.74 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.358 . . . . 63.35 110.908 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 11.2 mt -103.85 101.42 11.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 73.3 110.934 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -62.89 174.1 1.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 54.02 110.901 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.14 -26.49 38.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 34.51 110.891 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -80.63 -54.67 5.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 63.34 110.857 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -52.22 -38.85 59.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 61.21 110.899 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.3 mt -63.32 -32.96 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 74.11 111.115 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.7 -42.13 61.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 63.2 111.115 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.34 -25.9 45.77 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.713 -0.756 . . . . 72.53 112.465 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.2 tp -60.88 -55.85 28.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.851 0.358 . . . . 73.51 110.937 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 32.5 mt -52.03 -33.94 40.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 65.13 110.903 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -59.73 4.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 71.33 110.923 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.13 -41.42 61.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 72.31 110.832 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 89.0 m -53.44 -32.92 52.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 74.33 111.126 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -77.33 -51.23 11.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.895 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.522 ' HB2' ' ND2' ' A' ' 168' ' ' ASN . . . -58.19 -30.63 66.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 65.13 111.113 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.9 -46.77 64.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 65.44 110.922 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 33.1 mtm -76.8 -18.46 58.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 63.41 110.912 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 95.89 28.66 9.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.74 -0.743 . . . . 73.35 112.426 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 6.3 ttm -86.0 175.79 8.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 75.14 110.853 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.0 m -58.29 -22.97 54.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 71.32 110.848 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 162' ' ' ALA . 37.8 t-20 63.36 60.86 1.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 60.31 110.896 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -65.62 152.51 43.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 73.33 110.864 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.0 p -108.31 90.82 7.39 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.589 0.709 . . . . 73.33 111.135 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -171.19 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.28 . . . . 64.35 112.322 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.627 ' O ' HG23 ' A' ' 176' ' ' VAL . 34.3 p -126.5 -176.17 3.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.132 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -57.45 -26.36 61.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 64.51 110.918 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 178' ' ' ILE . 9.8 tt0 -72.53 -61.56 1.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 73.14 110.886 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -52.27 -48.82 65.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.477 . . . . 75.22 110.849 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 172' ' ' THR . 85.7 t -51.62 -34.87 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 54.22 111.115 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.27 -52.53 64.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 73.42 110.882 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.551 HD12 ' O ' ' A' ' 174' ' ' GLU . 3.8 mp -57.46 -25.83 25.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 72.14 111.171 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.513 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 49.6 t90 -82.69 -37.72 24.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 74.05 110.935 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.6 tt -57.63 -46.38 84.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 72.41 110.865 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -54.7 -36.38 64.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 61.34 110.925 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.2 mtm -65.79 -54.22 29.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 70.12 110.873 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.592 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . . . -64.53 -63.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 51.22 111.098 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -69.32 129.28 39.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 60.45 110.888 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 8.5 m -85.22 -24.79 27.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.123 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -89.39 -12.4 40.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 70.44 110.904 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 19.5 p 51.59 39.73 25.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 71.52 110.898 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -95.24 23.92 5.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.89 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 65.58 29.3 74.86 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.739 . . . . 50.13 112.49 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m -154.71 126.88 7.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.401 . . . . 63.32 110.828 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.71 106.38 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 60.24 111.133 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 19.1 t -72.1 178.32 3.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 72.43 110.86 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.536 ' O ' HD13 ' A' ' 193' ' ' LEU . 0.4 OUTLIER -63.67 -38.03 89.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 75.34 110.946 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -81.26 -25.59 36.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 63.32 110.899 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.35 -23.19 40.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 70.01 110.882 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.494 ' O ' HD12 ' A' ' 200' ' ' ILE . 19.4 t80 -84.27 -51.81 6.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 74.55 110.936 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.764 ' HB2' HD22 ' A' ' 130' ' ' LEU . 13.5 pt-20 -53.1 -43.83 67.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.487 . . . . 72.24 110.888 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -52.74 -41.91 64.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 65.22 110.909 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 183' ' ' ALA . 9.0 tt -52.42 -39.61 61.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 72.44 110.919 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 200' ' ' ILE . 5.3 mp -73.81 -25.85 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 70.34 111.152 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.771 HD11 HD11 ' A' ' 130' ' ' LEU . 50.5 mm -67.45 -38.14 80.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 73.42 111.121 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -66.28 -36.88 84.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.458 . . . . 72.34 110.9 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 43.7 m -78.36 -37.82 43.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.865 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.651 HD11 ' HB3' ' A' ' 129' ' ' LYS . 18.7 mt -57.8 -35.89 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 73.14 110.919 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -56.83 -37.71 71.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.908 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -85.59 -24.88 26.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 65.23 110.951 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.01 -22.74 67.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 75.34 111.126 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.72 24.15 3.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 65.13 112.51 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 mp -118.04 102.0 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.839 0.352 . . . . 71.33 111.135 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -69.45 101.26 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 53.51 110.915 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.444 HG13 HG21 ' A' ' 126' ' ' VAL . 21.2 t -76.9 150.38 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 75.51 111.142 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -123.41 126.27 46.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 71.32 110.876 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.97 158.94 43.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 71.42 110.889 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -83.89 84.63 7.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 64.13 110.895 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 12.4 p -74.85 167.67 21.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 72.0 110.847 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.2 pt? -146.77 175.94 10.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 73.25 110.886 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 39.7 t -58.78 109.85 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 73.3 111.091 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 75.11 110.845 -179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.912 0.387 . . . . 64.44 110.872 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -124.36 124.5 42.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 71.34 110.842 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -93.79 160.71 32.05 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.537 0.684 . . . . 73.53 110.933 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 131.95 22.2 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.66 2.24 . . . . 63.25 112.35 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -81.41 106.34 13.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 71.42 110.897 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -105.02 134.83 47.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 73.51 110.955 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.66 160.8 1.84 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 72.42 110.89 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -21.41 33.27 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.679 2.253 . . . . 75.0 112.337 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.94 -21.83 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 74.05 110.863 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.81 HG13 HD23 ' A' ' 204' ' ' LEU . 3.0 t -77.73 -61.17 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.23 111.173 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -52.08 -29.86 23.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.03 110.892 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.81 -38.73 70.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 44.44 111.132 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.542 ' HG2' HD11 ' A' ' 204' ' ' LEU . 16.9 tptm -83.95 -25.39 30.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.04 110.938 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 197' ' ' GLU . 90.2 mt -75.24 -30.27 60.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 70.21 110.933 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.65 -56.13 25.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.472 . . . . 64.51 110.847 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.97 -26.75 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 70.4 111.142 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.83 -32.2 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 51.02 111.091 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.711 ' HG2' HD11 ' A' ' 193' ' ' LEU . 37.0 mtt180 -59.94 -45.78 91.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 64.53 110.878 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -60.71 -33.03 72.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 73.45 110.864 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.0 tp -69.48 -26.32 64.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 41.43 110.921 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -64.07 -63.72 1.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 54.3 110.906 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -59.43 -26.64 65.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 64.22 110.89 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -55.99 -26.92 50.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.874 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -110.35 -27.19 9.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.959 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -73.12 78.74 1.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 73.42 110.848 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -26.11 33.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 73.25 110.926 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -70.78 -10.63 59.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.858 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.99 20.66 50.18 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.761 -0.733 . . . . 64.43 112.461 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 p -86.84 -22.09 26.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 65.11 110.829 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.21 23.1 41.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 31.32 112.473 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -138.28 152.01 48.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.805 0.336 . . . . 74.14 110.902 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 27.4 mt -118.81 102.69 9.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 51.04 110.895 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -70.62 173.9 6.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 72.42 110.875 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.455 ' HA ' HD12 ' A' ' 153' ' ' ILE . 3.5 p-10 -55.07 -26.76 39.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 54.52 110.879 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -78.4 -32.34 48.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 74.52 110.865 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -84.5 -26.26 28.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 70.23 110.857 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.509 ' CG2' HG13 ' A' ' 176' ' ' VAL . 21.3 mt -74.51 -41.04 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 71.2 111.149 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.56 -45.11 62.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 62.05 111.117 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -83.22 -22.84 56.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.716 -0.754 . . . . 60.03 112.496 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.9 tp -60.31 -54.41 46.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 65.34 110.953 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.91 -34.42 41.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 64.21 110.953 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -52.94 -49.21 66.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.3 110.899 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -82.25 -43.35 17.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 73.3 110.869 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.2 m -53.79 -30.95 47.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 54.1 111.207 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -81.04 -57.92 3.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.0 110.941 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.708 ' HB2' ' OD1' ' A' ' 168' ' ' ASN . . . -55.46 -25.6 37.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.45 111.143 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.17 -26.3 62.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.907 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 38.7 mtm -110.75 21.68 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.867 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.8 18.56 68.56 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.749 -0.739 . . . . 64.31 112.486 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 3.0 mmt -63.31 171.8 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.758 0.313 . . . . 75.35 110.903 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.1 t -59.83 -20.92 59.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 75.04 110.876 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 162' ' ' ALA . 6.5 t30 63.66 63.77 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 71.55 110.896 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -88.26 152.49 21.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 61.22 110.868 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.5 p -108.24 90.83 7.32 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.577 0.703 . . . . 60.24 111.148 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 157.03 61.75 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.639 2.226 . . . . 75.52 112.369 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.677 ' O ' HG23 ' A' ' 176' ' ' VAL . 71.9 p -91.91 -176.94 4.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.34 111.166 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -56.44 -25.38 50.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.864 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.633 ' O ' HD12 ' A' ' 178' ' ' ILE . 0.9 OUTLIER -73.15 -59.92 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 73.04 110.918 179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -52.99 -30.91 37.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.506 . . . . 44.41 110.905 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 172' ' ' THR . 69.7 t -69.4 -32.56 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 60.32 111.111 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.15 -43.66 94.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 65.33 110.899 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.633 HD12 ' O ' ' A' ' 174' ' ' GLU . 4.2 mp -63.98 -34.64 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 74.01 111.144 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' TRP . . . . . 0.677 ' CZ2' HD13 ' A' ' 199' ' ' LEU . 88.9 t90 -81.7 -25.72 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 72.23 110.901 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.476 HD13 ' CD1' ' A' ' 153' ' ' ILE . 31.1 tp -83.8 -25.34 30.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 71.32 110.89 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -52.98 -58.38 7.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 60.13 110.93 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 43.5 mtm -67.09 -46.05 75.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 63.53 110.851 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.807 ' HB2' HD11 ' A' ' 199' ' ' LEU . . . -56.1 -25.04 44.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 75.03 111.127 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -88.26 95.75 10.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.21 110.883 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 93.8 m -87.68 -34.5 18.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.473 . . . . 65.32 111.11 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.29 6.34 33.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 71.14 110.9 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 2.9 p 46.14 36.44 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 71.22 110.83 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -96.33 -16.27 21.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 74.41 110.802 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 99.29 19.44 20.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.767 -0.73 . . . . 63.4 112.476 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.2 m -142.31 -177.35 5.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.937 0.398 . . . . 62.1 110.838 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.87 106.37 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 61.41 111.155 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.0 t -77.51 -176.05 4.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.868 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.711 HD11 ' HG2' ' A' ' 134' ' ' ARG . 0.5 OUTLIER -66.99 -38.58 86.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 75.25 110.937 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -77.75 -25.65 49.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.905 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -84.93 -23.54 28.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 71.53 110.91 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.487 ' HD1' HD12 ' A' ' 199' ' ' LEU . 30.8 t80 -81.87 -43.53 18.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 71.33 110.877 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.527 ' HA ' HD13 ' A' ' 200' ' ' ILE . 10.9 pt-20 -54.06 -41.86 68.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 73.03 110.864 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -51.7 -44.08 63.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 73.55 110.932 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.807 HD11 ' HB2' ' A' ' 183' ' ' ALA . 53.4 mt -51.75 -33.88 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.921 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.527 HD13 ' HA ' ' A' ' 197' ' ' GLU . 5.3 mp -79.43 -36.08 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 60.45 111.114 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.44 -29.62 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.117 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.58 -62.16 2.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 64.02 110.912 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 46.3 t -53.14 -37.37 61.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 43.11 110.904 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.81 HD23 HG13 ' A' ' 126' ' ' VAL . 6.9 mp -55.65 -24.57 34.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 74.11 110.944 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.95 -58.98 3.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 74.01 110.894 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -78.78 -5.81 54.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 72.23 110.892 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.443 ' HB3' HG12 ' A' ' 209' ' ' ILE . . . -91.17 13.99 15.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 61.45 111.158 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 62.16 33.46 85.94 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.718 -0.753 . . . . 62.23 112.514 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ILE . . . . . 0.443 HG12 ' HB3' ' A' ' 207' ' ' ALA . 6.5 mm -102.1 111.72 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.829 0.347 . . . . 54.33 111.124 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 100.28 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 63.11 110.907 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 5.8 p -112.5 130.5 66.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 53.01 111.114 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.31 107.99 19.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 74.42 110.86 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.69 120.35 14.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 65.34 110.951 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -59.46 120.75 9.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 75.44 110.935 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 55.3 p -139.96 132.27 28.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 62.15 110.836 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.0 mp -104.14 143.64 32.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 61.34 110.927 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.41 145.15 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 74.43 111.153 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' PHE . . . . . . . . . . . . . 38.6 p90 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 65.44 110.853 -179.961 . . . . . . . . 0 0 . 1 stop_ save_